Posters

Type here to filter the list

Sunday, September 29, 2024
2:45 PM – 4:15 PM ET
2000 - Local Control by Motion Management Strategy of Thoracic Tumors: Secondary Analysis of the iSABR Trial
Location: Hall C
Presenter: Joseph Abi Jaoude, MD – Stanford University
2:45 PM – 4:15 PM ET
2001 - Worldwide Utilization of Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer: Are We All in Sync?
Location: Hall C
Presenter: Salem Alfaifi, MD, FRCPC – Cleveland Clinic
2:45 PM – 4:15 PM ET
2002 - Radiotherapy Resources in Central Asia: An International Atomic Energy Agency Update
Location: Hall C
Presenter: Sondos AlKhatib, MD – Henry Ford Cancer Institute
2:45 PM – 4:15 PM ET
2003 - Understanding Equity, Diversity and Inclusion within Canadian Radiation Oncology: Experiences of Residents and Fellows
Location: Hall C
Presenter: Jennifer Croke, MD, MHPE – Princess Margaret Cancer Centre
2:45 PM – 4:15 PM ET
2004 - Patterns and Predictors of Pneumonitis after Chemoradiation Followed by Durvalumab
Location: Hall C
Presenter: Lee Wilk – Sheba Medical Center
2:45 PM – 4:15 PM ET
2005 - Recent Industry Payment Trends across Radiation Oncology Residency Program Leadership
Location: Hall C
Presenter: Rojine Ariani, MD, MS – UCLA David Geffen School of Medicine/UCLA Medical Center
2:45 PM – 4:15 PM ET
2006 - The Impact of Rural Residence on Patient-Reported Toxicities and Outcomes of Prostate Cancer
Location: Hall C
Presenter: Mariam Atobiloye, BS – University of Utah School of Medicine
2:45 PM – 4:15 PM ET
2007 - Racial Disparities in Survival and Local Recurrence Among People of Color with Anal Cancer
Location: Hall C
Presenter: Nicholas Bader, MD – Emory University School of Medicine
2:45 PM – 4:15 PM ET
2009 - Project PARENT: An Open Access Family Leave Database for US Radiation Oncology and Medical Physics Residency Programs
Location: Hall C
Presenter: Claire Baniel, MD – Stanford University
2:45 PM – 4:15 PM ET
2010 - Efficacy of Postoperative Radiotherapy for Patients with 9th Stage N2 Descriptors in Completely Resected Non-Small Cell Lung Cancer: A Real-World Study
Location: Hall C
Presenter: Yongxing Bao, MD – National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, CAMS & PUMC
2:45 PM – 4:15 PM ET
2011 - Should All Medically Inoperable Patients with Early-Stage NSCLC Need SBRT Treatment?
Location: Hall C
Presenter: Tithi Biswas, MD, MBBS – University of Florida
2:45 PM – 4:15 PM ET
2012 - A Phase 2 Randomized Study of the BER Inhibitor TRC102 in Combination with Standard Pemetrexed-Platinum-Radiation in Stage III Non-Squamous Non-Small Cell Lung Cancer (NCI 10512)
Location: Hall C
Presenter: Tithi Biswas, MD, MBBS – University of Florida
2:45 PM – 4:15 PM ET
2013 - 5-Year Single-Institution Experience of Single-Fraction SABR for Non-Small Cell Lung Cancer
Location: Hall C
Presenter: Myriam Bouchard, MD – CHUS
2:45 PM – 4:15 PM ET
2014 - Predictive Value of Esophageal Circumferential Dose-Length Parameters for Dysphagia in Patients Receiving Thoracic Radiotherapy
Location: Hall C
Presenter: Andrea Brown, MD – Johns Hopkins Radiation Oncology Kimmel Cancer Center
2:45 PM – 4:15 PM ET
2015 - Association of Private vs. Public Postsecondary Education and Matriculation into Highly Ranked Radiation Oncology (RO) Residency Programs
Location: Hall C
Presenter: Ria Brown, MD, BS – Wellstar Kennestone Hospital
2:45 PM – 4:15 PM ET
2016 - Outcomes and Toxicity in Patients Treated with Stereotactic Body Radiation Therapy for Ultracentral Lung Tumors at a Single Institution
Location: Hall C
Presenter: David Buchberger, MD, MSc – Cleveland Clinic Foundation
2:45 PM – 4:15 PM ET
2017 - Dose to the Cardiac Substructures/Great Vessels and Survival in Patients Treated with Definitive Stereotactic Body Radiation Therapy for Lung Tumors - A Pilot Study
Location: Hall C
Presenter: David Buchberger, MD, MSc – Cleveland Clinic Foundation
2:45 PM – 4:15 PM ET
2018 - Predictors of Atrial Fibrillation after Thoracic Radiotherapy
Location: Hall C
Presenter: Santino Butler, MD – Stanford University School of Medicine
2:45 PM – 4:15 PM ET
2019 - Neoadjuvant Camrelizumab Combined with Chemotherapy for Resectable Stage IIIA-IIIB Non-Small Cell Lung Cancer: Single Arm Phase II Study
Location: Hall C
Presenter: Guoxin Cai, MD, PhD – Shandong Cancer Hospital and Institute
2:45 PM – 4:15 PM ET
2021 - Role of Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer Patients with Baseline Brain Metastases: A Retrospective Analysis Using IPTW-Adjusted Models
Location: Hall C
Presenter: Zhang Chaonan, MD
2:45 PM – 4:15 PM ET
2022 - Influence of Ethnicity and Birthplace on Breast Cancer Clinical Features, Treatment and Survival among Texas Women
Location: Hall C
Presenter: Ashley Chavana, BS – Baylor College of Medicine
2:45 PM – 4:15 PM ET
2023 - Treatment-Associated Lymphopenia from Hypofractionated vs. Conventional Chemoradiation in Locally Advanced Non-Small Cell Lung Cancer
Location: Hall C
Presenter: Kevin Chen, MD, MSCI – Washington University in St. Louis
2:45 PM – 4:15 PM ET
2024 - Establishing Radiotherapy Quality Indicators for Lung Cancer: A Modified Delphi Study
Location: Hall C
Presenter: Kim-Lin Chiew, MBBS – Princess Alexandra Hospital
2:45 PM – 4:15 PM ET
2025 - Predicting Thoracic Toxicity with Large Vision Foundation Model Using Pretreatment Data
Location: Hall C
Presenter: Chloe Choi, MS – Memorial Sloan Kettering Cancer Center
2:45 PM – 4:15 PM ET
2026 - Income and Regional Inequities in Rectal Spacer Utilization among Prostate Cancer Patients
Location: Hall C
Presenter: Sean Collins, MD, PhD – Tampa General Hospital
2:45 PM – 4:15 PM ET
2028 - Analysis of Sex Inequities in Medicare and Industry Payments in Radiation Oncology
Location: Hall C
Presenter: Patrick Courtney, MD, MAS – UCLA David Geffen School of Medicine/UCLA Medical Center
2:45 PM – 4:15 PM ET
2029 - Role of Whole-Heart Cardiac Dose (WH-CD) on OS in Non-Small Cell Lung Cancer (NSCLC) Patients (Pts) Receiving Post-Operative Radiotherapy (PORT)
Location: Hall C
Presenter: Ruben Cruz-Chamorro, MD – Moffitt Cancer Center
2:45 PM – 4:15 PM ET
2030 - Clinical Outcomes of Early-Stage NSCLC Treated with Definitive SBRT by KRAS and EGFR Status and PD-L1 Expression
Location: Hall C
Presenter: Erik Davies, MD – Cleveland Clinic Taussig Cancer Center
2:45 PM – 4:15 PM ET
2031 - Role of Whole-Heart Dose on Overall Survival (OS) in Locally-Advanced Non-Small Cell Lung Cancer (LA-NSCLC) Patients (Pts) Treated with Concurrent Definitive Chemoradiotherapy (CDCRT)
Location: Hall C
Presenter: Thomas Dilling, MD, MS, FASTRO – Moffitt Cancer Center
2:45 PM – 4:15 PM ET
2032 - Role of Cardiac Sub-Structure (CSS) Dose on Overall Survival (OS) in Locally-Advanced Non-Small Cell Lung Cancer (LA-NSCLC) Patients (Pts) Treated with Concurrent Definitive Chemoradiotherapy (CDCRT)
Location: Hall C
Presenter: Thomas Dilling, MD, MS, FASTRO – Moffitt Cancer Center
2:45 PM – 4:15 PM ET
2033 - Development and Implementation of a Diversity, Equity and Inclusion Task Force in a Radiation Oncology Department at an NCI-Designated Comprehensive Cancer Center
Location: Hall C
Presenter: Jason Domogauer, MD, PhD – NYU Langone Laura and Isaac Perlmutter Cancer Center
2:45 PM – 4:15 PM ET
2034 - Uptake of Attendee Pronoun Selection at Time of Registration for the 65th ASTRO Annual Meeting
Location: Hall C
Presenter: Jason Domogauer, MD, PhD – NYU Langone Laura and Isaac Perlmutter Cancer Center
2:45 PM – 4:15 PM ET
2035 - Online Adaptive Radiotherapy for Limited-Stage Small Cell Lung Cancer: A Prospective, Single-Armed, Phase II Trial
Location: Hall C
Presenter: Baiqiang Dong, MD, PhD – Sun Yat-Sen University Cancer Center
2:45 PM – 4:15 PM ET
2036 - Postoperative Pleural Fluid Cell-Free DNA Captures Locoregional MRD That Stratifies Risk for Lung Cancer Relapse after Surgery
Location: Hall C
Presenter: Noah Earland, PhD, BS – Washington University in St. Louis School of Medicine
2:45 PM – 4:15 PM ET
2037 - Prospective Evaluation of Non-Small Cell Lung Cancer Radiation Therapy Treatment Interruptions in a Large Statewide Quality Collaborative
Location: Hall C
Presenter: Ameer Elaimy, MD, PhD, BS – University of Michigan
2:45 PM – 4:15 PM ET
2038 - Inducing Abscopal Response by Local Radiotherapy and Granulocyte-Macrophage Colony-Stimulating Factor as Monotherapy in Patients with Pretreated Advanced Thymic Epithelial Tumors: A Retrospective Anal
Location: Hall C
Presenter: Min Fan, MD, PhD
2:45 PM – 4:15 PM ET
2039 - Impact of Radiation Therapy on Long-Term Survival in Patients with KRAS-Mutant Stage IV NSCLC Treated with Immune Checkpoint Inhibitors
Location: Hall C
Presenter: Sayeh Fattahi, MD – Harvard Radiation Oncology Program
2:45 PM – 4:15 PM ET
2040 - Clinical Efficacy of Postoperative Radiotherapy for High-Risk Locoregional Recurrence in Patients with Completely Resected Pathologic Stage IIIA(N2) Non-Small Cell Lung Cancer: A Propensity Score-Matc
Location: Hall C
Presenter: Wen Feng, MD – Shanghai Chest Hospital Shanghai Jiao Tong University
2:45 PM – 4:15 PM ET
2041 - A 3D CNN Model Using Deep Learning Based on Chest CT for Predicting Disease-Free Survival of Patients with Early Stage Lung Cancer Receiving Surgery and SBRT
Location: Hall C
Presenter: Yuanyuan Fu, MD
2:45 PM – 4:15 PM ET
2042 - Benefit of Consolidative Thoracic Radiotherapy Following First-Line Chemoimmunotherapy in Metastatic NSCLC: Based on PD-L1 Expression
Location: Hall C
Presenter: Aiqin Gao, PhD – Shandong Cancer Hospital Affiliated to Shandong First Medical University
2:45 PM – 4:15 PM ET
2043 - Correlation between irAEs and Efficacy of Consolidative PD-(L)1 Inhibitors Following Chemoradiotherapy in Locally Advanced Non-Small Cell Lung Cancer
Location: Hall C
Presenter: Aiqin Gao, PhD – Shandong Cancer Hospital Affiliated to Shandong First Medical University
2:45 PM – 4:15 PM ET
2044 - Immunomodulatory Effects of Lung SBRT in the Primary and Metastatic Setting: Results from the LAPIS Studies
Location: Hall C
Presenter: Eleni Gkika, MBA
2:45 PM – 4:15 PM ET
2045 - Geographical Disparities in Access to Radiotherapy in Brazil: An Observational Study
Location: Hall C
Presenter: Andre Gouveia, MD – McMaster University
2:45 PM – 4:15 PM ET
2046 - Association of Private Schooling with Matching at Highly Ranked Radiation Oncology (RO) Residency Programs: An Analysis of the Texas Star Dataset
Location: Hall C
Presenter: Elaine Cha, MD – MD Anderson Cancer Center
2:45 PM – 4:15 PM ET
2047 - Pretreatment Maximum Standard Uptake Value (SUV max) on Positron Emission Tomography (PET) and the Risk of Distant Failure for Patients with Stage I Non-Small Cell Lung Cancer (NSCLC) Receiving Stereo
Location: Hall C
Presenter: Nilanjan Haldar, MD, BS – Thomas Jefferson University
2:45 PM – 4:15 PM ET
2048 - Rates of Attrition in Black Patients with Prostate Cancer Enrolled in Randomized Controlled Trials: A Pooled Secondary Analysis of RTOG 9601, 9902, 0126, and 0415
Location: Hall C
Presenter: Muhammad Hamza, MD, BS – University of Maryland Radiation Oncology
2:45 PM – 4:15 PM ET
2049 - A Single-Arm Pilot Study of Combined SBRT and Electric Ablation for Lung Tumors
Location: Hall C
Presenter: Jeremy Harris, MD, MPhil – University of California Irvine
2:45 PM – 4:15 PM ET
2050 - Impact of Radiation Dose to the Immune Cells on Lymphopenia for Stage IV Non-Small Cell Lung Cancer Receiving Immunotherapy and Radiotherapy
Location: Hall C
Presenter: Jun yi He, BS
2:45 PM – 4:15 PM ET
2051 - Effect of Distance and Sociodemographic Variables on Radiotherapy Recommendation, Initiation and Completion
Location: Hall C
Presenter: Jacob Hogan, BS – Washington University in St. Louis School of Medicine
2:45 PM – 4:15 PM ET
2052 - Lactic Acidosis as a Potential Mechanism of Unexpected Cardiac Toxicity following Chemoradiation Therapy for Non-Small Cell Lung Cancer
Location: Hall C
Presenter: Kristian Holgersson, BS – Loma Linda University School of Medicine
2:45 PM – 4:15 PM ET
2053 - Integrating CT Images and Radiotherapy Dose Distribution Maps to Predict the Progression-Free Survival in Locally Advanced Non-Small Cell Lung Cancer Patients
Location: Hall C
Presenter: Runping Hou, PhD – Shanghai Chest Hospital Shanghai Jiao Tong University
2:45 PM – 4:15 PM ET
2054 - Overestimation of Contralateral Hilar Lymph Node Metastasis in Non-Metastatic Non-Small Cell Lung Cancer and Its Predictive Model: HAM
Location: Hall C
Presenter: Zan Hou, MD – Sun Yat-Sen University Cancer Center
2:45 PM – 4:15 PM ET
2055 - Assessing the Correlation between Travel Burden and Socioeconomic Status in Radiotherapy Access across Taiwanese Towns
Location: Hall C
Presenter: Wen-Han Hsieh, MD, MS – Taipei Veterans General Hospital
2:45 PM – 4:15 PM ET
2056 - Examining Potential Barriers to Obtaining Decipher Scores in Prostate Adenocarcinoma Considered for Radiation
Location: Hall C
Presenter: Audree Hsu, MD – Providence St. Vincent Medical Center
2:45 PM – 4:15 PM ET
2057 - SP1-Activated LINC00167 and Angiogenesis in Human NSCLC Cells
Location: Hall C
Presenter: Hao Huang, PhD
2:45 PM – 4:15 PM ET
2058 - Digital Spatial Profiling of the Tumor Microenvironment in Patients with Advanced Non-Small Cell Lung Cancer Reveals Biomarkers of Response to Anti-PD1 Antibody
Location: Hall C
Presenter: Xinyi Huang, MD
2:45 PM – 4:15 PM ET
2059 - Feasibility Study of Dose De-Escalation in Postoperative Intensity-Modulated Radiation Therapy (IMRT) for Stage II-III Thymoma
Location: Hall C
Presenter: Youn Ji Hur, MD
2:45 PM – 4:15 PM ET
2060 - Accelerated Hypofractionated Radiotherapy for the Definitive Management of Locally Advanced Non-Small Cell Lung Cancer: A Systematic Review
Location: Hall C
Presenter: Badr Id Said, MD, MS – MD Anderson Cancer Center
2:45 PM – 4:15 PM ET
2061 - Unplanned Hospitalizations and Lymphopenia after Proton Beam Therapy (PBT) vs. Intensity-Modulated Radiation Therapy (IMRT) in Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC): An Analysis of 74
Location: Hall C
Presenter: Michelle Iocolano, MD, MA – University of Pennsylvania
2:45 PM – 4:15 PM ET
2062 - Hypofractionation Improving Loco-Regional Control for Sequential Chemoradiotherapy in Non-Small Cell Lung Cancer. A Multicenter Long Term Experience.
Location: Hall C
Presenter: Alexandre Jacinto, MD, PhD – Hospital de Cancer de Barretos
2:45 PM – 4:15 PM ET
2063 - Outcomes of Stereotactic Body Radiotherapy (SBRT) in Patients with Oligometastatic or Oligoprogressive Lung Metastases from Renal Cell Cancer (RCC)
Location: Hall C
Presenter: Xuemei Ji, MD – Yale University
2:45 PM – 4:15 PM ET
2064 - SPICE Planning for Volumetric Modulated Arc Therapy SBRT in Early-Stage NSCLC: Some Like it Hot!
Location: Hall C
Presenter: Bryan Johnson, MD, MBA – Mayo Clinic Florida
2:45 PM – 4:15 PM ET
2065 - Characterizing Post-Treatment Cardiac and Pulmonary Hospitalizations in Locally Advanced Lung Cancer: A Statewide Quality Consortium Analysis
Location: Hall C
Presenter: Shruti Jolly, MD, MBA – University of Michigan
2:45 PM – 4:15 PM ET
2066 - Circulating miRNA Profiling Distinguishes Radiation-Induced Fibrosis from Locoregional Recurrence in Patients Who Received Radiotherapy for Lung Cancer
Location: Hall C
Presenter: Jesus Juarez Casillas, MD, MS – UCLA
2:45 PM – 4:15 PM ET
2067 - Demographic Attributes among ASTRO Fellow Awardees between 2006 and 2023
Location: Hall C
Presenter: Sophia Kamran, MD – Massachusetts General Hospital
2:45 PM – 4:15 PM ET
2068 - Incidence and Outcome of Brain Metastasis in NSCLC with KRAS Mutation. An Observational Study
Location: Hall C
Presenter: Muneeb Uddin Karim, MBBS, FCPS – McGill University
2:45 PM – 4:15 PM ET
2069 - Safety and Efficacy of Lung SBRT Alone or in Combination with Concurrent Systemic Therapies
Location: Hall C
Presenter: Silpa Karipineni, BS – University of Southern California Keck School of Medicine
2:45 PM – 4:15 PM ET
2070 - What Can 5,045 Peripheral Lymphocyte Count Measurements in 255 Patients Tell Us About Temporal Dynamics and Survival in Non-Small Cell Lung Cancer?
Location: Hall C
Presenter: Vaiva Kaveckyte, PhD – Copenhagen University Hospital Rigshospitalet
2:45 PM – 4:15 PM ET
2071 - Radiation Oncologists in Canada: A Comprehensive Survey of Gender Identity, Sexual Orientation, Disability, Race, Ethnicity, Religion and Workplace Harassment and Discrimination Experience
Location: Hall C
Presenter: Amanda Khan, MD, PhD – Tom Baker Cancer Centre / University of Calgary
2:45 PM – 4:15 PM ET
2072 - Risk of Clinically Significant Cardiovascular Disease Associated with Postoperative Radiotherapy in Non-Small Cell Lung Cancer Patients Receiving Surgical Resection Followed By Adjuvant Chemotherapy:
Location: Hall C
Presenter: Byoung Hyuck Kim, MD, PhD – Seoul National University College of Medicine
2:45 PM – 4:15 PM ET
2073 - Risk Analysis of Radiation Pneumonitis after Stereotactic Body Radiotherapy for Central Non-Small Cell Lung Cancer
Location: Hall C
Presenter: Nozomi Kita, MD, PhD – Nagoya City University Graduate School of Medical Sciences
2:45 PM – 4:15 PM ET
2074 - Income Inequality in Patients (Pts) with Locally Advanced (LA) Non-Small Cell Lung Cancer (NSCLC) Receiving Proton Beam Therapy
Location: Hall C
Presenter: Andre Konski, MD, MBA, MS, FASTRO – University of Pennsylvania
2:45 PM – 4:15 PM ET
2075 - Systematic analysis of cancer-testis specific genes identifies potential targets for lung adenocarcinoma radiosensitization
Location: Hall C
Presenter: Tangmin Lai, MS
2:45 PM – 4:15 PM ET
2076 - Transportation Insecurity among Patients with Cancer Undergoing Radiation Therapy
Location: Hall C
Presenter: Kaitlyn Lapen, MD – Memorial Sloan Kettering Cancer Center
2:45 PM – 4:15 PM ET
2077 - Deep Learning Based Estimation of Facial Age for Prognostication in Patients with Early-Stage Non-Small Cell Lung Cancer Undergoing Definitive Stereotactic Body Radiotherapy
Location: Hall C
Presenter: Grace Lee, MD – Harvard Radiation Oncology Program
2:45 PM – 4:15 PM ET
2078 - Dysfunction of CD8+ T Cells around Tumor Cells and Occult Lymph Node Metastasis in NSCLC Patients
Location: Hall C
Presenter: Chaozhuo Li, MS
2:45 PM – 4:15 PM ET
2079 - Treatment Toxicity and Outcomes Following Definitive Radiotherapy for Patients with Early-Stage Non-Small Cell Lung Cancers and Pre-Existing Interstitial Lung Disease - A Systematic Review
Location: Hall C
Presenter: George Li, MD – University of Toronto
2:45 PM – 4:15 PM ET
2080 - Irradiated Tumor Cell-Released Microparticles and the Therapeutic Efficacy of PD-1 Inhibitors by Promoting M1-TAMs Polarization in NSCLC Brain Metastases
Location: Hall C
Presenter: Ji Li, MD
2:45 PM – 4:15 PM ET
2081 - Hypofraction Radiotherapy (4Gy/f) for Limited-Stage Small Cell Lung Cancer: A Phase I/II Trial
Location: Hall C
Presenter: Xiaoyang Li, MD, PhD – Shanghai Chest Hospital, Shanghai JiaoTong University
2:45 PM – 4:15 PM ET
2082 - Mouse Mesenchymal Stem Cell-Derived Exosomal miR-466f-3p Reverses EMT Process through Inhibiting AKT/GSK3ß Pathway via c-MET in Radiation-Induced Lung Injury
Location: Hall C
Presenter: Yi Li, MD – The 920th Hospital of The Joint Logistic Support Forth
2:45 PM – 4:15 PM ET
2083 - Beta-Adrenergic Receptor Blockers and Survival in Patients with Advanced Non-Small Cell Lung Cancer Combined with Hypertension Undergoing Radiotherapy
Location: Hall C
Presenter: Xinyi Liang, MS
2:45 PM – 4:15 PM ET
2084 - Reduced Frequency and Severity of Radiation Esophagitis without Marginal Failure Risk By Contralateral Esophagus Sparing IMRT in Stage III Non-Small Cell Lung Cancer Patients Undergoing Definitive Con
Location: Hall C
Presenter: Haesol Lim, MD – Samsung Medical Center
2:45 PM – 4:15 PM ET
2085 - Histology-Driven Hypofractionated Radiotherapy Schemes for Early-Stage Lung Adenocarcinoma and Squamous Cell Carcinoma
Location: Hall C
Presenter: Michael Farris, MD – Wake Forest University Medical Center
2:45 PM – 4:15 PM ET
2086 - Induction or Consolidation Immunotherapy in Unresectable Stage III NSCLC Treated with Definitive Radiotherapy: A Retrospective Study
Location: Hall C
Presenter: Xia Gan, MBBS – Hunan Cancer Hospital
2:45 PM – 4:15 PM ET
2087 - Negative Predictors for Surgery Following Induction Chemo-Immunotherapy in Patients with Stage IB-III NSCLC between 2017-2021
Location: Hall C
Presenter: Jason Liu, MD – City of Hope South Pasadena
2:45 PM – 4:15 PM ET
2088 - [¹⁸F]AlF-NOTA-QHY-04 PET/CT may Predict Short-Term Outcome for Patients with Limited-Stage Small Cell Lung Cancer Treated by Concurrent Chemoradiotherapy
Location: Hall C
Presenter: Jingru Liu, MD
2:45 PM – 4:15 PM ET
2089 - Characterizing Metabolomic Signatures for Early Metastasis in Non-Small Cell Lung Cancer Patients Undergoing Definitive Radiation Therapy
Location: Hall C
Presenter: Manlu Liu – University of Wisconsin School of Medicine and Public Health
2:45 PM – 4:15 PM ET
2090 - A Prospective Observational Trial on Ablative SBRT for Mediastinal and Hilar Lymphnodes: Preliminary Results
Location: Hall C
Presenter: Mauro Loi, MD – Azienda Ospedaliera Universitaria Careggi
2:45 PM – 4:15 PM ET
2091 - Potential Link between Hypoxic Status of Tumors and Surgical Outcomes in NSCLC Patients
Location: Hall C
Presenter: Jie Man Low, MB, ChB – Buckinghamshire Healthcare NHS Trust
2:45 PM – 4:15 PM ET
2092 - Helical Tomotherapy Compared to Intensity-Modulated Radiation Therapy in Hippocampal Avoidance Prophylactic Cranial Irradiation in Patients with Limited-Stage Small-Cell Lung Cancer
Location: Hall C
Presenter: Shuangqing Lu
2:45 PM – 4:15 PM ET
2093 - Failure Patterns of Postoperative Patients with Positive LNS 2: Possibility of Optimizing Clinical Target Volume
Location: Hall C
Presenter: Yifei Lu, MD – Shanghai Chest Hospital, Shanghai Jiao Tong University
2:45 PM – 4:15 PM ET
2094 - Assessing the Safety and Efficacy of a Hypofractionated Regimen in the Treatment of Early-Stage Non-Small Cell Lung Cancer Patients with Central or Ultracentral Tumors
Location: Hall C
Presenter: Maryanne Lubas, DO – Fox Chase Cancer Center
2:45 PM – 4:15 PM ET
2095 - Impact of Locoregional Recurrence vs. Distant Metastasis on Overall Survival in Patients with Non-Small Cell Lung Cancer after Surgery: A Secondary Analysis of a Randomized Controlled Trial
Location: Hall C
Presenter: Zeliang Ma, MD – Mayo Clinic Rochester
2:45 PM – 4:15 PM ET
2096 - Longitudinal Trends in Patient Portal Use among Patients with Cancer
Location: Hall C
Presenter: Nathan Magalit, BA – UC San Diego School of Medicine
2:45 PM – 4:15 PM ET
2097 - Association between Inter-Fraction Tumor Volume Changes and Patient Outcomes from Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer
Location: Hall C
Presenter: Wilson Mai, MD, PhD – Stanford University Cancer Center
2:45 PM – 4:15 PM ET
2098 - A Pilot Study to Evaluate Percussive Ventilation Breath Hold to Improve Lung Stereotactic Ablative Radiotherapy (PVB-SABR)
Location: Hall C
Presenter: Wilson Mai, MD, PhD – Stanford University Cancer Center
2:45 PM – 4:15 PM ET
2099 - The Impact of the Time of Day of Radiotherapy and Systemic Therapy on Disease Control in Locally Advanced Non-Small Cell Lung Cancer Treated with Chemoradiation and Durvalumab
Location: Hall C
Presenter: Matthew McMillan, MD – Memorial Sloan Kettering Cancer Center
2:45 PM – 4:15 PM ET
2100 - Does NLR Remain Prognostic in Sarcopenic Lung and Oesophageal Cancer Patients?
Location: Hall C
Presenter: Alan McWilliam, PhD – University of Manchester
2:45 PM – 4:15 PM ET
2101 - Parametric Response Mapping to Predict Pulmonary Toxicity from Thoracic Radiation
Location: Hall C
Presenter: Sean Miller, MD – University of Michigan
2:45 PM – 4:15 PM ET
2102 - Cardiac Toxicity in Patients with NSCLC Receiving Radiotherapy or Combined Other Therapies
Location: Hall C
Presenter: You Mo
2:45 PM – 4:15 PM ET
2103 - Examining Barriers to Practice and Career Development among Non-Female GYN Radiation Oncologists and Non-Male GU Radiation Oncologists: A Nationwide Survey
Location: Hall C
Presenter: Shalini Moningi, MD – Brigham and Women's Hospital/Dana-Farber
2:45 PM – 4:15 PM ET
2104 - Language Disparities in Patient Portal Access and Use among Radiation Oncology Patients Across an Integrated Health Enterprise
Location: Hall C
Presenter: Javier Mora, MD – Harvard Radiation Oncology Program
2:45 PM – 4:15 PM ET
2105 - Dosimetric Impact of Online Adaptive Radiotherapy on a Phase II Study of Hypofractionated Concurrent Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer
Location: Hall C
Presenter: Ryan Mueller, MD, RT – Barnes Jewish Hospital
2:45 PM – 4:15 PM ET
2106 - Efficacy of Immune-Related Combination Therapy in Peri-Brain Radiotherapy on Non-Sensitive Genetic Mutation-Driven NSCLC with Brain Metastases
Location: Hall C
Presenter: Erha Munai
2:45 PM – 4:15 PM ET
2107 - Understanding the Landscape of Radiation Therapy in Alexandria, Egypt: A Comprehensive Study on Physicians, Supporting Staff and Patients Perspectives
Location: Hall C
Presenter: Ahmed Nawwar, MD, MPH – Harvard Medical College/Brigham and Women's Hospital/Dana Farbar Cancer Institute
2:45 PM – 4:15 PM ET
2108 - Evaluating Baseline Socioeconomic Factors and Ability for Self-Care in Patients with Head and Neck Cancer: Secondary Analysis of a Prospective Pilot Trial
Location: Hall C
Presenter: Nga Nguyen, MD, MD, MPH – Wake Forest Baptist Medical Center
2:45 PM – 4:15 PM ET
2109 - Complete vs. Incomplete Consolidative Radiotherapy in Patients with Extensive-Stage Small Cell Lung Cancer
Location: Hall C
Presenter: James Ninia, MD, MS – Yale Therapeutic Radiology
2:45 PM – 4:15 PM ET
2110 - Definitions of Local Control after Stereotactic Body Radiation Therapy for Early-Stage Lung Cancer: A Systematic Review of the Literature
Location: Hall C
Presenter: Niki Nourmohammadi, DO, MPH – Larkin Community Hospital
2:45 PM – 4:15 PM ET
2111 - Effect of the Time-of-Day of Radiotherapy Administration on Radiation-Induced Lymphocyte Depletion in Lung Cancer
Location: Hall C
Presenter: Zuzanna Nowicka, MD – Medical University of Lodz
2:45 PM – 4:15 PM ET
2112 - Real-World Practice Patterns of Immunotherapy, Chemotherapy, and Targeted Therapy with Radiation Therapy in Early-Stage Node-Negative Non-Small Cell Lung Cancer
Location: Hall C
Presenter: Patrick Oh, MD – Yale School of Medicine
2:45 PM – 4:15 PM ET
2113 - COPD, Pneumonia and Diabetes: Common Comorbidities Influence Pneumonitis Risk after ChemoRT and Adjuvant Durvalumab in Stage III Non Small Cell Lung Cancer
Location: Hall C
Presenter: Timur Mitin, MD, PhD – Oregon Health and Science University
2:45 PM – 4:15 PM ET
2114 - Cost-Utility Analysis of SBRT vs. Surgery for Patients with Stage I Non-Small Cell Lung Cancer in Japan
Location: Hall C
Presenter: Hiroshi Onishi, MD, PhD – University of Yamanashi School of Medicine
2:45 PM – 4:15 PM ET
2115 - Comprehensive Assessment of Pneumonitis, Pseudoprogression and Hyperprogression among Inoperable Stage III NSCLC Patients Treated with Trimodal Therapy
Location: Hall C
Presenter: Jayson Paragas, MD – McGill University Health Centre
2:45 PM – 4:15 PM ET
2116 - Omission of Prophylactic Cranial Irradiation for Limited Stage Small Cell Lung Cancer
Location: Hall C
Presenter: Sean Parker, MD – Cleveland Clinic Health System
2:45 PM – 4:15 PM ET
2117 - An Analysis of the Distribution and Density of Rectal Spacer Implanters for Men Receiving Prostate Radiotherapy across the United States
Location: Hall C
Presenter: Sagar Patel, MD – Emory University
2:45 PM – 4:15 PM ET
2118 - Congruence of the Per-Fraction Pet Signal and the Delivered Doses in Biology-Guided Radiotherapy (BgRT)
Location: Hall C
Presenter: Daniel Pham, PhD, CMD – Stanford Health Care
2:45 PM – 4:15 PM ET
2120 - A Combined Machine Learning Model for Predicting Pneumonitis of NSCLC Patients Treated with SBRT
Location: Hall C
Presenter: Tarun Podder, PhD – SUNY Upstate Medical University
2:45 PM – 4:15 PM ET
2121 - Overall Survival Prediction Utilizing Support Vector Machine with Cluster Partitioning Methodology for NSCLC Patients Treated with SBRT
Location: Hall C
Presenter: Tarun Podder, PhD – SUNY Upstate Medical University
2:45 PM – 4:15 PM ET
2122 - Human-Centered Systems Modeling for Mobile Radiation Oncology Implementation
Location: Hall C
Presenter: Alex Price, PhD, MS – University Hospitals Cleveland Medical Center
2:45 PM – 4:15 PM ET
2123 - National Survey of Factors Influencing Specialty Selection among Medical Students Interested in Oncology Careers
Location: Hall C
Presenter: Krishna Reddy, MD, PhD – University of Kansas Medical Center
2:45 PM – 4:15 PM ET
2124 - Randomized Phase II Trial of Hypofractionated IMRT with 2.5 Gy/Fxn vs. Standard-Fractionated IMRT, Concurrent with Carboplatin/paclitaxel and Followed By Consolidation Durvalumab, for Patients with St
Location: Hall C
Presenter: Krishna Reddy, MD, PhD – University of Kansas Medical Center
2:45 PM – 4:15 PM ET
2125 - Does the Implementation of Last Generation Radiation Therapy Equipments Impact in the Interval between the First Clinical Visit to the First Treatment Fraction in a Public Health Scenario?
Location: Hall C
Presenter: Jose Regis Neto, MD – Fundacao Assistencial da Paraiba (FAP)
2:45 PM – 4:15 PM ET
2126 - Role of Retreatment with Stereotactic Ablative Body Radiotherapy (SABR) in Oligorecurrent Mesothelioma: A Retrospective Monocentric Study
Location: Hall C
Presenter: Alberto Revelant, MD – CRO AVIANO
2:45 PM – 4:15 PM ET
2127 - Assessing Compliance and Diversity in Early Phase Radiation Oncology Clinical Trials in the United States
Location: Hall C
Presenter: Atefeh Rezaei, MD – Case Comprehensive Cancer Center, Case Western Reserve University
2:45 PM – 4:15 PM ET
2128 - Proton Radiotherapy for Primary Lung Cancer in Patients with Interstitial Lung Disease
Location: Hall C
Presenter: Richard Roden – Mayo Clinic Alix School of Medicine
2:45 PM – 4:15 PM ET
2129 - Self-Reported Financial Toxicity among Rural Cancer Patients Treated with Radiotherapy
Location: Hall C
Presenter: Melanie Rose, MD – Dartmouth-Hitchcock Medical Center
2:45 PM – 4:15 PM ET
2130 - Stereotactic Ablative Radiotherapy for Ultra-Central Lung Tumors: Local Control and Toxicity from a Seventeen-Year Single-Institution Experience
Location: Hall C
Presenter: Amir Safavi, MD, MSc – Memorial Sloan Kettering Cancer Center
2:45 PM – 4:15 PM ET
2132 - Validation of Spanish-Language Surveys Utilized for the Navigator-Assisted Hypofractionation Program to Aid Hispanic-American Breast Cancer Patients
Location: Hall C
Presenter: Abizairie Sánchez-Feliciano, BS – Case Western Reserve University School of Medicine
2:45 PM – 4:15 PM ET
2133 - Visualizing the Radiation Experience for Rural Cancer Patients
Location: Hall C
Presenter: Seth Seifert, MA – University of Utah School of Medicine
2:45 PM – 4:15 PM ET
2134 - Global Interobserver Variations of Prescription and Plan Evaluation within Heterogeneous Clinical Target Volume (CTV) Delineations among International Experts in Lung Cancer
Location: Hall C
Presenter: Ugur Selek, MD, FASTRO, Prof. – Koc University School of Medicine
2:45 PM – 4:15 PM ET
2135 - Telephone Utilization by Older Adults with Cancer Presenting for Radiation Oncology Consultation
Location: Hall C
Presenter: Yasamin Sharifzadeh, MD – Mayo Clinic Rochester
2:45 PM – 4:15 PM ET
2136 - NRG LU008: Phase III Prospective Randomized Trial of Primary Lung Tumor Stereotactic Body Radiation Therapy (SBRT) Followed by Concurrent Mediastinal Chemoradiation for Locally-Advanced Non-Small Cell
Location: Hall C
Presenter: Charles Simone, MD, FASTRO – New York Proton Center and Memorial Sloan Kettering Cancer Center
2:45 PM – 4:15 PM ET
2137 - Machine Learning Based Predictive Modeling of Pneumonitis in Patients Receiving Radiotherapy and Immunotherapy
Location: Hall C
Presenter: Deven Singh, BA – Rutgers Robert Wood Johnson Medical School
2:45 PM – 4:15 PM ET
2138 - A Phase II Randomized Clinical Trial (MC1623) of Concurrent Chemotherapy and Standard (60-66 Gy) vs. High (72 Gy) Dose Proton Beam Therapy (PBT) for Patients with Unresectable, Stage II/III Non-Small
Location: Hall C
Presenter: Terence Sio, MD, MS – Mayo Clinic
2:45 PM – 4:15 PM ET
2139 - Survival and Recurrence Rates Following SBRT or Surgery in Medically Operable Stage I NSCLC
Location: Hall C
Presenter: Michael Snider, BS – Duke University School of Medicine
2:45 PM – 4:15 PM ET
2140 - Exploring the Demographic Composition of Clinical Research Enrollment in Radiation Oncology
Location: Hall C
Presenter: Nichelle Solomon, BS – New York Proton Center
2:45 PM – 4:15 PM ET
2142 - Radiogenomics Models for Predicting Prognosis in Locally Advanced Non-Small Cell Lung Cancer Patients Undergoing Definitive Chemoradiotherapy
Location: Hall C
Presenter: Xiaoyu Song, MD – Shandong Cancer Hospital and Institute
2:45 PM – 4:15 PM ET
2143 - Clinical Factors and Major Pathological Response after Neoadjuvant Chemoimmunotherapy in Potentially Resectable Lung Squamous Cell Carcinoma
Location: Hall C
Presenter: Yingqiu Song – Liaoning Cancer Hospital
2:45 PM – 4:15 PM ET
2144 - Clinical and Dosimetric Predictors of Cardiotoxicity in Thoracic Radiotherapy for Locally Advanced Lung Cancer
Location: Hall C
Presenter: Ana Soto, MD – Hospital de la Santa Creu i Sant Pau
2:45 PM – 4:15 PM ET
2145 - Impact of Limited English Proficiency on Breast Cancer Outcomes
Location: Hall C
Presenter: Daphna Spiegel, MD, MS – Beth Israel Deaconess Medical Center
2:45 PM – 4:15 PM ET
2146 - Effects of Target Coverage on Local Recurrence in Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer
Location: Hall C
Presenter: Shuou Sudo, MD – Nagoya Proton Therapy Center
2:45 PM – 4:15 PM ET
2147 - Comparison of Perceptions of Barriers to Advancement for Women in Radiation Oncology between Men and Women Physicians
Location: Hall C
Presenter: Andrew Tam, MD – City of Hope National Medical Center
2:45 PM – 4:15 PM ET
2148 - The Risk and Survival Significance of Immunotherapy and Targeted Therapy in Patients with Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Location: Hall C
Presenter: Birhan Alemnew Tamene
2:45 PM – 4:15 PM ET
2149 - Effectiveness and Safety of Definitive Radiation Therapy in Oldest Old Patients (=90 years): A Matched Pair Analysis
Location: Hall C
Presenter: Hidekazu Tanaka, MD, PhD – Yamaguchi University Graduate School of Medicine
2:45 PM – 4:15 PM ET
2150 - Optimal Timing of Immunoradiotherapy: Immune Checkpoint Inhibitor before or after Radiation Therapy?
Location: Hall C
Presenter: Hidekazu Tanaka, MD, PhD – Yamaguchi University Graduate School of Medicine
2:45 PM – 4:15 PM ET
2151 - Analysis of the lung dose reduction in patients treated by deep-inspiration breath-hold real-time tumor-tracking radiotherapy
Location: Hall C
Presenter: Hidekazu Tanaka, MD, PhD – Yamaguchi University Graduate School of Medicine
2:45 PM – 4:15 PM ET
2152 - Upfront Stereotactic Body Radiotherapy to the Residual Primary Lung Lesions after First-Line Systemic Therapy in Polymetastatic Non-Small Cell Lung Cancer
Location: Hall C
Presenter: Dan Tao, MD – Chongqing University Cancer Hospital
2:45 PM – 4:15 PM ET
2153 - CRUISER: A Phase 2 Trial of Concurrent durvalumab with Chemoradiation Therapy Followed by durvalumab in Chinese Unresectable Stage III Non-Small Cell Lung Cancer Patients
Location: Hall C
Presenter: Feifei Teng, MD, PhD – Shandong Anti-Cancer Association
2:45 PM – 4:15 PM ET
2154 - Noninvasive Radiomic Biomarkers for Predicting Pseudoprogression and Hyperprogression in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors
Location: Hall C
Presenter: Feifei Teng, MD, PhD – Shandong Anti-Cancer Association
2:45 PM – 4:15 PM ET
2155 - CT-Based Radiomics and Genomics Analysis for Survival Prediction in Stage III Unresectable Non-Small Cell Lung Cancer Treated with Definitive Chemoradiotherapy Following with Immunotherapy
Location: Hall C
Presenter: Feifei Teng, MD, PhD – Shandong Anti-Cancer Association
2:45 PM – 4:15 PM ET
2156 - A Meta-Analysis of Daily vs. Nonconsecutive Fractionation Schedules for Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer
Location: Hall C
Presenter: Maximillian Tjauw – University of Oklahoma Health Sciences Center
2:45 PM – 4:15 PM ET
2157 - 4DPET/4DCT Image Features to Predict Long-Term Response after Chemo-Radiotherapy for Locally-Advanced Non-Small Cell Lung Cancer
Location: Hall C
Presenter: Daniel Tong, MbChB – Princess Margaret Cancer Centre
2:45 PM – 4:15 PM ET
2158 - A First-in-Human Study of the Radiopharmaceutical [²²⁵Ac]-FPI-2068 in Patients (pts) with Advanced Solid Tumors
Location: Hall C
Presenter: Aditya Juloori, MD – University of Chicago
2:45 PM – 4:15 PM ET
2159 - Application of Radiomic and Dosiomic Analyses to Predict for Pneumonitis in Patients with Locally Advanced Non-Small Cell Lung Cancer on the NRG Oncology RTOG 0617 Dataset
Location: Hall C
Presenter: Taman Upadhaya, PhD – Cedars-Sinai Medical Center
2:45 PM – 4:15 PM ET
2161 - Medically Inoperable Early-Stage Lung Cancer Patients with Organ Transplants Treated with SBRT Have Impaired Outcomes
Location: Hall C
Presenter: Gregory Videtic, MD, FASTRO, CM, FRCPC, FACR – Cleveland Clinic Taussig Cancer Center
2:45 PM – 4:15 PM ET
2162 - Outcomes of Patients with Interstitial Lung Disease and Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiotherapy
Location: Hall C
Presenter: Samantha Vuong, BS – University of Wisconsin School of Medicine and Public Health
2:45 PM – 4:15 PM ET
2163 - CCL20 Remodeling the Immune Microenvironment via the CD6-Alcam Axis Overcomes NSCLC Immunotherapy Resistance
Location: Hall C
Presenter: Weitao Wen, PhD – Shandong Cancer Hospital Affiliated to Shandong First Medical University
2:45 PM – 4:15 PM ET
2164 - Molecular Imaging Research on ¹⁸F-FDG PET/CT and Biomarker Analysis Predict the Efficacy of Neoadjuvant Camrelizumab Combined with Chemotherapy for Resectable Stage IIIA-IIIB NSCLC
Location: Hall C
Presenter: Kaiyue Wang, MBBS
2:45 PM – 4:15 PM ET
2165 - Incidence and Risk Factors for Pneumonitis Associated with Checkpoint Inhibitors and Chemotherapy in Extensive-Stage Small Cell Lung Cancer
Location: Hall C
Presenter: Linlin Wang, MD, PhD – Shandong Cancer Hospital and Institute
2:45 PM – 4:15 PM ET
2166 - Chemoradiotherapy (CRT) Combined with Consolidative Iruplinalkib for ALK/ROS1+ Unresectable Non-Small Cell Lung Cancer (NSCLC): ALK+ Cohort Results from Part 1 of the INNOVATION Study
Location: Hall C
Presenter: Linlin Wang, MD, PhD – Shandong Cancer Hospital and Institute
2:45 PM – 4:15 PM ET
2167 - Identification of a Novel Immune-Related Signature to Assess Prognosis and Immunotherapy Efficacy in Lung Squamous Cell Carcinoma
Location: Hall C
Presenter: Tianlu Wang, PhD – Liaoning Cancer Hospital
2:45 PM – 4:15 PM ET
2168 - Designing a Question-Based Patient Education System Powered by Generative AI to Narrow the Information Gap for Underserved Populations
Location: Hall C
Presenter: Yi Wang, PhD – Massachusetts General Hospital
2:45 PM – 4:15 PM ET
2169 - Small Cell Lung Cancer Patients with Supraclavicular or Cervical Lymph Node Metastasis should be Treated with Limited-Stage Treatment Regimen
Location: Hall C
Presenter: Yimeng Wang – Shandong Cancer Hospital and Institute
2:45 PM – 4:15 PM ET
2170 - The Value of Radiotherapy for Patients with Extensive-Stage Small Cell Lung Cancer Treated with First-Line Chemo-Immunotherapy
Location: Hall C
Presenter: Yunfeng Wang, MD – Shanghai Chest Hospital Shanghai Jiao Tong University
2:45 PM – 4:15 PM ET
2171 - Characterization of Decision Points, Metastatic Trajectories and Outcomes in Advanced NSCLC
Location: Hall C
Presenter: Ross Weber, MD, PhD – Memorial Sloan Kettering Cancer Center
2:45 PM – 4:15 PM ET
2172 - Improved Treatment Package Times with Head and Neck Multidisciplinary Clinic Care in Patients with High-Risk Socioeconomic Features
Location: Hall C
Presenter: Christopher Wilke, MD, PhD – UPMC Hillman Cancer Center
2:45 PM – 4:15 PM ET
2173 - Development of Evidence-Based Multilingual Patient Education Materials in a Multidisciplinary Rectal Cancer Clinic
Location: Hall C
Presenter: Matthew Abrams, MD – Beth Israel Deaconess Medical Center
2:45 PM – 4:15 PM ET
2174 - A Pragmatic Approach to Developing a Lung Nodal Station Atlas as Baseline Data for an Auto-segmentation Algorithm
Location: Hall C
Presenter: Harroun Wong, MD – Princess Margaret Cancer Center, University Health Network
2:45 PM – 4:15 PM ET
2175 - Benefit of Thoracic Radiotherapy Following First-Line Chemoimmunotherapy in ES-SCLC: Stratified by Clinical and Therapeutic Characteristics
Location: Hall C
Presenter: Jiake Wu – Shandong Cancer Hospital and Institute, Shandong First Medical University
2:45 PM – 4:15 PM ET
2176 - The Molecular Mechanism by Which Statins Overcome Radiotherapy Resistance in Non-Small Cell Lung Cancer
Location: Hall C
Presenter: Weitao Wen, PhD – Shandong Cancer Hospital Affiliated to Shandong First Medical University
2:45 PM – 4:15 PM ET
2177 - Impact of Race/Ethnicity on Receiving Post-Mastectomy Reconstruction and Proton Radiation
Location: Hall C
Presenter: Amulya Yalamanchili, MD – McGaw Medical Center of Northwestern University
2:45 PM – 4:15 PM ET
2178 - Reducing the Risk of Grade 3 or Greater Radiation Pneumonitis after Radical Radiotherapy to the Lung
Location: Hall C
Presenter: Yujie Yan
2:45 PM – 4:15 PM ET
2179 - A Deep Pathomics Model Based on Transformer for the Prediction of Radioimmune-Associated Pneumonitis in Non-Small Cell Lung Cancer
Location: Hall C
Presenter: Linlin Yang, MD – Shandong University
2:45 PM – 4:15 PM ET
2180 - Quantitative Evaluation of Accumulated and Planned Dose Deviations in Gated and Non-Gated Lung SBRT Patients
Location: Hall C
Presenter: Yaping Xu, PhD – Shanghai Pulmonary Hospital
2:45 PM – 4:15 PM ET
2181 - The Efficacy and Safety of TQB2450 Combined with Anlotinib as Maintenance Therapy for LS-SCLC after Definitive Concurrent or Sequential Chemoradiotherapy: A Prospective Phase Ib Study
Location: Hall C
Presenter: Xiaoyan Yin, MBBS – Shandong Cancer Hospital Affiliated to Shandong First Medical University
2:45 PM – 4:15 PM ET
2182 - CT-Based Radiomics Model Predicts Occult Lymph Node Metastasis in Patients with Early-Stage Lung Adenocarcinoma: A Multicenter Study
Location: Hall C
Presenter: Xiaoyan Yin, MBBS – Shandong Cancer Hospital Affiliated to Shandong First Medical University
2:45 PM – 4:15 PM ET
2184 - Predicting Micropapillary or Solid Pattern of Early-Stage Lung Adenocarcinoma with CT-Based Radiomics: A Multicenter Study
Location: Hall C
Presenter: Xiaoyan Yin, MBBS – Shandong Cancer Hospital Affiliated to Shandong First Medical University
2:45 PM – 4:15 PM ET
2185 - Development and External Validation of Predictive Models for Atrial Fibrillation Following Radiotherapy in Non-Small Cell Lung Cancer Patients
Location: Hall C
Presenter: Hong In Yoon, MD, PhD – Yonsei University College of Medicine
2:45 PM – 4:15 PM ET
2186 - Rural Practice Choice Among Radiation Oncology Graduates, 2015 to 2022
Location: Hall C
Presenter: Kristin Hsieh, MD – Icahn School of Medicine at Mount Sinai
2:45 PM – 4:15 PM ET
2187 - Stereotactic Body Radiotherapy Plus First-Line EGFR-TKIs for Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Meta-Analysis
Location: Hall C
Presenter: Ze Yuan, MD
2:45 PM – 4:15 PM ET
2188 - Incidence, Risk Factors and CT Characteristics of Radiation Recall Pneumonitis Induced by COVID-19 Infection in Lung Cancer
Location: Hall C
Presenter: Wenhua Yun
2:45 PM – 4:15 PM ET
2189 - Efficacy of Radiotherapy Combined with EGFR-TKI in the Treatment of EGFR/TP53 Co-Mutated NSCLC
Location: Hall C
Presenter: Siwei Zeng
2:45 PM – 4:15 PM ET
2190 - Optimized Hippo-Avoidance Prophylactic Cranial Irradiation in Limited-Stage Small Cell Lung Cancer Treated with First-Line Chemoradiotherapy
Location: Hall C
Presenter: Tianyou Zhan, MD – National Cancer Center/National Clinical Research Center for Cancer Cancer Hospital, CAMS & PUMC
2:45 PM – 4:15 PM ET
2191 - Timing of Once-Daily Thoracic Radiotherapy and Clinical Outcomes in Patients with Limited-Stage Small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy
Location: Hall C
Presenter: Tianyou Zhan, MD – National Cancer Center/National Clinical Research Center for Cancer Cancer Hospital, CAMS & PUMC
2:45 PM – 4:15 PM ET
2192 - Conditional Survival and Hazard Rates of Patients with LS-SCLC Underwent IMRT in the First-Line Chemoradiotherapy Era: Influence of Prognostics Factors over Time
Location: Hall C
Presenter: Tianyou Zhan, MD – National Cancer Center/National Clinical Research Center for Cancer Cancer Hospital, CAMS & PUMC
2:45 PM – 4:15 PM ET
2193 - Efficacy and Safety of Thoracic Radiotherapy for Extensive-Stage Small-Cell Lung Cancer in the Era of Immunotherapy: A Real-World Study
Location: Hall C
Presenter: Chaonan Zhang, MD – National Cancer Center/National Clinical Research Center for Cance
2:45 PM – 4:15 PM ET
2194 - Early Cardio-Oncology Intervention in Thoracic Radiotherapy: Results of the Cardiac Aggressive Risk Mitigation (CARMA) Pilot Study
Location: Hall C
Presenter: Samuel Zhang, MD – Cedars-Sinai Medical Center
2:45 PM – 4:15 PM ET
2195 - Personalized Tumor Neoantigen Peptide Vaccine Combined with Radiotherapy in the Treatment of Advanced Tumors - Phase II Randomized Group Study
Location: Hall C
Presenter: Yan Zhang, PhD – Shenzhen Hospital of University of Hong Kong
2:45 PM – 4:15 PM ET
2196 - Radiofrequency Radiation Reshapes Tumor Immune Microenvironment in Pulmonary Metastatic Melanoma By Inducing Active Transformation of Tumor-Infiltrating CD8⁺ T and NK Cells
Location: Hall C
Presenter: Yang Zhang, DSc, PhD
2:45 PM – 4:15 PM ET
2197 - Online Adaptive MR-Guided Fractionated Stereotactic Radiotherapy for Brain Metastases in Patients with Non-Small Cell Lung Cancer (GASTO-1075)
Location: Hall C
Presenter: Hui Liu, MD, PhD – Sun Yat-Sen University Cancer Center
2:45 PM – 4:15 PM ET
2198 - Efficacy of Radiotherapy Combined with Atezolizumab or Docetaxel in Patients with Previously Treated Non-Small-Cell Lung Cancer: A PSM-IPTW Cohort Study
Location: Hall C
Presenter: Jian-Guo Zhou, MD – Universitatsklinikum Erlangen Universitat Erlangen-Nurnberg
2:45 PM – 4:15 PM ET
2199 - First-Line Tyrosine Kinase Inhibitor with or without Upfront Stereotactic Body Radiotherapy for Residual Primary Lesions in Advanced EGFR-Mutated Non-Small Cell Lung Cancer
Location: Hall C
Presenter: We Zhou, MD
2:45 PM – 4:15 PM ET
2200 - Effect of Radiotherapy on Immunotherapy Efficacy for Advanced EGFR Mutant Non-Small Cell Lung Cancers after Osimertinib Resistance
Location: Hall C
Presenter: YuanLiang Zhou, MBBS
2:45 PM – 4:15 PM ET
2201 - Real-World Patterns of Cranial Radiation Therapy Among Patients with Brain Metastases from Non-Small Cell Lung Cancer in the Era of CNS-Penetrant Tyrosine Kinase Inhibitors
Location: Hall C
Presenter: Lin Zhu, MD, PhD – Harvard Radiation Oncology Program
2:45 PM – 4:15 PM ET
2202 - Disparities in the Efficacy of Different Treatment Modalities for Inoperable Non-Small Cell Lung Cancer in the Immune Era: A Retrospective, Real-World Study
Location: Hall C
Presenter: Xue-Ru Zhu, MD, PhD – Shanghai Jiao Tong University
2:45 PM – 4:15 PM ET
2203 - Distribution of Responsibility across the HDR Brachytherapy Team: Results of a Nationwide Survey
Location: Hall C
Presenter: Jacqueline Zoberi, PhD – Washington University School of Medicine in St. Louis
2:45 PM – 4:15 PM ET
3774 - Curative-Intent Chemoradiotherapy with Adjuvant Durvalumab plus SBRT to Metastatic Sites in Synchronous Oligometastatic NSCLC
Location: Hall C
Presenter: Kyra McComas, MD – Vanderbilt University Medical Center
4:45 PM – 6:00 PM ET
2204 - Observational Study Based on Interfractional Urinary Bladder Filling Variations during Image Guided Radiotherapy in Cervical Cancer Patients Using Cone Beam Computed Tomography
Location: Hall C
Presenter: Siddhartha Nanda, MD – AIIMS
4:45 PM – 6:00 PM ET
2205 - Investigating the Impact of CBCT Acquisition Speed on Normal Tissue Structure Localization Accuracy in the Presence of Subject Motion Using a Novel CBCT Scanner
Location: Hall C
Presenter: David Adam, PhD, MS – Johns Hopkins University School of Medicine
4:45 PM – 6:00 PM ET
2206 - Feasibility of a Multi-Isocenter Technique for Long Target Volume MR-Guided Radiotherapy
Location: Hall C
Presenter: Ergun Ahunbay, PhD – Medical College of Wisconsin
4:45 PM – 6:00 PM ET
2207 - Re-Evaluating the Necessity of Pre-Processing Magnetic Resonance Images for Deep Learning-Based Organ Segmentation: A Study on Segmentation Challenges Using MR-Linac Images
Location: Hall C
Presenter: Asma Amjad, PhD – Medical College of Wisconsin
4:45 PM – 6:00 PM ET
2208 - Stereotactic Body Radiation Therapy (SBRT) Treatment of Synchronous Lung Tumors via Single-Isocenter/Multi-Target (SIMT) Method: Reporting Single-Institutional Clinical Outcomes
Location: Hall C
Presenter: Evans Amoah, MD, MPH – University of Kentucky
4:45 PM – 6:00 PM ET
2209 - Deep Learning Based Synthetic CT Images Generated from Cone-Beam CT Using CycleGAN Model for Thoracic Cancer Adaptive Radiotherapy
Location: Hall C
Presenter: Eenas Omari, PhD, DABR – Medical College of Wisconsin
4:45 PM – 6:00 PM ET
2210 - Head and Neck Parotid Gland Sparing Techniques: Small Volume, Big Change
Location: Hall C
Presenter: Brian Anderson, PhD, MS – UNC School of Medicine
4:45 PM – 6:00 PM ET
2211 - Volumetric Modulated Arc Therapy Integrating Static Angle Ports and Dynamic Collimator Rotation: A New Approach to Spine SBRT Treatment
Location: Hall C
Presenter: Ben Archibald-Heeren, MS, BS – Icon Cancer Centres
4:45 PM – 6:00 PM ET
2212 - Neck Volume as a Novel Surrogate to Trigger Adaptation for Head and Neck Radiotherapy
Location: Hall C
Presenter: Laura Cervino, PhD – Memorial Sloan Kettering Cancer Center
4:45 PM – 6:00 PM ET
2213 - Monte Carlo Based Treatment Planning Workflow for Pre-Clinical and Clinical Electron Flash Studies
Location: Hall C
Presenter: Muhammad Ramish Ashraf, PhD – Stanford Radiation Oncology
4:45 PM – 6:00 PM ET
2214 - Performance Analysis and Knowledge-Based Quality Assurance of Critical Organ Auto-Segmentation for Craniospinal Irradiation in Pediatric Proton Therapy
Location: Hall C
Presenter: Ozgur Ates, PhD – St. Jude Children's Research Hospital
4:45 PM – 6:00 PM ET
2215 - Developing and Validating a Novel In Vivo Film Dosimetry System for Accurate Radiation Measurement
Location: Hall C
Presenter: Anandh Viswanathan, MBA, BS – Ashland Specialty Ingredients
4:45 PM – 6:00 PM ET
2216 - Performance Comparison of Different Kv-CBCT Technologies for Adaptive and Image Guided Radiotherapy
Location: Hall C
Presenter: Aurélien Badey
4:45 PM – 6:00 PM ET
2217 - A Probabilistic Unsupervised Model to Assess Pharmacokinetic Changes in Cerebral Tumors before and after Radiation Therapy
Location: Hall C
Presenter: Kundan Thind, PhD – Henry Ford Health System
4:45 PM – 6:00 PM ET
2218 - Influence of Gender on Setup Accuracy of Radiotherapy for Rectal Cancer: A Real-World Observational Study
Location: Hall C
Presenter: Fei Bai – radiotherapy department
4:45 PM – 6:00 PM ET
2219 - Enhancing X-Ray Based Adaptive Radiotherapy: Pilot Study on AI-Driven Contour Quality
Location: Hall C
Presenter: Ti Bai, PhD – UT Southwestern Medical Center
4:45 PM – 6:00 PM ET
2221 - Accurate Reconstruction of Plastic Interstitial Catheters in Image-Guided Prostate High Dose Rate Brachytherapy
Location: Hall C
Presenter: Margaret Barker, MS – MemorialCare Long Beach Medical Center
4:45 PM – 6:00 PM ET
2222 - Deep-Inspiration Breath Hold Radiation Treatment for Breast Cancer without Permanent Tattoos
Location: Hall C
Presenter: Margaret Barker, MS – MemorialCare Long Beach Medical Center
4:45 PM – 6:00 PM ET
2223 - Impact of a High Performance Imaging System on CTgART
Location: Hall C
Presenter: Robert Beckert, RT, BS – Washington University School of Medicine in St. Louis
4:45 PM – 6:00 PM ET
2224 - A Study to Evaluate Influence of Bladder Contrast Agent in Monte Carlo Dose Calculation Algorithm for Advanced Radiotherapy Techniques
Location: Hall C
Presenter: Narendra Bhalla, MD – Fortis Cancer Institute
4:45 PM – 6:00 PM ET
2225 - Urethra and Bladder Dosimetry in Patients Treated with Prostate SBRT with and without Intra-Prostatic Boost (IPB)
Location: Hall C
Presenter: Nisha Bhargava, BS – Beth Israel Deaconess Medical Center
4:45 PM – 6:00 PM ET
2226 - The Positioning Accuracy of Individualized Open-Face Mask in Patients with Intracranial Tumors Receiving Radiotherapy - A Randomized Controlled Study
Location: Hall C
Presenter: Li Bo
4:45 PM – 6:00 PM ET
2227 - First Steps toward Implementing Pencil Beam Scanning Pristine Bragg Peak FLASH Planning into a Commercial Treatment Planning System
Location: Hall C
Presenter: Alexander Bookbinder, BS – New York Proton Center
4:45 PM – 6:00 PM ET
2228 - Biology-Guided Radiotherapy (BgRT) Emulated Delivery: Simulating Target Motion
Location: Hall C
Presenter: Girish Bal, PhD
4:45 PM – 6:00 PM ET
2229 - Evaluation of Automated Whole Breast Tangential Field Technique
Location: Hall C
Presenter: Chirag Shah, MD – Cleveland Clinic
4:45 PM – 6:00 PM ET
2230 - Clinical Use of a High-Resolution Detector Array for Proton Therapy
Location: Hall C
Presenter: Marc Bussiere, MSc – Massachusetts General Hospital
4:45 PM – 6:00 PM ET
2231 - Evaluation of Setup Accuracy and PTV Boundary in Patients with Limb Tumors Receiving VMAT Treatment - A Multicenter Retrospective Study
Location: Hall C
Presenter: Rong Cai
4:45 PM – 6:00 PM ET
2232 - Dose Prescription with Very High Energy Electron (VHEE): The Clinical Dosimetric Approach Applied to Challenging Cases in Conventional and Flash Delivery Scenarios
Location: Hall C
Presenter: Daniele Carlotti, MD, PhD – Universita di Roma Sapienza
4:45 PM – 6:00 PM ET
2233 - User Evaluation of Metal Artifact Reduction Reconstruction for Daily Radiotherapy Treatment Imaging
Location: Hall C
Presenter: Ashley Cetnar, PhD, MS – The Ohio State University
4:45 PM – 6:00 PM ET
2234 - Potential and Benefits of Incorporating Predicted Weekly Anatomy in IMPT Optimization with Reduced Set up Error from 3mm to 1mm
Location: Hall C
Presenter: Mark Ka Heng Chan, PhD – University Nebraska Medical Center
4:45 PM – 6:00 PM ET
2235 - Feasibility Study of Treating Small Targets with Different PET Uptake Concentration Using BgRT
Location: Hall C
Presenter: Jina Chang, PhD – University of Pittsburgh Medical Center
4:45 PM – 6:00 PM ET
2236 - Acute Cardiac Inflammation 1-Year after Left-Sided Breast Cancer Radiotherapy Assessed with Hybrid PET/MRI
Location: Hall C
Presenter: Oi Wai Chau, PhD – Mayo Clinic Alix School of Medicine
4:45 PM – 6:00 PM ET
2237 - Evaluation of Biology-Guided Radiotherapy (BgRT) in Motion Phantom with Real Patient Breathing Patterns
Location: Hall C
Presenter: Huixiao Chen, PhD – Yale University School of Medicine
4:45 PM – 6:00 PM ET
2238 - Automated Delineation of Primary Gross Tumor Volume in Cervical Cancer Using a 3D Res-U-Net Model: Performance and Challenges
Location: Hall C
Presenter: Jie Chen, MS
4:45 PM – 6:00 PM ET
2239 - Robust Optimization for Spot Scanning Proton Therapy Based on Dose-Linear Energy Transfer (LET) Volume Constraints
Location: Hall C
Presenter: Wei Liu, PhD, MS, BS, FAAPM – Mayo Clinic
4:45 PM – 6:00 PM ET
2240 - The Synthesis of Bi₂S₃-CeO₂@Phe and its Radiosensitization and Radiation Protection to Esophageal Cancer
Location: Hall C
Presenter: Liting Chen
4:45 PM – 6:00 PM ET
2241 - Pretreatment Prediction of Multi-Leaf Collimator Positional Deviations in Patient-Specific Plan Control Points Using Complexity Metrics
Location: Hall C
Presenter: Liyuan Chen, MS – Chongqing University Cancer Hospital
4:45 PM – 6:00 PM ET
2242 - Improving Liver SBRT Target Localization with Hybrid MRI/CBCT Technology
Location: Hall C
Presenter: Mark Chen, MD, PhD – Duke University
4:45 PM – 6:00 PM ET
2243 - Evaluation of an Externally Trained Deep-Learning Based GTV Auto-Segmentation Model for Head and Neck Cancer
Location: Hall C
Presenter: Quan Chen, PhD – Mayo Clinic Arizona
4:45 PM – 6:00 PM ET
2246 - Advancing Pancreatic Cancer Treatment with Bragg Peak Proton FLASH Radiotherapy: Escalating Target Dose through Biological Optimization of the FLASH Effect
Location: Hall C
Presenter: Minglei Kang, PhD – University of Wisconsin
4:45 PM – 6:00 PM ET
2247 - Verification of a Simulation Toolkit Step-By-Step Reaction Diffusion Master Equation Model for Long-Term Simulation of Radiolysis in Fricke Dosimetry
Location: Hall C
Presenter: Chang Heon Choi, PhD – Seoul National University Hospital
4:45 PM – 6:00 PM ET
2248 - Development of an Automated Simulation-Free Platform for Emergent Radiotherapy
Location: Hall C
Presenter: Suzanne Chungbin, MS – Mayo Clinic Arizona
4:45 PM – 6:00 PM ET
2249 - Evaluation of the Skin Dose Increase with the Use of a Novel Immobilization Device in Prone Breast Radiotherapy
Location: Hall C
Presenter: Giovanna Dipasquale, MS, MSc – Herosupport SA
4:45 PM – 6:00 PM ET
2250 - Dosiomics and Radiomics Guided Precision Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma Patients
Location: Hall C
Presenter: Yongbin Cui
4:45 PM – 6:00 PM ET
2251 - Dosimetry and Treatment Planning Tools for Ultra-High Dose Rate Radiotherapy Preclinical Research with a Compact Electron Linac
Location: Hall C
Presenter: Tianyuan Dai, PhD
4:45 PM – 6:00 PM ET
2252 - Preliminary Clinical Evaluation of a Convolutional Long Short-Term Memory (ConvLSTM) Based Real-Time 4D-CBCT Prediction Method
Location: Hall C
Presenter: Jun Dang, PhD – Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
4:45 PM – 6:00 PM ET
2253 - SAM-Based Auto-Segmentation of Critical Structures for Head and Neck Cancer Radiotherapy
Location: Hall C
Presenter: Jun Deng, PhD, FASTRO – Yale University
4:45 PM – 6:00 PM ET
2254 - Evaluation of Scriptable Surface Area Informed Optimization (SAIO) to Enhance a Vendor Automated Multi-Metastases Planning Solution
Location: Hall C
Presenter: Dharmin Desai, PhD – Varian Medical Systems
4:45 PM – 6:00 PM ET
2255 - Dual Port Tissue Expander Displacement in Post Mastectomy Radiotherapy: Dosimetric Challenges
Location: Hall C
Presenter: Khaled Dibs, MD – The James Cancer Hospital & Solove Research Institute
4:45 PM – 6:00 PM ET
2256 - A Cylindrical Slit Approach to Study the Focal Spot of Photon Beams from a Medical Linear Accelerator
Location: Hall C
Presenter: George Ding, PhD – Vanderbilt University Medical Center
4:45 PM – 6:00 PM ET
2257 - Integration of Enhanced Therapy and X-Ray Fluorescence Computed Tomography Using Inverse Compton Scattering Source
Location: Hall C
Presenter: Hao Ding, PhD – Tsinghua University
4:45 PM – 6:00 PM ET
2258 - Investigating Scaled and Iso-Layer Repainting to Mitigate Interplay Effect for Carbon Ion Pencil Beam Scanning over the Full Breathing Cycle
Location: Hall C
Presenter: Hongdong Liu, PhD – Sun Yat-Sen University Cancer Center
4:45 PM – 6:00 PM ET
2259 - Advanced Solution: Accurate Patient Alignment without Unnecessary Imaging Dose via Synthesizing Patient-Specific 3D CT Images from 2D KV Images
Location: Hall C
Presenter: Wei Liu, PhD, MS, BS, FAAPM – Mayo Clinic
4:45 PM – 6:00 PM ET
2260 - Tailoring Treatment Margins: A Study of PTV Reduction Using X-Ray Based Adaptive Radiotherapy for Stereotactic Partial Breast Irradiation (A-SPBI) Treatments
Location: Hall C
Presenter: David Parsons, PhD – University of Texas Southwestern Medical Center
4:45 PM – 6:00 PM ET
2261 - Assessing Intra-fractional Organ Motion on Prostate Adaptive Radiotherapy
Location: Hall C
Presenter: Olga Maria Dona Lemus, PhD – University of Miami Sylvester Comprehensive Cancer Center
4:45 PM – 6:00 PM ET
2262 - Clinical Implementation of Triggered Imaging for Prostate SBRT Motion Management: An Initial Experience
Location: Hall C
Presenter: Huiming Dong, PhD – University of California Los Angeles
4:45 PM – 6:00 PM ET
2263 - Evaluation of ¹⁸F-FDG and ¹⁸F-FMISO PET Imaging for Biology-Guided Radiotherapy in Lung and Abdomen Cancer Patients
Location: Hall C
Presenter: Emily Draeger, PhD – Yale University School of Medicine
4:45 PM – 6:00 PM ET
2264 - Renal Dosimetry for ¹⁷⁷Lu-DOTATATE: Impact of Region of Interest Selection
Location: Hall C
Presenter: Brandon Driscoll, MASc, BASc – Princess Margaret Hospital
4:45 PM – 6:00 PM ET
2265 - A Concept of Equivalent-Volume Conformity Index Used in Target Volumes Comparison
Location: Hall C
Presenter: Qinghua Du, MD – Second Affiliated Hospital of Guangxi Medical University
4:45 PM – 6:00 PM ET
2266 - Investigation of the Dosimetric Advantages of a Novel X-Ray and ?-Ray Combined Modality in Prostate Cancer Treatment
Location: Hall C
Presenter: Jie Duan, MS
4:45 PM – 6:00 PM ET
2267 - Pre-Clinical Evaluation of Stopping-Power Ratio Prediction for Proton Therapy Planning Based on Dual-Energy CT: An End-to-End Validation
Location: Hall C
Presenter: Jinghao Duan, MD, PhD
4:45 PM – 6:00 PM ET
2268 - Qualitative and Quantitative Evaluation of Adaptation Strategies for Maximal Dosimetric Benefit in Patients Receiving CBCT-Guided Online Adaptive Radiotherapy for Lung Cancer
Location: Hall C
Presenter: Jingwei Duan, PhD – The University of Alabama at Birmingham
4:45 PM – 6:00 PM ET
2269 - Optimization of Treatment Plan Parameters Used in Helical Tomotherapy for Small Cell Lung Cancer Patients with Extensive Pleural Metastasis
Location: Hall C
Presenter: Longyan Duan, MD
4:45 PM – 6:00 PM ET
2270 - Clinically-Dependent Fully Automatic Treatment Planning System via Reinforcement Learning
Location: Hall C
Presenter: Paul Dubois – TheraPanacea
4:45 PM – 6:00 PM ET
2271 - Role of Diffusion Weighted Imaging in Prediction of Patterns of Failure for Recurrent Head and Neck Cancer
Location: Hall C
Presenter: Abdallah Mohamed, MD, PhD – Baylor College of Medicine
4:45 PM – 6:00 PM ET
2272 - Initial Experience with a CBCT-Based Adaptive Radiotherapy System
Location: Hall C
Presenter: Ahmed Eldib, PhD – Fox Chase Cancer Center
4:45 PM – 6:00 PM ET
2273 - AI Contouring in HDR Prostate Brachytherapy Using a General Foundation Model
Location: Hall C
Presenter: Sharif Elguindi, MS – Memorial Sloan Kettering Cancer Center
4:45 PM – 6:00 PM ET
2274 - Dosimetric Comparison between Intensity Modulated Radiation Therapy and 3-Dimensional Conformal Radiation Therapy in Both Semi-Lateral Decubitus and Supine Positions for Left Breast Cancer Radiation T
Location: Hall C
Presenter: Amr ElSaid, MD, PhD – Alexandria University
4:45 PM – 6:00 PM ET
2275 - On Table Adaptation in MR Guided Prostate Cancer Treatments. Can RTTs Replace the Physician?
Location: Hall C
Presenter: Dan Epstein, M.Sc – Assuta Medical Centers
4:45 PM – 6:00 PM ET
2276 - Experiments and Monte Carlo Simulations on Out-of-Field Secondary Neutron Dose in Proton Pencil Beam Scanning with Collimating Apertures
Location: Hall C
Presenter: Johannes Esser
4:45 PM – 6:00 PM ET
2277 - Deep Learning in Liver Tumor Segmentation: Impact of Tumor Heterogeneity on Model Performance
Location: Hall C
Presenter: Jin Sung Kim, PhD
4:45 PM – 6:00 PM ET
2278 - 4pi Treatment Planning Strategy Regularized by Voxel-Wise T1 Reduction Rate for Liver Function Avoidance SBRT
Location: Hall C
Presenter: Joshua Everts, MS – University of California, San Francisco
4:45 PM – 6:00 PM ET
2279 - Assessing and Quantifying Patient External Contour Changes for Node Positive Dose Escalated Prostate Cancer Using Proton Therapy
Location: Hall C
Presenter: Marcio Fagundes, MD – Miami Cancer Institute
4:45 PM – 6:00 PM ET
2280 - Leveraging MV-KV Imaging Based Quantitative Intrafractional Motion Tracking for Safe Paraspinal SBRT: The Impact of Patient Movement on Radiation Dose
Location: Hall C
Presenter: Qiyong Fan, PhD – Memorial Sloan Kettering Cancer Center
4:45 PM – 6:00 PM ET
2281 - Creation of Novel Inexpensive Low Artifact Brachytherapy Contrast Markers Compatible with CT and MRI
Location: Hall C
Presenter: Michael Farris, MD – Wake Forest University Medical Center
4:45 PM – 6:00 PM ET
2282 - Comparison of Thermoluminescent Dosimetry to Calculated Dosimetry in the Tumor Margins in Diffusing Alpha-Emitters Radiation Therapy
Location: Hall C
Presenter: Jon Feldman, PhD – Haddasah Medical Center
4:45 PM – 6:00 PM ET
2283 - Adaptive Team Training Based on Incident Learning
Location: Hall C
Presenter: Farnoush Forghani, PhD – Washington University in St. Louis
4:45 PM – 6:00 PM ET
2284 - Optimizing Radiation Therapy Planning: A Hybrid Approach Integrating Physician Preferences and Automated Planning Systems
Location: Hall C
Presenter: Timothy Fox, PhD – Lumonus
4:45 PM – 6:00 PM ET
2285 - X-Ray Image-Based Real-Time Simultaneous Intrafractional Spine and Lung Tumor Tracking via Target Decomposition
Location: Hall C
Presenter: Xiang Li, PhD – Memorial Sloan Kettering Cancer Center
4:45 PM – 6:00 PM ET
2286 - Feasibility Study on Real-Time Volume Gating Technique for Particle Therapy with an Anthropomorphic Digital Phantom
Location: Hall C
Presenter: Takaaki Fujii, PhD – Hitachi Ltd., Japan
4:45 PM – 6:00 PM ET
2287 - Impact of Compressed Breast Thickness and Breast Density in Mammography on Setup Error for Partial Breast Irradiation
Location: Hall C
Presenter: Saya Fujimura, RT, BS – Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital
4:45 PM – 6:00 PM ET
2288 - Toward Clinical Proton FLASH Trials: Commercial-TPS Treatment Planning Validation and In-House Optimization Algorithm Development
Presenter: Hao Gao, PhD – University of Kansas Medical Center
4:45 PM – 6:00 PM ET
2289 - Quality Assurance in a Dedicated Workflow for Addressing Deformed Anatomies and Varied Fractionation Schemes in Re-Irradiation Planning
Location: Hall C
Presenter: Eric Paulson, PhD – Medical College of Wisconsin
4:45 PM – 6:00 PM ET
2290 - Impact of AI-Generated Pre-Contouring on Interobserver Variability and Editing Requirements for Brain Metastasis GTVs
Location: Hall C
Presenter: Eli Gibson, PhD – Siemens Healthineers
4:45 PM – 6:00 PM ET
2291 - Film Dosimetry Metrics for Biology-Guided Radiotherapy (BgRT)
Location: Hall C
Presenter: Jeffrey Schmall, PhD
4:45 PM – 6:00 PM ET
2292 - Initial Biology-guided Radiotherapy (BgRT) Phantom Design, Characterization and Planning with Multiple Asynchronous Targets for Metastatic Lung Treatment
Location: Hall C
Presenter: Jeffrey Schmall, PhD
4:45 PM – 6:00 PM ET
2293 - Is Separating Targets Necessary in Single-Isocenter Multi-Targets Radiosurgery Treatments?
Location: Hall C
Presenter: Lin Ma, PhD – Mayo Clinic College of Medicine and Science Rochester
4:45 PM – 6:00 PM ET
2294 - Semi-Automated Angulation and Segmentation of the Seventeen Segments of the Left Ventricle for Ventricular Tachycardia Radioablation
Location: Hall C
Presenter: Ping Xia, PhD – Cleveland Clinic
4:45 PM – 6:00 PM ET
2295 - Treatment Planning Feasibility Study for Lattice SBRT of Locally Advanced Head and Neck Cancer
Location: Hall C
Presenter: Ryan Hall, MS – Henry Ford Health System
4:45 PM – 6:00 PM ET
2296 - Enhancing Organs-at-Risk Protection in Ocular SBRT with Bragg-Peak FLASH Biological Optimization
Location: Hall C
Presenter: Jenghwa Chang, PhD – Northwell Health
4:45 PM – 6:00 PM ET
2297 - RadAIonc: Enhancing Decision-Making in Radiation Oncology with a GPT-4-Based Prompt-Driven Large Language Model
Location: Hall C
Presenter: Bin Han, PhD – Stanford University
4:45 PM – 6:00 PM ET
2298 - Pre-Clinical Evaluation of a Ring Gantry-Based Linac with a Dual-Layer Mlc for Total Marrow and Lymphoid Irradiation and Intensity-Modulated Total Body Irradiation for Pediatric Patients
Location: Hall C
Presenter: Chunhui Han, PhD – City of Hope National Medical Center
4:45 PM – 6:00 PM ET
2299 - Clinical Implementation of SCINTIX Biology-Guided Radiotherapy: A Single Institution Experience from Initial Patient Selection to First SCINTIX Delivery
Location: Hall C
Presenter: Chunhui Han, PhD – City of Hope National Medical Center
4:45 PM – 6:00 PM ET
2300 - First Clinical Experience with a Novel Onboard Dual-Layer Imager
Location: Hall C
Presenter: Ross Berbeco, PhD – Brigham and Women's Hospital/Dana-Farber
4:45 PM – 6:00 PM ET
2301 - Deformable Dose Accumulation and Toxicity Analysis in Prostate Cancer Patients Undergoing MR-Guided Adaptive Radiotherapy
Location: Hall C
Presenter: Nima Hassan Rezaeian, PhD – Memorial Sloan Kettering Cancer Center
4:45 PM – 6:00 PM ET
2302 - Feasibility of an On-Site Trained Auto-Segmentation Model Using Our Institution Data to Improve Physician Satisfaction for Breast Cancer
Location: Hall C
Presenter: Eun Jeong Heo, MS – Korea University
4:45 PM – 6:00 PM ET
2303 - Sculpting Dose Inhomogeneity with Consideration of the Dominant Intraprostatic Lesion in Prostate SBRT: A Planning Feasibility Study
Location: Hall C
Presenter: Emily Hollis, MD – UNC School of Medicine
4:45 PM – 6:00 PM ET
2304 - Optimizing Radiation Treatment for Glioblastoma Patients: Contrasting Dosimetric Profiles of HyperArc and Volumetric Arc Therapy
Location: Hall C
Presenter: Wei-Ju Hong, MD – Chi Mei Medical Center
4:45 PM – 6:00 PM ET
2306 - Development and Evaluation of Deep Learning-Based CBCT Enhancement in Automatic OAR Segmentation
Location: Hall C
Presenter: Xue Feng, PhD – Carina AI
4:45 PM – 6:00 PM ET
2307 - Intrafraction Motion Management of CBCT Guided Online Stereotactic Adaptive Prostate Cancer Radiotherapy
Location: Hall C
Presenter: Yimei Huang, PhD – Henry Ford Health System
4:45 PM – 6:00 PM ET
2308 - Characterization of a Treatment Plan Optimization Algorithm for VMAT with Integrated Static-Angle Ports
Location: Hall C
Presenter: Emily Hubley, MS, DABR – University of Pennsylvania
4:45 PM – 6:00 PM ET
2309 - Automatic Skin Flash Optimization in VMAT with Static-Angle Ports: Effect of Flash Margin Size on Breast and Chestwall Plan Quality and Robustness
Location: Hall C
Presenter: Emily Hubley, MS, DABR – University of Pennsylvania
4:45 PM – 6:00 PM ET
2310 - Should We Evaluate Liver as an Organ at Risk for Radiotherapy Right Breast Cancer Treatment?
Location: Hall C
Presenter: Sandra Huerta Vega, MS – ABC Medical Center
4:45 PM – 6:00 PM ET
2311 - Novel SRS Program Using Universal Inflatable Headrest and Automatic Planning: Retrospective Validation of Patient Immobilization Using Mid-SRS CBCT
Location: Hall C
Presenter: Soon Huh, PhD – University of Florida Proton Therapy Institute
4:45 PM – 6:00 PM ET
2312 - Optimal Planning Organs-at-Risk Volume Margins Considering Displacement of Implanted Fiducial Markers and Organ Motions in High-Risk Prostate Radiation Therapy
Location: Hall C
Presenter: Soon Huh, PhD – University of Florida Proton Therapy Institute
4:45 PM – 6:00 PM ET
2313 - Dosimetric Comparison of O-Ring and C-Arm Linac for Volumetric Modulated Arc Therapy with Simultaneous Integrated Boost of Left-Sided Breast Cancer under Deep Inspiration Breath Hold
Location: Hall C
Presenter: Tim Hui, MS, BS – Union Oncology Centre
4:45 PM – 6:00 PM ET
2314 - Deep Learning-Based Auto Contouring of Mandibular Sub-Volumes Based on the ClinRad System for Spatial Localization of Osteoradionecrosis of the Jaw
Location: Hall C
Presenter: Laia Humbert-Vidan, PhD – The University of Texas MD Anderson Cancer Center
4:45 PM – 6:00 PM ET
2315 - Proof-of-Concept Simulations Towards a Novel, FLASH-Capable Compact Small Animal Irradiator
Location: Hall C
Presenter: Benjamin Insley, PhD
4:45 PM – 6:00 PM ET
2316 - Variation of Liver Dome Position vs. Targets Distances and Locations in Liver Segments during Exhale Breath-Hold Liver SBRT
Location: Hall C
Presenter: Rojymon Jacob, MD – University of Mississippi Medical Center
4:45 PM – 6:00 PM ET
2317 - Single Pixel Cherenkov Imaging of Radiation Therapy Dose
Location: Hall C
Presenter: Mengyu Jia, PhD – Tianjin University
4:45 PM – 6:00 PM ET
2318 - Dosimetric Analysis and Outcome Correlations in Intravenous Brachytherapy for Coronary Artery Disease: A Retrospective Study
Location: Hall C
Presenter: Yijian Cao, PhD – Northwell Health
4:45 PM – 6:00 PM ET
2321 - Feasibility of Automated Radiotherapy Treatment Planning to Increase Patient Throughput in Limited Resource Settings
Location: Hall C
Presenter: Yao Hao, PhD – Washington University in St. Louis
4:45 PM – 6:00 PM ET
2322 - Comparison of Automated Treatment Planning Based on External Beam Radiation Therapy with High Dose Rate Brachytherapy for Focal Intraprostatic Boost Radiation Therapy for Localized Prostate Cancer
Location: Hall C
Presenter: Christopher Kehayias, PhD – Brigham and Women's Hospital/Dana-Farber
4:45 PM – 6:00 PM ET
2323 - A Quantitative Comparison of CT- and PET/SPECT-Based Dosimetry Following Yttrium-90 Radioembolization with Radiopaque Glass Microspheres
Location: Hall C
Presenter: Andrew Kennedy, MD, FACRO – Sarah Cannon Cancer Center at TriStar Health
4:45 PM – 6:00 PM ET
2324 - Feasibility of Spinal Cord Diffusion MRI Near Metal
Location: Hall C
Presenter: Thammathida Ketsiri, PhD – Barrow Neurological Institute
4:45 PM – 6:00 PM ET
2326 - Evaluation of Lung Dose Reduction in VMAT Treatment Plans for Esophageal Cancer: A Comparative Study of Avoidance Strategies
Location: Hall C
Presenter: Dong Kyu Kim – Samsung Medical Center
4:45 PM – 6:00 PM ET
2327 - Assessing Dynamic Collimator Rotation and Integrated Static Angle Ports in VMAT for Treating Recurrent Glioblastoma: A Preliminary Study
Location: Hall C
Presenter: Grace Kim, PhD – University of California San Diego
4:45 PM – 6:00 PM ET
2328 - Development of a Surface-Guided Radiation Therapy (SGRT) Objective Operational Motion (SOOM) Phantom for SGRT Systems
Location: Hall C
Presenter: James Sohn, PhD – University of Chicago
4:45 PM – 6:00 PM ET
2329 - Predictive Analysis of DQA (Delivery Quality Assurance) Failures in Tomotherapy Plans: Utilizing Plan Parameters and Dosiomics
Location: Hall C
Presenter: Jina Kim, PhD – Ajou University Medical Center
4:45 PM – 6:00 PM ET
2330 - Dosimetric Evaluation of Large-Area Proton Minibeam Radiation Therapy System for Clinical Applications
Location: Hall C
Presenter: Jusung Kim, PhD – National Cancer Center, Korea
4:45 PM – 6:00 PM ET
2331 - Effect of Prolonged Supine Positioning on CBCT Bowel Gas Artifact in Pancreatic Cancer Patients Undergoing CT-Guided Adaptive Stereotactic Body Radiotherapy
Location: Hall C
Presenter: Minji Kwon – Saint Louis University
4:45 PM – 6:00 PM ET
2332 - Evaluation of Delivered vs. Planned Dose in Head and Neck Treatments
Location: Hall C
Presenter: Siete Koch, PhD – Medisch Spectrum Twente
4:45 PM – 6:00 PM ET
2333 - _{Translation Accuracy of Scanning Protocols across Various CT and PET/CT Scanner Models and Manufacturers Using Quantitative Methods}
Location: Hall C
Presenter: Sean Berry, PhD – Memorial Sloan Kettering Cancer Center
4:45 PM – 6:00 PM ET
2334 - Adaptive Lung Radiotherapy Planning with Expedited Constrained Hierarchical Optimization (ECHO) Empowered Knowledge-Based Models on Ethos(E³)
Location: Hall C
Presenter: LiCheng Kuo, MS – Memorial Sloan Kettering Cancer Center
4:45 PM – 6:00 PM ET
2335 - Cherenkov Imaging with a Predicted Surface Dose Overlay for Treatment Verification
Location: Hall C
Presenter: Abigail Lauder, MD – Dartmouth Health
4:45 PM – 6:00 PM ET
2336 - Rotationally Intensified Proton Lattice (RIPL): A Novel Lattice Technique Using Spot-Scanning Proton Arc Therapy
Location: Hall C
Presenter: Joseph Lee, MD, PhD – Corewell Health William Beaumont University Hospital
4:45 PM – 6:00 PM ET
2337 - Single Institution Retrospective Study of Tolerance of Voluntary Deep Inspiration Breath Hold for Abdominal Radiotherapy
Location: Hall C
Presenter: Sangkyu Lee, PhD, MS – Memorial Sloan Kettering Cancer Center
4:45 PM – 6:00 PM ET
2338 - Modification of Needle Arrangement for HDR Prostate Brachytherapy Cases according to an Unpaired T-Test
Location: Hall C
Presenter: Etienne Letourneau, MS – CICL
4:45 PM – 6:00 PM ET
2339 - Benefits of Regular Breath-Holding Training for DIBH Treatment
Location: Hall C
Presenter: Hongming Li, PhD, RT – Chinese Academy of Medical Sciences and Peking Union Medical College
4:45 PM – 6:00 PM ET
2340 - Improving the Clinical Workflow of Lung Cancer Patients Treated at MR-Linac by Synthetic CT Validation
Location: Hall C
Presenter: Jie Li, PhD, MS, Prof – Sichuan Cancer Hospital and Institute
4:45 PM – 6:00 PM ET
2341 - Priority of Observation Objects in High Dose Rate Vaginal Brachytherapy with Temporal Factor Analysis Based on NRG-GY020 Clinical Trial Cases
Location: Hall C
Presenter: Kaile Li, PhD, MS, DABR MHA – Varian Medical Systems, A Siemens Healthineers Company
4:45 PM – 6:00 PM ET
2342 - The Impact of Treatment Plan Complexity on Calculation and Measurement-Based Pre-Treatment Verifications in Intensity-Modulated Radiotherapy
Location: Hall C
Presenter: Shi Li, MS – Chongqing University Cancer Hospital
4:45 PM – 6:00 PM ET
2344 - Control Dosimetric Outcome of AI-Generated Plans through OAR Prioritization for Head-and-Neck Cancer: An Investigation on Input Sensitivity
Location: Hall C
Presenter: Xinyi Li, PhD – Duke University Medical Center
4:45 PM – 6:00 PM ET
2345 - Construction of a Lymph Node Metastasis Prediction Model for Endometrial Cancer Based on MRI Radiomics
Location: Hall C
Presenter: Zhuang Li, MD, No
4:45 PM – 6:00 PM ET
2346 - Correlation between Changes in Primary Tumor Radiomic Features and Response during Definitive Radiation for Lung Cancer
Location: Hall C
Presenter: Andrew Lian, BS – Western University of Health Sciences, College of Osteopathic Medicine of the Pacific
4:45 PM – 6:00 PM ET
2347 - Comprehensive Evaluation of Two Ring Gantry LINAC Cone-Beam Computed Tomography Systems for Online Adaptive Radiation Therapy
Location: Hall C
Presenter: Seng (Gary) Lim, PhD – Memorial Sloan Kettering Cancer Center
4:45 PM – 6:00 PM ET
2350 - Evaluation and Validation of Open Access Knowledge Based Planning (KBP) Model in India Developed for Treatment of Bilateral Head and Neck Cancer
Location: Hall C
Presenter: Hefei Liu, MD, MS – University of Pennsvania Radiation Oncology
4:45 PM – 6:00 PM ET
2351 - Compromised Target Coverage with Protracted-Fractionation/Moderately Hypofractionated Radiation Treatment Courses for Pancreatic Cancer
Location: Hall C
Presenter: I-Chia Liu, MD – Johns Hopkins Radiation Oncology Kimmel Cancer Center
4:45 PM – 6:00 PM ET
2353 - A First Quantitative Evaluation of Plan Quality Effects from Gantry Rotational Error on Spot-Scanning Arc Therapy (SPArc)
Location: Hall C
Presenter: Peilin Liu, MD, MS – Corewell Health William Beaumont University Hospital
4:45 PM – 6:00 PM ET
2354 - Investigating the Influence of Spot Error on Plan Quality: A Comparative Study of Spot-Scanning Arc Therapy (SPArc) and Intensity-Modulated Proton Therapy (IMPT)
Location: Hall C
Presenter: Peilin Liu, MD, MS – Corewell Health William Beaumont University Hospital
4:45 PM – 6:00 PM ET
2356 - Improving Plan Quality by Reducing Setup Uncertainty Using an Online Adaptive Proton Workflow
Location: Hall C
Presenter: Weiren Liu, MD, MS – Washington University School of Medicine in St. Louis
4:45 PM – 6:00 PM ET
2357 - A Robust Auto-Planning Algorithm Based Artificial Intelligence for Pencil Beam Scanning Proton Therapy
Location: Hall C
Presenter: Yaoying Liu, PhD – School of Physics, Beihang University
4:45 PM – 6:00 PM ET
2358 - Retreatment Review for Abdominal Cancer: Assessing the Impact of Deformable Image Registration and AI Auto-Segmentation on Dose Accumulation
Location: Hall C
Presenter: Yilin Liu, PhD – Memorial Sloan Kettering Cancer Center
4:45 PM – 6:00 PM ET
2359 - The Feasibility of Using Daily Online CT Image Evaluation as an Indication to Trigger Adaptive Radiation Therapy for Esophageal Cancer
Location: Hall C
Presenter: Yimei Liu, MS – Sun Yat-Sen University Cancer Center
4:45 PM – 6:00 PM ET
2360 - Intra- and Inter-Fraction Errors and Deformation during Pancreas SBRT: Analysis and Predictability of Dose Variations for Upper Gastrointestinal Organs
Location: Hall C
Presenter: Mauro Loi, MD – Azienda Ospedaliera Universitaria Careggi
4:45 PM – 6:00 PM ET
2361 - Deep Dive into the Performance of the 5D Breathing Motion Model
Location: Hall C
Presenter: Daniel Low, PhD, FASTRO – UCLA Radiation Oncology
4:45 PM – 6:00 PM ET
2362 - Optimal Dose Fractionation Scheme of SFRT Based on Thread-Effect of Helical Tomotherapy in Carcinoma of Uterine Cervix
Location: Hall C
Presenter: Huanli Luo, PhD – Chongqing University Cancer Hospital
4:45 PM – 6:00 PM ET
2363 - A Patient-Specific Based Strategy for Predicting Deep Inspiration Breath-Hold CT from Free-Breathing CT in Breast Radiotherapy
Location: Hall C
Presenter: Tie Lv, PhD – School of Physics, Beihang University
4:45 PM – 6:00 PM ET
2364 - Effect of Different Bladder Water Injection Volumes on Target Area Dose and OAR in 129 Cases of Radical Cervical Cancer Treated with Intracavitary Brachytherapy: A Real-World Study
Location: Hall C
Presenter: Juan Ma
4:45 PM – 6:00 PM ET
2365 - Vertices Geometric Efficiency Optimization for Lung Cancer Lattice Therapy Treatment Planning
Location: Hall C
Presenter: Ryan Mansfield, BS – Duke University Medical Center
4:45 PM – 6:00 PM ET
2366 - Dosimetric Analysis for Clinical Treatment Volumes Using a Novel CBCT Imaging System
Location: Hall C
Presenter: Peter Martin, PhD – Nova Scotia Health Authority - NS Cancer Centre
4:45 PM – 6:00 PM ET
2367 - Cherenkov Imaging Combined with Scintillation Dosimetry Provides Real-Time Positional and Dose Monitoring for Patients with Cardiac Implanted Electronic Devices
Location: Hall C
Presenter: Allison Matous, MD – Dartmouth-Hitchcock Medical Center
4:45 PM – 6:00 PM ET
2368 - Feasibility of Longitudinal Relaxation Rate Mapping with Non-Cartesian Sequences on a 1.5T MR-Linac
Location: Hall C
Presenter: Lucas McCullum, BS – MD Anderson Cancer Center
4:45 PM – 6:00 PM ET
2369 - Spectral CT Imaging for the Visualization of Hyaluronic Acid Based Rectal Spacers prior to Radiation Therapy
Location: Hall C
Presenter: Romy Megahed, MD – UAMS Radiation Oncology
4:45 PM – 6:00 PM ET
2370 - Dose-Response Modeling of Dysphagia and Xerostomia for Previously Irradiated Head and Neck Cancer
Location: Hall C
Presenter: Moyed Miften, PhD, FASTRO – University of Colorado School of Medicine
4:45 PM – 6:00 PM ET
2371 - Development of Volumetric Quantitative Evaluation Software for Assessing Respiratory-Induced Target Motion
Location: Hall C
Presenter: Hideharu Miura, PhD – Hiroshima High-Precision Radiotherapy Cancer Center
4:45 PM – 6:00 PM ET
2372 - Evaluating Commercial Auto-Segmentation Software Generated Contours on MRI and their Clinical Acceptability for Cranial Stereotactic Radiosurgery
Location: Hall C
Presenter: Hem Moktan, PhD – University of Kansas Medical Center
4:45 PM – 6:00 PM ET
2374 - Innovative Patient CT Scan Extensions for Accurate Organ Dose Estimations Following Proton and Photon Therapy: A Pilot Study
Location: Hall C
Presenter: Sergio Morato Rafet, PhD
4:45 PM – 6:00 PM ET
2375 - Prediction of Radiation-Induced Acute Urinary Toxicities for Prostate Cancer
Location: Hall C
Presenter: Maryam Moteabbed, PhD – Massachusetts General Hospital
4:45 PM – 6:00 PM ET
2376 - Investigating the Feasibility of Using Spot-Scanning Proton Arc Therapy to Mitigate the Dosimetric Perturbations in the Presence of Large Metal Implants
Location: Hall C
Presenter: Derek Mumaw, MD – Corewell Health William Beaumont University Hospital
4:45 PM – 6:00 PM ET
2377 - In Silico Comparison of SPArc and IMPT throughput
Location: Hall C
Presenter: Derek Mumaw, MD – Corewell Health William Beaumont University Hospital
4:45 PM – 6:00 PM ET
2378 - Dosimetric Evaluation of PTV Margin Reduction for Online Adaptive Radiotherapy in Head and Neck Cancer Sequential Boost Treatments
Location: Hall C
Presenter: Nour Nasser, PhD, MS, BS – Moffitt Cancer Center
4:45 PM – 6:00 PM ET
2379 - The Feasibility of Newly Developed AI-Based Automatic Radiotherapy Planning for Lung Cancer in SBRT-VMAT: Comparison with Manual Treatment Planning
Location: Hall C
Presenter: Hikaru Nemoto, MS – University of Yamanashi School of Medicine
4:45 PM – 6:00 PM ET
2380 - Validation of Monte Carlo Calculation on Skin Dose in HDR Brachytherapy for Keloid with PHITS
Location: Hall C
Presenter: Jie Ni, MD – The First Affiliated Hospital of Soochow University
4:45 PM – 6:00 PM ET
2381 - Application of Standardized Tissue Repair Discount Factors to Guide Spinal Cord Dose in Reirradiation
Location: Hall C
Presenter: Josiah Nieto, MD – University of Michigan
4:45 PM – 6:00 PM ET
2382 - Evaluation of Automated Skin Flash for Breast Cancer Patients
Location: Hall C
Presenter: Topi Nykanen, MSc – Hospital Nova of Central Finland, Wellbeing Services County of Central Finland
4:45 PM – 6:00 PM ET
2383 - Initial Examination of Commercial Photon Counting CT for Prostate Planning
Location: Hall C
Presenter: Ross Berbeco, PhD – Brigham and Women's Hospital/Dana-Farber
4:45 PM – 6:00 PM ET
2384 - Evaluating the Impact of Workflow Modifications on Plan Quality in Gamma Knife Radiosurgery
Location: Hall C
Presenter: Seungjong Oh, PhD, MS, BS – Washington University School of Medicine in St. Louis
4:45 PM – 6:00 PM ET
2385 - Evaluation of Cardiac Implantable Electronic Devices-Induced Distortion on 0.35T and 3.0T MR Scanners
Location: Hall C
Presenter: Alireza Omidi, PhD – VCUHealth System
4:45 PM – 6:00 PM ET
2386 - Accurate Delivery of VMAT Including Static Angle Ports and Dynamic Collimator
Location: Hall C
Presenter: Grace Kim, PhD – University of California San Diego
4:45 PM – 6:00 PM ET
2387 - Accuracy of a Physician-Free Workflow for Daily Adaptive Stereotactic Partial Breast Radiation Therapy (A-SPBI)
Location: Hall C
Presenter: David Parsons, PhD – University of Texas Southwestern Medical Center
4:45 PM – 6:00 PM ET
2388 - Dosimetric Evaluation of Adaptive Stereotactic Radiotherapy Boost for Locally Advanced Cervical Cancer
Location: Hall C
Presenter: Jared Pasetsky, MD – New York Presbyterian Hospital Columbia Campus
4:45 PM – 6:00 PM ET
2389 - Coronary Arterial Dose in Right Sided Breast Cancer Radiotherapy: A Dosimetric Analysis of Techniques
Location: Hall C
Presenter: Taylor Stamey, MOP – East Carolina University Brody School of Medicine
4:45 PM – 6:00 PM ET
2391 - Assessment of the Precision and Reliability of a Novel Enhanced Cone Beam Computed Tomography for Head and Neck Cancer Radiation Therapy
Location: Hall C
Presenter: Piyush Pathak, MD – Baylor College of Medicine
4:45 PM – 6:00 PM ET
2392 - Feasibility of an Online MR-Guided Scan-Plan-Treat Workflow for Emergency Palliation
Location: Hall C
Presenter: Eric Paulson, PhD – Medical College of Wisconsin
4:45 PM – 6:00 PM ET
2393 - Dosimetric Verification of a TPS-Guided Novel Arc-TBI Technique
Location: Hall C
Presenter: Stefano Peca, PhD – Beth Israel Deaconess Medical Center
4:45 PM – 6:00 PM ET
2394 - Reporting Inter-Fraction Patient Positioning Accuracy Using Hyperarc Stereotactic Radiotherapy for Recurrent Head and Neck Cancers with Initial Clinical Outcomes
Location: Hall C
Presenter: Damodar Pokhrel, PhD – UK Kentucky, Markey Comprehensive Cancer Center
4:45 PM – 6:00 PM ET
2395 - Feasibility and Safety of Subsequent Course(s) of Single-Isocenter/Multi-Lesion (SIML) Stereotactic Body Radiation Therapy (SBRT) to Synchronous Primary or Oligometastatic Lung Lesions
Location: Hall C
Presenter: Damodar Pokhrel, PhD – UK Kentucky, Markey Comprehensive Cancer Center
4:45 PM – 6:00 PM ET
2396 - Free-Breathing Gated Proton Pencil Beam Scanning (PBS) Delivery - Proof of Concept Phantom Study with Respiratory Monitory System
Location: Hall C
Presenter: Hang Qi, PhD – New York Proton Center
4:45 PM – 6:00 PM ET
2397 - Impact of Hip Prostheses on Restriction Spectrum Imaging for Prostate Cancer Detection
Location: Hall C
Presenter: Edmund Qiao, MD – University of California San Diego
4:45 PM – 6:00 PM ET
2398 - Clinical Commissioning of Orthovoltage-Based Minibeam Radiation Therapy (MBRT)
Location: Hall C
Presenter: chrystian Quintero Mateus, MS – Mayo Clinic
4:45 PM – 6:00 PM ET
2399 - One Fiducial for All Modalities: Optimized Trackability and Minimized Beam Perturbation for Fiducials Used across Multi-Modalities
Location: Hall C
Presenter: Robabeh Rahimi, PhD, DABR, MBA (mini_Healthcare) – University of Maryland
4:45 PM – 6:00 PM ET
2400 - Robotic Bronchoscope Housing a Plastic Catheter for HDR Brachytherapy Ensured Target Coverage While Minimizing Endobronchial Luminal Epithelium Dose
Location: Hall C
Presenter: Mahbubur Rahman, PhD – UT Southwestern Medical Center
4:45 PM – 6:00 PM ET
2401 - Conformal Simulation Omitted Treatment of Palliative Patients
Location: Hall C
Presenter: Andrew R. Godley, PhD
4:45 PM – 6:00 PM ET
2402 - Training a Diffusion-GAN to Improve the Head-and-Neck Intensity Modulated Radiation Therapy Fluence Generator
Location: Hall C
Presenter: Scott Reid, BS – Duke University Medical Center
4:45 PM – 6:00 PM ET
2403 - Initial Validation of Cone Beam Computed Tomography (CBCT) Only Treatment Planning Using a C-Arm Linac CBCT Solution
Location: Hall C
Presenter: Atefeh Rezaei, MD – Case Comprehensive Cancer Center, Case Western Reserve University
4:45 PM – 6:00 PM ET
2405 - Automated Planning Dose Optimization Methods for ProstateSBRT to Generate Synthetic Dose Data for Training a Plan Optimization Deep Learning Neural Network
Location: Hall C
Presenter: Jonathan Sackett, MD – University of Cincinnati - Barrett Cancer Center
4:45 PM – 6:00 PM ET
2406 - From Adults to Pediatrics: The Reliability and Reproducibility of AI Auto-Contouring in Pediatric Cancer Treatment
Location: Hall C
Presenter: Sogand Sadeghi, PhD – MD Anderson Cancer Center
4:45 PM – 6:00 PM ET
2407 - Feasibility of a Laser Scanning System in Reconstructing 3D Surface for Collision Detection during Radiotherapy
Location: Hall C
Presenter: Ziad Saleh, PhD – Washington University School of Medicine in St Louis
4:45 PM – 6:00 PM ET
2408 - Striking the Balance in Learning: Precision and Context in Lung Tumor Segmentation with 3D UNet Models
Location: Hall C
Presenter: Sagnik Sarkar, MS – Northwestern University Feinberg School of Medicine
4:45 PM – 6:00 PM ET
2409 - Class-Based Automatic Contour Correction Method for MR-Guided Online Adaptive Radiotherapy on a MR-Linac
Location: Hall C
Presenter: Asma Amjad, PhD – Medical College of Wisconsin
4:45 PM – 6:00 PM ET
2410 - Integrating Radiation-Induced Functionally-Weighted Airway Damage Modeling with Radiation-Induced Parenchymal Damage Modeling For Prediction of Post-RT Ventilation Loss
Location: Hall C
Presenter: Amit Sawant, PhD – University of Maryland
4:45 PM – 6:00 PM ET
2411 - Optimizing Dose Escalation for Lung Cancer Reirradiation: Integrating Conformal Bragg Peak FLASH Radiotherapy with FLASH Biological Optimization
Location: Hall C
Presenter: Minglei Kang, PhD – University of Wisconsin
4:45 PM – 6:00 PM ET
2411 - Optimizing Dose Escalation for Lung Cancer Reirradiation: Integrating Conformal Bragg Peak FLASH Radiotherapy with FLASH Biological Optimization
Location: Hall C
Presenter: Balaji Selvaraj, PhD – New York Proton Center
4:45 PM – 6:00 PM ET
2412 - Bragg Peak FLASH Technique with Clinical SBRT Regimen Delivers High-Conformity FLASH Radiotherapy for Spinal Cancers
Location: Hall C
Presenter: Minglei Kang, PhD – University of Wisconsin
4:45 PM – 6:00 PM ET
2413 - Quantitative Assessment of Tracked Dose Delivery with Biology-Guided Radiotherapy (BgRT)
Location: Hall C
Presenter: Sanchit Sharma, PhD
4:45 PM – 6:00 PM ET
2414 - Automated Contouring, Planning and Quality Assurance for VMAT Craniospinal Irradiation (VMAT CSI)
Location: Hall C
Presenter: Nataliya Kovalchuk, PhD – Stanford Cancer Institute Palo Alto
4:45 PM – 6:00 PM ET
2415 - Application of Photon-Derived Worst-Case Robustness Criteria to Prostate Cancer Proton Therapy Planning
Location: Hall C
Presenter: Krishmita Siwakoti, MD – University of Alabama at Birmingham
4:45 PM – 6:00 PM ET
2416 - CBCT-Based Dosimetric Comparison of Two Generic Imaging Algorithms
Location: Hall C
Presenter: Jennifer Smetanick, BS – University of Arizona College of Medicine - Phoenix
4:45 PM – 6:00 PM ET
2417 - A Comprehensive Workflow of Selecting Local Tolerance Limits to Detect Systematic Multi-Leaf Collimator Positional Errors by Combining Statistical Process Control and Error Curve Model
Location: Hall C
Presenter: Xin Yi, PhD – The First Affiliated Hospital of Chongqing Medical University
4:45 PM – 6:00 PM ET
2418 - Mobile LIDAR and 3D Sensors as a Feasible Method for the Preparation of 3D Printed Custom Boluses
Location: Hall C
Presenter: Mateusz Spałek, MD, DSc, PhD, MBA – Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie – Panstwowy Instytut Badawczy w Warszawie
4:45 PM – 6:00 PM ET
2419 - Auto-Contouring of Normal Organs Using AI and Intensity-Based Deformable Image Registration Algorithms: Opportunities and Caveats
Location: Hall C
Presenter: Bradley Stiehl, PhD – Cedars-Sinai Medical Center
4:45 PM – 6:00 PM ET
2420 - Fully Automated Online Adaptive Radiotherapy Decision Making for Cervical Cancer Using Artificial Intelligence
Location: Hall C
Presenter: Shuai Sun, MD, PhD – Peking Union Medical College Hospital
4:45 PM – 6:00 PM ET
2421 - Prediction Models of Cardiac Sparing during Deep Inspiration Breath-Hold in Left-Sided Breast Cancer with Internal Mammary Node Irradiation
Location: Hall C
Presenter: Xianglu Sun
4:45 PM – 6:00 PM ET
2422 - Evaluation of BgRT Delivery Accuracy for Multiple Small Targets of Varying Sizes
Location: Hall C
Presenter: Murat Surucu, PhD – Stanford University School of Medicine
4:45 PM – 6:00 PM ET
2423 - Effect of Biodistribution Changes via Increase in Target Size in Biology-Guided Radiotherapy (BgRT)
Location: Hall C
Presenter: Murat Surucu, PhD – Stanford University School of Medicine
4:45 PM – 6:00 PM ET
2424 - Preclinical FLASH-SARRP System: Initial Experience on Small Animal Setup and Workflow
Location: Hall C
Presenter: MohammadAli Tajik-Mansoury, PhD – Johns Hopkins Hospital
4:45 PM – 6:00 PM ET
2425 - A Novel Time-Varying Bi-Parametric Hyperelastic Bio-Mechanical Model for Personalized Lung Tumor Motion and Deformation
Location: Hall C
Presenter: Liang Tan, MS – Chongqing University Cancer Hospital
4:45 PM – 6:00 PM ET
2426 - An Investigation on the Relationships of Target Irregularities, Plan Complexities and Patient-Specific Quality Assurance Pre- and during Treatment
Location: Hall C
Presenter: Xia Tan, MS – Chongqing University Cancer Hospital
4:45 PM – 6:00 PM ET
2427 - Ablative Bone Metastasis Radiotherapy Using Diagnostic Computed Tomography Scans for Planning
Location: Hall C
Presenter: Edward Taylor, PhD – University Health Network
4:45 PM – 6:00 PM ET
2428 - Dosimetry Test of TaiChi Accelerator Intensity-Modulated Radiation Therapy and Volumetric-Modulated Arc Therapy
Location: Hall C
Presenter: Pang Tingtian
4:45 PM – 6:00 PM ET
2429 - Commission Test of S7 Mode Stereotactic Radiosurgery CyberKnife System with Multileaf Collimator Based on AAPM MPPG.5a Guide
Location: Hall C
Presenter: Pang Tingtian
4:45 PM – 6:00 PM ET
2431 - Dosimetric Comparison of Photon and Proton Radiosurgery for Large Arteriovenous Malformations
Location: Hall C
Presenter: Roman Travis, MD – University of Alabama Medical Center
4:45 PM – 6:00 PM ET
2432 - Feasibility and Safety of Multiple Courses of Gamma Knife Radiosurgery Treatment to Recurrent Trigeminal Neuralgia: A Single-Institutional Clinical Outcomes
Location: Hall C
Presenter: James Trosper – University of Kentucky College of Medicine
4:45 PM – 6:00 PM ET
2433 - Driving Efficiency of Lung SAbR X-Ray Based Adaptive Planning with TPS-Integrated Automation Tools
Location: Hall C
Presenter: Mu-Han Lin, PhD – UT Southwestern Medical Center
4:45 PM – 6:00 PM ET
2434 - Accuracy of Patient Setup in Breast Cancer Radiation Therapy Using Cone Beam Computed Tomography and Surface-Guided Radiotherapy - A Comparative Analysis
Location: Hall C
Presenter: Abiramasundari Vivekanandan, MBBS – All India Institute of Medical Sciences
4:45 PM – 6:00 PM ET
2435 - Impact of Intrafraction Patient Motion on Plan Dosimetry and Local Control for Lung SBRT
Location: Hall C
Presenter: Yohan Walter, MS – Willis-Knighton Cancer Center
4:45 PM – 6:00 PM ET
2439 - Application of Monitoring Internal Tumor Motion with Surface Guided System for Lung Stereotactic Body Radiotherapy in Deep Inspiration Breath-Hold
Location: Hall C
Presenter: Jiaxin Wang, PhD
4:45 PM – 6:00 PM ET
2440 - Mid-Range Arc Therapy—Enhancing Dosimetric Quality, Robustness and Efficiency for Proton Treatment with Simple Planning
Location: Hall C
Presenter: Qingying Wang, MS – University of Texas Southwestern Medical Center
4:45 PM – 6:00 PM ET
2441 - Development and Clinical Evaluation of a Portable Pixelated Radio-Luminescent Organic Phantom for Radiotherapy Quality Assurance
Location: Hall C
Presenter: Siqi Wang, PhD – Stanford
4:45 PM – 6:00 PM ET
2442 - Dosimetric Advantages of Simultaneous Integrated Boost Plan Using New Radiotherapy Platform in the Treatment of Brain Metastases
Location: Hall C
Presenter: Wei Wang – Xijing Hospital Air Force Medical University
4:45 PM – 6:00 PM ET
2443 - Image Guidance and Real-Time Dose Calculation of Low-Energy X-Ray Intraoperative Radiotherapy Based on Flat Applicators
Location: Hall C
Presenter: Wei Wang, MS – Tianjin Medical University Cancer Institute and Hospital
4:45 PM – 6:00 PM ET
2444 - Cross-Technique Transfer Learning to Predict the Dose Distribution for Radiotherapy Planning Based on a Limited Sample Size
Location: Hall C
Presenter: Xiaohong Wang, MD
4:45 PM – 6:00 PM ET
2445 - Dosimetric Advantage of a Novel X-Ray and ?-Ray Combination Technique in Patients with Cervical Cancer
Location: Hall C
Presenter: Zhongfei Wang, MD
4:45 PM – 6:00 PM ET
2446 - Dosimetric Advantage of Lattice Radiotherapy for Soft Tissue Sarcomas Using a Novel X-Ray and ?-Ray Combination Technique
Location: Hall C
Presenter: Zhongfei Wang, MD
4:45 PM – 6:00 PM ET
2447 - Commissioning of the Reflexion Positron Emission Tomography Guided Radiation Planning and Delivery System
Location: Hall C
Presenter: William Watkins, PhD – City of Hope National Medical Center
4:45 PM – 6:00 PM ET
2448 - Evaluation of a Real-Time Positional Verification System for High-Dose Dorsal Spinal Nerve Radiosurgery
Location: Hall C
Presenter: Seng (Gary) Lim, PhD – Memorial Sloan Kettering Cancer Center
4:45 PM – 6:00 PM ET
2449 - Radiation-Induced Cardiac Toxicity Risk Stratification Using Deep Learning-Based Dose Prediction
Location: Hall C
Presenter: Carri Glide-Hurst, PhD – University of Wisconsin Madison
4:45 PM – 6:00 PM ET
2450 - Effectiveness of Personalized Open-Face Mask Combined with Styrofoam Fixation in Radiotherapy Treatment of Head and Neck Cancers: A Prospective Randomized Controlled Trial
Location: Hall C
Presenter: Fa Yang
4:45 PM – 6:00 PM ET
2451 - Feasibility of Cardiac Chamber Auto-Segmentation and Dose Optimization for MR-Guided Online Adaptive Radiotherapy of Central Lung Cancer
Location: Hall C
Presenter: Jinzhong Yang, PhD – MD Anderson Cancer Center
4:45 PM – 6:00 PM ET
2452 - A Novel Predictive Model of Efficacy for Concurrent Chemoradiotherapy in Esophageal Squamous Cell Carcinoma
Location: Hall C
Presenter: Xin Yang, MS – Chongqing University Cancer Hospital
4:45 PM – 6:00 PM ET
2453 - Spatiotemporal Fractionation Schemes and Additional OAR Sparing for Single-Beam-per-Fraction FLASH-RT Using Transmission Proton Beam
Location: Hall C
Presenter: Zhiyong Yang
4:45 PM – 6:00 PM ET
2454 - Accelerated High-Resolution Monte-Carlo Dose Calculation by a Patient-Specific Deep Learning Image Super-Resolution Framework
Location: Hall C
Presenter: Siqi Ye, PhD – Stanford University
4:45 PM – 6:00 PM ET
2455 - Clinical Background of the Tolerance of the In-Air Spot Size Variation of Proton Beams
Location: Hall C
Presenter: Byong Yong Yi, PhD – University of Maryland
4:45 PM – 6:00 PM ET
2456 - Initial Assessment of Organ-at-Risk Variance Using Hounsfield Unit-Accurate Cone Beam CT and Auto-Segmentation for External Beam Radiation Therapy for Prostate Cancer
Location: Hall C
Presenter: Adam Olson, MD, MS – UPMC Hillman Cancer Center
4:45 PM – 6:00 PM ET
2457 - Multiplexed Deformable Contour Propagation and Deep Learning Auto Segmentation Using Automatic Contour Quality Assurance for Abdominal MR-Guided Online Adaptive Radiotherapy
Location: Hall C
Presenter: Mohammad Zarenia, PhD, MS – Medstar Georgetown University Hospital
4:45 PM – 6:00 PM ET
2458 - A Tumor Tracking Method with Deformation Image Registration-Enhanced Deep Learning Model in Surface-Guided Radiotherapy
Location: Hall C
Presenter: Gongsen Zhang, MD
4:45 PM – 6:00 PM ET
2459 - Clinical Implementation and Evaluation of an Integrated Automatic Contouring and VMAT Planning Workflow for Postoperative Breast Cancer
Location: Hall C
Presenter: Jing Zhang
4:45 PM – 6:00 PM ET
2460 - Efficacy of Preheating Bolus for Reducing Setup Errors in Patients with Breast Cancer Undergoing Postoperative Radiotherapy: A Randomized Controlled Study
Location: Hall C
Presenter: Hua Zhang – radiotherapy department
4:45 PM – 6:00 PM ET
2461 - Does Critical Neurological Tumor Radiotherapy Have Emergency?Clinical Application and Positioning Errors Analysis
Location: Hall C
Presenter: Ping Zhang, MD – Guangdong Sanjiu Brain Hospital
4:45 PM – 6:00 PM ET
2462 - Feasibility Study of Cone-Beam CT-Generated Synthetic CT for Cranial Tumor Proton Adaptive Radiotherapy
Location: Hall C
Presenter: Ran Zhang, MS – Shandong Tumor Hospital
4:45 PM – 6:00 PM ET
2463 - An Optimization Strategy for Midpiece Esophageal Cancer Treatment Plan Using Deep Learning-Based Dose Prediction
Location: Hall C
Presenter: Te Zhang, MD
4:45 PM – 6:00 PM ET
2465 - Unet-Attention Guided Cycle Generative Adversarial Networks Based Synthetic 4DCT from 4D-CBCT Generation for Lung Cancer Stereotactic Body Radiotherapy
Location: Hall C
Presenter: Xiangyu Zhang – West China Hospital of Sichuan University
4:45 PM – 6:00 PM ET
2466 - Different Treatment Strategies in Microbeam Radiation Therapy (MRT)
Location: Hall C
Presenter: Yating Zhang, MS – Technical University of Munich (TUM), Radiation Oncology
4:45 PM – 6:00 PM ET
2467 - An Intentionally-Overfitting Automatic Contour Quality Assurance Tool for Auto-Segmentation in MR-Guided Online Adaptive Radiotherapy
Location: Hall C
Presenter: Ying Zhang, PhD – University of Texas Southwestern Medical Center at Dallas
4:45 PM – 6:00 PM ET
2468 - Dosimetry and Quality Assurance of a Phase I Trial of Proton GRID Therapy on a Compact Proton Therapy Delivery System
Location: Hall C
Presenter: Xiandong Zhao, PhD – Washington University School of Medicine in St. Louis
4:45 PM – 6:00 PM ET
2469 - Gating QA Measurement to Investigate the Impact of Volumetric Repainting on a Compact Proton Therapy Delivery System
Location: Hall C
Presenter: Xiandong Zhao, PhD – Washington University School of Medicine in St. Louis
4:45 PM – 6:00 PM ET
2470 - Investigating the Portability of an Universal PBS Beam Model in a Compact Proton Therapy Delivery System
Location: Hall C
Presenter: Xiandong Zhao, PhD – Washington University School of Medicine in St. Louis
4:45 PM – 6:00 PM ET
2471 - M6 Intracranial Tumor SBRT Different Fixed Devices Analysis on the Influence of PTV Expansion Boundary
Location: Hall C
Presenter: Chunling Zheng, BS
4:45 PM – 6:00 PM ET
2472 - Assessment of Knowledge-Based Plan Optimization for a Clinical PET/CT-LINAC
Location: Hall C
Presenter: Weili Zhong, PhD – Yale New Haven Health
4:45 PM – 6:00 PM ET
2473 - CBCT Guided Daily Online Adaptive Treatment with Reduced Margin to Treat Gastric MALT Lymphoma
Location: Hall C
Presenter: Xinran Zhong, PhD – UT Southwestern Medical Center
4:45 PM – 6:00 PM ET
2474 - Investigation of Intravoxel Incoherent Motion (IVIM) on Unity MR-Linac for Head and Neck
Location: Hall C
Presenter: Yue Zhao, MD, PhD – China
4:45 PM – 6:00 PM ET
2475 - Feasibility of Dose Calculation for Pelvic Treatment Plans Using Electron Density Map from Novel Spectral CT Simulator
Location: Hall C
Presenter: Qizhen Zhu
Monday, September 30, 2024
8:00 AM – 9:00 AM ET
3469 - Association between Neurodevelopment and Neurocognitive Outcomes: A Multi-Trajectory Analysis in Childhood Brain Tumor Survivors
Location: Hall C
Presenter: Elizabeth Olatunji, BS, MPhil – Johns Hopkins Medicine
8:00 AM – 9:00 AM ET
3470 - Dosimetric Outcomes with the Addition of Interstitial Needles in HDR Brachytherapy for Non-Bulky Cervical Tumors
Location: Hall C
Presenter: Scarlett Acklin, MD – Duke University
8:00 AM – 9:00 AM ET
3471 - Radiation Oncology Provider Perceptions and Attitudes Towards Virtual Tumor Boards: Is Quality Maintained and Does Virtual Format Improve Work-Life Balance?
Location: Hall C
Presenter: Matt Adams, BS – Lake Erie College of Osteopathic Medicine
8:00 AM – 9:00 AM ET
3472 - A Cross Sectional Analysis of Radiation Oncology Presence on Tiktok
Location: Hall C
Presenter: Rimsha Afzal, BS – Kentucky College of Osteopathic Medicine
8:00 AM – 9:00 AM ET
3473 - Radiate & Educate: Empowering Future Physicians through an International Radiation Oncology Student Newsletter
Location: Hall C
Presenter: Anthony Alanis, BS – University of Texas Rio Grande Valley School of Medicine
8:00 AM – 9:00 AM ET
3474 - Research Match: Connecting Researchers to Projects
Location: Hall C
Presenter: James Alin, BS – Medical College of Georgia
8:00 AM – 9:00 AM ET
3475 - Quality of Life in Cervical Cancer Survivors Treated with Chemoradiotherapy: A Systematic Review
Location: Hall C
Presenter: Isabela Anawate, BA – University of Texas Southwestern Medical Center
8:00 AM – 9:00 AM ET
3476 - Standardizing Research Training in Radiation Oncology Residency: A Pilot Program Evaluation
Location: Hall C
Presenter: Rojine Ariani, MD, MS – UCLA David Geffen School of Medicine/UCLA Medical Center
8:00 AM – 9:00 AM ET
3477 - Evaluating the Impact of Bowel Gas Variations for Wilms Tumor in Pediatric Proton Therapy
Location: Hall C
Presenter: Ozgur Ates, PhD – St. Jude Children's Research Hospital
8:00 AM – 9:00 AM ET
3478 - Transforming into a Trauma-Informed Care Radiation Oncology Department: Training Program Design, Execution and Evaluation of our Programs Impact
Location: Hall C
Presenter: Courtney Misher, RT, BS, MPH – Penn Medicine
8:00 AM – 9:00 AM ET
3479 - Adjuvant Chemotherapy with High-Dose-Rate Vaginal Cuff Brachytherapy Alone vs. Chemotherapy with Pelvic Radiation (with or without Brachytherapy) in Locally Advanced Endometrial Cancer: Single Institu
Location: Hall C
Presenter: Mustafa Basree, DO, MS – University of Wisconsin Hospitals and Clinics
8:00 AM – 9:00 AM ET
3480 - The Comparison of Vaginal Cuff Brachytherapy and External Pelvic Radiotherapy in Stage IB Grade 3 Endometrial Cancer
Location: Hall C
Presenter: Ferah Yildiz, MD – Hacettepe University Medical School
8:00 AM – 9:00 AM ET
3481 - Funded Radiation Oncology Visiting Medical Student Electives: A Cross-Sectional Analysis
Location: Hall C
Presenter: Colin McNamara, MSN – Dartmouth Geisel School of Medicine
8:00 AM – 9:00 AM ET
3482 - Long-Term Outcomes following Proton Therapy for Pediatric Spinal Low-Grade Glioma
Location: Hall C
Presenter: Ryan Brisson, MD – University of Florida
8:00 AM – 9:00 AM ET
3483 - Radiation Oncology Hands-on Undergraduate Teaching: Digital Cross Sectional Anatomy and Tumor Pathology in CT, MRI and PET
Location: Hall C
Presenter: Thomas Brunner, MD – Medical University Graz
8:00 AM – 9:00 AM ET
3484 - Pretreatment Risk Factors for Cervical Cancer Recurrence: Examining Potential Indications for Treatment Intensification
Location: Hall C
Presenter: Santino Butler, MD – Stanford University School of Medicine
8:00 AM – 9:00 AM ET
3485 - Beyond the City Lights: Mapping the Rural Training Terrain for U.S. Radiation Oncology Residency Programs
Location: Hall C
Presenter: Vincent Cassidy, MD, MBA – University of Florida
8:00 AM – 9:00 AM ET
3486 - AI-Generated Image-Based Mnemonics: Enhancing Learning Efficiency in Radiation Oncology
Location: Hall C
Presenter: Basil Chaballout, MD – David Geffen School of Medicine at UCLA
8:00 AM – 9:00 AM ET
3487 - Impact of Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio on Definitive Treatment of Locally Advanced Cervical Cancer
Location: Hall C
Presenter: Yhana Chavis, DO – University of Virginia Health Systems
8:00 AM – 9:00 AM ET
3488 - Pilot Study of an Integrated Clinical and Didactic Interprofessional Curriculum on Breast Radiotherapy
Location: Hall C
Presenter: Jie Jane Chen, MD – University of California, San Francisco
8:00 AM – 9:00 AM ET
3489 - Efficacy of Concurrent Intensity Modulated Chemoradiotherapy Combined with Induction Chemotherapy or Adjuvant Chemotherapy in the Treatment of Locally Cervical Cancer with 2018FIGO Stage Correction
Location: Hall C
Presenter: Shaojun Chen, MD, MS, RT – Fourth Affiliated Hospital of Guangxi Medical University
8:00 AM – 9:00 AM ET
3490 - Digital vs. Human Scribes: Radiation Oncology Provider Perceptions and Attitudes
Location: Hall C
Presenter: Sylvia Choo, BA – University of South Florida College of Medicine
8:00 AM – 9:00 AM ET
3491 - Factors Associated with Stereotactic Body Radiotherapy Use in Oligometastatic Uterine Cancer and Implications for Survival
Location: Hall C
Presenter: Cheryl Claunch, MD, PhD – Baylor College of Medicine
8:00 AM – 9:00 AM ET
3492 - Patterns of Care and Clinical Outcomes for Pediatric Wilms Tumor Treated with Proton Therapy on the Multi-Institutional Pediatric Proton Consortium Registry
Location: Hall C
Presenter: Erron Collins, MD – WellStar Health System
8:00 AM – 9:00 AM ET
3493 - Template Based Transperineal Interstitial Brachytherapy for Gynecological Cancer: A Multi-Institutional Analysis of 319 Patients
Location: Hall C
Presenter: Ryan Davis, MD – City of Hope National Medical Center
8:00 AM – 9:00 AM ET
3494 - Characteristics of Radiation Oncology Residency Program Directors in 2023
Location: Hall C
Presenter: Sanjana Davuluri, BS, MHS – Rowan SOM
8:00 AM – 9:00 AM ET
3495 - Clinical Outcomes of Stage IVB Gynecologic Malignancies Treated with Definitive Radiotherapy
Location: Hall C
Presenter: Khaled Dibs, MD – The James Cancer Hospital & Solove Research Institute
8:00 AM – 9:00 AM ET
3496 - The Use of Stereotactic Body Radiation Therapy in the Management of Oligometastatic Disease in Uterine Cancer
Location: Hall C
Presenter: Baher Elgohari, MD, MS, MBBS – UPMC Hillman Cancer Center
8:00 AM – 9:00 AM ET
3497 - Adjuvant Treatment of Stage I-II Serous Endometrial Carcinoma: A Single Canadian Institutions 20-Year Retrospective Review
Location: Hall C
Presenter: Francois Fabi, MD, PhD
8:00 AM – 9:00 AM ET
3498 - The Radiosurgery Society Mentored Publications: Advancing Guidance and Collaboration in Stereotactic Radiation Therapy while Enhancing Physician Wellness
Location: Hall C
Presenter: Fatemeh Fekrmandi, MD, MS – Roswell Park Comprehensive Cancer Center
8:00 AM – 9:00 AM ET
3499 - Treatment Patterns and Outcomes in Geriatric Women with Cervical Cancer
Location: Hall C
Presenter: Sarah Feldkamp, MD – University of Cincinnati
8:00 AM – 9:00 AM ET
3500 - Clinical Outcomes of Neuroendocrine Carcinoma of the Cervix: Retrospective Review from a Large Academic Cancer Center
Location: Hall C
Presenter: Jason Fernandes, MD – University of Toronto
8:00 AM – 9:00 AM ET
3501 - Radiation Oncology Patient Education: A Scoping Review to Identify Future Directions for Scholarship
Location: Hall C
Presenter: Kathryn Fink, BS – Northwestern Feinberg School of Medicine
8:00 AM – 9:00 AM ET
3502 - Craniospinal Irradiation with Proton Beams Comparing Irradiation Method for Pediatric Patients
Location: Hall C
Presenter: Nobuyoshi Fukumitsu, MD, PhD – Kobe Proton Center
8:00 AM – 9:00 AM ET
3503 - The Role of Adjuvant Radiotherapy and Chemotherapy for Surgically Staged Non-Myoinvasive Uterine Serous Carcinoma with Negative Peritoneal Washings
Location: Hall C
Presenter: Ahmed Ghanem, MD, PhD – Henry Ford Cancer Institute/Alexandria University
8:00 AM – 9:00 AM ET
3504 - Feasibility of Biology-Guided Radiotherapy for Tumors in the Cervix Using a PET-CT Linac
Location: Hall C
Presenter: Grant Gibbard, MS – RefleXion
8:00 AM – 9:00 AM ET
3505 - Long Term Proton Therapy Outcomes in the Reirradiation Setting for Recurrent Pediatric Ependymoma
Location: Hall C
Presenter: Gobind Gill, MD – University of Alabama at Birmingham
8:00 AM – 9:00 AM ET
3506 - Incidence and Dosimetric Characteristics Associated with Mandible Osteoradionecrosis in Pediatric Patients Treated with Proton Therapy for Head and Neck Malignancies
Location: Hall C
Presenter: Sage Copling, BS – MD Anderson Cancer Center
8:00 AM – 9:00 AM ET
3507 - Gavage of Limosilactobacillus reuteri Releasing IL-22 (LR-IL-22), the Tumor Microenvironment, and Irradiation in Ovarian Cancer
Location: Hall C
Presenter: Diala Hamade, MD – University of Pittsburgh Medical Center
8:00 AM – 9:00 AM ET
3508 - Hypofractionated Pelvic Irradiation Followed by Image-Guided Brachytherapy in Women with Primary Gynecological Carcinoma or Oligometastatic Disease to Gynecological Tract: A New Paradigm of Care
Location: Hall C
Presenter: Diala Hamade, MD – University of Pittsburgh Medical Center
8:00 AM – 9:00 AM ET
3509 - Improving the Therapeutic Ratio in Parameningeal Rhabdomyosarcoma through the Use of LET-Optimized Proton Arc Therapy
Location: Hall C
Presenter: Andreas Handeland
8:00 AM – 9:00 AM ET
3510 - Local Recurrence Rates following Equivocal 3-month Post-Treatment PET after High Dose Rate Brachytherapy for Locally Advanced Cervical Cancer: An Updated Cohort
Location: Hall C
Presenter: Emily Harris, MD – Duke Cancer Institute
8:00 AM – 9:00 AM ET
3511 - FDG-PET/CT Guided Bone Marrow Sparing: Should We Spare Marrow Volume or Marrow Load
Location: Hall C
Presenter: Dimitre Hristov, PhD – Stanford University
8:00 AM – 9:00 AM ET
3512 - Assessing Individuals Who Graduate from a U.S. Radiation Oncology Residency Program and Subsequently Pursued a Fellowship
Location: Hall C
Presenter: Kristin Hsieh, MD – Icahn School of Medicine at Mount Sinai
8:00 AM – 9:00 AM ET
3513 - Improved Toxicities with Volumetric Modulated Arc Therapy Compared to 2D Total Body Irradiation
Location: Hall C
Presenter: Nataliya Kovalchuk, PhD – Stanford Cancer Institute Palo Alto
8:00 AM – 9:00 AM ET
3514 - Prognostic Factors in H3K7M-Mutant Diffuse Midline Gliomas
Location: Hall C
Presenter: Samantha Induni – Georgetown University
8:00 AM – 9:00 AM ET
3515 - Re-Irradiation in Children with Recurrent Medulloblastoma
Location: Hall C
Presenter: Ayca Iribas, MD – Istanbul University
8:00 AM – 9:00 AM ET
3516 - Outcomes and Patterns of Failure for Women with FIGO Stage I-II Uterine Non-Endometroid Carcinoma after Surgical Staging, Adjuvant Chemotherapy and Vaginal Cuff Brachytherapy
Location: Hall C
Presenter: Yoonsun Jee, MD – Henry Ford Hospital-Henry Ford Cancer Institute
8:00 AM – 9:00 AM ET
3517 - Cervical Clear Cell Adenocarcinoma: Real-World Insights on Patient Profiles, Treatments and Comparative Efficacy of Locoregional Treatments
Location: Hall C
Presenter: Samyukta Jhavar – Baylor College of Medicine
8:00 AM – 9:00 AM ET
3518 - Systemic Immune-Inflammatory Index Predict Short-Term Outcome in Cervical Cancer Patients Treated with PD-1 Inhibitor
Location: Hall C
Presenter: Ruiqiu Zhu, MD, PhD – Soochow University
8:00 AM – 9:00 AM ET
3519 - Bulky Primary Thoracic Sarcomas in Children Treated with Preoperative Proton Radiotherapy
Location: Hall C
Presenter: Cecilia Jiang, MD – University of Pennsylvania
8:00 AM – 9:00 AM ET
3520 - The Safety and Efficacy of Cadonilimab in the First-Line Treatment of Recurrent or Metastatic Cervical Cancer: A Retrospective, Real-World Study
Location: Hall C
Presenter: Ge Jin, PhD – The Fourth Hospital of Hebei Medical University
8:00 AM – 9:00 AM ET
3521 - Implementation of a Radiation Oncology Protocol Committee for Clinical Trial Review and Prioritization
Location: Hall C
Presenter: Melinda Jin – Penn State University
8:00 AM – 9:00 AM ET
3522 - Implementation and Evaluation of a Patient-Reported Health Status Survey for Survivors of Childhood Malignancies Treated with Radiation
Location: Hall C
Presenter: Jaitri Joshi, MS – Massachusetts General Hospital
8:00 AM – 9:00 AM ET
3523 - Eight-Year Results of a Phase II Prospective Trial of Proton Therapy for Non-Metastatic Pediatric Non-Rhabdomyosarcoma Soft Tissue and Bone Sarcomas
Location: Hall C
Presenter: Soo Kang, BSN – Massachusetts General Hospital
8:00 AM – 9:00 AM ET
3524 - Human Papilloma Virus Profiles in Healthy Women, Women with Cervical Intraepithelial Neoplasia, and Women with Invasive Cervical Cancer in Botswana
Location: Hall C
Presenter: Caroline Kernell, BS – UT Southwestern Medical Center
8:00 AM – 9:00 AM ET
3525 - Hypofractionated Radiotherapy in Treatment of Cervical Cancer: A Systematic Review
Location: Hall C
Presenter: Madelyn Fahhoum, BA – Medical College of Wisconsin
8:00 AM – 9:00 AM ET
3526 - Dosimetric Evaluation of a Novel HDR Brachytherapy Applicator for Intensity-Modulated Intracavitary Brachytherapy in Locally Advanced Cervical Cancers
Location: Hall C
Presenter: Dohyeon Kim, PhD, Resident – National Cancer Center, Korea
8:00 AM – 9:00 AM ET
3527 - Outcomes Following Radiation Therapy (RT) for Embryonal Tumor with Multilayered Rosettes (ETMR): Results from the Pediatric Proton/Photon Consortium Registry (PPCR)
Location: Hall C
Presenter: Jacquelyn Krisch, MD, ME – SUNY Upstate Medical University
8:00 AM – 9:00 AM ET
3528 - Utility of Virtual Information Sessions to Inform Medical Students about Radiation Oncology Residency Programs
Location: Hall C
Presenter: Conley Kriegler, MD – University of Alberta
8:00 AM – 9:00 AM ET
3529 - Impact of Didactic Instruction upon Medicolegal Quality of Radiation Oncology Resident Physician Documentation
Location: Hall C
Presenter: Vaishvi Patel, MD – Cross Cancer Institute
8:00 AM – 9:00 AM ET
3530 - Hybrid Intracavitary-Interstitial High-Dose-Rate Brachytherapy for Vaginal Recurrence from Endometrial Cancer
Location: Hall C
Presenter: Pavnesh Kumar, MD, MBBS – The Ohio State University James Cancer Hospital
8:00 AM – 9:00 AM ET
3531 - Assessment of Speaker Roles for Radiation Oncologists in ASCO Annual Conference Education Sessions
Location: Hall C
Presenter: Ritesh Kumar, MD – Rutgers Cancer Institute of New Jersey
8:00 AM – 9:00 AM ET
3532 - A Pilot Study of an Educational and Clinical Mobile Application for Patients Receiving Radiation Treatment
Location: Hall C
Presenter: Colton Ladbury, MD, BS – City of Hope National Medical Center
8:00 AM – 9:00 AM ET
3533 - Outcomes of Exclusive Use of Magnetic Resonance Image-Guided Brachytherapy in Locally Advanced Cervical Cancer with a Focus on Central Control and Evaluation of an Auto-Segmentation Tool for High-Risk
Location: Hall C
Presenter: Yosef Landman Gigi, MD – Johns Hopkins Hospital
8:00 AM – 9:00 AM ET
3534 - Analysis of Radiation Oncology Residency Program Websites: A Call for Further Improvements
Location: Hall C
Presenter: David Lee, MD – University of Miami - Sylvester Cancer Center
8:00 AM – 9:00 AM ET
3535 - Prognostic Value of Metabolic Change in Patients with Locally Advanced Cervical Cancer Treated with Chemoradiotherapy
Location: Hall C
Presenter: Haoting Shi, MD – Ruijin Hospital, Shanghai Jiaotong University School of Medicine
8:00 AM – 9:00 AM ET
3536 - AI-Assisted 3D Printing Transvaginal Template Guidance for Interstitial Brachytherapy in Patients with Cervical Cancer with Parametrial Invasion
Location: Hall C
Presenter: Huiling Li, MD – Affiliated Hospital of Xuzhou Medical University
8:00 AM – 9:00 AM ET
3537 - Characterization of Clinical Outcomes for Patients with Relapsed High-Risk Neuroblastoma after External Beam Radiotherapy
Location: Hall C
Presenter: Kevin Liu, MD, DPhil – Brigham and Womens Hopsital
8:00 AM – 9:00 AM ET
3538 - Animated, Multilingual, ADA-Accessible Videos to Improve Patient Education and Radiation Treatment Outcomes
Location: Hall C
Presenter: Eulanca Liu, MD, PhD – UCLA Radiation Oncology
8:00 AM – 9:00 AM ET
3539 - Implementation of a Holistic Review Pipeline for Radiation Oncology Residency Applicants: A Test Case Evaluating Gender Equity
Location: Hall C
Presenter: Eulanca Liu, MD, PhD – UCLA Radiation Oncology
8:00 AM – 9:00 AM ET
3540 - Impact of Total Dose and Treatment Modality on Survival in Inoperable Endometrial Cancer in the National Cancer Database
Location: Hall C
Presenter: Alexander Lukez, MD – Fox Chase Cancer Center
8:00 AM – 9:00 AM ET
3541 - Adaptive Magnetic Resonance Guided Radiation Therapy for Definitive Treatment of Gynecologic Malignancies
Location: Hall C
Presenter: Kathryn Marqueen, MD – University of Texas MD Anderson Cancer Center
8:00 AM – 9:00 AM ET
3542 - Impact of Role Identification Badge Placards on Radiation Oncology Staff Job Satisfaction and Wellbeing
Location: Hall C
Presenter: Elizabeth McKone, MD – Mayo Clinic Rochester
8:00 AM – 9:00 AM ET
3543 - Utility of ⁶⁸Ga DOTA-Octreotate PET/CT in Characterization of Pediatric Neuroendocrine Tumors
Location: Hall C
Presenter: Elizabeth McKone, MD – Mayo Clinic Rochester
8:00 AM – 9:00 AM ET
3544 - Gaps in Understanding of Cardio-Oncology amongst Cardiologists and Oncologists Working in Multidisciplinary Academic Institutions
Location: Hall C
Presenter: Shagun Misra, MD – Sanjay Gandhi Postgraduate Institute of Medical Sciences
8:00 AM – 9:00 AM ET
3545 - Twice Daily Template-Based Interstitial Brachytherapy for Gynecologic Cancers: What is the Optimal Dose?
Location: Hall C
Presenter: Ria Mulherkar, MD – UPMC Cancer Center
8:00 AM – 9:00 AM ET
3546 - Preclinical efficacy of TTFields and PARP inhibitors in ovarian cancer models
Location: Hall C
Presenter: Helena Mumblat, PhD – Novocure
8:00 AM – 9:00 AM ET
3547 - Tumor Treating Fields (TTFields) Augment the Efficacy of Cisplatin for Treatment of Cervical Cancer, In Vitro and In Vivo
Location: Hall C
Presenter: Helena Mumblat, PhD – Novocure
8:00 AM – 9:00 AM ET
3548 - The Global Framework for the Education of Radiation Therapists.
Location: Hall C
Presenter: Colleen Dickie, MS, RT – Princess Margaret Cancer Centre
8:00 AM – 9:00 AM ET
3549 - High-Dose-Rate Interstitial Brachytherapy for Cervical Cancer - The More Catheters the Merrier?
Location: Hall C
Presenter: Shyamal Patel, MD
8:00 AM – 9:00 AM ET
3550 - Impact of Cachexia on Overall Survival and Recurrence Rates in Locally Advanced Cervical Cancer Patients
Location: Hall C
Presenter: Linzi Paul, MS – LSUHSC- New Orleans
8:00 AM – 9:00 AM ET
3551 - Adjuvant Treatment and Outcomes for Stage III Serous Endometrial Cancer Patients at a Single Institution
Location: Hall C
Presenter: Joanne Jang, MD, PhD – Beth Israel Deaconess Medical Center
8:00 AM – 9:00 AM ET
3552 - Outcomes of Salvage Radiotherapy and Chemotherapy for Vaginal Vault Carcinoma Following Earlier Hysterectomy
Location: Hall C
Presenter: Satyajit Pradhan, MD – Mahamana Pandit Madan Mohan Malaviya Cancer Centre
8:00 AM – 9:00 AM ET
3553 - Pre-Radiotherapy Absolute Lymphocyte Counts Predict Benefit from Having Cisplatin Chemotherapy with Radiotherapy in Cervical Carcinoma
Location: Hall C
Presenter: James Price, MBBS, FRCR – The Christie NHS Foundation Trust
8:00 AM – 9:00 AM ET
3554 - A Simple Method to Generate Descriptive Images for Recurrent Cervix Cancer Using Predictive ResNet Model Weights and Feature Maps
Location: Hall C
Presenter: Destie Provenzano, MS – George Washington University
8:00 AM – 9:00 AM ET
3555 - Misinformation Regarding Medical Cannabis as a Cancer Cure among Patients with Central Nervous System and Gastrointestinal Cancer
Location: Hall C
Presenter: Vera Qu, BS – University of Southern California Keck School of Medicine
8:00 AM – 9:00 AM ET
3556 - Impact of Resident-Lead Didactics on Referring Trainee Radiotherapy Knowledge and Consultation Comfort
Location: Hall C
Presenter: Katelyn Ragland, MD – University of Alabama at Birmingham
8:00 AM – 9:00 AM ET
3557 - Studying the Necessity to Account for Rotational Errors in a 3D PTV for Translational Motion in Pelvic Radiotherapy
Location: Hall C
Presenter: Vrushab Rao, MBBS, PDCR – Ruby Hall Clinic
8:00 AM – 9:00 AM ET
3558 - Improving Academic Productivity or Raising Ethical Concerns? Time-Series Analysis of AI-Assisted Scientific Writing
Location: Hall C
Presenter: Charlotte Read, MS, BS – Icahn School of Medicine at Mount Sinai
8:00 AM – 9:00 AM ET
3559 - CT and MRI Time Difference on OAR Dose in HDR for Cervical Cancer
Location: Hall C
Presenter: Atefeh Rezaei, MD – Case Comprehensive Cancer Center, Case Western Reserve University
8:00 AM – 9:00 AM ET
3560 - Neighborhood Socioeconomic Status of Women with Locally Advanced Cervical Cancer and Access to Brachytherapy
Location: Hall C
Presenter: Lucy Rose, MA – Ohio State University College of Medicine
8:00 AM – 9:00 AM ET
3561 - Systematic Review and Meta-Analysis of Adjuvant Radiation Dose for Pediatric Patients (=22y) with Non-Metastatic Intracranial Ependymomas
Location: Hall C
Presenter: Melanie Rose, MD – Dartmouth-Hitchcock Medical Center
8:00 AM – 9:00 AM ET
3562 - Comparative Analysis of Adjuvant Treatment Outcomes in Stage III Endometrial Cancer
Location: Hall C
Presenter: Joanne Jang, MD, PhD – Beth Israel Deaconess Medical Center
8:00 AM – 9:00 AM ET
3563 - Impact of Adjuvant Radiation on Mortality in Surgically Staged Stage IB Grade 3 and II Endometrioid Endometrial Cancer: Propensity Score Matching Analysis
Location: Hall C
Presenter: Shoshana Rosenzweig, MD – Memorial Sloan Kettering Cancer Center
8:00 AM – 9:00 AM ET
3564 - Assessment of a Student-Run Multidisciplinary Oncology Shadowing Program
Location: Hall C
Presenter: Marco Santos Teles, BS – Rutgers New Jersey Medical School
8:00 AM – 9:00 AM ET
3565 - Implementation of a Multidisciplinary Cancer Center Clinical Oncology and Research Symposium for Medical Students, Residents, Fellows and Faculty
Location: Hall C
Presenter: Aronne Schottstaedt, MD, MS – MCWAH
8:00 AM – 9:00 AM ET
3566 - Application of NRS Nutritional Status Evaluation in Radiotherapy and Chemotherapy of Patients with Cervical Cancer
Location: Hall C
Presenter: Lang Shan
8:00 AM – 9:00 AM ET
3567 - Ovary Sparing IMRT for Locally Advanced Cervical Cancer after Laparoscopic Ovarian Transposition
Location: Hall C
Presenter: Jeffrey Shogan, DO – University of Pittsburgh Medical Center
8:00 AM – 9:00 AM ET
3568 - Efficacy and Safety of Brachytherapy in Primary Vaginal Carcinoma
Location: Hall C
Presenter: Ingrid Sidibe, MD – CHU de Quebec - Universite Laval - Centre integre de cancerologie
8:00 AM – 9:00 AM ET
3569 - Pre-Treatment and Pre-Brachytherapy MRI First-Order Radiomic Features By a Commercial Software As Survival Predictors in Radiotherapy for Cervical Cancer
Location: Hall C
Presenter: Tissana Prasartseree, MD – Siriraj Hospital Mahidol University
8:00 AM – 9:00 AM ET
3570 - Utilization Assessment of the Introductory Radiation Oncology Curriculum (IROC) for Radiation Oncology Trainees
Location: Hall C
Presenter: Amanda Stark, MD – VCU Health Stony Point/Massey Cancer Center
8:00 AM – 9:00 AM ET
3571 - Interstitial High-Dose Rate Brachytherapy with or without Interstitial Hyperthermia for Gynecologic Malignancies
Location: Hall C
Presenter: Austin Thompson, MD – University of Maryland Medical Center
8:00 AM – 9:00 AM ET
3572 - The MEDaphor Project: Comparing Readability and Access of Novel Cancer Education Materials for Patients with Limited Health Literacy
Location: Hall C
Presenter: Michelle Tibbs, MD, MAS – UCSD Radiation Medicine and Applied Sciences
8:00 AM – 9:00 AM ET
3573 - The Effect of Institutional Support vs. Peer Influence on Match Rates into Radiation Oncology over 5 Years: 2019 to 2023
Location: Hall C
Presenter: Olivia Trumble, BS – University of Florida College of Medicine
8:00 AM – 9:00 AM ET
3574 - Evaluation of a Graphic Narrative Patient Education Tool to Reduce Pre-Treatment Anxiety for Patients Receiving Radiotherapy in a Latin American Hospital
Location: Hall C
Presenter: Augustin Vannier, BA – University of Chicago Pritzker School of Medicine
8:00 AM – 9:00 AM ET
3575 - A Randomized Crossover Trial to Compare Two Rectum Separation Techniques during High-Dose-Rate Intracavitary Brachytherapy with Tandem-Ring Applicators for Cancer Cervix
Location: Hall C
Presenter: Siddharth Vats, MD – Cancer Hospital Shimla
8:00 AM – 9:00 AM ET
3576 - Dosimetric Effects of Intrafraction Changes in High Dose Rate (HDR) Cervical Brachytherapy - Can We Avoid Replanning for Every Fraction in MR Guided Brachytherapy Era?
Location: Hall C
Presenter: Jeyaanth Venkatasai, MD, MBBS, FRCR – Guy's and St Thomas' NHS Foundation Trust
8:00 AM – 9:00 AM ET
3577 - A Single-Institution Retrospective Analysis of the TBI-ARC Technique in Patients Who Received Total Body Irradiation
Location: Hall C
Presenter: Benson Wan, MD, BS – McGill University
8:00 AM – 9:00 AM ET
3578 - Comparing the Effects of Paclitaxel Liposomes and Albumin-Bound Paclitaxel on the Tumor Regression Rate among Cervical Cancer Patients Undergoing Concurrent Radiotherapy
Location: Hall C
Presenter: Che Wang – The First Affiliated Hospital of Xi'an Jiaotong University
8:00 AM – 9:00 AM ET
3579 - Investigation and Analysis of Nutritional Risks on Oral Nutrition Supplementation during the Peri-Radiotherapy Period: A Multicenter Cross-Sectional Study
Location: Hall C
Presenter: Cong Wang, PhD – Qilu Hospital of Shandong University
8:00 AM – 9:00 AM ET
3580 - The Association of Linear Energy Transfer and Dose with Radiation Necrosis after Proton Therapy in Pediatric Posterior Fossa Tumors
Location: Hall C
Presenter: Jarey Wang, MD, PhD – Johns Hopkins University School of Medicine
8:00 AM – 9:00 AM ET
3581 - Comprehensive Evaluation of the Prognostic Value of Hematological Parameters, Nutritional Status Indices and Serum Tumor Markers in Patients with Locally Advanced Cervical Cancer: A Retrospective Stud
Location: Hall C
Presenter: Shanshan Wang, PhD, MS, BS, MBBS – Shanghai Jiao Tong University
8:00 AM – 9:00 AM ET
3582 - Compared to 18F-FDG PET/CT, the Value of 18F-NOTA TATE PET/CT in Predicting the Short-Term Outcome of Neuroblastoma in Children
Location: Hall C
Presenter: Wenjiao Wang, ChB
8:00 AM – 9:00 AM ET
3583 - Prognosis of Children with Rhabdomyosarcoma Treated with Radiotherapy
Location: Hall C
Presenter: Yuqing Wang, MD, PhD
8:00 AM – 9:00 AM ET
3584 - Appraisal of Utility of ctDNA in Patients with Vulvar Cancer Treated with Radiation: Early Report
Location: Hall C
Presenter: Gabriella Wernicke, MD, MS – Northwell Health Cancer Institute
8:00 AM – 9:00 AM ET
3585 - Analyzing Stage Migration between the FIGO 2009 and 2023 Staging Classifications in Endometrial Cancer Patients
Location: Hall C
Presenter: John White, MD – University of Chicago
8:00 AM – 9:00 AM ET
3586 - Defining a Radiation Oncology Observership Curriculum via the Delphi Method
Location: Hall C
Presenter: Matthew Abrams, MD – Beth Israel Deaconess Medical Center
8:00 AM – 9:00 AM ET
3587 - Implementing a Flipped Classroom Concept for Radiation Oncology Physics Curriculum
Location: Hall C
Presenter: Christopher Williamson, MD, MS – Emory University
8:00 AM – 9:00 AM ET
3588 - Overall Experience of Two Clinical Trials for FUS-Mediated Blood Brain Barrier-Opening for Patients with DIPG/DMG Delivered in Radiation Oncology
Location: Hall C
Presenter: Cheng-Chia Wu, MD, PhD – Virginia Tech Carilion School of Medicine
8:00 AM – 9:00 AM ET
3589 - Effects of Vertebral-Body-Sparing Proton Craniospinal Irradiation on Spinal Growth and Acute Toxicities in Pediatric Patients Using Pencil Beam Scanning
Location: Hall C
Presenter: Chuyu Xia, MD – Peking University First Hospital
8:00 AM – 9:00 AM ET
3590 - Position Selection for Postoperative Cervical Cancer Treatment with Volumetric Modulated Arc Therapy: Supine or Prone Position
Location: Hall C
Presenter: Nan Xiao, MD – Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
8:00 AM – 9:00 AM ET
3591 - Phase II Study of Induction Immunotherapy Combined with Platinum-Base Doublet Chemotherapy Followed by Immunotherapy and Chemoradiotherapy in High-Risk Locally Advanced Cervical Cancer
Location: Hall C
Presenter: Xiao-Fan Li, MD
8:00 AM – 9:00 AM ET
3592 - Problem-Based Learning on the WeChat Public Platform in Radiation Oncology Residency Training Programs
Location: Hall C
Presenter: Yi Rui Zhai, MD – National Cancer Center/National Clinical Research Center for Cance
8:00 AM – 9:00 AM ET
3593 - Analysis of Conditional Survival in Patients with Gynecologic Malignancies Treated with Radiation
Location: Hall C
Presenter: Jimmy Patel, MD, PhD – Emory University
8:00 AM – 9:00 AM ET
3594 - A CNN-Based Dose Prediction Method for Brachytherapy Treatment Planning of Patients with Cervical Cancer
Location: Hall C
Presenter: Wenjun Zhang
8:00 AM – 9:00 AM ET
3595 - Evaluating the Potential of Proton Therapy for Whole Abdominal Radiotherapy
Location: Hall C
Presenter: Conan Zhao, PhD – Mayo Clinic Alix School of Medicine
8:00 AM – 9:00 AM ET
3596 - Incorporating POLD1 for Prognostication of Black Endometrial Cancer Patients
Location: Hall C
Presenter: Shuhua Zheng, DO, PhD – Northwestern Feinberg School of Medicine
10:45 AM – 12:00 PM ET
2477 - Repeat Stereotactic Radiosurgery in Patients with Spinal Metastases Recurrent Following Initial Radiosurgery
Location: Hall C
Presenter: Joseph Abi Jaoude, MD – Stanford University
10:45 AM – 12:00 PM ET
2478 - PD-L1, Tumor Mutational Burden (TMB) and Intracranial Outcomes in Patients with Non-Small Cell Lung Cancer (NSCLC) and Brain Metastases
Location: Hall C
Presenter: Elio Adib, MD – Mass General Brigham
10:45 AM – 12:00 PM ET
2479 - Ablative Stereotactic MR-Guided Adaptive Radiotherapy in Patients with Infra-Diaphragmatic Oligometastatic Disease
Location: Hall C
Presenter: Eyub Yasar Akdemir, MD – Baptist Health
10:45 AM – 12:00 PM ET
2480 - Radiation Therapy for Palliation of Symptomatic Bone Metastases: An ASTRO Clinical Practice Guideline
Location: Hall C
Presenter: Sara Alcorn, MD, PhD, MPH – University of Minnesota
10:45 AM – 12:00 PM ET
2481 - Metastasis-Directed Stereotactic Body Radiation Therapy in Oligometastatic and Oligoprogressive Solid Malignancy: Outcomes and Effect on Systemic Treatment
Location: Hall C
Presenter: Abdulla Alzibdeh, MD – King Hussein Cancer Center
10:45 AM – 12:00 PM ET
2482 - Patient Reported Outcomes Following Brain Reirradiation (reRT) with Proton Therapy
Location: Hall C
Presenter: Joshua Anderson, MD, BS – Emory University School of Medicine
10:45 AM – 12:00 PM ET
2483 - Response to ONC201 by Prior Radiotherapy Regimen in Recurrent H3 K27M-Mutant Diffuse Midline Glioma
Location: Hall C
Presenter: Pablo Lee, MD – Chimerix
10:45 AM – 12:00 PM ET
2484 - Incidence and Risk Factors Associated with Need for Treatment of Vertebral Compression Fractures after Spine Stereotactic Radiosurgery
Location: Hall C
Presenter: Jessica Bai, BS – Case Western Reserve School of Medicine
10:45 AM – 12:00 PM ET
2485 - Additional Salvage Spine Stereotactic Radiosurgery (SRS) Following Radiographic Progression of Spinal Metastases in Patients Previously Re-Irradiated with SRS
Location: Hall C
Presenter: Jessica Bai, BS – Case Western Reserve School of Medicine
10:45 AM – 12:00 PM ET
2486 - Progesterone Contraception and Tumor-Related Visual Impairment in Premenopausal Women with Meningioma Referred for Radiation
Location: Hall C
Presenter: Morgan Bailey, MD – University of Cincinnati - Barrett Cancer Center
10:45 AM – 12:00 PM ET
2487 - Efficacy of Stereotactic Body Radiation Therapy (SBRT) to Prolong Systemic Therapy (ST) for Patients with Oligoprogressive (OP) Metastatic Breast Cancer (MBC)
Location: Hall C
Presenter: Jose Bazan, MD, MS – City of Hope Comprehensive Cancer Center
10:45 AM – 12:00 PM ET
2488 - Impact of CT-Derived Radiomics and Dosiomics on Survival Prognosis in Glioblastoma Patients
Location: Hall C
Presenter: Ali Kamen, PhD – Siemens Healthineers
10:45 AM – 12:00 PM ET
2489 - Comparison of Distant Intracranial Disease Control between Central Nervous System-Penetrating Tyrosine Kinase Inhibitors and Immunotherapy in Non-Small Cell Lung Cancer Metastatic to Brain Following S
Location: Hall C
Presenter: Adam Beighley, MD – Kaiser Permanente Los Angeles Medical Center
10:45 AM – 12:00 PM ET
2490 - Predictors of Local Failure in the Durable Palliation of Recurrent Breast Cancer Following Concurrent Hyperthermia and High Dose Radiation
Location: Hall C
Presenter: Mark Solter, BA – Cleveland Clinic Lerner College of Medicine
10:45 AM – 12:00 PM ET
2491 - Predictors of Vertebral Compression Fracture Following Spine Stereotactic Body Radiotherapy Vary with Pre-Existing Fracture
Location: Hall C
Presenter: Laura Burgess, MD, MS – Odette Cancer Centre
10:45 AM – 12:00 PM ET
2492 - Predictors of Vertebral Compression Fracture Following Spine Stereotactic Body Radiotherapy Vary with Cause: Iatrogenic or in Conjunction with Local Failure
Location: Hall C
Presenter: Laura Burgess, MD, MS – Odette Cancer Centre
10:45 AM – 12:00 PM ET
2493 - Efficacy and Safety of Magnetic Resonance-Guided Online Adaptive Stereotactic Radiotherapy in Oligometastatic Gynecologic Malignancies: A Multi-Institutional Outcomes Study
Location: Hall C
Presenter: Danielle Cerbon, MD – University of Miami
10:45 AM – 12:00 PM ET
2494 - Clinical Outcomes and Toxicities Associated with Radiation Therapy for Patients with Leptomeningeal Dissemination of Primary Gliomas
Location: Hall C
Presenter: Ashley Chavana, BS – Baylor College of Medicine
10:45 AM – 12:00 PM ET
2495 - Symptom Palliation with QUADSHOT Regimen for Advanced Cervical Cancer
Location: Hall C
Presenter: Tsion Chema, MD – Addis Ababa University
10:45 AM – 12:00 PM ET
2496 - Comparison of Efficacy between Osteolytic vs. Osteoblastic Metastatic Lesion in Lung Cancer Following Radiotherapy
Location: Hall C
Presenter: Dong-Jie Chen, MS – ShenZhen Cancer Hospital
10:45 AM – 12:00 PM ET
2497 - Management of Multiple Brain Metastases with Serial Stereotactic Radiosurgery vs. Whole Brain Radiation Therapy
Location: Hall C
Presenter: Jie Jane Chen, MD – University of California, San Francisco
10:45 AM – 12:00 PM ET
2498 - Impact of KEAP1/NFE2L2 Mutations on Local Recurrence in Patients Receiving Stereotactic Radiosurgery for Non-Small Cell Lung Cancer Brain Metastases
Location: Hall C
Presenter: Mark Chen, MD, PhD – Duke University
10:45 AM – 12:00 PM ET
2499 - Efficacy and Safety of STUPP Regimen ± Anlotinib for Newly Diagnosed Glioblastoma: A Multicenter, Double-Blind, Randomized Phase II Trial
Location: Hall C
Presenter: Yuanyuan Chen, MD – Sun Yat-Sen University Cancer Center
10:45 AM – 12:00 PM ET
2500 - Identifying Risk Factors Associated with Outcomes for Patients with Recurrent and Progressive Meningiomas: A Secondary Analysis of SWOG S9005
Location: Hall C
Presenter: Hua-Ren Cherng, MD – University of Maryland Medical Center
10:45 AM – 12:00 PM ET
2501 - Tumor Treating Fields Utilization for Glioblastoma at a Large Multicenter Academic Practice
Location: Hall C
Presenter: David Crompton, MD, BS – Mayo Clinic College of Medicine and Science Jacksonville
10:45 AM – 12:00 PM ET
2502 - Modern Patterns of Failure for Glioblastoma at a Large Multicenter Academic Practice
Location: Hall C
Presenter: David Crompton, MD, BS – Mayo Clinic College of Medicine and Science Jacksonville
10:45 AM – 12:00 PM ET
2503 - Identification of Triapine as a Novel Radiosensitizer in Glioblastoma
Location: Hall C
Presenter: Tiantian Cui, MD, PhD – City of Hope National Medical Center
10:45 AM – 12:00 PM ET
2504 - Optimal Intervention Timing for Craniocerebral Radiotherapy in Patients with EGFR-Mutant Lung Adenocarcinoma and Brain Metastases
Location: Hall C
Presenter: Guangchuan Deng, PhD, MBBS – Shandong Cancer Hospital and Institute
10:45 AM – 12:00 PM ET
2505 - Inter-Fraction Dynamics and Dosimetric Assessment during MR-Guided Online Adaptive Radiotherapy for Glioblastoma
Location: Hall C
Presenter: Shouliang Ding, PhD, MS – Sun Yat-Sen University Cancer Center
10:45 AM – 12:00 PM ET
2506 - Exploring the Impact of Personalized Ultra-Fractionated Stereotactic Adaptive Radiotherapy for the Treatment of Brain Metastases
Location: Hall C
Presenter: Michael Dohopolski, MD – UT Southwestern Medical Center
10:45 AM – 12:00 PM ET
2507 - Characterization of Clinical Feasibility, Reproducibility and Dosimetric Impact of Palliative Immobilization Devices to Optimize Patient Comfort
Location: Hall C
Presenter: Victoria Doss, MD – Johns Hopkins Medicine
10:45 AM – 12:00 PM ET
2508 - Time-Delayed Contrast-Enhanced T2-FLAIR and Accuracy of GTV Determination in Brain Metastases
Location: Hall C
Presenter: Shanshan Du, MS
10:45 AM – 12:00 PM ET
2509 - In-Depth Pattern-of-Failure Analysis of Grade 2 Meningiomas after Proton and Photon-Based Fractionated Radiotherapy
Location: Hall C
Presenter: Felix Ehret, MD – Massachusetts General Hospital
10:45 AM – 12:00 PM ET
2510 - Dosimetric Analysis of Salvage SBRT Reirradiation after Initial Spine SBRT; Single Institution Experience
Location: Hall C
Presenter: Ahmed Elguindy, MD – James Cancer Hospital-Solove Research Institute
10:45 AM – 12:00 PM ET
2511 - Cumulative Incidence of Sarcoma Brain Metastases: Report from a High-Volume Cancer Center
Location: Hall C
Presenter: Ayah Erjan, MD
10:45 AM – 12:00 PM ET
2512 - Clinical Experience with Palliative Treatment of Bulky Tumors Using VMAT-Based Lattice Radiotherapy
Location: Hall C
Presenter: Diego Fernandez, MD, PhD – Centro Medico Dean Funes
10:45 AM – 12:00 PM ET
2513 - Adaptive Radiation Therapy (ART) of Spinal Metastases: Motion between a Rock and a Hard Place
Location: Hall C
Presenter: Robert Freeman, MD – Fox Chase Cancer Center
10:45 AM – 12:00 PM ET
2514 - Long-Term Impact of a High-Volume Inpatient Radiation Oncology Consult Service on Cancer Care Delivery
Location: Hall C
Presenter: Morgan Freret, MD, PhD – Memorial Sloan Kettering Cancer Center
10:45 AM – 12:00 PM ET
2515 - Contrast-Enhancing Lesions Induced by CNS-Directed Intensity Modulated Proton Therapy: Distribution Patterns, Kinetics and Clinical Outcomes
Location: Hall C
Presenter: Omer Gal, MD – Miami Cancer Institute: Baptist Health South Florida
10:45 AM – 12:00 PM ET
2516 - Assessing the Outcomes of Personalized Ultra-Fractionated Stereotactic Adaptive Radiotherapy in Reirradiation for Recurrent Glioblastoma
Location: Hall C
Presenter: Luiza Giuliani Schmitt, MD – University of Texas Southwestern Medical Center
10:45 AM – 12:00 PM ET
2517 - Genomic Signature for Initial Brain Metastasis Velocity (iBMV) in Non-Small Cell Lung Cancer Patients: The Elusive Biomarker to Predict the Development of Brain Metastases?
Location: Hall C
Presenter: Sarah Glynn, DO – Wake Forest Baptist Health
10:45 AM – 12:00 PM ET
2518 - Temporally Corrected Dose Accumulation: Standardizing Analysis and Documentation of Re-Irradiation
Location: Hall C
Presenter: Vishhvaan Gopalakrishnan, MD, MSE – Johns Hopkins Medicine
10:45 AM – 12:00 PM ET
2519 - Mapping Symptomatic Radionecrosis after Stereotactic Radiosurgery with Functional Magnetic Resonance Imaging
Location: Hall C
Presenter: Chengcheng Gui, MD – Memorial Sloan Kettering Cancer Center
10:45 AM – 12:00 PM ET
2520 - Stereotactic Radiosurgery and Whole Brain Radiotherapy for Germ Cell Tumor Brain Metastases: Practice Patterns and Outcomes
Location: Hall C
Presenter: Chengcheng Gui, MD – Memorial Sloan Kettering Cancer Center
10:45 AM – 12:00 PM ET
2521 - Clinicogenomic Predictors of Survival and Intracranial Progression after Stereotactic Radiosurgery for Colorectal Cancer Brain Metastases
Location: Hall C
Presenter: Chengcheng Gui, MD – Memorial Sloan Kettering Cancer Center
10:45 AM – 12:00 PM ET
2522 - Stereotactic Body Radiation Therapy vs. Palliative Radiotherapy, with or without Immunotherapy, in Metastatic Bladder Cancer: A Canadian Population Analysis
Location: Hall C
Presenter: Enrique Gutierrez, MD – Princess Margaret Cancer Center
10:45 AM – 12:00 PM ET
2523 - Perspectives on Oligometastatic Disease Treatment: A Survey Among Radiation Oncologists and Medical Oncologists
Location: Hall C
Presenter: Ruchika Gutt, MD – Washington DC VA Medical Center
10:45 AM – 12:00 PM ET
2524 - The Impact of Sequencing Checkpoint Inhibitors and Radiotherapy on Clinical Outcomes of Patients with Melanoma Brain Metastases: Meta-Analysis of Comparative Studies
Location: Hall C
Presenter: Philip Haddad, MD, MPH, MHA – LSU Health Sciences Center Shreveport
10:45 AM – 12:00 PM ET
2525 - Memory Tract Sparing Using Diffuse Tensor Imaging in Radiation Planning of Primary Brain Tumor
Location: Hall C
Presenter: Ory Haisraely, MD, MPH – MD Anderson Cancer Center
10:45 AM – 12:00 PM ET
2526 - Re-Irradiation of Anaplastic Meningioma. Local Control Factors and Toxicity Report.
Location: Hall C
Presenter: Ory Haisraely, MD, MPH – MD Anderson Cancer Center
10:45 AM – 12:00 PM ET
2527 - Impact of Race/Ethnicity on Inpatient vs. Outpatient Access to Palliative RT
Location: Hall C
Presenter: Anthony Heng, BS – University of Washington School of Medicine
10:45 AM – 12:00 PM ET
2528 - Stereotactic Radiosurgery for Newly Diagnosed and Recurrent Chordomas of the Skull Base and Spine
Location: Hall C
Presenter: Jamie Ho, BS – Stanford Medicine
10:45 AM – 12:00 PM ET
2529 - Prognostic Factors for Early Demise Following Palliative Spatially Fractionated Radiotherapy
Location: Hall C
Presenter: Jared Hobson, MD, BSN, RN – Mayo Clinic Rochester
10:45 AM – 12:00 PM ET
2530 - Magnetic Resonance-Guided Stereotactic Body Radiotherapy for Reirradiation in the Abdomen
Location: Hall C
Presenter: Thomas Howard, MD, PhD – Mass General Brigham/Massachusetts General Hospital/Harvard Med School
10:45 AM – 12:00 PM ET
2531 - Effect of Preoperative vs. Postoperative Radiation on Leptomeningeal Disease in Treatment of Brain Metastases
Location: Hall C
Presenter: John Hoyle, MD, MS – University of Alabama Birmingham School of Medicine
10:45 AM – 12:00 PM ET
2532 - Assessing the Impact of Targeted Therapy and Immunotherapy on Clinical Outcomes in Intact Brain Metastases Treated with Stereotactic Radiosurgery - A Single Institution Experience
Location: Hall C
Presenter: Ahmad Kh. Ibrahimi, MD – King Hussein Cancer Center
10:45 AM – 12:00 PM ET
2533 - Effect of Molecular Classification on Glioma Outcomes in Hispanic Patients
Location: Hall C
Presenter: Emily Ishak, BS – Columbia University College of Physicians and Surgeons
10:45 AM – 12:00 PM ET
2534 - Simulation-Free Single-Fraction Stereotactic Body Radiotherapy for Non-Spine Bone Metastases
Location: Hall C
Presenter: Joanna Javor, MS, CMD, RT – UHN
10:45 AM – 12:00 PM ET
2535 - Nine Month Report Assessing the Safety and Effectiveness of Amniotic Bladder Therapy in Patients with Refractory Chronic Radiation Cystitis
Location: Hall C
Presenter: Julian Jeberaeel, DO – Detroit Medical Center/Wayne State University
10:45 AM – 12:00 PM ET
2536 - Outcomes of Palliative Whole Posterior Fossa Radiotherapy for Adult Brain Metastases
Location: Hall C
Presenter: Cecilia Jiang, MD – University of Pennsylvania
10:45 AM – 12:00 PM ET
2537 - External Validation of a Novel Prognostic Score for Patients with Brain Metastases Referred for Stereotactic Radiosurgery
Location: Hall C
Presenter: David Johnston, MB, MBBCHIR – NHS
10:45 AM – 12:00 PM ET
2538 - Modern Photon-Based Craniospinal Irradiation in Leptomeningeal Disease
Location: Hall C
Presenter: Emily Keit, MD – Moffitt Cancer Center
10:45 AM – 12:00 PM ET
2539 - Brain Metastases Treated by Stereotactic Radiotherapy: Real-Time Surveillance of Acute and Delayed Toxicities via Enterprise-Wide Standardized Radiation Oncology OIS Platform
Location: Hall C
Presenter: Andrew Kennedy, MD, FACRO – Sarah Cannon Cancer Center at TriStar Health
10:45 AM – 12:00 PM ET
2540 - A Combined Phase 0/1b Trial of ATM Inhibitor AZD1390 in Combination with Radiation in Patients with Newly-Diagnosed, MGMT-Unmethylated Glioblastoma
Location: Hall C
Presenter: William Kennedy, MD – Barrow Neurological Institute
10:45 AM – 12:00 PM ET
2541 - Evaluation of 18F-DOPA PET Imaging Features and Impact on Radiation Target Volumes for Patients with Oligodendroglioma
Location: Hall C
Presenter: Adam Kessel, MD – Mayo Clinic Rochester
10:45 AM – 12:00 PM ET
2542 - Multi-Institutional Report of Trastuzumab-Deruxtecan and Stereotactic Radiosurgery for HER2+ Breast Cancer Brain Metastases
Location: Hall C
Presenter: Vaseem Khatri, MD – Moffitt Cancer Center
10:45 AM – 12:00 PM ET
2543 - Association of Age with IDH-Status and Progression in Diffuse Gliomas
Location: Hall C
Presenter: Connor Kinslow, MD – Columbia University Irving Medical Center
10:45 AM – 12:00 PM ET
2544 - Treatment Patterns and Outcomes for Colorectal Cancer Spine Metastases Treated with SRS
Location: Hall C
Presenter: Dasha Klebaner, MD, BS, MPH – Stanford University Cancer Center
10:45 AM – 12:00 PM ET
2545 - Utilization of Brain-Directed Therapy for Patients with Melanoma Brain Metastases Treated with Ipilimumab and Nivolumab
Location: Hall C
Presenter: Troy Kleber, MD, MS – MD Anderson Cancer Center
10:45 AM – 12:00 PM ET
2546 - Single-Fraction vs. Multi-fraction Stereotactic Ablative Body Radiotherapy [SBRT] for Colorectal Pulmonary Oligometastases
Location: Hall C
Presenter: Jenna Kocsis, MD – Cleveland Clinic Taussig Cancer Center
10:45 AM – 12:00 PM ET
2547 - Impact of Concurrent Antibody-Drug Conjugates and Radiotherapy on Symptomatic Radiation Necrosis in Breast Cancer Patients with Brain Metastases: A Multicenter Retrospective Study
Location: Hall C
Presenter: Yutaro Koide, MD, PhD – Aichi Cancer Center Hospital
10:45 AM – 12:00 PM ET
2548 - Comparing Pain Response to Palliative Radiotherapy in Painful Bone Metastases vs. Painful Non-Bone Lesions: A Secondary Analysis of a Prospective Observational Study
Location: Hall C
Presenter: Yutaro Koide, MD, PhD – Aichi Cancer Center Hospital
10:45 AM – 12:00 PM ET
2549 - Local Failure after Radiosurgery for Spinal Metastases with Epidural Spinal Cord Compression
Location: Hall C
Presenter: Tanaya Kollipara, BS – Stanford University
10:45 AM – 12:00 PM ET
2550 - Safety and Efficacy of Combination PRaG Regimen with Dynamic and Precise Regulation of Thymalfasin Dose Based on T Lymphocyte Count for the Treatment of Chemo-Refractory Metastatic Solid Tumors: An Op
Location: Hall C
Presenter: Yuehong Kong
10:45 AM – 12:00 PM ET
2551 - Impact of Systemic Therapy Selection on Brain Metastasis Outcomes in Lung Cancer Patients Treated with Stereotactic Radiosurgery
Location: Hall C
Presenter: Rupesh Kotecha, MD – Miami Cancer Institute
10:45 AM – 12:00 PM ET
2552 - Conventionally Fractionated Reirradiation of Recurrent High Grade Gliomas: A Look at Dose Escalation and Safety
Location: Hall C
Presenter: Michael LeCompte, MD, MS – Johns Hopkins Radiation Oncology Kimmel Cancer Center
10:45 AM – 12:00 PM ET
2553 - Clinical Outcomes of Patients with Oligometastatic Renal Cell Cancer Treated with Stereotactic Body Radiation Therapy: Results from a Prospective Registry Trial
Location: Hall C
Presenter: Katie Lee, MD, PhD – The Mayo Clinic
10:45 AM – 12:00 PM ET
2554 - Genotypically-Selected Pan Cancer Trial of Camonsertib with Palliative Radiation in the Treatment of Metastatic Tumors Harboring an Ataxia-Telangiectasia Mutated (ATM) Mutation
Location: Hall C
Presenter: Nancy Lee, MD, FASTRO – Memorial Sloan Kettering Cancer Center
10:45 AM – 12:00 PM ET
2555 - Comparative Efficacy and Safety of Stereotactic Body Radiation Therapy Dose-Fractionation Regimens for Spinal Metastases: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
Location: Hall C
Presenter: Shing Fung Lee, MBBS – National University Hospital
10:45 AM – 12:00 PM ET
2556 - Population-Based Local Control and Survival Outcomes of Brain Post-Metastasectomy Adjuvant Radiotherapy vs. Observation
Location: Hall C
Presenter: Zhang Hao (Jim) Li, MD – BC Cancer Agency
10:45 AM – 12:00 PM ET
2557 - Deep Learning-Based Automatic Segmentation of Brain Tumors in Heterogenous Multi-Center Magnetic Resonance Imaging Sets
Location: Hall C
Presenter: Wenjun Liao, PhD
10:45 AM – 12:00 PM ET
2558 - Radiotherapy Triggered AEP/EIF4A1/PGE2 Feedback Loop Facilitates Tumor Survival via Regulating Neuronal Senescence
Location: Hall C
Presenter: Yingying Lin, PhD – Ruijin Hospital, Shanghai Jiaotong University School of Medicine
10:45 AM – 12:00 PM ET
2559 - End of Treatment Monocyte and Lymphocyte Counts Predict for Survival over Three Years in Patients with Glioblastoma Treated with Conventional Radiation
Location: Hall C
Presenter: I-Chia Liu, MD – Johns Hopkins Radiation Oncology Kimmel Cancer Center
10:45 AM – 12:00 PM ET
2560 - Quantitative Study of the Changes in the Hippocampus after Radiotherapy Via Multisequence MR Radiomics
Location: Hall C
Presenter: Rui Liu, MBBS
10:45 AM – 12:00 PM ET
2561 - A Pilot Study of Temporally-Modulated Pulsed Radiation Therapy to Reirradiate Recurrent IDH-Mutant Gliomas after Prior External Beam Radiation Therapy: An Interim Analysis
Location: Hall C
Presenter: Weiren Liu, MD, MS – Washington University School of Medicine in St. Louis
10:45 AM – 12:00 PM ET
2562 - Anatomic Delineation of Celiac Axis for Dosimetric Evaluation of Adaptive MRI Treatment
Location: Hall C
Presenter: Yirong Liu, MD, PhD – Northwestern Memorial Hospital
10:45 AM – 12:00 PM ET
2563 - Assessment of Local Control and Pain Relief of Rib Metastases Treated with SBRT
Location: Hall C
Presenter: Mauro Loi, MD – Azienda Ospedaliera Universitaria Careggi
10:45 AM – 12:00 PM ET
2564 - Utilization of Inpatient Radiation Therapy and Spine Surgery during Hospitalization for Metastatic Spinal Cord Compression
Location: Hall C
Presenter: Sifan Lu, BA – Maimonides Medical Center/SUNY Downstate HSU
10:45 AM – 12:00 PM ET
2565 - MRI Relaxometry for Glioblastoma Response Assessment during Radiation Therapy on a 0.35 T MRI Linear Accelerator
Location: Hall C
Presenter: Natalia Lutsik, MD – University of Miami Sylvester Comprehensive Cancer Center
10:45 AM – 12:00 PM ET
2566 - IKBKE, the c-myc/CSF-1 Signaling Axis, and Mediating Recruitment of M2 Tumor-Associated Macrophages (TAMs) after Radiotherapy in Glioblastoma
Location: Hall C
Presenter: Weitao Wen, PhD – Shandong Cancer Hospital Affiliated to Shandong First Medical University
10:45 AM – 12:00 PM ET
2567 - Stereotactic Radiotherapy Alone for Multiple Brain Metastases after Intracranial Progression in Patients with EGFR-Mutant Lung Adenocarcinoma Receiving EGFR-TKIs: A Multi-Center, Single Arm, Phase II
Location: Hall C
Presenter: Yuchao Ma, MD – Cancer Institute & Hospital Chinese Acedemy of Medical Sciences
10:45 AM – 12:00 PM ET
2568 - CDKN2A/B Alterations are Associated with Worse Prognosis in IDH Mutated 1p/19q Co-Deleted Oligodendrogliomas
Location: Hall C
Presenter: Wilson Mai, MD, PhD – Stanford University Cancer Center
10:45 AM – 12:00 PM ET
2569 - Evaluation of the Safety and Efficacy of Stereotactic Body Radiotherapy for Oligometastasis: Real-World Data from a Developing Country
Location: Hall C
Presenter: Gustavo Marta, MD, PhD – Hospital Sirio-Libanes
10:45 AM – 12:00 PM ET
2570 - Reduced Treatment Volumes for Glioblastoma Result in Lower Rates of Radionecrosis and Lymphopenia: A Pooled Analysis
Location: Hall C
Presenter: Susan McGovern, MD, PhD – MD Anderson Cancer Center
10:45 AM – 12:00 PM ET
2572 - Fractionation Sensitivity in Childhood Medulloblastoma: A Roadmap for Individualized Radiotherapy
Location: Hall C
Presenter: Christiane Matuschek, MD – University of Duesseldorf
10:45 AM – 12:00 PM ET
2573 - Feasibility and Outcomes of Navigated Transcranial Magnetic Stimulation Based Diffusion Tensor Imaging Tractography of Motor Pathways in Patients Undergoing Stereotactic Radiosurgery
Location: Hall C
Presenter: Jordan McDonald, MD – MD Anderson Cancer Center
10:45 AM – 12:00 PM ET
2574 - Impact of Tumor-Associated Macrophage/Microglia Markers on Survival Outcome in Lower Grade Glioma Patients
Location: Hall C
Presenter: Wei Meng, PhD, MBA – The Ohio State University
10:45 AM – 12:00 PM ET
2575 - Patient Outcomes Following Palliative Hypofractionated Fast Neutron Therapy
Location: Hall C
Presenter: Ankita Menon – University of Washington
10:45 AM – 12:00 PM ET
2576 - Video Assisted Learning in Supportive Care and Improving Overall Patient PerceptioN of PALLiative Care and Clinical Trials (VISION-PALL)
Location: Hall C
Poster Presenter: C Jillian Tsai, MD, PhD, MS – Princess Margaret Cancer Centre, University Health Network, University of Toronto
Palliative Care
10:45 AM – 12:00 PM ET
2577 - Phase 2 Study of Stereotactic Body Radiation Therapy Using Intensity-Modulated Radion Therapy with Dose Escalation by Simultaneous Integrated Boost (SIB-IM-SBRT) for Spinal Metastases
Location: Hall C
Presenter: Takamasa Mitsuyoshi, MD, PhD – Kobe City Medical Center General Hospital
10:45 AM – 12:00 PM ET
2578 - Time-Dependent Interactions between Immune Checkpoint Blockade and Stereotactic Radiosurgery for Brain Metastases
Location: Hall C
Presenter: Joseph Sia, MB, ChB, PhD, MBBS, FRANZCR – Peter MacCallum Cancer Centre
10:45 AM – 12:00 PM ET
2579 - Comparison of 3 vs. 5 Fraction Single Isocenter Radiosurgery for Brain Metastases
Location: Hall C
Presenter: Luke Moradi, MD – University of Alabama at Birmingham
10:45 AM – 12:00 PM ET
2580 - Fractionated Stereotactic Radiotherapy for Large Brain Metastases: Investigating Dosimetric Predictors of Radiation-Induced Brain Necrosis
Location: Hall C
Presenter: Taro Murai, MD, PhD – Almana General Hospitals
10:45 AM – 12:00 PM ET
2581 - Outcomes of Stereotactic Radiotherapy with Dose of 38 Gy or 35 Gy in 3 Fractions for Brain Metastases: A Single-Institution Analysis
Location: Hall C
Presenter: Hiroto Murata, MD, PhD – Saitama Cancer Center
10:45 AM – 12:00 PM ET
2582 - Genotype and Sex Impact Memory Function after Brain Irradiation
Location: Hall C
Presenter: Jean Nakamura, MD – University of California, San Francisco
10:45 AM – 12:00 PM ET
2583 - Rib Fracture Outcomes in Patients Receiving Lung Stereotactic Body Radiotherapy
Location: Hall C
Presenter: Otasowie Odiase, MD – Kaiser Permanente Los Angeles Medical Center
10:45 AM – 12:00 PM ET
2584 - Associations between Cognitive Ability and Changes in Quality of Life among Older Adults with Metastatic Cancer Undergoing Palliative Radiation Therapy
Location: Hall C
Presenter: Amare Osei – Icahn School of Medicine at Mount Sinai
10:45 AM – 12:00 PM ET
2585 - Outcomes and Toxicities of Stereotactic Radiosurgery for Large Brainstem Metastases
Location: Hall C
Presenter: Jacob Oyeniyi, MD – Corewell Health William Beaumont University Hospital
10:45 AM – 12:00 PM ET
2586 - Early Apparent Diffusion Coefficient (ADC) Changes during Concurrent Chemoradiation (CRT): An Imaging Biomarker for Recurrence Prediction in Glioblastoma
Location: Hall C
Presenter: Daniel Palhares, MD, MSc – Sunnybrook Odette Cancer Centre
10:45 AM – 12:00 PM ET
2587 - A Prospective Survey Study of Radiation Therapy Patient Interest in Psychedelic Research
Location: Hall C
Presenter: Jino Park, MD – University of California Irvine
10:45 AM – 12:00 PM ET
2588 - Benefit of Reirradiation in Recurrent Glioblastoma after Temozolomide-Based Chemoradiation: A Secondary and Updated Analysis of the [BLINDED] Study
Location: Hall C
Presenter: Sangjoon Park, MD, PhD – Yonsei University Health System
10:45 AM – 12:00 PM ET
2589 - Impact of Tumor Volume on Survival in Patients with Five or More Brain Metastases Undergoing Stereotactic Radiosurgery
Location: Hall C
Presenter: Melisa Pasli, BS – Brody School of Medicine
10:45 AM – 12:00 PM ET
2590 - Pre-Operative Single Fraction vs. Fractionated Stereotactic Radiotherapy: A Single-Institution Analysis of 299 Resected Metastases
Location: Hall C
Presenter: Haley Perlow, MD – Case Western Reserve University/University Hospitals Cleveland Medical Center
10:45 AM – 12:00 PM ET
2591 - Standard Dose vs. Reduced Dose Single Fraction Preoperative Radiosurgery for Resected Brain Metastases: A PROPS-BM International Multicenter Cohort Study
Location: Hall C
Presenter: Roshan Prabhu, MD, MS – Southeast Radiation Oncology Group PA
10:45 AM – 12:00 PM ET
2592 - Stereotactic Body Radiotherapy for Oligometastatic and Oligoprogressive Breast Cancer: Insights from a Single-Institution
Location: Hall C
Presenter: Mohammed Qamber, MD – Bahrain Oncology Center
10:45 AM – 12:00 PM ET
2593 - Lung SBRT for Oligo to Poly-Metastatic Colorectal Cancer
Location: Hall C
Presenter: Kaili Ranta, MD, PhD, BS – UW Health Radiation Oncology
10:45 AM – 12:00 PM ET
2594 - Prognostic Factors in Radionecrosis Following Post-Operative Stereotactic Brain Radiation Therapy from a Multicentric Retrospective Analysis
Location: Hall C
Presenter: Nicolas Roquet
10:45 AM – 12:00 PM ET
2595 - Rapid Early Progression after Surgery for IDH-Wildtype Glioblastoma and the Importance of the Pre-Radiation Planning MRI
Location: Hall C
Presenter: Jonathan Sackett, MD – University of Cincinnati - Barrett Cancer Center
10:45 AM – 12:00 PM ET
2596 - The association between time to postoperative radiotherapy, local control, and symptomatic adverse radiation effect in patients with resected brain metastases
Location: Hall C
Presenter: Mia Salans, MD, BA, MAS – University of California San Francisco
10:45 AM – 12:00 PM ET
2597 - Association of ALPS-Index and Glymphatic Flow with Neurocognitive Changes in Patients Receiving Brain Irradiation: Secondary Analysis of a Prospective Study
Location: Hall C
Presenter: Anurag Saraf, MD – Brigham and Women's Hospital/Dana-Farber
10:45 AM – 12:00 PM ET
2598 - Hypofractionated IMRT for Oligometastatic or Oligoprogressive Cancer Not Amenable to SBRT
Location: Hall C
Presenter: Angela Sarkisian, MS – George Washington University
10:45 AM – 12:00 PM ET
2599 - Local and Marginal Failures in Spinal and Non-Spinal Osseous Metastases Receiving SBRT and Immunotherapy: A Secondary Analysis of Phase I Trials
Location: Hall C
Presenter: Lucas Serra, MD, MS – University of Chicago
10:45 AM – 12:00 PM ET
2600 - Evaluating Serum CXCL Levels as Potential Biomarkers in Glioblastoma: Observed Alteration with Concurrent Chemoirradiation in Upfront Management
Location: Hall C
Presenter: Andra Krauze, MD – National Cancer Institute NIH
10:45 AM – 12:00 PM ET
2601 - Off-Protocol Radiotherapy in Phase III Metastatic Solid Tumor Trials
Location: Hall C
Presenter: Alexander Sherry, MD – University of Texas MD Anderson Cancer Center
10:45 AM – 12:00 PM ET
2602 - Policy vs. Pandemic: Effects on Utilization of Shorter Radiation Regimens for Palliating Osseous Metastases
Location: Hall C
Presenter: Yangyang Shi, MD, BS – University of Arizona
10:45 AM – 12:00 PM ET
2603 - Stereotactic Body Radiation Therapy for Oligometastatic Non-Spine Bone Metastases: A Retrospective Two-Center Study
Location: Hall C
Presenter: Yurika Shindo, MD – Aichi Cancer Center Hospital
10:45 AM – 12:00 PM ET
2604 - Functional Interaction between Tribbles1 (TRIB1) Pseudokinase and PTEN Tumor Suppressor in GBM Tumorigenesis
Location: Hall C
Presenter: Karnika Singh, PhD, MBA – OSU CCC
10:45 AM – 12:00 PM ET
2605 - Treatment Time Effect on Prescription Dose in the Treatment of Vestibular Schwannomas
Location: Hall C
Presenter: Matthew Skinner, MS – Kaiser Permanente South San Francisco
10:45 AM – 12:00 PM ET
2607 - Occurrence of Rapid Early Progression (REP) and Rapid Early Response (RER) in Patients with Newly Diagnosed GBM Undergoing Resection and Immediate Post Resection Brachytherapy: A Preliminary Report fr
Location: Hall C
Presenter: Lindsey Sloan, MD, PhD – University of Minnesota
10:45 AM – 12:00 PM ET
2608 - Stereotactic Body Radiation Therapy for Liver Oligometastases in Pancreatic Cancer: Enhancing Precision and Outcomes
Location: Hall C
Presenter: Fady Sourial, DO – Allegheny Health Network
10:45 AM – 12:00 PM ET
2609 - Dosimetric Comparison between Photon and Proton Stereotactic Radiosurgery for Cerebral Arteriovenous Malformations: A Single Institution Experience
Location: Hall C
Presenter: Will Sperduto, MD – Mayo Clinic Arizona
10:45 AM – 12:00 PM ET
2610 - Dose Escalation with Simultaneously Integrated Boost Followed by Cyberknife Boost(SIB-CK) with BEVULTRA-100 in Newly Diagnosed Glioblastoma Multiformae (GBM): A Real World Data Analysis
Location: Hall C
Presenter: Papaiah Susheela Sridhar, MD – Healthcare Global Enterprises Ltd.
10:45 AM – 12:00 PM ET
2611 - Stereotactic Radiation Therapy to Extracranial Sites of Symptomatic vs. Asymptomatic Metastatic Disease
Location: Hall C
Presenter: Ethan Steele, MD, MS – University of North Carolina at Chapel Hill
10:45 AM – 12:00 PM ET
2612 - Evaluating the Inter-Planner Contouring Variation in GRID Placement for Spatially Fractionated Radiation Therapy
Location: Hall C
Presenter: Matthew Sullivan, MS
10:45 AM – 12:00 PM ET
2613 - Therapeutic and Prognostic Impact of Target Volume Delineation in Postoperative Radiotherapy for High-Grade Glioblastoma Patients with Subventricular Zone Involvement
Location: Hall C
Presenter: Fei Sun
10:45 AM – 12:00 PM ET
2615 - Systemic Inflammation Biomarkers are Prognostic Factors in Palliative Radiation Therapy for Stage IV Lung Cancer
Location: Hall C
Presenter: Hidekazu Tanaka, MD, PhD – Yamaguchi University Graduate School of Medicine
10:45 AM – 12:00 PM ET
2616 - Presentation and Outcomes for Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Melanoma Presenting with Leptomeningeal Disease at the Time of Initial Central Nervous System Involvement
Location: Hall C
Presenter: Ryan Tang, BA – University of South Florida College of Medicine
10:45 AM – 12:00 PM ET
2617 - Prospective Study of All Sensations Patients Experience While Proton or Photon External Beams Are on
Location: Hall C
Presenter: Sara Teplow, BA – University of Washington
10:45 AM – 12:00 PM ET
2618 - Risk of Radiation Necrosis after Stereotactic Radiosurgery with and without Immune Checkpoint Inhibition in Patients with NSCLC Brain Metastases in Eloquent Locations
Location: Hall C
Presenter: Andre Thomas, MD – University of Chicago
10:45 AM – 12:00 PM ET
2619 - Long-Term Outcomes of Single-Fraction Stereotactic Ablative Radiotherapy (SAbR) Using a Simultaneous-Integrated Boost (SIB) Approach for the Treatment of de Novo Spinal Metastases
Location: Hall C
Presenter: Brett Tortelli, MD, PhD – UT Southwestern Medical Center
10:45 AM – 12:00 PM ET
2620 - Radiation Therapy Oncology Group 8502 "QUAD Shot" Regimen Using Volumetric Modulated Arc Radiotherapy for Incurable Head and Neck Cancer
Location: Hall C
Presenter: Ryo Toya, MD, PhD – Nagasaki University
10:45 AM – 12:00 PM ET
2621 - Robotic Radiosurgery for the Treatment of Pediatric Arteriovenous Malformations
Location: Hall C
Presenter: Teeradon Treechairusame, MD – Memorial Sloan Kettering Cancer Center
10:45 AM – 12:00 PM ET
2622 - Postoperative Treatment for Metastatic Brain Metastases from Non-Small Cell Lung Cancer after Intracranial Tumor Resection: A Multi-Institutional Retrospective Study
Location: Hall C
Presenter: Megumi Uto, MD, PhD – Kyoto University Graduate School of Medicine
10:45 AM – 12:00 PM ET
2623 - Patterns of Care of Brain Metastasis for Non-Small Cell Lung Cancer (NSCLC) in the Era of Immunotherapy
Location: Hall C
Presenter: Sunitha Varghese, MD, MBBS – University of Kansas Medical Center
10:45 AM – 12:00 PM ET
2624 - Clinical Outcomes of Stereotactic Body Radiotherapy for Spinal Metastases with Paraspinal Extension
Location: Hall C
Presenter: Neil Vuppala, BA – Alabama College of Osteopathic Medicine
10:45 AM – 12:00 PM ET
2625 - Radiotherapy Combined with Pyrotinib Plus Capecitabine in Patients with Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer and Brain Metastases: A Single-Arm, Exploratory Trial
Location: Hall C
Presenter: Jing Wang, MD – Tianjin Cancer Hospital
10:45 AM – 12:00 PM ET
2626 - Postoperative Radiotherapy for Malignant Cord Compression Treated in a Public and Private Hospital
Location: Hall C
Presenter: Jonathan Wang, BS – University of Southern California Keck School of Medicine
10:45 AM – 12:00 PM ET
2627 - Spatially Fractionated Radiotherapy GRID for Bulky Tumor: A Large Single Institution Experience
Location: Hall C
Presenter: Kaidi Wang, MD – University of Arkansas for Medical Sciences (UAMS)
10:45 AM – 12:00 PM ET
2628 - Prediction Study of Prognostic Nutrition Index on the Nausea and Vomiting of Patients with Cancer Undergoing Chemotherapy or Concurrent Chemoradiotherapy Based on Cisplatin
Location: Hall C
Presenter: Lili Wang, BS
10:45 AM – 12:00 PM ET
2629 - Optimizing Glioblastoma Radioimmunotherapy through Peptide-Based Immuno-PET/CT: Monitoring PD-L1 Upregulation Post-Radiation
Location: Hall C
Presenter: Yong Wang
10:45 AM – 12:00 PM ET
2630 - The Role MRI Perfusion Scans with Carbon Fiber Reinforced PEEK for SBRT Planning Post Spinal Fusion
Location: Hall C
Presenter: Vikram Chakravarthy, MD – The Ohio State University James Cancer Hospital
10:45 AM – 12:00 PM ET
2631 - Carbon Fiber-PEEK Allows for Earlier Detection of Tumor Recurrence Compared to Titanium Instrumentation: A Comparative Study
Location: Hall C
Presenter: Vikram Chakravarthy, MD – The Ohio State University James Cancer Hospital
10:45 AM – 12:00 PM ET
2632 - Biological Effective Dose-Based Fractionated Stereotactic Radiation Therapy for Brain Metastasis in the New Era: A Retrospective Multi-Institution Study
Location: Hall C
Presenter: Takahiro Watakabe, MD, PhD – Kumamoto University
10:45 AM – 12:00 PM ET
2633 - Different Detection Rates of Brain Metastasis in Different Pathological Types of Lung Cancer by ¹⁸F-FAPI PET/CT
Location: Hall C
Presenter: Yuchun Wei, MD, PhD – Shandong Cancer Hospital and Institute
10:45 AM – 12:00 PM ET
2634 - A Pilot Phase 2 Study Evaluating Dose De-Escalation in Whole Brain Radiation Therapy with Simultaneous Integrated Boost for Patients with Brain Metastases
Location: Hall C
Presenter: Michael Weisman, MD – IU Health Methodist Hospital
10:45 AM – 12:00 PM ET
2635 - Radiation Dose Fractionations for Malignant Spinal Cord Compression in Patients Not Eligible for Surgery: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
Location: Hall C
Presenter: Shing Fung Lee, MBBS – National University Hospital
10:45 AM – 12:00 PM ET
2635 - Radiation Dose Fractionations for Malignant Spinal Cord Compression in Patients Not Eligible for Surgery: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
Location: Hall C
Presenter: Henry Wong, MBBS – Princess Margaret Hospital Hong Kong
10:45 AM – 12:00 PM ET
2636 - Can Individualized Dosimetry Improve Treatment Efficacy for ¹⁷⁷Lu-DOTATATE (D) Therapy in Primary Site Agnostic Neuroendocrine Tumors?
Location: Hall C
Presenter: Rebecca Wong, MB, ChB, MS – Princess Margaret Cancer Centre
10:45 AM – 12:00 PM ET
2637 - The Eurytopic Paradigm of Simultaneous Integrated Boost Volumetric Modulated Arc Radiotherapy for Brain Metastases: A Phase Ib/II Clinical Trial
Location: Hall C
Presenter: Mingyao Wu, MD – Fudan University Shanghai Cancer Center
10:45 AM – 12:00 PM ET
2638 - A Predictive Nomogram for Long-Term Outcomes of High-Grade Meningiomas Undergoing Postoperative Radiotherapy
Location: Hall C
Presenter: Tianqi Wu, PhD
10:45 AM – 12:00 PM ET
2639 - Modeling of Out-of-Pocket Costs across Medicaid and Medicare Plans of Standard-of-Care External Beam Radiation Therapy vs. Radiosurgery for Symptomatic Metastatic Spine Cancer
Location: Hall C
Presenter: Victoria Wu, BA – Case Western Reserve School of Medicine
10:45 AM – 12:00 PM ET
2640 - Modeling of Out-Of-Pocket Costs Across Medicaid and Medicare Plans of Standard-of-Care Radiosurgery Duration for Metastatic Spine Cancer
Location: Hall C
Presenter: Victoria Wu, BA – Case Western Reserve School of Medicine
10:45 AM – 12:00 PM ET
2641 - Whole-Brain Radiation Therapy with Simultaneous Integrated Boost vs. Stereotactic Radiotherapy for the Treatment of Brain Metastasis from Non-Small Cell Lung Cancer
Location: Hall C
Presenter: Ziwei Wu
10:45 AM – 12:00 PM ET
2642 - Complete Epidural Decompression Combined with Spine Radiosurgery in High-Grade Epidural Spinal Cord Compression (ESCC): A Dosimetric and Outcome Analysis
Location: Hall C
Presenter: Yen-Ruh Wuu, MD – Northwell Health
10:45 AM – 12:00 PM ET
2643 - Efficacy and Safety of Enzyme-Cleavable EGFR-MMAE Combined with Radiotherapy in Treating GBM: A Preclinical Phase Study
Location: Hall C
Presenter: Yun Xing, BS – Tianjin University
10:45 AM – 12:00 PM ET
2645 - Development of a Machine Learning-Based Tool to Predict Local Failure after Stereotactic Radiosurgery for Small Brain Metastases
Location: Hall C
Presenter: Sreenija Yarlagadda, MD – Miami Cancer Institute
10:45 AM – 12:00 PM ET
2646 - Advanced MRI and 18F-DOPA PET/CT and Their Impact on Radiotherapy Target Volumes in Glioblastoma
Location: Hall C
Presenter: Eyesha Younus, PhD – Mayo Clinic
10:45 AM – 12:00 PM ET
2647 - MDM2 Inhibition and the Efficacy of Radiotherapy and PD-L1 Antibody Combination Therapy by Reprogramming the Glioblastoma Tumor Microenvironment
Location: Hall C
Presenter: Chunhui Yuan, BS
10:45 AM – 12:00 PM ET
2648 - Prognostic Factors for Local Failure and Overall Survival in Patients with Epidural Disease at the Cauda Equina Following Stereotactic Body Radiotherapy: A Clinical, Anatomic and Dosimetric Analysis
Location: Hall C
Presenter: Sondos Zayed, MD, MPH, FRCPC – University of Ottawa at The Ottawa Hospital
10:45 AM – 12:00 PM ET
2649 - Stereotactic Radiotherapy vs. Whole Brain Radiation Therapy in EGFR Mutated NSCLC: Results and Reflections from the Prematurely Closed Phase III HYBRID Trial
Location: Hall C
Presenter: Ming Zeng, MD, PhD – Sichuan Taikang Hospital
10:45 AM – 12:00 PM ET
2650 - Clinical Outcomes Following Stereotactic Radiosurgery in Breast Cancer Brain Metastasis with or without Systemic Metastasis
Location: Hall C
Presenter: Dekuang Zhao, DO, PhD – Moffitt Cancer Center
10:45 AM – 12:00 PM ET
2651 - Long-Term Outcomes Following Stereotactic Radiosurgery and Radiotherapy for Benign Skull Base Meningioma
Location: Hall C
Presenter: Nancy Zhou, MD – Kaiser Permanente Los Angeles Medical Center
3:00 PM – 4:00 PM ET
2652 - Analysis of Failure Risk Factors in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy: A Large Cohort Retrospective Study
Location: Hall C
Presenter: George Naoum, MD, MS – Northwesrn Memorial Hospital
3:00 PM – 4:00 PM ET
2653 - Exploration of Flap-Protected Hypofractionated Radiotherapy in Patients with Locally Advanced Autologous Reconstructive Breast Cancer
Location: Hall C
Presenter: Muyasha Abulimiti, MD, dr – National Clinical Research Center for Cancer/Cancer Hospital
3:00 PM – 4:00 PM ET
2654 - Over Treatment of Stage I, Node-Negative, Hormone-Sensitive Breast Cancer? Analysis of Techniques and Doses at a Comprehensive Cancer Center with Community Network Affiliates
Location: Hall C
Presenter: Jose Bazan, MD, MS – City of Hope Comprehensive Cancer Center
3:00 PM – 4:00 PM ET
2656 - Smoking History and Breast Shrinkage Following Breast Conserving Treatment and Radiation Therapy
Location: Hall C
Presenter: Miriam Becker, MS – UC San Diego School of Medicine
3:00 PM – 4:00 PM ET
2657 - Comparison between Proton LET-Dependent RBE Dose and Photon Physical Dose for Acute Radiation Dermatitis in Caucasian and African-American Breast Cancer Patients Undergoing Radiation Therapy
Location: Hall C
Presenter: Nrusingh Biswal, PhD, DABR – University of Maryland School of Medicine, Baltimore
3:00 PM – 4:00 PM ET
2658 - Rare but Relevant: Exploring Factors behind the Exclusion of Inflammatory Breast Cancer from Breast Cancer Clinical Trials
Location: Hall C
Presenter: Erica Braschi Jordan, MD – University of Florida
3:00 PM – 4:00 PM ET
2659 - Beyond Traditional Borders: Outcomes with Curative Intent Therapy for Stage IV Breast Cancer Defined by Non-Regional Nodal Metastases
Location: Hall C
Presenter: Erica Braschi Jordan, MD – University of Florida
3:00 PM – 4:00 PM ET
2660 - Post-Lumpectomy Radiation Therapy and Patient-Reported Shoulder Function: A Dosimetric Analyses of the Shoulder Skeletal Muscles
Location: Hall C
Presenter: Renata Braudy, PhD, MS, OCS, CLT – University of Minnesota Department of Radiation Oncology and Twin Cities Orthopedics
3:00 PM – 4:00 PM ET
2661 - Accelerated Partial Breast Irradiation for Patients with Invasive Lobular Carcinoma
Location: Hall C
Presenter: Lior Braunstein, MD – Memorial Sloan Kettering Cancer Center
3:00 PM – 4:00 PM ET
2662 - Trends in Incidence, Treatment Patterns and Genomic Testing Utilization among Male Breast Cancer Patients Using the OneFlorida Database
Location: Hall C
Presenter: Anthony Casper, DO – University of Florida Shands Cancer Center
3:00 PM – 4:00 PM ET
2663 - Breast Cancer-Related Lymphedema Quantified by Bioimpedance Spectroscopy in Patients Undergoing Axillary Node Dissection, Lymphatic Microsurgical Preventive Healing Approach (LYMPHA) and Regional Noda
Location: Hall C
Presenter: Danielle Cerbon, MD – University of Miami
3:00 PM – 4:00 PM ET
2664 - Cardiopulmonary Substructure Doses are Not Correlated with Cardiorespiratory Fitness among Breast Cancer Survivors Treated with Contemporary Radiotherapy
Location: Hall C
Presenter: Laura Cervino, PhD – Memorial Sloan Kettering Cancer Center
3:00 PM – 4:00 PM ET
2665 - Ultra-Hypofractionated Whole Breast Radiation Therapy Using a Novel Boost Regimen for Early-Stage Breast Cancer
Location: Hall C
Presenter: Molly Chakraborty, BSE – Rutgers New Jersey Medical School
3:00 PM – 4:00 PM ET
2666 - Reconstructive Outcomes and Complications after Mastectomy and Proton Therapy for Breast Cancer
Location: Hall C
Presenter: Molly Chakraborty, BSE – Rutgers New Jersey Medical School
3:00 PM – 4:00 PM ET
2667 - The Impact of Immune Microenvironment on Local Control of Breast Ductal Carcinoma In Situ Receiving Breast Conservative Therapy
Location: Hall C
Presenter: Jia-Yi Chen, PhD
3:00 PM – 4:00 PM ET
2668 - Investigation of the Optimal Design of the Low Dose Radiotherapy Machine for the Osteoarthritis Based on the Monte Carlo Simulation
Location: Hall C
Presenter: Chang Heon Choi, PhD – Seoul National University Hospital
3:00 PM – 4:00 PM ET
2669 - Photon vs. Proton Post-Mastectomy Radiotherapy Toxicities in Pre-Pectoral Implant-Based Breast Reconstruction
Location: Hall C
Presenter: Seraphina Choi, MD – University of Miami Miller School of Medicine
3:00 PM – 4:00 PM ET
2670 - Stereotactic Radiotherapy (SRT) with Maintenance Systemic Therapy vs. Standard-of-Care (SOC) Systemic Therapy for Oligoprogressive ER-Positive, HER2-Negative Breast Cancer (AVATAR II)
Location: Hall C
Presenter: Emma Connolly, MB, BCH BAO MRCPI – Peter MacCallum Cancer Centre
3:00 PM – 4:00 PM ET
2671 - Final Results from the SAVE-HEART Study - Surface-Based Deep Inspiration Breath-Hold Radiotherapy in Left-Sided Breast Cancer
Location: Hall C
Presenter: Stefanie Corradini, MD – LMU Munich
3:00 PM – 4:00 PM ET
2672 - Impact of Consensus Guidelines, Clinical Trials and COVID 19 on Fractionation Practices for Node Negative Intact Breast Cancer
Location: Hall C
Presenter: Jessica Cruttenden, MD – Huntsman Cancer Institute at the University of Utah
3:00 PM – 4:00 PM ET
2673 - Factors Influencing the Utilization of the Integrated Magnetic Resonance Linac for Accelerated Partial Breast Irradiation
Location: Hall C
Presenter: Jenna Dean, RT – Olivia Newton John Cancer & Wellness Centre
3:00 PM – 4:00 PM ET
2674 - Real-Life Impact of Hypofractionated IMRT in Early Breast Cancer on Cardiovascular Risk
Location: Hall C
Presenter: Ana Aurora Diaz-Gavela, MD – Hospital Universitario Quiron Madrid
3:00 PM – 4:00 PM ET
2675 - Prospective Evaluation of Acute Toxicity from Tumor Bed Boost Following Whole Breast Radiotherapy
Location: Hall C
Presenter: Michael Dykstra, MD – University of Michigan
3:00 PM – 4:00 PM ET
2676 - Do Standard Tangents Cover High-Risk Nodes among Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy?
Location: Hall C
Presenter: Madeline Flanagan, MD – Baylor College of Medicine
3:00 PM – 4:00 PM ET
2677 - Novel Use of SCOUT^® Reflector for Target Localization in Preoperative Breast Radiotherapy
Location: Hall C
Presenter: Nader Ghassemi, PhD – Thomas Jefferson University
3:00 PM – 4:00 PM ET
2678 - Safety of Concurrent Administration of TDM1 and Radiotherapy in Patients with HER2+ Breast Cancer with Residual Disease Post-Neoadjuvant Chemotherapy
Location: Hall C
Presenter: Laura Girres, MD
3:00 PM – 4:00 PM ET
2679 - Improving Breast Cancer Quality Metrics with Early Radiation Oncology Internal Referral Model
Location: Hall C
Presenter: Ronald Goldsberry, BS – Baylor College of Medicine
3:00 PM – 4:00 PM ET
2680 - Long Term Single Institution Clinical Outcomes for Locally Recurrent Breast Cancer Patients Treated with a Second Breast Conserving Surgery and Intraoperative Radiotherapy
Location: Hall C
Presenter: Fabiana Gregucci, MD – Weill Cornell Medicine
3:00 PM – 4:00 PM ET
2681 - Heart and Left Anterior Descending Coronary Artery (LAD) Exposure from Hypo-Fractionated Whole Breast Radiotherapy with a Prone Set Up
Location: Hall C
Presenter: Fabiana Gregucci, MD – Weill Cornell Medicine
3:00 PM – 4:00 PM ET
2682 - Dosimetric and Clinical Data from Linac-Based Stereotactic Arrhythmia Radioablation
Location: Hall C
Presenter: Fabiana Gregucci, MD – Weill Cornell Medicine
3:00 PM – 4:00 PM ET
2683 - Ultra-Hypofractionated Radiation in Older Patients with Low Risk Early-Stage Breast Cancer
Location: Hall C
Presenter: Bin Gui, MD, MS – Northwell Health
3:00 PM – 4:00 PM ET
2684 - Predicting Cardiotoxicity after Breast Cancer Radiotherapy Utilizing Dosimetry and Imaging
Location: Hall C
Presenter: Felicia Guo, BA – Strong Memorial Hospital
3:00 PM – 4:00 PM ET
2685 - Effectiveness of Hypofractionated Radiotherapy in Microinvasive Breast Cancer
Location: Hall C
Presenter: Camille Hardy Abeloos, MD – NYU Grossman School of Medicine
3:00 PM – 4:00 PM ET
2686 - Relationship of Immediate Breast Reconstruction and the Development of Lymphedema in Breast Cancer Patients with Radiotherapy
Location: Hall C
Presenter: Soon Woo Hong, MD – Seoul National University Hospital
3:00 PM – 4:00 PM ET
2687 - Complications of Implant-Based Reconstruction and Post-Mastectomy Radiation in the Era of Adjuvant CDK4/6 Inhibitors
Location: Hall C
Presenter: Hamail Iqbal, BS – Cooper Medical School of Rowan University
3:00 PM – 4:00 PM ET
2688 - Locoregional Recurrence and Survival Outcome of HER2-Low Breast Cancer Patients after Upfront Surgery and Adjuvant Radiotherapy
Location: Hall C
Presenter: Kairui Jin, MD, PhD
3:00 PM – 4:00 PM ET
2689 - Early Results of a Phase II Trial of Ultra-hypofractioNated Adjuvant Radiotherapy ± sImultaneous Integrated Boost for Low-risk Breast Cancer Patients (UNIQUE)
Location: Hall C
Presenter: Hao Jing, MD – CAMS
3:00 PM – 4:00 PM ET
2690 - Early Results of a Prospective Study of Preoperative Tumor-Bed Boost Followed by Oncoplastic Surgery and Adjuvant Whole Breast Radiotherapy for Early-Stage Breast Cancer
Location: Hall C
Presenter: Hao Jing, MD – CAMS
3:00 PM – 4:00 PM ET
2691 - Predictors of Acute Skin Toxicity in Patients Undergoing Hypofractionated Adjuvant Whole Breast Radiotherapy with VMAT or Helical Tomotherapy
Location: Hall C
Presenter: Didem Karacetin, MD – Health Science University, Basaksehir Cam and Sakura City Hospital
3:00 PM – 4:00 PM ET
2692 - Analysis of Patient Reported Outcomes in the Prevention of Acute Radiation Dermatitis with Topical Therapies
Location: Hall C
Presenter: Aria Kieft, MD – Michigan Radiation Oncology Consultants
3:00 PM – 4:00 PM ET
2693 - Contemporary Trends in Radiation Protocols for Breast Cancer Treatment: A Population-Based Analysis
Location: Hall C
Presenter: Gary Ko, MD – Princess Margaret Cancer Center, University Health Network
3:00 PM – 4:00 PM ET
2694 - Reconstruction Complications and Oncologic Outcomes Among Women Treated with Nipple or Skin Sparing Mastectomy and Adjuvant Radiation
Location: Hall C
Presenter: Sravya Koduri, MD, BS – NYU Langone Health
3:00 PM – 4:00 PM ET
2695 - Low Dose Radiation Therapy for Osteoarthritis: A Retrospective Single Institution Analysis of 51 Patients and 85 Joints
Location: Hall C
Presenter: Nagendra (Bobby) Koneru, MD, FASTRO – FHN Memorial Hospital
3:00 PM – 4:00 PM ET
2696 - Serial Quality-of-Life Scores Following Ultrahypofractionated Radiotherapy (UHFRT) and Simultaneous Integrated Boost (SIB) Post Breast Conserving Surgery: Largest Real-World Data of a Prospectively Fo
Location: Hall C
Presenter: Revathy Krishnamurthy, MD – ACTREC, TMC
3:00 PM – 4:00 PM ET
2697 - Unveiling Patient and Provider Perceptions on Medical Tattoos in Breast Cancer Radiotherapy
Location: Hall C
Presenter: Grace Lee, RT, MHSc – Princess Margaret Cancer Centre
3:00 PM – 4:00 PM ET
2698 - Development and Validation of a Prediction Model for Major Adverse Cardiac Events in Patients with Hepatocellular Carcinoma Undergoing Stereotactic Body Radiation Therapy
Location: Hall C
Presenter: Hye In Lee, MD – Seoul National University Hospital
3:00 PM – 4:00 PM ET
2699 - Re-Irradiation Toxicity and Survival Outcomes for Locoregionally Recurrent or New Ipsilateral Breast Cancer
Location: Hall C
Presenter: Kamaria Lee, MD, AB – MD Anderson Cancer Center
3:00 PM – 4:00 PM ET
2700 - Risk Factors of Radiation Pneumonitis in Breast Cancer with Internal Mammary Chain Irradiation
Location: Hall C
Presenter: Sang Min Lee – Seoul National University College of Medicine
3:00 PM – 4:00 PM ET
2701 - Long-Term Outcomes of a Phase I/II Trial for Stereotactic Arrhythmia Radioablation in Ventricular Tachycardia
Location: Hall C
Presenter: Jing Li, MD
3:00 PM – 4:00 PM ET
2702 - Daily Online Adaptive Radiotherapy with Narrow Margins for Ultra-Hypofractionated Whole Breast Irradiation (A-FF-WBI): Dosimetry and Early Clinical Outcomes
Location: Hall C
Presenter: Xingzhe Li, MD, MPH – UT Southwestern Medical Center
3:00 PM – 4:00 PM ET
2703 - Diagnostic Value of ¹⁸F-FAPI-04 PET/CT for Identification of Benign Breast Lesions and Breast Cancers: Comparison with Traditional Imaging Examinations
Location: Hall C
Presenter: Jingru Liu, MD
3:00 PM – 4:00 PM ET
2704 - Treatment Implications of Low Compliance with Endocrine Therapy for Older Women with Early-Stage Breast Cancer
Location: Hall C
Presenter: Maryanne Lubas, DO – Fox Chase Cancer Center
3:00 PM – 4:00 PM ET
2705 - Dosimetric Comparison of Simultaneous Integrated Boost Using Field-in-Field IMRT vs. Hybrid VMAT vs. Ring Gantry VMAT for Left-Sided Breast Cancers
Location: Hall C
Presenter: Beela Sarah Mathew, MD – Regional Cancer Centre
3:00 PM – 4:00 PM ET
2706 - Low-Dose Radiotherapy for Heel Spur Treatment: A Retrospective Study of Efficacy and Safety
Location: Hall C
Presenter: Christiane Matuschek, MD – University of Duesseldorf
3:00 PM – 4:00 PM ET
2707 - Impact of COVID on Utilization of Ultra-Hypofractionation in Breast Cancer Treatment
Location: Hall C
Presenter: Riley McDougall, MD – University of Arizona
3:00 PM – 4:00 PM ET
2708 - Impact of COVID on Utilization of Hypofractionation in Node-Positive Breast Cancer Treatment
Location: Hall C
Presenter: Jonathan Gabriel, DO, MS – University of Arizona College of Medicine Tucson
3:00 PM – 4:00 PM ET
2709 - A New Method for Breast Cancer Classification: Comprehensive Application of Latent Class Analysis in Clinical and Genetic Expression Information
Location: Hall C
Presenter: Qingyu Meng, MD, PhD, RT – Peking Union Medical College Hospital
3:00 PM – 4:00 PM ET
2710 - Long-Term Complete Response Rates of Arteriovenous Malformations Treated with LINAC-Based Stereotactic Radiosurgery
Location: Hall C
Presenter: Hari Menon, MD, BS – University of Wisconsin Radiation Oncology
3:00 PM – 4:00 PM ET
2711 - Palliative Radiotherapy in Breast Cancer with Skin Involvement
Location: Hall C
Presenter: Sunho Min, MD – Yonsei Cancer Center
3:00 PM – 4:00 PM ET
2712 - Comparing Protons vs. Photons on Breast Reconstruction Outcomes and Dosimetry Analysis
Location: Hall C
Presenter: George Naoum, MD, MS – Northwesrn Memorial Hospital
3:00 PM – 4:00 PM ET
2713 - Cardiac Events and Dynamic Echocardiogram Changes in Low Cardiovascular Risk Patients with Triple Negative Breast Cancer Treated with Immunotherapy
Location: Hall C
Presenter: Jean Philippe Nesseler, MD, MS – Cedars-Sinai Medical Center
3:00 PM – 4:00 PM ET
2714 - The Impact of a Bra upon Inframammary Skin Fold Measurements for Large-Breasted Women, Positioned Upright
Location: Hall C
Presenter: Jemma Nunn, RT – Leo Cancer Care
3:00 PM – 4:00 PM ET
2715 - Preliminary Results of a Phase I Trial Using Preoperative Stereotactic Ablative Breast Radiotherapy (SABER) for Selected Early-Stage Breast Cancer
Location: Hall C
Presenter: Ifeanyichukwu Ogobuiro, MD, MS – University of Miami Sylvester Comprehensive Cancer Center
3:00 PM – 4:00 PM ET
2716 - Safety and Efficacy of Hypofractionated Radiation Therapy in Patients who undergo Post mastectomy Radiation Therapy
Location: Hall C
Presenter: Oluwatimileyin Ojo, MD – Northwell Health
3:00 PM – 4:00 PM ET
2717 - Cosmetic Outcomes Following Whole Breast or Partial Breast Radiation Therapy for Breast Cancer: A Single Institutional Experience
Location: Hall C
Presenter: Anna Okabe, BS – California Northstate University College of Medicine
3:00 PM – 4:00 PM ET
2718 - Targeting Accuracy of Frameless Linear Accelerator Thalamotomy
Location: Hall C
Presenter: Richard Popple, PhD – University of Alabama at Birmingham
3:00 PM – 4:00 PM ET
2719 - The PREDICT II Registry: A Prospective Study to Evaluate the Clinical Utility of a 7-Gene Predictive Biosignature on Treatment Decisions in Patients with Ductal Carcinoma In Situ
Location: Hall C
Presenter: Rachel Rabinovitch, MD, FASTRO – University of Colorado Denver
3:00 PM – 4:00 PM ET
2720 - Multi-Institutional Phase II Trial Using Dose Escalated Five Fraction Stereotactic Partial Breast Irradiation (S-PBI) with a Cobalt Stereotactic Unit for Early Stage Breast Cancer
Location: Hall C
Presenter: Asal Rahimi, MD, MS – University of Texas Southwestern Medical Center
3:00 PM – 4:00 PM ET
2721 - Early Outcomes of Accelerated Partial Breast Irradiation with Interstitial Brachytherapy vs. Extreme Hypo-Fractionated EBRT in Indian Females with Early Breast Cancer - A Randomized Controlled Trial
Location: Hall C
Presenter: Daya Nand Sharma, MD – AIIMS New Delhi
3:00 PM – 4:00 PM ET
2722 - Ultra-Hypofractionated One-Week Locoregional Radiation for Early Breast Cancer: Dose Distribution to Target Volumes and Organs-at-Risk
Location: Hall C
Presenter: Ivica Ratosa, MD, PhD – Institute of Oncology Ljubljana
3:00 PM – 4:00 PM ET
2723 - Complications of Post-Mastectomy Radiotherapy in Immediate Two-Stage Implant Reconstruction: Contemporary Outcomes at an Academic Hospital System
Location: Hall C
Presenter: Matthew Riina, MD – Hospital of the University of Pennsylvania
3:00 PM – 4:00 PM ET
2725 - Partial Breast Radiation Outcomes and Toxicity for Women with Early Breast Cancer in a Large Community Based Practice
Location: Hall C
Presenter: Michael Karp, MD – Maimonides Cancer Center
3:00 PM – 4:00 PM ET
2726 - Obliteration Rates for High-Risk Arteriovenous Malformations with Dose-Escalated Hypofractionated Radiosurgery
Location: Hall C
Presenter: Sophia Shah, BS
3:00 PM – 4:00 PM ET
2727 - Clinical Outcomes in Breast Cancer Patients with Underlying Germline PALB2 Mutations Treated with Radiation .
Location: Hall C
Presenter: Ahmed Shalaby, MD – CINJ/RWJ
3:00 PM – 4:00 PM ET
2728 - Impact of Strength Training on Metabolism, Body Composition, Strength and Mobility during Adjuvant Radiotherapy for Breast Cancer
Location: Hall C
Presenter: Parisa Shamsesfandabadi, MD – Allegheny Health Network
3:00 PM – 4:00 PM ET
2729 - Predictors of Survival in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy, Surgery, and Radiotherapy
Location: Hall C
Presenter: Shali Shao, MS – Fudan University Shanghai Cancer Center
3:00 PM – 4:00 PM ET
2730 - Involved Quadrant Irradiation (IQI) Post Breast Conservation Surgery: Preliminary Results of Ongoing Phase 3 Randomized Controlled Trial
Location: Hall C
Presenter: Daya Nand Sharma, MD – AIIMS New Delhi
3:00 PM – 4:00 PM ET
2731 - Postoperative Breast Radiation Therapy Using Deformable Image Registration of Initial PET/CT in the Same Posture before Primary Systemic Therapy: Does PET-Based Precise Planning Translate into a Clini
Location: Hall C
Presenter: Kenshiro Shiraishi, MD, PhD – Teikyo University
3:00 PM – 4:00 PM ET
2732 - Evolution of Radiotherapy Options for Elderly Patients with Early Stage ER+ Breast Cancer: A 10 Year Review
Location: Hall C
Presenter: Karin Skalina, MD, PhD – Montefiore Medical Center/Albert Einstein College of Medicine
3:00 PM – 4:00 PM ET
2733 - Large Tumor-Bed Boost Size and Cosmesis after Breast-Conserving Surgery and Whole Breast Irradiation: A Post Hoc Analysis of a Phase III Randomized Trial Comparing Hypofractionated and Conventional Fr
Location: Hall C
Presenter: Yuchun Song, MD – Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
3:00 PM – 4:00 PM ET
2735 - Evaluation of Cardiac Damage by Cardiac CT in Patients with Esophageal Cancer prior to Radiotherapy
Location: Hall C
Presenter: Akinori Takada, MD, PhD – Mie University Hospital
3:00 PM – 4:00 PM ET
2736 - Adoption of Hypofractionated and Ultrahypofractionated Adjuvant Radiation Therapy for Breast Cancer Treatment among Providers at a Large Academic Medical Center
Location: Hall C
Presenter: Leila Tchelebi, MD – Northern Westchester Hospital
3:00 PM – 4:00 PM ET
2737 - Thermal Dose-Effect on Locoregional Control in Locoregional Recurrent Breast Cancer Patients
Location: Hall C
Presenter: C. Paola Tello Valverde, MS – Amsterdam University Medical Center (AUMC)
3:00 PM – 4:00 PM ET
2738 - A Single-Institution Retrospective Review Intensity-Modulated Accelerated Partial Breast Irradiation Using a Radiopaque Filament and Breath-Hold to Facilitate Reduced CTV to PTV Margin
Location: Hall C
Presenter: Vincenzo Theobald – Inova Schar Cancer Institute
3:00 PM – 4:00 PM ET
2739 - Pre-Operative, Single Fraction Stereotactic Partial Breast Irradiation (S-PBI) for Early-Stage Breast Cancer: Radiology-Pathology Correlation of Tumor Response in a Phase 2 Clinical Trial
Location: Hall C
Presenter: Marco Trovo, MD – Asuiud Udine Hospital
3:00 PM – 4:00 PM ET
2740 - Lens-Sparing IMRT for the Management of Sturge-Weber Syndrome Associated Diffuse Choroidal Hemangiomas: An Institutional Experience
Location: Hall C
Presenter: Adannia Ufondu, MD, BA – Cleveland Clinic
3:00 PM – 4:00 PM ET
2741 - Radiation or Axillary Lymph Node Dissection after Positive Sentinel Lymph Node Biopsy Following Neoadjuvant Chemotherapy for Breast Cancer: A Retrospective Review
Location: Hall C
Presenter: Kathleen Waeldner, BA – Robert Larner, MD College of Medicine at the University of Vermont
3:00 PM – 4:00 PM ET
2742 - Simultaneous Integrated Tumor Bed Boost vs. Sequential Boost during Conventional Fractionated Whole-Breast Irradiation after Breast-Conserving Surgery
Location: Hall C
Presenter: Dan-Qiong Wang, MD – National Cancer Center/ National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Acade
3:00 PM – 4:00 PM ET
2743 - Simultaneous Integrated Tumor Bed Boost vs. Sequential Boost during Hypofractionated Whole-Breast Irradiation after Breast-Conserving Surgery
Location: Hall C
Presenter: Dan-Qiong Wang, MD – National Cancer Center/ National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Acade
3:00 PM – 4:00 PM ET
2744 - Study on Short-Term Complications and Quality of Life for Breast Cancer Patients Who Underwent Breast-Conserving Surgery Combined with Intraoperative Radiotherapy
Location: Hall C
Presenter: Jing Wang, MD – Tianjin Cancer Hospital
3:00 PM – 4:00 PM ET
2745 - Dosimetric Benefit and Clinical Feasibility of Deep Inspiratory Breath-Hold and Volumetric Modulated Arc Therapy Based Postmastectomy Radiotherapy for Left-Sided Breast Cancer
Location: Hall C
Presenter: Shijia Wang, MD
3:00 PM – 4:00 PM ET
2746 - Clinical Outcomes after Post-Operative Radiotherapy for Breast Cancer Patients Presenting with Ipsilateral Supraclavicular Metastasis: Considerations on the Cranial Border of Irradiation Field
Location: Hall C
Presenter: Xiaofang Wang, PhD – Fudan University Shanghai Cancer Center
3:00 PM – 4:00 PM ET
2747 - Is Proton Therapy for Synchronous Bilateral Breast Cancer a Medical Necessity?
Location: Hall C
Presenter: Cyrus Washington, MD, MS – University of Miami
3:00 PM – 4:00 PM ET
2748 - Predicting Radiation-Induced Acute Toxicity in Breast Cancer Patients: A Radiogenomic Approach
Location: Hall C
Presenter: Shouyi Wei – Rutgers Cancer Institute of New Jersey
3:00 PM – 4:00 PM ET
2749 - Accelerated Partial Breast Irradiation for Low-Risk Hormone-Sensitive Breast Cancer is Underutilized but Increasing in the National Cancer Database 2010-2021
Location: Hall C
Presenter: Jose Bazan, MD, MS – City of Hope Comprehensive Cancer Center
3:00 PM – 4:00 PM ET
2750 - Thoracic Anatomic Features Predict Benefit from Proton Therapy in Breast Cancer Patients: A Study Based on NTCP Model of Lung Toxicity
Location: Hall C
Presenter: Xiao-Yu Wu, MD
3:00 PM – 4:00 PM ET
2751 - Safety and Feasibility of Concurrent Abemaciclib and Postoperative Radiotherapy for Breast Cancer: A Real-World Analysis
Location: Hall C
Presenter: Liang Xuan
3:00 PM – 4:00 PM ET
2752 - Selection of Patients with Left Breast Cancer for DIBH Based on Three-Dimensional Dose Prediction
Location: Hall C
Presenter: Kun Zhang
3:00 PM – 4:00 PM ET
2753 - Radiotherapy Quality Assurance of the Ongoing Potential Phase III Randomized Controlled Trial Investigating the Role of Internal Mammary Lymph Node Irradiation for Breast Cancer: An Individual Case Re
Location: Hall C
Presenter: Xuran Zhao, MD – National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy
3:00 PM – 4:00 PM ET
2754 - Cardiac Dose and Injury after Radiotherapy in Patients with Postoperative Left-Sided Breast Cancer: A Cardiac Magnetic Resonance Study
Location: Hall C
Presenter: Jun Yin, MD – Sichuan Cancer Hospital and Institute
3:00 PM – 4:00 PM ET
2755 - Is the Strategy of Regional Nodal Irradiation (RNI) in cT1-2N0M0 Breast Patients with Limited Positive Sentinel Nodes (SLNs) Forgoing ALND Associated with the Risk of Non-SLNs Metastasis: A Multi-Cent
Location: Hall C
Presenter: Siyue Zheng, MD – Ruijin Hospital, Shanghai Jiaotong University School of Medicine
3:00 PM – 4:00 PM ET
2756 - Can Surface-Guided Radiation Therapy (SGRT) be Used to Monitor Intrafraction Motion of Patients Receiving Accelerated Partial Breast Irradiation (APBI)?
Location: Hall C
Presenter: Shifeng Chen, PhD – University of Maryland
3:00 PM – 4:00 PM ET
2757 - Safety of Concurrent Capecitabine and Radiotherapy in Breast Cancer Patients:A Real-World Analysis
Location: Hall C
Presenter: Chaofan Zhu
5:00 PM – 6:00 PM ET
2758 - Optimal Treatment Sequence for CDK4/6 Inhibitors and Radiation Combination Therapy in Estrogen Receptor-Positive Breast Cancer
Location: Hall C
Presenter: Reine Abou Zeidane, MD – Case Western Reserve School of Medicine
5:00 PM – 6:00 PM ET
2759 - Spatiotemporal Evaluation of the Early Inflammatory Response of the Gut to Radiation Using Non-Invasive In Vivo Redox Imaging
Location: Hall C
Presenter: Kosei Adachi, RT – Gifu University / Asahi University Hospital
5:00 PM – 6:00 PM ET
2760 - Role of ATP Binding Cassette Subfamily A Member 1 (ABCA1) in Renal Toxicity
Location: Hall C
Presenter: Anis Ahmad, PhD – University of Miami
5:00 PM – 6:00 PM ET
2761 - Sex as a Variable in Susceptibility to Radiation Induced Lung Injury and Macrophage Accumulation
Location: Hall C
Presenter: Heesu Ahn, PhD – National Institute of Health
5:00 PM – 6:00 PM ET
2762 - Modeling Twist1 Overexpression in a Pancreatic Ductal Adenocarcinoma Mouse Model
Location: Hall C
Presenter: Muhammad Ajmal Khan, PhD – University of Maryland School of Medicine
5:00 PM – 6:00 PM ET
2763 - Disparities in Completion of Patient-Reported Outcomes in Thoracic Radiation Oncology Patients
Location: Hall C
Presenter: Monzer Alatrach, MS, BS – MD Anderson Cancer Center
5:00 PM – 6:00 PM ET
2766 - Cannabis Assessment in Radiation Oncology - Evaluation Survey (CARES Study): Understanding Usage Patterns in Rural Underserved Radiation Cohort
Location: Hall C
Presenter: Evans Amoah, MD, MPH – University of Kentucky
5:00 PM – 6:00 PM ET
2767 - Counting the Cost: An Observational Study on Exploring Financial Toxicity and Its Determinants among Cancer Patients
Location: Hall C
Presenter: Yogesh Anap, MD, DNB – Kolhapur Cancer Centre
5:00 PM – 6:00 PM ET
2768 - Potential Utility of Interim PET CT as Predictive and Prognostic Marker is Locally Advanced Head and Neck Squamous Cell Carcinoma Patients Treated with Simultaneous Integrated Boost-IMRT- Can One Scan
Location: Hall C
Presenter: P Anuradha, MBBS – Health Care Global Limited
5:00 PM – 6:00 PM ET
2769 - Therapy Dogs Supported Radiotherapy in Cancer Patients Treated with MR Linac - Preliminary Results
Location: Hall C
Presenter: Banu Atalar, MD, RT – Acibadem Maslak Hospital
5:00 PM – 6:00 PM ET
2770 - Hypofractionated Radiation and T Cells in Oral Cancer on a Phase I Clinical Trial of Preoperative Radiation
Location: Hall C
Presenter: Musaddiq Awan, MD – Medical College of Wisconsin
5:00 PM – 6:00 PM ET
2771 - Comparison of Post Treatment Hematologic Changes between FLASH and Conventional Dose Rate Murine Brain Irradiation
Location: Hall C
Presenter: Khaled Aziz, MD, PhD – Johns Hopkins Radiation Oncology Kimmel Cancer Center
5:00 PM – 6:00 PM ET
2772 - Mechanisms of B-Cell Activity in Tumor Microenvironment
Location: Hall C
Presenter: Khaled Aziz, MD, PhD – Johns Hopkins Radiation Oncology Kimmel Cancer Center
5:00 PM – 6:00 PM ET
2773 - Ginsenoside Rg5 affects irradiation-induced lung fibrosis in mice via macrophage-mediated phagocytosis involving MERTK and PTX3
Location: Hall C
Presenter: Hansong Bai, MD, PhD – Georgetown - Lombardi Cancer Center and Georgetown Medical School
5:00 PM – 6:00 PM ET
2774 - Patient-reported outcomes from an App-delivered Yogic breathing when compared to mindfulness in post-radiation therapy in breast cancer survivors: a randomized controlled trial
Location: Hall C
Presenter: Sundar Balasubramanian, PhD – Medical University of South Carolina
5:00 PM – 6:00 PM ET
2775 - Radiation-Activated Prodrugs: An Investigation of Optimal Linker Chemistries and Radiation Parameters
Location: Hall C
Presenter: Leou Ismael Banla, MD, PhD – Harvard Radiation Oncology Program
5:00 PM – 6:00 PM ET
2777 - Radiation Enhances the Efficacy of HER2.28?/PD-L1.BB CAR-T Cells Against Triple-Negative Breast Cancer By Increased the Infiltration of CD8+ T Cells into Tumors
Location: Hall C
Presenter: Zhang Benxia – Sichuan University
5:00 PM – 6:00 PM ET
2778 - Impact of Survivorship Care Plans (SCPs) on Patients Perceptions of Information Provided from Diagnosis to Follow-Up in Breast Cancer Patients Treated at a Rural Community Cancer Center
Location: Hall C
Presenter: Paige Bordelon, BS, MPH – Vail Health Hospital
5:00 PM – 6:00 PM ET
2779 - Radiopharmaceutical Cell Surface Target Selection
Location: Hall C
Presenter: Scot Callahan, MD, PhD – UW Carbone Cancer Center
5:00 PM – 6:00 PM ET
2780 - The Association of Genetic Polymorphisms in the TNF-a Gene and Mucositis in Head and Neck Cancer Patients Treated with Combined Radiotherapy and Chemotherapy
Location: Hall C
Presenter: Ronaldo Cavalieri, MD, PhD – OncoBeda - Centro Integrado de Oncologia
5:00 PM – 6:00 PM ET
2781 - Investigating the Role of TNIK in the Pathogenesis of Lung Squamous Cell Carcinoma
Location: Hall C
Presenter: Jin Hee Chang, BS – University of Maryland School of Medicine
5:00 PM – 6:00 PM ET
2782 - Enrichment of Tumor-Associated Fragmentomic Features in Plasma with Focused Ultrasound-Enabled Liquid Biopsy in Glioma Patients
Location: Hall C
Presenter: Pradeep Chauhan, PhD – Mayo Clinic Rochester
5:00 PM – 6:00 PM ET
2783 - Impact of senolytic therapy on macrophages in radiation-induced skin fibrosis
Location: Hall C
Presenter: Eun Chung, PhD – National Institute of Health
5:00 PM – 6:00 PM ET
2784 - Highly-Multiplex Detection and Quantitation of Plasma Cell-Free Human Papillomavirus-16 DNA in Oropharyngeal Carcinoma
Location: Hall C
Presenter: Payton Clark, BS – Cleveland Clinic Foundation
5:00 PM – 6:00 PM ET
2785 - Autophagy is Required to the Regeneration of Salivary Gland after Radiation Injury
Location: Hall C
Presenter: Liu Dengqun, PhD – Sichuan Cancer Hospital
5:00 PM – 6:00 PM ET
2787 - MTA3 and Radiosensitivity of Non-Small Cell Lung Cancer through Enhancing Glutamine Synthetase-Mediated Cancer Stemness
Location: Hall C
Presenter: Liang Du, PhD – Chongqing University Cancer Hospital
5:00 PM – 6:00 PM ET
2788 - Bragg Peak Proton Radiotherapy Demonstrates Differing Radiobiological Phenotype on Phosphoproteomic Analysis
Location: Hall C
Presenter: Daniel Ebner, MD, MPH – Mayo Clinic
5:00 PM – 6:00 PM ET
2789 - Machine Learning-Based Prediction of Acute Care during Radiation Therapy Using the NCCN Distress Thermometer
Location: Hall C
Presenter: Jonathan Ejie, BS – University of California San Francisco
5:00 PM – 6:00 PM ET
2790 - Novel Role for SMPDL3b in Radiation Nephropathy
Location: Hall C
Presenter: Marina Francis, PhD – Stanford University School of Medicine
5:00 PM – 6:00 PM ET
2792 - Skeletal Muscle Loss after Short ADT Duration in Prostate Cancer Patients Treated with Radiation Therapy
Location: Hall C
Presenter: Ramesh Gadam, MD, MBBS – University of Kansas Medical Center
5:00 PM – 6:00 PM ET
2793 - Can Hyperthermia Treatment Restore Sensitivity to Anti-PDL1 Therapy in Immunological Cold Tumors? Lessons Learned from Preclinical Murine Models
Location: Hall C
Presenter: Guanyu Gong, PhD – Affiliated Zhongshan Hospital of Dalian University
5:00 PM – 6:00 PM ET
2794 - AP97-110 Combined with AZD6738 and Radiotherapy Sensitivity of Liver Cancer by Inhibiting XPO1 and ATR
Location: Hall C
Presenter: Liuyun Gong, MD, PhD – Xiamen University First Affiliated Hospital
5:00 PM – 6:00 PM ET
2795 - Unbiased Functional Genomics Screen Identifies Unique Therapeutic Vulnerabilities in Osimertinib-Resistant NSCLCs
Location: Hall C
Presenter: Alex Gooding, MD, PhD – Duke University
5:00 PM – 6:00 PM ET
2796 - Longitudinal T-Cell Receptor Analysis of Patients with Locally Advanced NSCLC Treated with Hypofractionated Chemoradiation and SABR Boost
Location: Hall C
Presenter: Jesus Juarez Casillas, MD, MS – UCLA
5:00 PM – 6:00 PM ET
2798 - SWItch/Sucrose NonFermentable Complex-Deficient Pulmonary Neoplasms: Clinicopathologic Characteristics and Outcomes to Radiotherapy and Immunotherapy
Location: Hall C
Presenter: Yu Gu, PhD
5:00 PM – 6:00 PM ET
2799 - A Feasibility Study of Using ⁶⁴Cu-ATSM PET for Radiation Dose Painting Escalation in Locally Advanced Rectal Cancers
Location: Hall C
Presenter: Dorine de Jong, PhD – RefleXion
5:00 PM – 6:00 PM ET
2800 - Predictors of Clinically Significant Change on the Brief Fatigue Inventory
Location: Hall C
Presenter: Heather Gunn, PhD – Mayo Clinic
5:00 PM – 6:00 PM ET
2801 - Patient Reported Quality of Life after Chemoradiation for Esophageal Cancer: Analysis of Clinical and Dosimetric Predictors
Location: Hall C
Presenter: Nikita Gupta, BS – Georgetown University School of Medicine
5:00 PM – 6:00 PM ET
2802 - A Clinically-Mimetic Focal Bowel Irradiation Model to Assess Spatial Microbiome Perturbations after Duodenal Radiotherapy
Location: Hall C
Presenter: LeMoyne Habimana-Griffin, MD, PhD – Barnes Jewish Hospital
5:00 PM – 6:00 PM ET
2803 - Clonogenic Cell Survival Following In Vitro Irradiation Using Open vs. 2-Dimensional GRID Field Spatially Fractionated Radiotherapy of Murine Lymphoma, Breast and Renal Carcinoma
Location: Hall C
Presenter: Hye Ri Han, MD, MS – University of Southern California/Los Angeles General Medical Center
5:00 PM – 6:00 PM ET
2804 - Efficacy of Fas-4-1BB Immunomodulatory Fusion Proteins Engineered T-Cells in Applying to Targeted Pubic Neoantigen Immunotherapy Using Encapsulated Nanoparticles Directed by Radiation
Location: Hall C
Presenter: Satoshi Harada, MD, PhD – Iwate Medical University School of Medicine
5:00 PM – 6:00 PM ET
2805 - Mechanistic Study of the Anti-Tumor Effects of PRaG Therapy in a Mouse Colorectal Cancer Tumor Model
Location: Hall C
Presenter: Yaping He
5:00 PM – 6:00 PM ET
2806 - Radiation-Induced Pelvic Insufficiency Fractures and Sacro-Iliac Joint Optimisation in Pelvic External Beam Radiotherapy
Location: Hall C
Presenter: Emer Herlihy, MB – St. Luke's Radiation Oncology Network
5:00 PM – 6:00 PM ET
2807 - Assessing the Impact of Medical Physicists Education Consult in Radiotherapy Patients Care: A Pilot Study in Mexico
Location: Hall C
Presenter: Mariana Hernandez-Bojorquez, PhD, MS – American British Cowdray Medical Center
5:00 PM – 6:00 PM ET
2808 - The Mitigating Effects of Hyperbaric Oxygen Therapy on Radiation-Induced Neuronal Damage and Microglial Activation in Rats
Location: Hall C
Presenter: Sheng-Yow Ho, MD, MS – Chi Mei Medical Center
5:00 PM – 6:00 PM ET
2809 - Interferon-Dependent Cancer-Associated Fibroblasts Render the Responsiveness of Neoadjuvant Radiotherapy in Colorectal Cancer
Location: Hall C
Presenter: Lili Huang, MD, PhD – Fudan University Shanghai Cancer Center
5:00 PM – 6:00 PM ET
2810 - ITGA5 and Radioresistance through DNA Damage Repair in Esophageal Squamous Cell Carcinoma
Location: Hall C
Presenter: Xinyi Huang, MD
5:00 PM – 6:00 PM ET
2811 - Single-Cell Transcriptomic Analysis Deciphers Key Signatures Associated with Dynamic Evolution in Radiation-Induced Esophageal Injury
Location: Hall C
Presenter: Xinyi Huang, MD
5:00 PM – 6:00 PM ET
2812 - Inhibition of Tumor-Intrinsic BANF1 Sheds Light on Lung Cancer Radiotherapy
Location: Hall C
Presenter: Yiheng Huang, PhD
5:00 PM – 6:00 PM ET
2813 - Dosimetric Predictors of Dysphonia in Long-Term Survivors of Locally Advanced Head and Neck Cancer Treated with Radiation Therapy
Location: Hall C
Presenter: Adam Hubler, MD – University of Alabama at Birmingham
5:00 PM – 6:00 PM ET
2814 - A Pilot Study to Detect Inflammatory Biomarkers of Pneumonitis in Exhaled Breath during Chemoradiotherapy for Stage III Non-Small Cell Lung Cancer
Location: Hall C
Presenter: Ryan Hughes, MD – Wake Forest University School of Medicine
5:00 PM – 6:00 PM ET
2815 - Urinary Quality of Life in Patients Treated with Prostate SBRT with Intra-Prostatic Boost
Location: Hall C
Presenter: Nisha Bhargava, BS – Beth Israel Deaconess Medical Center
5:00 PM – 6:00 PM ET
2816 - Patient Reported Outcomes and Patterns of Care after Proton Beam Therapy (PRT) for Gastrointestinal (GI) Cancers
Location: Hall C
Presenter: Michelle Iocolano, MD, MA – University of Pennsylvania
5:00 PM – 6:00 PM ET
2817 - Radiation Therapy Is Associated with Prefrailty in Breast Cancer Survivors Aged 40-65
Location: Hall C
Presenter: Brigitte Jia, BA – Vanderbilt University School of Medicine
5:00 PM – 6:00 PM ET
2818 - Effects and Mechanisms of Fractionated Radiotherapy Combined with CD47/PD-L1 Inhibitors in the Treatment of Esophageal Cancer
Location: Hall C
Presenter: Yang Jiao, MD, PhD – Medical College of Soochow University
5:00 PM – 6:00 PM ET
2819 - Prospective Longitudinal Patient Reported Outcomes (PROs) in Head and Neck Cancers (HNC) Treated with Chemoradiotherapy (CRT)
Location: Hall C
Presenter: Seema Kacker, MD, PhD – Johns Hopkins University
5:00 PM – 6:00 PM ET
2820 - Patient-Reported Xerostomia in Men Treated with Prostate Stereotactic Body Radiation Therapy: Implications for Future Radionuclide Therapy
Location: Hall C
Presenter: Diya Kallam, BA – George Washington University School of Medicine
5:00 PM – 6:00 PM ET
2821 - Financial Toxicity among Long Term Survivors of Prostate Cancer
Location: Hall C
Presenter: Katelyn Kane, MD – University of Kansas Medical Center
5:00 PM – 6:00 PM ET
2822 - Impact of Mental Health on Long-Term Patient-Reported Outcomes and Quality of Life after Head and Neck Radiation
Location: Hall C
Presenter: Ari Kassardjian, MD – City of Hope Comprehensive Cancer Center
5:00 PM – 6:00 PM ET
2823 - Patient-Derived Pancreatic Tumor Organoids as a Surrogate to Predict Radiation and Chemotherapy Response in Individual Patients: A Model for Precision Medicine
Location: Hall C
Presenter: Zachery Keepers, BS – University of Maryland School of Medicine
5:00 PM – 6:00 PM ET
2825 - The Impact of Neoadjuvant Relugolix on Multi-Dimensional Patient-Reported Fatigue
Location: Hall C
Presenter: Min Ji Koh – Georgetown University Hospital
5:00 PM – 6:00 PM ET
2826 - Combining Plk1 Inhibition and Radiation to Target Head and Neck Cancer
Location: Hall C
Presenter: Julianna Korns, BS – University of Cincinnati
5:00 PM – 6:00 PM ET
2827 - The Radiotherapy Information Gap in Survivorship Care Plans
Location: Hall C
Presenter: Ramez Kouzy, MD – MD Anderson Cancer Center
5:00 PM – 6:00 PM ET
2828 - Impact of Mindfulness in Patients with Prostate Cancer Treated with Radiation Therapy
Location: Hall C
Presenter: Bhupesh Parashar, MD, PhD – Zucker School of Medicine at Hofstra/Northwell
5:00 PM – 6:00 PM ET
2829 - The Role of RNA Stability in the Invasive Capacity of Radioresistant Triple Negative Breast Cancer
Location: Hall C
Presenter: Ayush Kumar, BS – UMass Chan Medical School / QARC
5:00 PM – 6:00 PM ET
2830 - Impact of TWIST1 Transactivation Domain towards Oncogene-Induced Senescence Suppression in Non-Small Cell Lung Cancer
Location: Hall C
Presenter: Audrey Lafargue, PhD – University of Maryland School of Medicine
5:00 PM – 6:00 PM ET
2831 - Survivorship Therapy after RadiOtherapy for head/Neck cancer: opportunities for Growth (STRONG)
Location: Hall C
Presenter: Alexis Larson, MSN, OCN, APRN – Northwestern Memorial Hospital
5:00 PM – 6:00 PM ET
2832 - Apolipoprotein E Mediates Radioresistance of Pancreatic Adenocarcinoma
Location: Hall C
Presenter: Talya Laufer, MD – Sidney Kimmel Cancer Center at Thomas Jefferson University
5:00 PM – 6:00 PM ET
2833 - Remotely Monitoring Patient-Reported Outcomes during and Immediately after Radiation Therapy
Location: Hall C
Presenter: Grace Lee, RT, MHSc – Princess Margaret Cancer Centre
5:00 PM – 6:00 PM ET
2834 - Prediction of Parotid Gland Changes in Radiation-Induced Oral Mucositis of Nasopharyngeal Carcinoma Based on Metabolism-Imaging Bimodal Omics
Location: Hall C
Presenter: Lei Ji, MD – The First Affiliated Hospital of Soochow University
5:00 PM – 6:00 PM ET
2835 - Exploration of the Effectiveness and Mechanism of Reversal of Radiotherapy Resistance in Head and Neck Squamous Cell Carcinoma by High-Energy X-Ray Based FLASH Radiotherapy
Location: Hall C
Presenter: Hong-Shuai Li
5:00 PM – 6:00 PM ET
2836 - Dual-Responsive Intelligent Nanosystem, Radiotherapy Resistance in Hypoxic Tumors, and Systemic Antitumor Immunity
Location: Hall C
Presenter: Ruidan Li
5:00 PM – 6:00 PM ET
2837 - Preliminary Study on Immunological Mechanism of Partial Stereotactic Ablative Boost Radiotherapy (P-SABR)
Location: Hall C
Presenter: Shanshi Li, PhD – Peking University First Hospital
5:00 PM – 6:00 PM ET
2838 - The Circadian Clock Gene, BMAL1, and Radiosensitization in Nasopharyngeal Carcinoma by Inhibiting the Epithelial-to-Mesenchymal Transition via the TGF-ß1/Smads/Snail1 axis
Location: Hall C
Presenter: Yuxin Li, MS
5:00 PM – 6:00 PM ET
2839 - SBRT-Induced Tumor Cell Necroptosis Facilitates Immune Evasion by Recruiting MDSCs via the Secretion of CXCL4
Location: Hall C
Presenter: Zhiyun Liao, MD – Chongqing University Cancer Hospital and Chongqing Cancer Institute
5:00 PM – 6:00 PM ET
2840 - Unraveling the Molecular Mechanisms of Radioresistance in Breast Cancer: A Transcriptomic and Proteomic Analysis
Location: Hall C
Presenter: Reine Abou Zeidane, MD – Case Western Reserve School of Medicine
5:00 PM – 6:00 PM ET
2841 - Verifying the Protective Effect of Miniaturized High-Energy X-Rays FLASH-RT Device and the Impact of Irradiation Fraction on Normal Tissues
Location: Hall C
Presenter: Binwei Lin, MD, MS – MianYang Central Hospital
5:00 PM – 6:00 PM ET
2842 - Unveiling the Intricate Interplay of ROS, Autophagy and p53 in Radioresistance of Hepatocellular Carcinoma
Location: Hall C
Presenter: Yu-Wei Lin, MD, PhD, MS – Kaohsiung Veterans General Hospital
5:00 PM – 6:00 PM ET
2843 - Study of Therapeutic Effect of Targeted IGF2BP2 Regulating SESN2 on Radiation-Induced Intestinal Injury
Location: Hall C
Presenter: Ruiqiu Zhu, MD, PhD – Soochow University
5:00 PM – 6:00 PM ET
2844 - Nucleic Acid Drug Targeting PEX5 for Sensitization to Radiotherapy in Hepatocellular Carcinoma
Location: Hall C
Presenter: Silin Liu
5:00 PM – 6:00 PM ET
2845 - Correlation between Primary Uptake of [¹⁸F]AlF-NOTA-FAPI-04 and Molecular Subtypes of Breast Cancer
Location: Hall C
Presenter: Tianxin Liu, MBBS
5:00 PM – 6:00 PM ET
2846 - Old Wine in a New Bottle: The Antimycotic Agent Oxiconazole and PRDX2-Mediated Ferroptosis in NSCLC
Location: Hall C
Presenter: Xu Liu – Shandong Cancer Hospital and Institute
5:00 PM – 6:00 PM ET
2847 - Economic Evaluation of Pediatric Cancer Survivors after Receiving Proton Radiotherapy Compared to Photon Radiotherapy: Real-World Data from 2010-2022
Location: Hall C
Presenter: Natalie Logie, MD – Tom Baker Cancer Centre / University of Calgary
5:00 PM – 6:00 PM ET
2848 - Pulsed vs. Single Shot Immune-Amplified 1Gy Miniscule Radiotherapy Synchronic with Immune-Check Point Inhibitors and SBRT in Disseminated Malignancies-Immuno-Rad(i-RT) Concept to Reprogram Microenviro
Location: Hall C
Presenter: G Lohith, MD – HCG
5:00 PM – 6:00 PM ET
2849 - Preoperative Radiosurgery on Early Breast Cancer Patients: Analysis of Tumor Genetic Background and Tumor Immune Microenvironment
Location: Hall C
Presenter: Mauro Loi, MD – Azienda Ospedaliera Universitaria Careggi
5:00 PM – 6:00 PM ET
2850 - EQFX - A Transformation of Previous Radiotherapy Dose to Stereotactic Fractionation
Location: Hall C
Presenter: Brian Loughery, PhD
5:00 PM – 6:00 PM ET
2851 - Identifying Potential Risk Factors for Increased Distress in Lung Cancer Patients Receiving Radiotherapy
Location: Hall C
Presenter: Bailey Loving, MD – Beaumont Health - Royal Oak
5:00 PM – 6:00 PM ET
2852 - Predictive Model of Family Resilience in Cervical Cancer Patients and Evaluation of Intervention Outcomes
Location: Hall C
Presenter: Jue Lu
5:00 PM – 6:00 PM ET
2853 - FLASH Radiotherapy Attenuated Indirect Radiation Damage of Mouse Liver Caused by Non-Target Effects
Location: Hall C
Presenter: Xingyu Lu, PhD – Southern Medical University
5:00 PM – 6:00 PM ET
2854 - CXCR4-Directed PET/CT may Distinguish Different Subtypes of Small Cell Lung Cancer
Location: Hall C
Presenter: Yuxi Luo, MD
5:00 PM – 6:00 PM ET
2855 - Combination of Radiotherapy and Complement-Mediated Immunotherapy
Location: Hall C
Presenter: Lixin Mai, MD – German Cancer Research Center (DKFZ)
5:00 PM – 6:00 PM ET
2856 - Biological Response Heterogeneity along the Proton Depth-Dose Curve
Location: Hall C
Presenter: Julian Malicki, PhD – Poznan University of Medical Sciences
5:00 PM – 6:00 PM ET
2857 - Photobiomodulation for the Prevention of Oral Mucositis in Patients Treated with Radiotherapy for Head and Neck Cancer
Location: Hall C
Presenter: Patrick Martin, MD
5:00 PM – 6:00 PM ET
2858 - Applying a Portable Pocket Handheld Ultrasound Scanner to Monitor Tumor Volume in Preclinical Studies
Location: Hall C
Presenter: Stavros Melemenidis, PhD – Stanford University
5:00 PM – 6:00 PM ET
2859 - Spirituality and Religiousness as a Special Resource for Patients with Breast Cancer
Location: Hall C
Presenter: Oliver Micke, MD – Franzikus Hospital Bielefeld
5:00 PM – 6:00 PM ET
2860 - Multifunctional Ruthenium Covalent Organic Framework Sequentially Sensitize Radio-Radio-Dynamic-Immunotherapy against Cancer
Location: Hall C
Presenter: Yu Min, MD
5:00 PM – 6:00 PM ET
2861 - Conventional Radiotherapy may Potentiate Anti-Tumor Immunity in Patients with Meningioma
Location: Hall C
Presenter: Shubhendu Mishra, MD, MS – University of Minnesota Radiation Oncology Clinic University Campus
5:00 PM – 6:00 PM ET
2862 - Multi-Omics Analysis of Pulmonary Toxicity Induced by Radiotherapy and Combination of Immune Checkpoint Blockade and Radiotherapy
Location: Hall C
Presenter: You Mo
5:00 PM – 6:00 PM ET
2863 - Surprising Dose Dependent Sparing Effects of Fractionated FLASH Electrons in Experimental Radiation Induced Lung Fibrosis Model
Location: Hall C
Presenter: Mahmoud Moustafa, DVM, PhD
5:00 PM – 6:00 PM ET
2864 - Exploring Quality of Life, and Changes in Sexual Function and Urinary Symptoms in Patients Commencing Combined Hormonal Therapy with Abiraterone Acetate and a GnRH Agonist: A Prospective Study [CTRIAL
Location: Hall C
Presenter: Geraldine Murphy, MD, MB – Princess Margaret Cancer Center, University Health Network
5:00 PM – 6:00 PM ET
2865 - Focused CRISPR Activation-Based Screening to Identify Novel Targets of Chemoradiation Resistance in Pancreatic Cancer
Location: Hall C
Presenter: Sindhu Nair, PhD, DMD – City of Hope National Medical Center
5:00 PM – 6:00 PM ET
2866 - Genetic Profiling of Aggressive Prostate Cancer in Patients Undergoing High Dose Rate (HDR) Brachytherapy
Location: Hall C
Presenter: Beth Neilsen, MD, PhD – University of California Los Angeles
5:00 PM – 6:00 PM ET
2867 - Clinical Factors that Affect Patient-Reported Outcomes of Vaginal Stenosis after Pelvic Radiation Treatment for Cervical Cancer
Location: Hall C
Presenter: Anna Norman, BS – Baylor College of Medicine
5:00 PM – 6:00 PM ET
2868 - Changes in Systemic Immune Response and Its Dosimetric Correlates in Patients with Non-Small-Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy
Location: Hall C
Presenter: Zuzanna Nowicka, MD – Medical University of Lodz
5:00 PM – 6:00 PM ET
2869 - Development of a Multidisciplinary Sexual Health Program (MSHP): A Supportive Care Needs Assessment for Gynecological Cancer Survivors at a Community Hospital
Location: Hall C
Presenter: Joy Ogunmuyiwa, MD – New York Presbyterian
5:00 PM – 6:00 PM ET
2870 - Prediction of the Cell Killing Effect of Clinically-Used Mixed-LET Carbon Ions By Clustered Dsbs Volumes Using Super-Resolution Microscopy
Location: Hall C
Presenter: Takahiro Oike, MD, PhD – Gunma University
5:00 PM – 6:00 PM ET
2871 - Prostate Cancer Somatic Mutations and Outcomes of Salvage Radiation and Hormonal Therapy for Post-Prostatectomy Recurrence
Location: Hall C
Presenter: David Miyamoto, MD, PhD – Massachusetts General Hospital
5:00 PM – 6:00 PM ET
2872 - Non-Invasive Imaging of Acute Radiation-Induced Esophagitis by Targeting CXCR4
Location: Hall C
Presenter: Jinli Pei, PhD – Shandong Cancer Hospital and Institute
5:00 PM – 6:00 PM ET
2873 - Stereotactic Radiosurgery for Spinal Metastases with Gastrointestinal Histology vs. Other Radioresistant Histologies
Location: Hall C
Presenter: Dasha Klebaner, MD, BS, MPH – Stanford University Cancer Center
5:00 PM – 6:00 PM ET
2874 - Nanoparticles Reassembled Whole Cancer Cell Components, Detecting Tumor-Specific T Cells, and the Abscopal Effect
Location: Hall C
Presenter: Zhunyi Gao, BS
5:00 PM – 6:00 PM ET
2875 - Assessment of Sleep as an Individual Toxicity of Radiotherapy
Location: Hall C
Presenter: Vrushab Rao, MBBS, PDCR – Ruby Hall Clinic
5:00 PM – 6:00 PM ET
2876 - Comparison of Two Triple Therapy Regimens Involving RT and Anti-PD-1 in Tumor-Bearing Mice
Location: Hall C
Presenter: XI Rao, MD
5:00 PM – 6:00 PM ET
2877 - Evaluation of Financial Distress among Patients with Cancer in a Country with a Public Health Care System
Location: Hall C
Presenter: Ivica Ratosa, MD, PhD – Institute of Oncology Ljubljana
5:00 PM – 6:00 PM ET
2878 - Using Virtual Reality Technology to Improve Patient Anxiety and Reduce Opioids Use during HDR Brachytherapy Procedure for Patients with Gynecological Cancer
Location: Hall C
Presenter: Santanu Samanta, MD – University of Arkansas for Medical Sciences (UAMS)
5:00 PM – 6:00 PM ET
2879 - Mitophagy Promoting Fasting Diet Positioned Radiation Therapy for Harmonizing Dysregulated Cellular Energetics in Locally Advanced Non Metastatic Cancers: Conceptual Comparative Clinical Application S
Location: Hall C
Presenter: Krithikaa Sekar, MD, MBBS – Healthcare Global Enterprises Ltd.
5:00 PM – 6:00 PM ET
2880 - Reduced Gastrointestinal Toxicity with Rectal Spacing in Men Treated with Prostate Stereotactic Body Radiation Therapy and Supplemental Pelvic Intensity Modulated Radiation Therapy
Location: Hall C
Presenter: Vaibhav Sharma, MD – Medstar Georgetown University Hospital
5:00 PM – 6:00 PM ET
2881 - Biochemical and Biophysical Studies of Novel Small Molecules Targeting Proteasome Subunit Alpha Type-7 (PSMA7) for the Treatment of Glioblastoma
Location: Hall C
Presenter: Christian Showalter, PhD – The Ohio State University
5:00 PM – 6:00 PM ET
2882 - Systemic and Local Immunological Responses to Stereotactic Radiosurgery for HER2+ Breast Cancer Brain Metastasis
Location: Hall C
Presenter: Joseph Sia, MB, ChB, PhD, MBBS, FRANZCR – Peter MacCallum Cancer Centre
5:00 PM – 6:00 PM ET
2883 - ROA2233: A Prospective Study of Electronic Patient-Reported Outcomes Monitoring and Management
Location: Hall C
Presenter: Will Sperduto, MD – Mayo Clinic Arizona
5:00 PM – 6:00 PM ET
2884 - Ulinastatin and Radiation-Induced Brain Injury via Inhibition of Notch 1 in Mice
Location: Hall C
Presenter: Ning SU
5:00 PM – 6:00 PM ET
2885 - The transcriptional landscape of radiation-induced heart disease in mice using single-nucleus RNA sequencing
Location: Hall C
Presenter: Xi Su, MD – Shanghai Chest Hospital, Shanghai Jiao Tong University
5:00 PM – 6:00 PM ET
2887 - Financial Toxicities of Cancer Treatment for Patients Who Received Curative-Intent Radiation Therapy
Location: Hall C
Presenter: Elsa Sutton, MD – Mayo Clinic Rochester
5:00 PM – 6:00 PM ET
2888 - Characteristics and Trends in ESAS Scores of Radiation Oncology Patients Undergoing Outpatient Palliative Care Medicine at a Community Hospital
Location: Hall C
Presenter: Meghan Tahbaz, BA – University of South Florida College of Medicine
5:00 PM – 6:00 PM ET
2889 - Survey of Sexual Health Concerns among Patients with Treatment-Naïve Prostate Cancer
Location: Hall C
Presenter: Andrew Tam, MD – City of Hope National Medical Center
5:00 PM – 6:00 PM ET
2890 - Glucose-Enhanced Tumor Oxidative Phosphorylation and the Efficacy of Hypofractionated Radiotherapy through IFN-I Pathway
Location: Hall C
Presenter: Qingxu Tao, PhD
5:00 PM – 6:00 PM ET
2891 - Loss of Tumor Intrinsic RIPK1, Antitumor Immune Responses, and the Efficacy of PD-1 Blockade
Location: Hall C
Presenter: Feifei Teng, MD, PhD – Shandong Anti-Cancer Association
5:00 PM – 6:00 PM ET
2892 - Targeting A-to-I RNA Editing and Radiation-Induced CD8+ T Cell Dysfunction in Non-Small-Cell Lung Cancer
Location: Hall C
Presenter: Zengfu Zhang, MD – Shandong Cancer Hospital and Institute
5:00 PM – 6:00 PM ET
2893 - Irradiation-Induced Intestinal Injury and Mucus Secretion from Goblet Cells by Activating Endoplasmic Reticulum Stress
Location: Hall C
Presenter: Ye Tian, MD – The Second Affiliated Hospital of Soochow University
5:00 PM – 6:00 PM ET
2894 - Partial Kidney Radiation Modeling for the Effect of Kidney Dysfunction in Pediatric Cancer
Location: Hall C
Presenter: Federico Ticona, MD, International Medical Graduate – Huntsman Cancer Institute at the University of Utah
5:00 PM – 6:00 PM ET
2895 - Implementing ePROMs in a Safety-Net Radiation Oncology Clinic: Pre- and Post-COVID-19
Location: Hall C
Presenter: Rebecca N. Tsai, MS, BS – Boston University School of Medicine
5:00 PM – 6:00 PM ET
2896 - First Steps toward Prevention of Patchy Alopecia Following Linac Based Fractionated Stereotactic Radiotherapy (fSRT) for Arteriovenous Malformation(AVM): A Retrospective, Single Institutional Experien
Location: Hall C
Presenter: Birjoo Vaishnav, PhD, DABR – Mayo Clinic College of Medicine and Science Rochester
5:00 PM – 6:00 PM ET
2898 - Prospective Longitudinal Study of Quality of Life, Brain Substructure Atrophy, and Neurocognitive Outcomes in Children Following Proton Therapy for Brain Tumors
Location: Hall C
Presenter: Katherine Von Werne, MSN – Miami Cancer Institute: Baptist Health South Florida
5:00 PM – 6:00 PM ET
2899 - Remodeling the Tumor-Immune Microenvironment by Radiotherapy and Anti-BTLA Blockade Enhance Anti-PD-L1 Efficacy
Location: Hall C
Presenter: Bin Wang, MS
5:00 PM – 6:00 PM ET
2900 - The Correlation of Mean Dose Rate with Electron FLASH Effect in Mouse Skin and Associated Metabonomic Profile Analysis
Location: Hall C
Presenter: Chen Wang, MD
5:00 PM – 6:00 PM ET
2901 - CDC42 Inhibitor and the Radiosensitivity of Non-Small Cell Lung Cancer by Restraining BRCA1-Mediated DNA Damage Repair
Location: Hall C
Presenter: Fei Wang, PhD
5:00 PM – 6:00 PM ET
2902 - Targeting Solid Stress to Improve Radiotherapeutic Efficacy via Chromatin Modulation
Location: Hall C
Presenter: Jin Wang
5:00 PM – 6:00 PM ET
2903 - Radiation Combined with Anti-PD-1 Inhibitor and Myocardial Injury via NLRP3 Inflammasome in Mice
Location: Hall C
Presenter: Jun Wang, PhD
5:00 PM – 6:00 PM ET
2904 - Radiation Enhances PD-L1 in Cardiomyocytes: Implications for Combined Radiation and Anti-Programmed Death-1 (PD-1) Antibody-Induced Myocardial Injury
Location: Hall C
Presenter: Jun Wang, MD, PhD – Fourth Hospital of Hebei Medical University
5:00 PM – 6:00 PM ET
2905 - NLRP3 Inflammasome Activation by mtROS in Cardiomyocytes and Radiation Induced Acute Myocardial Injury
Location: Hall C
Presenter: Jun Wang, MD, PhD – Fourth Hospital of Hebei Medical University
5:00 PM – 6:00 PM ET
2906 - Adding a PPARa Agonist Enhances T Cell-Mediated Effects of RT in Combination with Anti-PD-1
Location: Hall C
Presenter: Meidan Wang, PhD – University of Freiburg
5:00 PM – 6:00 PM ET
2907 - Targeting O-GlcNAcylation Rearrangement and Radiotherapy Sensitivity in NSCLC via the Axis of OGA/HCF1/ RAD18
Location: Hall C
Presenter: Zengfu Zhang, MD – Shandong Cancer Hospital and Institute
5:00 PM – 6:00 PM ET
2908 - Enhancing Cancer Therapy: Synergistic Effects of Withaferin A and Ionizing Radiation on Lung Cancer Cells
Location: Hall C
Presenter: Yu-Jen Wang, MD, PhD – Fu Jen Catholic University Hospital
5:00 PM – 6:00 PM ET
2909 - Targeting Ferroptosis to Prevent Radiation-induced Intestinal Injury
Location: Hall C
Presenter: Yun-Long Wang
5:00 PM – 6:00 PM ET
2910 - Radiobiology Population Modeling of Intestinal Stem Cells and Intestinal Epithelial Cells to Predict Radiation Induced Toxicity
Location: Hall C
Presenter: William Watkins, PhD – City of Hope National Medical Center
5:00 PM – 6:00 PM ET
2911 - PD-L1 Coexpression Gene Analysis in Esophageal Squamous Cell Carcinoma, B2M, and the Prognosis and Infiltration of Immune Cells
Location: Hall C
Presenter: Yahong Wei, MD
5:00 PM – 6:00 PM ET
2912 - Regulation Mechanism of Radioresistance in Cervical Cancer Mediated By Trfs through SLC31A1-Dependent Cuproptosis
Location: Hall C
Presenter: Ning Wu
5:00 PM – 6:00 PM ET
2913 - Effects of FLASH Irradiation on Liver Metabolomics in Mice Subjected to Partial-Liver Irradiation
Location: Hall C
Presenter: Dehuan Xie, MD – Guangdong Provincial People's Hospital
5:00 PM – 6:00 PM ET
2914 - Lycopene and Radiotherapy Induced Radiation Enteritis Regarding the SAA3-Mediated Inflammatory Factor Storm
Location: Hall C
Presenter: Xin Chen, MBBS – Cancer Hospital Chinese Academy of Medical Sciences
5:00 PM – 6:00 PM ET
2915 - Radiation-Induced Antigen Expression Benefits Tumor Uptake of ICAM1 Antibody-Drug Conjugates
Location: Hall C
Presenter: Yun Xing, BS – Tianjin University
5:00 PM – 6:00 PM ET
2916 - m6A Modification of Zbp1 and Tfam in Regulates Radiation-Induced Skin Fibrosis via Senescence-Associated Secretory Phenotype (SASP)
Location: Hall C
Presenter: Jiahe Xu, MS
5:00 PM – 6:00 PM ET
2917 - Preclinical Evaluation and Pilot Clinical Study of [¹⁸F]AlF-NOTA-QHY-04 for PET Imaging of CXCR4 Expression in Hematologic Malignancy and Solid Tumors
Location: Hall C
Presenter: Shengnan Xu, MD
5:00 PM – 6:00 PM ET
2918 - Patient Related Outcomes for Gynecologic Radiation Oncology (PRO-GRO)
Location: Hall C
Presenter: Victoria Xu, BS – University of North Carolina at Chapel Hill
5:00 PM – 6:00 PM ET
2919 - Inhibition of Tumor Intrinsic SLC16A3, Radiotherapy Efficacy, and Tumor Immune Microenvironment Improvement
Location: Hall C
Presenter: Xin Xu, MD, PhD
5:00 PM – 6:00 PM ET
2920 - Effect of NLRP3 Inhibition on Immune Priming and Abscopal Responses Induced by Radiotherapy Combined with Immunotherapy in Colon Cancer
Location: Hall C
Presenter: Peipei Yan
5:00 PM – 6:00 PM ET
2921 - Investigating Tumor Response and Efficacy of 5-Aminolevulinic Acid-Mediated Radiodynamic Therapy: Utilizing Photon Irradiation, Activation of Photosensitizer and Catalytic Effects
Location: Hall C
Presenter: Dae-Myoung Yang, PhD – Fox Chase Cancer Center
5:00 PM – 6:00 PM ET
2922 - Fanconi Anemia Complementation Group I (FANCI) Mediates Oncogenic BRAF-Driven Radiation Resistance in Thyroid Cancer
Location: Hall C
Presenter: Linlin Yang, MD, PhD – City of Hope Comprehensive Cancer Center
5:00 PM – 6:00 PM ET
2923 - Enhancing Histological Image Analysis and Automation through Unsupervised Attention-Guided Deep Learning for Robust Stain Normalization in H&E-Stained Images
Location: Hall C
Presenter: Zi Yang, PhD – Stanford University
5:00 PM – 6:00 PM ET
2924 - Molecular Profiling of Skin Cells Identifies Distinct Cellular Signatures in Radiation-Induced Skin Injury across Various Stages
Location: Hall C
Presenter: Zengfu Zhang, MD – Shandong Cancer Hospital and Institute
5:00 PM – 6:00 PM ET
2925 - Effects of Lactobacillus rhamnosus DY801 on Acute Bowel Injury During Radiochemotherapy: Regulation of Methionine Metabolism and Th17 Cells
Location: Hall C
Presenter: Lu Yu, MD, PhD
5:00 PM – 6:00 PM ET
2926 - ILT4, Immunosuppression, and Resistance to Radioimmunotherapy (iRT) in Non-Small Cell Lung Cancer (NSCLC) through Recruiting SHP2 to Induce Mitochondrial Oxidative Stress-Mediated Tumor-Associated Mac
Location: Hall C
Presenter: Meng Yuan, MS
5:00 PM – 6:00 PM ET
2927 - The Role and Mechanism of Fatty Acids in Radiation-Induced Skin Injury
Location: Hall C
Presenter: Xiao Yuji
5:00 PM – 6:00 PM ET
2928 - The Impact of EBF1 on Radiation Sensitivity of NSCLC via GS-Induced Enhancement of Cancer Stemness
Location: Hall C
Presenter: Siwei Zeng
5:00 PM – 6:00 PM ET
2929 - CXCL3 Signaling and the Tumor-Promoting Activity of Cancer-Associated Fibroblasts in Esophageal Squamous Cell Carcinoma
Location: Hall C
Presenter: Hongfang Zhang, PhD – Hangzhou Cancer Hospital
5:00 PM – 6:00 PM ET
2930 - Impacts of Combining Anti-PD-1 Immunotherapy and PLDR on the Tumour Immune Microenvironment in a Murine Lung Cancer Model
Location: Hall C
Presenter: Peng Zhang, MD – Sichuan Cancer Hospital and Institute
5:00 PM – 6:00 PM ET
2931 - Fibulin-5 Secreted by Cancer-Associated Fibroblasts and Radioresistance in Non-Small Cell Lung Cancer
Location: Hall C
Presenter: Ran Zhang, PhD – Shandong Cancer Hospital Affiliated to Shandong First Medical University
5:00 PM – 6:00 PM ET
2932 - SET, Non-Small Cell Lung Cancer Cell Stemness, and Radio-Immunotherapy Resistance Via JAK/STAT-TGF ß Signaling Network
Location: Hall C
Presenter: Xiao Zhang, MD, PhD, MS, RT
5:00 PM – 6:00 PM ET
2933 - Radiotherapy Plus Aurora A Kinase Inhibitor Reshape the Immune Microenvironment and Potentiate Anti-Tumor Responses
Location: Hall C
Presenter: Weitao Wen, PhD – Shandong Cancer Hospital Affiliated to Shandong First Medical University
5:00 PM – 6:00 PM ET
2934 - Mechanistic of RBM3 Regulating Rad51 Alternative Splicing Mediated DNA Damage Repair Promoting Radioresistance of Nasopharyngeal Carcinoma
Location: Hall C
Presenter: Lina Zhao, MD, PhD – Xijing Hospital, Air Force Medical University
5:00 PM – 6:00 PM ET
2935 - Anti-Tumor Responses of Icaritin Combined Radiotherapy Treatment and Its Immune Mechanisms
Location: Hall C
Presenter: Yue Zhao, MD, PhD – China
5:00 PM – 6:00 PM ET
2936 - Radiotherapy Combined with Repurposed Old Drugs Effects on Polyploid Giant Triple Negative Breast Cancer Cells
Location: Hall C
Presenter: Mengli Zhou, MD – ShenZhen Cancer Hospital
5:00 PM – 6:00 PM ET
2937 - Short Chain Fatty Acids for Prevention and Treatment of Radiation Lung Injury
Location: Hall C
Presenter: Xingyu Zhou, MS, BS
5:00 PM – 6:00 PM ET
2938 - FLASH-RT has Advantages over Conventional-RT in Promoting DC Homing to Lymph Nodes and T Cell Activation
Location: Hall C
Presenter: Ziqi Zhou, MD – Peking Union Medical College Hospital
5:00 PM – 6:00 PM ET
2939 - Nanocarrier-Based Immunotherapy Combined with Radiation Therapy to Enhance the Radiosensitivity of Colorectal Cancer
Location: Hall C
Presenter: Ziwei Zhu – Sichuan Cancer Hospital
5:00 PM – 6:00 PM ET
2940 - Reflexology as an Integrative Approach to Improve Stress, Energy, and Pain in Women Receiving Radiotherapy for Breast Cancer
Location: Hall C
Presenter: Heather Zinkin, MD – Northwell Health
5:00 PM – 6:00 PM ET
2941 - Toxicity with Contemporary Radiotherapy in Inflammatory Bowel Disease Patients Treated for Pelvic Malignancies
Location: Hall C
Presenter: Julia ZInkin
5:00 PM – 6:00 PM ET
2942 - Toward a Clinical Trial in the Human Liver: Effect of Intralesional Diffusing Alpha Emitters Radiation Therapy on Orthotopic Murine Liver Colorectal Metastasis Growth, Healthy Liver Tissue and Immune
Location: Hall C
Presenter: Ronen Segal, PhD, MBA – Alpha TAU Medical Ltd.
5:00 PM – 6:00 PM ET
2943 - COST-FACIT Analysis of Cancer Patients Treated with Radiotherapy in a Publicly Funded Healthcare System in One Country
Location: Hall C
Presenter: Barbara Helena Zobec Logar, MD, PhD, MS – Institute of Oncology Ljubljana, Faculty of Medicine, University of Ljubljana
5:00 PM – 6:00 PM ET
2974 - Salvage Radiotherapy in Isolated Locoregional Recurrence of Pancreatic Adenocarcinoma Post-Radical Surgical Resection: Prudent or Pointless? A Retrospective Comparative Analysis
Location: Hall C
Presenter: Aruz Mesci, MD, PhD – Princess Margaret Cancer Center, University Health Network
5:00 PM – 6:00 PM ET
3186 - Is there an association between the location of the dominant intraprostatic lesion and biochemical/clinical failure following treatment with LDR prostate brachytherapy?
Location: Hall C
Presenter: Suneil Jain, MB, PhD – Queen's University Belfast
Tuesday, October 1, 2024
12:45 PM – 2:00 PM ET
2946 - Spatially Fractionated Radiotherapy (SFRT) for Large Tumors: A Single Institutional Experience of Dosimetry and Clinical Outcomes
Location: Hall C
Presenter: Katherine Amarell, MD, BS – Cleveland Clinic Foundation
12:45 PM – 2:00 PM ET
2947 - Clinical Outcomes and Risk Stratification in Unresectable Biliary Tract Cancers Undergoing Radiation Therapy
Location: Hall C
Presenter: Uri Amit, MD, PhD, MPH – Tel Aviv Sourasky Medical Center- Ichilov Hospital
12:45 PM – 2:00 PM ET
2948 - Outcomes Following Combined Modality Treatment to the Primary Site in Patients with Metastatic Soft Tissue Sarcoma
Location: Hall C
Presenter: Andrew Arifin, MD – London Health Sciences Centre
12:45 PM – 2:00 PM ET
2949 - Rates of Sexual Dysfunction and Prevalence of Estrogen Supplementation after Pelvic Radiation for Women with Early-Onset Rectal Cancer
Location: Hall C
Presenter: Angelica Arzola, MSPA – MD Anderson Cancer Center
12:45 PM – 2:00 PM ET
2950 - Dosimetric Factors Linked to Postoperative Pulmonary Complications and Intensive Care Unit Stay in Locally Advanced Esophageal Cancer Patients Undergoing Preoperative Chemoradiotherapy
Location: Hall C
Presenter: Barbaros Aydin, MD
12:45 PM – 2:00 PM ET
2951 - Partial Stereotactic Ablative Radiotherapy Boost before Conventional Radiotherapy (P-SABR) for Large (= 5 cm) Unresectable Soft Tissue Sarcoma
Location: Hall C
Presenter: Yun Bai, MD – Peking University First Hospital
12:45 PM – 2:00 PM ET
2952 - Proton Re-Irradiation for Esophageal Cancer: A Single-Institution Retrospective Series
Location: Hall C
Presenter: Mina Bakhtiar, MD – Mass General Brigham/Massachusetts General Hospital/Harvard Med School
12:45 PM – 2:00 PM ET
2953 - Single Institution Treatment Outcomes for Patients Treated with SBRT for Borderline Resectable Pancreatic Cancer
Location: Hall C
Presenter: Leou Ismael Banla, MD, PhD – Harvard Radiation Oncology Program
12:45 PM – 2:00 PM ET
2954 - Assessing Dose Response and Patterns of Failure in Patients with Node Negative Anal Squamous Cell Carcinoma
Location: Hall C
Presenter: Kara Banson, MD – NYU Langone Health- Radiation Oncology
12:45 PM – 2:00 PM ET
2955 - Phase IA/IB Study of OAR-Based, Dose-Escalated SBRT with Real Time Adaptive MRI Guidance for Liver Metastases: Preliminary Safety and Efficacy Results
Location: Hall C
Presenter: Mustafa Basree, DO, MS – University of Wisconsin Hospitals and Clinics
12:45 PM – 2:00 PM ET
2956 - Ablative Radiotherapy in Patients with Large Volume Liver Metastases and in Those with Prior Liver Directed Therapies: An Analysis of Safety and Local Control
Location: Hall C
Presenter: Jared Bassmann, BA – Memorial Sloan Kettering Cancer Center
12:45 PM – 2:00 PM ET
2957 - Predictors of Local and Distant Recurrence after Neoadjuvant Chemoradiation for Extended Criteria Borderline Resectable Pancreatic Cancer
Location: Hall C
Presenter: Cole Billena, MD – Cleveland Clinic Foundation
12:45 PM – 2:00 PM ET
2958 - Hypertension and Survival Outcomes after Radiotherapy in Esophageal Cancer
Location: Hall C
Presenter: Tyren Busby, BS – The Ohio State University Wexner Medical Center
12:45 PM – 2:00 PM ET
2959 - Feasibility Analysis of Omitting the Clinical Target Volume in Thoracic Radiotherapy for Locally Advanced Esophagus Cancer: A Propensity Score-Matched Cohort Study
Location: Hall C
Presenter: Dong-Jie Chen, MS – ShenZhen Cancer Hospital
12:45 PM – 2:00 PM ET
2960 - Stereotactic Ablative Radiotherapy Combined with Fruquintinib and Tislelizumab in Metastatic Colorectal Cancer: Updated Findings from a Single-Arm, Prospective Phase II Trial (RIFLE)
Location: Hall C
Presenter: Yajie Chen, PhD – Fudan University Shanghai Cancer Center
12:45 PM – 2:00 PM ET
2961 - Short-Course Radiotherapy Combined with Chemotherapy and PD-1 Inhibitor in Proficient Mismatch Repair or Microsatellite Stable (pMMR/MSS) Low-Lying Early Rectal Cancer: Preliminary Findings from a Pro
Location: Hall C
Presenter: Yajie Chen, PhD – Fudan University Shanghai Cancer Center
12:45 PM – 2:00 PM ET
2962 - A Phase II Clinical Trial of Sintilimab Combined with Lower Dose Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
Location: Hall C
Presenter: Yicong Chen
12:45 PM – 2:00 PM ET
2963 - Novel Roles of HOXD11 and HOXD13 in Mediating Response to Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma
Location: Hall C
Presenter: Zhenguo Shi, MD – Department of Radiation Oncology, Cancer Center, Zhongshan Hospital, Fudan University
12:45 PM – 2:00 PM ET
2964 - Combining Avelumab with Platinum/5-Fluorouracil and Radical Hypofractionated Radiotherapy for Newly Diagnosed Metastatic Esophageal Squamous Cell Carcinoma: A Phase II Prospective Trial
Location: Hall C
Presenter: Jason Chia-Hsien Cheng, MD, PhD, MS, FASTRO – National Taiwan University Hospital
12:45 PM – 2:00 PM ET
2965 - Alpha Fetoprotein Kinetics in Unresectable Hepatocellular Carcinoma Treated with Concurrent Radiation and Immunotherapy
Location: Hall C
Presenter: Daniel Cherry, MD, MAS – Mount Sinai Hospital
12:45 PM – 2:00 PM ET
2967 - Volumetric Change of Myxoid Liposarcoma During Preoperative Radiotherapy
Location: Hall C
Presenter: Pasqualina D'Urso, MD – Regina Elena National Cancer Institute
12:45 PM – 2:00 PM ET
2968 - Predicting Radiation Induced Immune Suppression Following Radiation Therapy to Pancreatic Cancer
Location: Hall C
Presenter: Gabriel Lucas Andrade de Sousa, MS, BS – University of Virginia
12:45 PM – 2:00 PM ET
2969 - Long-Term Outcomes of More Than a Decade Treating Patients with Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma
Location: Hall C
Presenter: Wilhelm den Toom, RT – Erasmus MC Cancer Institute
12:45 PM – 2:00 PM ET
2970 - A Prospective Study to Assess the Role of Neo-Adjuvant Chemoradiation in Locally Advanced Carcinoma Gallbladder
Location: Hall C
Presenter: Treshita Dey, MD – PGIMER Chandigarh
12:45 PM – 2:00 PM ET
2971 - Neoadjuvant Long-Course Radiotherapy Concurrent with Trafluridine Tepirimidine for Locally Advanced Rectal Cancer — A Single-Arm, Multicenter, Phase ? Trial
Location: Hall C
Presenter: Xue Dou, MD – Shandong First Medical University and Shandong Academy of Medical Sciences
12:45 PM – 2:00 PM ET
2972 - Addition of SBRT and Outcomes in Borderline Resectable Pancreatic Cancer Patients Having Suboptimal Response to Neoadjuvant Chemotherapy
Location: Hall C
Presenter: Reena Engineer, MD – Tata Memorial Hospital
12:45 PM – 2:00 PM ET
2973 - mRECIST Outcomes in EMERALD-1: A Phase 3, Randomized, Placebo-Controlled Study of Transarterial Chemoembolization plus Durvalumab with or without Bevacizumab in Participants with Embolization-Eligible
Location: Hall C
Presenter: Manila Hada – AstraZeneca
12:45 PM – 2:00 PM ET
2975 - Microbiome Diversity as a Predictor of Radiation Response and Toxicity in Rectal Cancer
Location: Hall C
Presenter: Nicholas Eustace, MD, PhD – City of Hope National Medical Center
12:45 PM – 2:00 PM ET
2976 - A Randomized, Phase II Clinical Trial of TIme-Restricted Eating vs. Dietary Counseling to Improve Effect of Radiotherapy (TIDIER)
Location: Hall C
Presenter: Nicholas Eustace, MD, PhD – City of Hope National Medical Center
12:45 PM – 2:00 PM ET
2977 - Safety of NBTXR3 Radioenhancer Delivery in Liver Metastases
Location: Hall C
Presenter: Benjin Facer, MD – James Cancer Center at Ohio State University
12:45 PM – 2:00 PM ET
2978 - A Phase II Clinical Trial of Radiotherapy Combined with Anlotinib in Locoregional Recurrent Esophageal Squamous Cell Carcinoma after Radical Surgery
Location: Hall C
Presenter: ChengCheng Fan, MD – The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital
12:45 PM – 2:00 PM ET
2979 - Matched Cohort Analysis of Ultra-Hypofractionated Preoperative Radiation Therapy vs. Standard Fractionation for Soft Tissue Sarcoma
Location: Hall C
Presenter: Cong Fan, BS – Cleveland Clinic Lerner College of Medicine
12:45 PM – 2:00 PM ET
2980 - Clinical Outcomes of Chemoradiotherapy Using Volumetric Modulated Arc Therapy (VMAT) for Locally Advanced Esophageal Cancer: A Single Institute Experience
Location: Hall C
Presenter: Syed Raza, BS, MBBS, FCPS – Cancer Care Hospital and Research Center Lahore Pakistan
12:45 PM – 2:00 PM ET
2981 - Prognostic Immune Markers in Esophageal Cancer Patients Managed with Trimodal Therapy
Location: Hall C
Presenter: Mark Farrugia, MD, PhD – Roswell Park Cancer Institute
12:45 PM – 2:00 PM ET
2982 - Neoadjuvant Radiation Practice Patterns in Resected Pancreatic Ductal Adenocarcinoma at Academic Cancer Centers Participating in the Canopy Cancer Collective Learning Health Network
Location: Hall C
Presenter: Fatemeh Fekrmandi, MD, MS – Roswell Park Comprehensive Cancer Center
12:45 PM – 2:00 PM ET
2983 - Radiation Doses to Small Bowel, Sigmoid and Anal Canal during Preoperative Radiation for Locally Advanced Rectal Cancer: Do They Impact Long-Term Bowel Function?
Location: Hall C
Presenter: Ty Forbes, BS – McGovern Medical School
12:45 PM – 2:00 PM ET
2984 - Treatment Outcomes and Toxicity of Chemoradiation in HIV Positive Patients with Anal Squamous Cell Carcinoma in the Modern Era
Location: Hall C
Presenter: Gabriel Fuligni, BS – NYU Grossman School of Medicine
12:45 PM – 2:00 PM ET
2985 - Immunomodulatory Effects of SBRT in Primary Liver Cancer Patients: Results from the LAPIS Study
Location: Hall C
Presenter: Eleni Gkika, MBA
12:45 PM – 2:00 PM ET
2986 - Liver Cancer Volume Changes during MR Guided SBRT
Location: Hall C
Presenter: Aisling Glynn, MD – Princess Margaret Cancer Center, University Health Network
12:45 PM – 2:00 PM ET
2987 - Outcomes Based on Surgical Timing after Neoadjuvant Therapy for Locally Advanced Esophageal Cancer
Location: Hall C
Presenter: Sarah Goodchild, BS, BA – Moffitt Cancer Center
12:45 PM – 2:00 PM ET
2988 - Neoadjuvant (Chemo-) Radiotherapy for Locally Advanced Soft Tissue Sarcoma
Location: Hall C
Presenter: Daniela Greto, MD – Azienda Ospedaliera Universitaria Careggi
12:45 PM – 2:00 PM ET
2989 - Direct-to-Unit Adaptive Celiac Plexus Radiation Therapy
Location: Hall C
Presenter: Beatriz Guevara, MS – University Hospitals Cleveland Medical Center
12:45 PM – 2:00 PM ET
2990 - Pattern of Primary Tumor Residual and Lymph Node Spread in Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy with or without Pembrolizumab
Location: Hall C
Presenter: Xuan Han, MD – Ruijin Hospital, Shanghai Jiaotong University School of Medicine
12:45 PM – 2:00 PM ET
2991 - Predicting Benefit of Elective Nodal Irradiation in Pancreatic Adenocarcinoma: A Supervised Machine Learning Approach
Location: Hall C
Presenter: Garrett Harada, MD – UCI Health
12:45 PM – 2:00 PM ET
2992 - Effect of Blood Uric Acid on Tumor Regression Response to Preoperative Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
Location: Hall C
Presenter: Lei He, MD – Lanzhou university
12:45 PM – 2:00 PM ET
2993 - Analyzing the Changes of Inflammation-related Cytokines by Using Olink immunoassay during Treatment of SCRT Combined with ICI in Proficient Mismatch Repair locally advanced Rectal Cancer
Location: Hall C
Presenter: Nan Xiao, MD – Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
12:45 PM – 2:00 PM ET
2994 - Predictive Value of Post-Radiotherapy PET with or without MRI to Identify Residual Disease in Patients with Anal Squamous Cell Carcinoma
Location: Hall C
Presenter: Sylvia Choo, BA – University of South Florida College of Medicine
12:45 PM – 2:00 PM ET
2995 - MRI-Defined Moderate Radiation Dose-Escalation for Locally Advanced Pancreas Cancer: A Phase II Study
Location: Hall C
Presenter: Jason Hirshberg, DO, MS – Medical College of Wisconsin
12:45 PM – 2:00 PM ET
2996 - Does Pre-Operative Hypofractionated Radiotherapy Improve Survival in Soft Tissue Sarcomas?
Location: Hall C
Presenter: Jason Hirshberg, DO, MS – Medical College of Wisconsin
12:45 PM – 2:00 PM ET
2997 - Vaginal Melanoma: A Systematic Review of the Literature
Location: Hall C
Presenter: Emily Hollis, MD – UNC School of Medicine
12:45 PM – 2:00 PM ET
2998 - Modeling Radiosensitivity with Gene Interactions Improves the Prediction of Pathological Response to Neoadjuvant Concurrent Chemoradiation in Esophageal Squamous Cell Carcinoma
Location: Hall C
Presenter: Feng-Ming Hsu, MD, PhD – National Taiwan University Hospital
12:45 PM – 2:00 PM ET
2999 - Does Social Vulnerability Index Correlate to Adverse Outcomes in Soft Tissue Sarcoma?
Location: Hall C
Presenter: Reese Jacobson, BA – Froedtert Hospital
12:45 PM – 2:00 PM ET
3000 - Effects of Local Treatment in Combination with Systemic Therapy for Advanced Esophageal Cancer: A Systematic Review and Meta-Analysis
Location: Hall C
Presenter: Jianrui Ji, MD
12:45 PM – 2:00 PM ET
3001 - Efficacy and Safety of the Contrast Agent Gadoterate in the Context of MR-Guided Stereotactic Body Radiotherapy for Upper Abdominal Tumors: A Preliminary Investigation
Location: Hall C
Presenter: Wenheng Jiang – Shandong Cancer Hospital and Institute
12:45 PM – 2:00 PM ET
3002 - MR-Guided Radiotherapy vs. Cone-Beam CT-Guided Radiotherapy for Hepatocellular Carcinoma: A Propensity-Matched Analysis
Location: Hall C
Presenter: Wenheng Jiang – Shandong Cancer Hospital and Institute
12:45 PM – 2:00 PM ET
3003 - Neoadjuvant Tislelizumab Combined with Chemoradiotherapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Single-Arm Phase II Study and Exploration of Immunologic Features
Location: Hall C
Presenter: Peng Jin, PhD
12:45 PM – 2:00 PM ET
3004 - Safety and Efficacy of Neoadjuvant Chemoradiotherapy with Concurrent Weekly Versus Tri-Weekly Cisplatin/Nab-Paclitaxel in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma
Location: Hall C
Presenter: Xuquan Jing – Shandong Cancer Hospital and Institute
12:45 PM – 2:00 PM ET
3005 - Patterns of Recurrence in High-Risk Gastric Cancer: Defining the Role of Postoperative Radiation
Location: Hall C
Presenter: Juan Jose Juarez Vignon Whaley, MD – Beth Israel Deaconess Medical Center
12:45 PM – 2:00 PM ET
3006 - Efficacy and Safety of Concurrent Radioimmunotherapy for Locally Advanced and Metastatic Cutaneous Squamous Cell Carcinoma
Location: Hall C
Presenter: Ari Kassardjian, MD – City of Hope Comprehensive Cancer Center
12:45 PM – 2:00 PM ET
3007 - Observed Survival for Esophageal Cancer Patients Receiving High-Dose (>50Gy) vs. Low-Dose (=45.0 Gy) Radiation in Tri-Modality Therapy and Differences in Dose to Thoracic Organs at Risk (OAR)
Location: Hall C
Presenter: Cymon Kersch, MD, PhD, MS – Oregon Health and Science University
12:45 PM – 2:00 PM ET
3007 - Observed Survival for Esophageal Cancer Patients Receiving High-Dose (>50Gy) vs. Low-Dose (=45.0 Gy) Radiation in Tri-Modality Therapy and Differences in Dose to Thoracic Organs at Risk (OAR)
Location: Hall C
Presenter: Jason Burton, MD, PhD – Oregon Health and Science University
12:45 PM – 2:00 PM ET
3008 - Local Control of Merkel Cell Carcinoma Treated with Standard of Care Radiation Therapy Compared to Palliative Dose Radiation Therapy
Location: Hall C
Presenter: Reid Thompson, MD, PhD – Oregon Health & Science University
12:45 PM – 2:00 PM ET
3008 - Local Control of Merkel Cell Carcinoma Treated with Standard of Care Radiation Therapy Compared to Palliative Dose Radiation Therapy
Location: Hall C
Presenter: Cymon Kersch, MD, PhD, MS – Oregon Health and Science University
12:45 PM – 2:00 PM ET
3009 - MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer (MRI-ENHANCE): A Phase I Dose-Escalation Trial for Locally Advanced Rectal Cancer
Location: Hall C
Presenter: Emily Kolyvas, PhD – Medical College of Wisconsin (MCW)
12:45 PM – 2:00 PM ET
3010 - Concurrent Radiation and Immunotherapy for Unresectable Hepatocellular Carcinoma with Portal Vein Thrombus
Location: Hall C
Presenter: Nithya Krishnamurthy – Icahn School of Medicine at Mount Sinai
12:45 PM – 2:00 PM ET
3011 - Phase II Randomized Study of Short Course Radiotherapy Based Total Neo-Adjuvant Therapy and Brachytherapy Boost with or without Chlorophyllin in Reducing the Incidence of Acute Toxicity in Advanced Re
Location: Hall C
Presenter: Rahul Krishnatry, MD – Tata Memorial Hospital
12:45 PM – 2:00 PM ET
3012 - Development of Organs at Risk Constraints for Proton-Based Intensity Modulated Treatment for Prospective Randomized Trial in Anal Cancer
Location: Hall C
Presenter: Rahul Krishnatry, MD – Tata Memorial Hospital
12:45 PM – 2:00 PM ET
3013 - Meta-Analysis of Prospective Randomized Controlled Trials Evaluating of External Beam Radiation vs. Transarterial Chemoembolization for Hepatocellular Carcinoma (HCC)
Location: Hall C
Presenter: Ryan Kuehnle, BS – University of Texas Health Science Center San Antonio
12:45 PM – 2:00 PM ET
3014 - Outcomes and Predictive Factors in Large Hepatocellular Carcinoma Managed with Image-Guided Hypo-Fractionated Radiotherapy
Location: Hall C
Presenter: Ritesh Kumar, MD – Rutgers Cancer Institute of New Jersey
12:45 PM – 2:00 PM ET
3015 - CBCT-Guided Online Adaptive Radiotherapy for Rectal Cancer: Initial Dosimetric and Clinical Experience
Location: Hall C
Presenter: Albert Lee, MD – Columbia University Irving Medical Center
12:45 PM – 2:00 PM ET
3016 - Rates of Hepatotoxicity Following Liver-Directed Ablative External Beam Radiotherapy and Transarterial Radioembolization for Hepatocellular Carcinoma
Location: Hall C
Presenter: Grace Lee, MD – Harvard Radiation Oncology Program
12:45 PM – 2:00 PM ET
3017 - Transarterial Chemoembolization plus Radiotherapy vs. Transarterial Chemoembolization Alone for Single Hepatocellular Carcinoma within BCLC Stage 0-A
Location: Hall C
Presenter: Hye In Lee, MD – Seoul National University Hospital
12:45 PM – 2:00 PM ET
3018 - Tracking the Invisible: Primary Analysis of Real-Time Image Guidance in Liver SBRT from the XXXX : XXXX Trial
Location: Hall C
Presenter: Yoo Young Lee, MB, ChB – Princess Alexandra Hospital
12:45 PM – 2:00 PM ET
3019 - The Role of Oligoprogression Radiotherapy in Delaying Second-Line Therapy in Patients with Hepatocellular Carcinoma
Location: Hall C
Presenter: Boyu Leng
12:45 PM – 2:00 PM ET
3020 - Multi-Modality Machine Learning Prediction Model of Hematologic Toxicity in Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
Location: Hall C
Presenter: Bin Li, PhD – Sun Yat-Sen University Cancer Center
12:45 PM – 2:00 PM ET
3021 - Preoperative Short-Course Radiotherapy Followed by Chemotherapy and PD-1 Inhibitor Administration for Locally Advanced Rectal Cancer: The Initial Results of a Randomized Phase II/III Trial (STELLAR II
Location: Hall C
Presenter: Haoyue Li, MD
12:45 PM – 2:00 PM ET
3022 - Longitudinal Dynamic Trajectories of Inflammatory Biomarkers as Prognostic Factors for Esophageal Squamous Cell Carcinoma Patients Receiving Definitive (Chemo)Radiotherapy
Location: Hall C
Presenter: Jie Li
12:45 PM – 2:00 PM ET
3023 - Prognostic Impact of Increased Radiotoxicity in Locally Advanced Esophagus Squamous Cell Cancer Treated with Definitive Chemoradiotherapy
Location: Hall C
Presenter: Li Li, MD, PhD, RT – Shandong Cancer Hospital and Institute
12:45 PM – 2:00 PM ET
3024 - Proteomic Predictive Model Associated with Response to Radical Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Cancer
Location: Hall C
Presenter: Li Li, MD, PhD, RT – Shandong Cancer Hospital and Institute
12:45 PM – 2:00 PM ET
3025 - The Addition of Pembrolizumab to Neoadjuvant Chemoradiotherapy and the Risk of Developing Postoperative Anastomotic Leakage for ESCC: An Analysis from a Prospective Cohort
Location: Hall C
Presenter: Shuyan Li, PhD
12:45 PM – 2:00 PM ET
3026 - The Relationship between Effective Dose to Immune Cells and Vertebral Marrow Dose and Hematologic Toxicity in Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma
Location: Hall C
Presenter: Zhenjiang Li, PhD – Shandong Cancer Hospital and Institute
12:45 PM – 2:00 PM ET
3028 - Induction Immunochemotherapy Followed by Concurrent Chemoradiotherapy for Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma (RICE): A Prospective, Single-Arm, Phase II Trial
Location: Hall C
Presenter: Lin Lin, MD – Shanghai Chest Hospital Shanghai Jiao Tong University
12:45 PM – 2:00 PM ET
3029 - First-Line Low-Dose Radiotherapy with Immunochemotherapy Followed by Conventionally Fractionated Radiotherapy and Immunotherapy in Metastatic Esophageal Squamous Cell Carcinoma: A Phase Ib Trial
Location: Hall C
Presenter: Lin Lin, MD – Shanghai Chest Hospital Shanghai Jiao Tong University
12:45 PM – 2:00 PM ET
3030 - Preliminary Study on Biology-Guided Radiotherapy Planning for Metastatic Liver Lesions Using a Novel O-Ring PET Linac Platform
Location: Hall C
Presenter: An Liu, PhD – City of Hope National Medical Center
12:45 PM – 2:00 PM ET
3031 - Assessing Tumor Regression Grade Accuracy via MRI in Rectal Cancer Patients Following Neoadjuvant Chemoradiotherapy: Impact on Clinical Complete Remission Rate
Location: Hall C
Presenter: Guoqing Liu, MD, MS – University of Electronic Science and Technology
12:45 PM – 2:00 PM ET
3032 - Tumor Immune Microenvironment Remodeling and Prognosis of Patients with Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemotherapy with and without Immunotherapy
Location: Hall C
Presenter: Lihong Liu, MS
12:45 PM – 2:00 PM ET
3033 - Comparative Analysis of Matching Accuracy and Dose Discrepancies: Bone vs. Fiducial Alignment in Free-Breathing Ablative Pancreatic Cancer Radiotherapy
Location: Hall C
Presenter: Yilin Liu, PhD – Memorial Sloan Kettering Cancer Center
12:45 PM – 2:00 PM ET
3034 - Neoadjuvant Immunotherapy Combined with Chemoradiation in Esophageal Cancer: An Individual Patient Data Meta-Analysis
Location: Hall C
Presenter: Yunsong Liu, MD – National Cancer Center/National Clinical Research Center for Cancer Cancer Hospital, CAMS & PUMC
12:45 PM – 2:00 PM ET
3035 - Sintilimab Combined with Definitive Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma: A Single-Arm, Multicenter, Phase 2 Trial
Location: Hall C
Presenter: Jiahua Lv, MD, PhD – Sichuan Cancer Hospital and Institute
12:45 PM – 2:00 PM ET
3036 - Exploratory Study on a Novel Mixed-Dose Liver Radiotherapy Strategy to Reverse Solid Tumor Resistance to Immunotherapy
Location: Hall C
Presenter: Hong Ma, MD, PhD – Tongji Hospital Affiliated to Tongji Medical College of Huazhong University
12:45 PM – 2:00 PM ET
3037 - Clinical Considerations of Splenic Dose Constraints
Location: Hall C
Presenter: Yifu Ma – The Second Affiliated Hospital of Soochow University
12:45 PM – 2:00 PM ET
3038 - Clinical Outcomes Associated with CA 19-9 Dynamics during Chemoradiation in Unresectable Pancreatic Ductal Adenocarcinoma
Location: Hall C
Presenter: Serena Mao, MD, PhD – Johns Hopkins Radiation Oncology Kimmel Cancer Center
12:45 PM – 2:00 PM ET
3039 - Patient Reported Quality of Life and Functional Outcomes after Pre-Operative Chemoradiation for Hilar Cholangiocarcinoma
Location: Hall C
Presenter: Tafadzwa Mapiki, DO, BS – Mayo Clinic Rochester
12:45 PM – 2:00 PM ET
3040 - Patient-Reported Outcomes in Rectal Cancer: A Prospective Study of Treatments with Chemoradiotherapy Alone or Followed by Surgery
Location: Hall C
Presenter: Constanza Martinez, MD, PhD – McGill University Health Centre
12:45 PM – 2:00 PM ET
3044 - A Phase II Trial of Hepatic Ablation of Metastases to Modulate and Enhance Immunotherapy Response (HAMMER) in Non-Small Cell Lung Cancer
Location: Hall C
Presenter: Matthew McMillan, MD – Memorial Sloan Kettering Cancer Center
12:45 PM – 2:00 PM ET
3045 - Radiotherapy for Adolescents and Young Adults with Ewing Sarcoma and Rhabdomyosarcoma Compared to Children
Location: Hall C
Presenter: Karin Meijer, MSc – Amsterdam University Medical Center (AUMC)
12:45 PM – 2:00 PM ET
3046 - Short Course Radiotherapy with Simultaneous Integrated Boost in the Treatment of Rectal Cancer: Clinical and Pathological Response Rates
Location: Hall C
Presenter: Michael Melton, MD – University of Alabama Birmingham Hospital
12:45 PM – 2:00 PM ET
3047 - A Comparative Study on the Determination of Gross Tumor Volume for Hepatocellular Carcinoma Radiotherapy based on Multi-Phase Contrast-Enhanced Magnetic Resonance Imaging
Location: Hall C
Presenter: Kangning Meng, MBBS
12:45 PM – 2:00 PM ET
3048 - Stereotactic Body Radiation Following Prior Radiotherapy for Pancreatic Cancer: A Single Institution Experience
Location: Hall C
Presenter: Mohammed Mohammed, MD – UPMC Hillman Cancer Center
12:45 PM – 2:00 PM ET
3049 - Adaptive MR-Guided Stereotactic Ablative Body Radiotherapy (MRgSABR) for Pancreas Cancer: Dosimetric Evaluation from EMERALD Trial
Location: Hall C
Presenter: Elena Moreno-Olmedo, MD – GenesisCare
12:45 PM – 2:00 PM ET
3050 - Implementation and Early Outcomes of Stereotactic Body Radiotherapy for Treating Hepatocellular Carcinoma at a Latin American Institution
Location: Hall C
Presenter: Pablo Munoz Schuffenegger, MD – Pontificia Universidad Catolica de Chile
12:45 PM – 2:00 PM ET
3051 - Image-Guided Proton Therapy for Unresectable Trunk Soft-Tissue Sarcoma
Location: Hall C
Presenter: Koichiro Nakajima, MD, PhD – Nagoya Proton Therapy Center
12:45 PM – 2:00 PM ET
3052 - Neoadjuvant Short-Course Radiotherapy Followed by Chemotherapy for Rectal Adenocarcinoma: Analysis of Clinical and Pathological Responses of Patients Treated in a Brazilian Tertiary General Hospital
Location: Hall C
Presenter: Marta Nassif Pereira-Lima, MD – Hospital Moinhos de Vento
12:45 PM – 2:00 PM ET
3053 - Comparison of External Beam Radiation Modalities (Photon vs. Proton vs. Carbon Ion) in the Treatment of Hepatocellular Carcinoma: A Network Metanalysis
Location: Hall C
Presenter: David Nganga, MD, BS – University of North Carolina Hospitals
12:45 PM – 2:00 PM ET
3054 - Dosimetric Analysis of Stereotactic vs. Intensity-Modulated Radiation Therapy for Pancreatic Cancer
Location: Hall C
Presenter: Patrick Oh, MD – Yale School of Medicine
12:45 PM – 2:00 PM ET
3055 - Promising Pathologic Response of Spatially Fractionated Radiotherapy Preceding Standard Neoadjuvant Conventionally Fractionated Radiotherapy in Aggressive Soft Tissue Sarcoma
Location: Hall C
Presenter: Adeniyi Olabumuyi, MB, BS, MB, BS – University of Maryland Medical Center
12:45 PM – 2:00 PM ET
3056 - Predicting Pathological Lymph Node Involvement Using Machine Learning in Locally Advanced Rectal Cancer Patients Treated with Neoadjuvant Chemo-Radiotherapy
Location: Hall C
Presenter: Gulsah Ozden, MD – Marmara University
12:45 PM – 2:00 PM ET
3057 - Efficacy of Immune Checkpoint Inhibitors in Advanced Esophageal Squamous Cell Carcinoma Patients with Hepatitis B
Location: Hall C
Presenter: Junfan Pan, PhD – Fujian Medical University
12:45 PM – 2:00 PM ET
3058 - Increased Tumor Size and Progression Free Survival after 177Lu-DOTATATE for Metastatic Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
Location: Hall C
Presenter: Jimmy Patel, MD, PhD – Emory University
12:45 PM – 2:00 PM ET
3059 - Disparities in Diagnosis and Access to Care in Patients with Young-Onset Colorectal Cancers in Northeast Ohio
Location: Hall C
Presenter: Rohan Patel, MD – UH Seidman Cancer Center Case Western Reserve University
12:45 PM – 2:00 PM ET
3060 - Matched Pair Analysis of Locally Advanced Pancreatic Cancer Patients Treated with Neoadjuvant Chemotherapy vs. Neoadjuvant Chemoradiotherapy (MAPLAP)
Location: Hall C
Presenter: Reena Engineer, MD – Tata Memorial Hospital
12:45 PM – 2:00 PM ET
3061 - Ablative MRI-Guided Radiation for GI Neuroendocrine Tumors: Assessment of Local Control and Toxicity
Location: Hall C
Presenter: John Peterson, MD – H. Lee Moffitt Cancer Center and Research Institute
12:45 PM – 2:00 PM ET
3062 - Toward Non-Operative Management of Locally Advanced Rectal Cancer Patients Undergoing Short Course Chemoradiotherapy: Early Response Prediction via Longitudinal Apparent Diffusion Coefficient
Location: Hall C
Presenter: Jonathan Pham, PhD – UCLA
12:45 PM – 2:00 PM ET
3063 - Safe Distance for Ovarian Transposition Prior to Pelvic Radiation Therapy for Lower GI Cancers
Location: Hall C
Presenter: Thomas A. DiPetrillo, MD
12:45 PM – 2:00 PM ET
3064 - First Exploration of the Characterization and Dosimetric Predictors for Absolute Lymphocyte Count Changes during nCRT with or without Pembrolizumab for Esophageal Squamous Cell Carcinoma: An Analysis
Location: Hall C
Presenter: Wei-Xiang Qi, MD, RT – Ruijin Hospital, Shanghai Jiaotong University School of Medicine
12:45 PM – 2:00 PM ET
3065 - Frailty Index and Early Mortality in Older Adults with Gastrointestinal Malignancies Treated with Radiation
Location: Hall C
Presenter: Katelyn Ragland, MD – University of Alabama at Birmingham
12:45 PM – 2:00 PM ET
3066 - Safety and Efficacy of Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma in Patients with Advanced Cirrhosis Awaiting Liver Transplantation: An ROI-funded Prospective Pilot Study
Location: Hall C
Presenter: Ramtin Rahmani, BS – Oregon Health and Science University
12:45 PM – 2:00 PM ET
3067 - Alliance A022101/NRG-GI009: A Pragmatic Randomized Phase III Trial Evaluating Total Ablative Therapy for Patients with Limited Metastatic Colorectal Cancer - Evaluating Radiation, Ablation and Surgery
Location: Hall C
Presenter: Paul Romesser, MD – Memorial Sloan Kettering Cancer Center
12:45 PM – 2:00 PM ET
3068 - Radiosensitization Adding Hydrogen Peroxide to Neoadjuvant Chemoradiotherapy of Rectal Cancer
Location: Hall C
Presenter: Anneyuko Saito, MD, PhD – Juntendo University Faculty of Medicine
12:45 PM – 2:00 PM ET
3069 - Sinonasal Melanoma Outcomes after Neoadjuvant Immunotherapy
Location: Hall C
Presenter: Aya Salem, MD – MD Anderson Cancer Center
12:45 PM – 2:00 PM ET
3070 - Efficacy and Safety of Toripalimab Combined with Radiotherapy and S-1 Followed by Adjuvant Toripalimab Maintenance Therapy for Older Patients with Esophageal Cancer
Location: Hall C
Presenter: Wen Bin Shen, MD – The Fourth Hospital of Hebei Medical University
12:45 PM – 2:00 PM ET
3071 - Outcomes of Salvage Ablative Radiotherapy on Hepatocellular Carcinoma for Isolated Location Recurrence in Regional Lymph Nodes and Adrenal Glands
Location: Hall C
Presenter: Kristin Hsieh, MD – Icahn School of Medicine at Mount Sinai
12:45 PM – 2:00 PM ET
3072 - A Prospective Pilot Study of Cardiac MRI (cMRI) for Evaluation of Early Cardiac Toxicity in Patients Receiving Neoadjuvant Chemoradiotherapy (nCRT) for Esophageal Cancer
Location: Hall C
Presenter: Muhammad Shuja, MD – Mayo Clinic Rochester
12:45 PM – 2:00 PM ET
3073 - Predicting Patient-Specific Benefits in Pancreatic Cancer Adaptive Radiotherapy: A Machine Learning Approach
Location: Hall C
Presenter: Adam Riegel, PhD – Columbia University Irving Medical Center
12:45 PM – 2:00 PM ET
3074 - Survival Outcomes for Gastrointestinal Stromal Tumors between Geriatric and Non-Geriatric Patients from 2000-2019
Location: Hall C
Presenter: Abhiram Singh – Northwell Health
12:45 PM – 2:00 PM ET
3075 - Locally Advanced Rectal Cancer: Can Total Mesorectal Irradiation Decrease Pelvic Toxicity?
Location: Hall C
Presenter: Pranit Singh, BS – USF Health Morsani College of Medicine
12:45 PM – 2:00 PM ET
3076 - EMERALD-Y90: A Phase 2 Study to Evaluate Transarterial Radioembolization Followed by Durvalumab and Bevacizumab for the Treatment of Unresectable Hepatocellular Carcinoma Eligible for Embolization
Location: Hall C
Presenter: Benjamin Spieler, MD – Sylvester Comprehensive Cancer Center
12:45 PM – 2:00 PM ET
3077 - Enhancing Radiotherapy Response via Intratumoral Injection of the TLR9 Agonist CpG to Stimulate CD8 T Cells in an Autochthonous Mouse Model of Sarcoma
Location: Hall C
Presenter: Chang Su, BS – Duke University
12:45 PM – 2:00 PM ET
3078 - Prognosis and Treatment Outcomes of Oligometastatic Melanoma with Intracranial Involvement
Location: Hall C
Presenter: Andrew Tam, MD – City of Hope National Medical Center
12:45 PM – 2:00 PM ET
3079 - MRI as a Biomarker for Pelvic Floor Atrophy in Rectal Cancer Patients Undergoing Chemoradiation Therapy
Location: Hall C
Presenter: Rehema Thomas, MD – MD Anderson Cancer Center
12:45 PM – 2:00 PM ET
3080 - Outcomes and Predictors of Toxicity after Stereotactic Body Radiotherapy for Child-Pugh B or C Hepatocellular Carcinoma in a Fiducial-Less Setting
Location: Hall C
Presenter: Rituraj Upadhyay, MD, MBBS, DNB – Ohio State University
12:45 PM – 2:00 PM ET
3081 - Functionally Guided NTCP Modeling Using DCE-MRI in Hepatocellular Carcinoma
Location: Hall C
Presenter: Christian Velten, MSc – Montefiore Medical Center
12:45 PM – 2:00 PM ET
3082 - Long-Term Outcomes after Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Cancer
Location: Hall C
Presenter: Alberto Vera, MD – UPMC Cancer Center
12:45 PM – 2:00 PM ET
3083 - Tradeoffs in Patient Decision Making about Rectal Cancer Treatment: Early Results from The PATHOS Study
Location: Hall C
Presenter: Te Vuong, MD – McGill University
12:45 PM – 2:00 PM ET
3084 - Optimizing Eligibility for and Access to Non-Operative Management for Rectal Adenocarcinoma
Location: Hall C
Presenter: Kathleen Waeldner, BA – Robert Larner, MD College of Medicine at the University of Vermont
12:45 PM – 2:00 PM ET
3085 - Comprehensive Evaluation of the Effects of Immune Rich Organs on Radiation Induced Immune Suppression during Radiation Therapy to Pancreas
Location: Hall C
Presenter: Kristin Walker, MD, MBA – UVA Department of Radiation Oncology
12:45 PM – 2:00 PM ET
3086 - LASSO Regression to Identify Significant Patient Factors and Develop Survival Model in Patients with Cutaneous Melanoma: Results of 20,981 Cases from SEER Database
Location: Hall C
Presenter: Huiwei Wang
12:45 PM – 2:00 PM ET
3087 - Multi-Omics Sequencing Unveils Tumor Microenvironment Remodeling Induced by Combined Radiotherapy and Immunotherapy in Microsatellite-Stable Locally Advanced Rectal Cancer
Location: Hall C
Presenter: Zhen Zhang, MD, PhD – Fudan University Shanghai Cancer Center
12:45 PM – 2:00 PM ET
3088 - Pathological Response and Survival Outcome after Neoadjuvant Chemoradiotherapy vs. Immunochemotherapy for Patients with Locally Advanced Esophageal Squamous Cell Carcinoma
Location: Hall C
Presenter: Jun Wang, PhD
12:45 PM – 2:00 PM ET
3089 - Efficacy and Safety of Radiotherapy Combined with Chemoimmunotherapy vs. Chemoimmunotherapy Alone as First-Line Treatment for Advanced Esophageal Squamous Cell Carcinoma with Oligorecurrence
Location: Hall C
Presenter: Jun Wang, PhD
12:45 PM – 2:00 PM ET
3090 - Radiotherapy Combined with Chemoimmunotherapy vs. Chemoimmunotherapy Alone As First-Line Treatment for Advanced Esophageal Squamous Cell Carcinoma with Oligometastasis at Initial Diagnosis
Location: Hall C
Presenter: Jun Wang, PhD
12:45 PM – 2:00 PM ET
3091 - Simultaneous Integrated Boost Intensity-Modulated Radiotherapy (SIB-IMRT) Combined with Nimotuzumab for Locally Advanced Esophageal Squamous Cell Carcinoma (ESCC): A Phase ? Clinical Trial
Location: Hall C
Presenter: Lan Wang, MD
12:45 PM – 2:00 PM ET
3092 - Phase II Study of Sintilimab Combined with Chemotherapy and Sequential Radiotherapy in First-Line Treatment of Oligometastatic Esophageal Cancer
Location: Hall C
Presenter: Linlin Wang, MD, PhD – Shandong Cancer Hospital and Institute
12:45 PM – 2:00 PM ET
3093 - Toripalimab plus Chemotherapy and Radiotherapy for Treatment-Naive, Advanced Esophageal Squamous Cell Carcinoma: A Single-Arm Phase II Trial
Location: Hall C
Presenter: Qifeng Wang, MD, PhD – Sichuan Cancer Hospital and Institute
12:45 PM – 2:00 PM ET
3094 - Tislelizumab plus Chemotherapy Sequential Neoadjuvant Therapy for Non-cCR Patients after Neoadjuvant Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma (ETNT): An Exploratory Stu
Location: Hall C
Presenter: Qifeng Wang, MD, PhD – Sichuan Cancer Hospital and Institute
12:45 PM – 2:00 PM ET
3095 - Evaluation of Breath-Hold Techniques for Pancreatic Cancer Stereotactic Ablative Radiotherapy via Intra-Fractional Kilo-Voltage Imaging and Fiducial Tracking
Location: Hall C
Presenter: Siqiu Wang, PhD – University of Texas Southwestern Medical Center
12:45 PM – 2:00 PM ET
3096 - Evaluating the Long-term Outcomes of Preoperative Radiation and Conservative Surgery in Extremity and Trunk Soft Tissue Sarcoma
Location: Hall C
Presenter: Nattinee Wattakiyanon, MD, RT – Princess Margaret Cancer Center, University Health Network
12:45 PM – 2:00 PM ET
3097 - Preoperative Short-Course Radiotherapy Combined with Chemotherapy and Tislelizumab for Locally Advanced Middle-Low Rectal Cancer: A Randomized Phase I/II Clinical Study
Location: Hall C
Presenter: Lichun Wei, PhD, CMD – Xijing Hospital
12:45 PM – 2:00 PM ET
3098 - Evaluation of Fiducial Motion during Treatment of Upper Abdominal Lymph Nodes with Stereotactic Body Radiation Therapy
Location: Hall C
Presenter: Matthew Abrams, MD – Beth Israel Deaconess Medical Center
12:45 PM – 2:00 PM ET
3100 - Sarcopenia as an Independent Prognostic Factor for Neoadjuvant Chemoradiation Efficacy in Locally Advanced Rectal Cancer: A Retrospective Analysis
Location: Hall C
Presenter: Jeng-You Wu, MD, MBA – Taipei Municipal WanFang Hospital
12:45 PM – 2:00 PM ET
3101 - Prognostic Nomogram for Prediction of Progression Free Survival after Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma
Location: Hall C
Presenter: Qi-Qiao Wu, MD, PhD Candidate – Fudan Univerisity Zhongshan Hospital(Xiamen)
12:45 PM – 2:00 PM ET
3103 - Comparison of Radiation Esophagitis Associated with Morning vs. Evening Radiotherapy in Patients with Esophageal Squamous Cell Carcinoma
Location: Hall C
Presenter: Geng Xiang
12:45 PM – 2:00 PM ET
3104 - Comparison of Anlotinib and S-1 Combined with Radiotherapy in the Treatment of Elderly Patients with Inoperable Esophageal Squamous Cell Cancer: An Open-Label, Phase 2, Randomized Controlled Trial
Location: Hall C
Presenter: Geng Xiang
12:45 PM – 2:00 PM ET
3105 - Prognostic Value of Sarcopenia and Inflammatory Indices Synergy in Patients with Esophageal Squamous Cell Carcinoma Undergoing Chemoradiotherapy
Location: Hall C
Presenter: Ling Xiao, MD, PhD – Sichuan Cancer Hospital and Institute
12:45 PM – 2:00 PM ET
3106 - A Single Arm Phase II Study of Neoadjuvant Chemoradiotherapy and AK104 in pMMR/MSS Locally Advanced Rectal Cancer with Positive PD-L1 Expression
Location: Hall C
Presenter: WeiWei Xiao, MD, PhD – Sun Yat-Sen University Cancer Center
12:45 PM – 2:00 PM ET
3107 - A Real-World Long-Term Outcome of Intensity-Modulated Radiation Therapy plus Concurrent Chemotherapy in Locally Advanced Anal Squamous Cell Carcinoma
Location: Hall C
Presenter: Tongzhen Xu, MD – Chinese Academy of Medical Science
12:45 PM – 2:00 PM ET
3108 - The Japanese Nationwide Prospective Cohort Data of Proton Beam Therapy for Liver Oligometastasis in Pancreatic Cancer Patients
Location: Hall C
Presenter: Hisashi Yamaguchi, MD, PhD – The Ohio State University
12:45 PM – 2:00 PM ET
3109 - Survival and Follow-Up Strategies of Watch-and-Wait Patients with a Clinical Complete Response after Selective High-Dose Neoadjuvant Radiotherapy in Rectal Cancer
Location: Hall C
Presenter: Chen Yang, MD – Sun Yat-Sen University Cancer Center
12:45 PM – 2:00 PM ET
3110 - Neoadjuvant Chemoradiotherapy plus Sequential Tislelizumab Followed by Surgery for Esophageal Carcinoma (CRISEC study): A Prospective, Single-Arm, Phase II Trial
Location: Hall C
Presenter: Jinsong Yang, MD – Cancer Institute and Hospital Chinese Acedemy of Medical Sciences
12:45 PM – 2:00 PM ET
3111 - Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR) for the Treatment of Gastrointestinal Cancers
Location: Hall C
Presenter: Orly Yariv, MD – National Cancer Inst
12:45 PM – 2:00 PM ET
3112 - The Role of Tumor Location and Motion in Local Failures after Radiation Therapy for Hepatocellular Carcinoma
Location: Hall C
Presenter: Pete Yeh, MD – University of Washington School of Medicine
12:45 PM – 2:00 PM ET
3114 - The Outcomes of Moderately-Hypofractionated Intensity Modulated Radiotherapy for Unresectable Locally Advanced Pancreatic Cancer
Location: Hall C
Presenter: Michio Yoshimura, MD, PhD – Kyoto University
12:45 PM – 2:00 PM ET
3115 - Final Results of the First Clinical Trial of a Novel Unidirectional Permanent Device for Intraoperative Brachytherapy
Location: Hall C
Presenter: Irini Youssef, MD – Memorial Sloan Kettering Cancer Center
12:45 PM – 2:00 PM ET
3116 - "Pacific" Modality in Locally Advanced Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched Analysis of a Real-World Multicenter Study
Location: Hall C
Presenter: Nuo Yu, BS
12:45 PM – 2:00 PM ET
3117 - Chemoradioimmunotherapy Followed by Chemoimmunotherapy is Tolerable and Feasible in Inoperable Biliary Tract Cancer: A Phase Ib Clinical Trial
Location: Hall C
Presenter: Jinbo Yue, MD, PhD – Shandong Cancer Hospital and Institute
12:45 PM – 2:00 PM ET
3118 - President: A Randomised Phase III Trial of Preoperative Chemoradiation Versus Post Operative Chemoradiation for Locally Advanced Potential Resectable Gastric Cancer.
Location: Hall C
Presenter: Ming Zeng, MD, PhD – Sichuan Taikang Hospital
12:45 PM – 2:00 PM ET
3119 - Radiotherapy in Patients with Early-Onset Pancreatic Cancer: Clinical Characteristics and Treatment Outcomes
Location: Hall C
Presenter: Letian Zhang, MD – Chinese PLA General Hospital
12:45 PM – 2:00 PM ET
3120 - Radiotherapy Delays Second-Line Drug Therapy for Oligo Progressive Hepatocellular Carcinoma: A Multicenter, Single-Arm, Phase II Clinical Trial
Location: Hall C
Presenter: Xiang Zhang, MD, PhD – Shandong Cancer Hospital and Institute
12:45 PM – 2:00 PM ET
3121 - Pathological Response and Locoregional Control in Gastric Cancer Patients after Preoperative Chemoradiation Versus Preoperative Chemotherapy: Data from the Neo-Crag Clinical Trial
Location: Hall C
Presenter: Yujing Zhang, MD, PhD – Sun Yat-Sen University Cancer Center
12:45 PM – 2:00 PM ET
3122 - Cellular Senescence Index Predicts Radiotherapy Response and Outcomes in Esophagus Cancer Patients
Location: Hall C
Presenter: Zengfu Zhang, MD – Shandong Cancer Hospital and Institute
12:45 PM – 2:00 PM ET
3123 - Improving Resectability and Prognosis in Initially Unresectable Locally Advanced Colon Cancer through Neoadjuvant Chemoradiotherapy: A Single-Center Retrospective Study
Location: Hall C
Presenter: Zi-tong Zhang, MD – Sun Yat-Sen University Cancer Center
12:45 PM – 2:00 PM ET
3124 - Dosimetric Predictors of Acute Hematological Toxicity during nCRT with or without Pembrolizumab for Esophageal Squamous Cell Carcinoma
Location: Hall C
Presenter: Zhao Chaofen, MD
12:45 PM – 2:00 PM ET
3125 - Efficacy and Safety of the Combination of Tislelizumab with Chemoradiotherapy in Oligorecurrence Esophageal Squamous Cell Carcinoma: A Prospective Phase II Study
Location: Hall C
Presenter: ziyu zheng, MB – National Cancer Center/National Clinical Research Center for Cancer Cancer Hospital, CAMS & PUMC
12:45 PM – 2:00 PM ET
3126 - Efficacy and Safety of PD-1 Inhibitors and Targeted Drugs Combined with Radiotherapy in First-Line Treatment of Oligometastatic Hepatocellular Carcinoma
Location: Hall C
Presenter: Kunli Zhu
12:45 PM – 2:00 PM ET
3127 - Ablative Treatment with CT Guided Adaptive Radiation Therapy for Pancreatic Cancer
Location: Hall C
Presenter: Tiffany Zhu – Washington University School of Medicine
12:45 PM – 2:00 PM ET
3128 - Mortality And Equitability of Radiation Treatment in Locally Advanced Rectal Cancer: A Review from a National Cohort
Location: Hall C
Presenter: Joshua Zweigle, MD
2:30 PM – 3:45 PM ET
3129 - Assessment of Pattern of Requirement of General Anesthesia for Pediatric Patients Undergoing Radiotherapy
Location: Hall C
Presenter: Aashita Aashita, MD – NCI AIIMS
2:30 PM – 3:45 PM ET
3130 - Early PSA Kinetics in Patients Treated with Prostate SBRT with Intra-Prostatic Boost
Location: Hall C
Presenter: Nima Aghdam, MD, MS – Beth Israel Deaconess Medical Center
2:30 PM – 3:45 PM ET
3131 - National Value-Based Care Competition - A Six Sigma Training Program
Location: Hall C
Presenter: James Alin, BS – Medical College of Georgia
2:30 PM – 3:45 PM ET
3132 - Ablative Radiotherapy for Unfavorable Prostate Tumors (ABRUPT): Analysis of Toxicity and Quality of Life from a Prospective Study
Location: Hall C
Presenter: Stefano Arcangeli, MD – University of Milan Bicocca
2:30 PM – 3:45 PM ET
3133 - Utilizing of a Dedicated Radiation Oncology Documentation Software Designed with Physician Input and Note Completion Times
Location: Hall C
Presenter: Joshua Asper, PA-C – Mays Cancer Center, UT Health San Antonio, MD Anderson Cancer Center
2:30 PM – 3:45 PM ET
3134 - Managing for Daily Improvement: A System for Real-Time Quality Improvement and Patient Safety
Location: Hall C
Presenter: Margaret Barker, MS – MemorialCare Long Beach Medical Center
2:30 PM – 3:45 PM ET
3135 - Node Positive Prostate Cancer Treated with Brachytherapy Boost
Location: Hall C
Presenter: Rahul Barve, MD – Memorial Sloan Kettering Cancer Center
2:30 PM – 3:45 PM ET
3136 - Patient Reported Quality of Life (QOL) Outcomes for Intermediate-High Risk-Very High Risk Prostate Cancers Treated By SBRT and Androgen Deprivation Therapy (ADT)
Location: Hall C
Presenter: Trinanjan Basu, MD – HCG Cancer Center, Mumbai
2:30 PM – 3:45 PM ET
3137 - Association of Tumor Volume and Radiographic T-Stage for Patients with Localized Prostate Cancer Treated with Radiation or Radical Prostatectomy
Location: Hall C
Presenter: Martin King, MD, PhD – Brigham and Womens Hospital
2:30 PM – 3:45 PM ET
3138 - Daily Adaptive Post-Prostatectomy Radiation Therapy (DAPPER): Initial Treatment Planning and Delivery Outcomes Using CT-Based Online Adaptive Radiation Therapy
Location: Hall C
Presenter: Alexandra Bennett, MD – Mayo Clinic College of Medicine and Science Rochester
2:30 PM – 3:45 PM ET
3139 - Effectiveness of an Iodinated Perirectal Hydrogel Spacer for Prostate Cancer Treated with Stereotactic Body Radiotherapy (SBRT): A Prospective, Multi-Center, Randomized Trial ("SABRE")
Location: Hall C
Presenter: Pierre Blanchard, MD, PhD – Gustave Roussy Cancer Center
2:30 PM – 3:45 PM ET
3140 - Development of a Consensus Checklist for Systematic Radiation Treatment Plan Review
Location: Hall C
Presenter: Graham Boyd, MD – Dana-Farber/Brigham and Women's Cancer Center
2:30 PM – 3:45 PM ET
3141 - MRI-Guided Adaptive SBRT for Kidney and Adrenal Gland Tumors: An Analysis of the Intra-Fractional Tumor Motion and Inter-Fractional Dosimetric Impact
Location: Hall C
Presenter: Lingling Cai, MB – Sun Yat-Sen University Cancer Center
2:30 PM – 3:45 PM ET
3142 - 3D-Printed Seed Placement Template for ¹²⁵I Seed Plaque Assembly with Custom Eye Plaques
Location: Hall C
Presenter: Kaitlyn Calabresi, BS – Louisiana State University Health Sciences Center
2:30 PM – 3:45 PM ET
3143 - Geographical Comparison of Medicare & Medicaid Services (CMS) Standard Charges for Complex Proton Therapy
Location: Hall C
Presenter: Kasey Cargill, PhD – University of Pittsburgh School of Medicine
2:30 PM – 3:45 PM ET
3144 - Severe Genitourinary Events Following Definitive Radiation Therapy for Patients with Locally Advanced and Metastatic Bladder Cancer: A Single Institution Experience
Location: Hall C
Presenter: Patrick Carriere, MD, PhD – MD Anderson Cancer Center
2:30 PM – 3:45 PM ET
3145 - An LLM-Based Framework for Zero-Shot De-Identifying Flexible Text Data in Protected Health Information Enabling Potential Risk-Informed Patient Safety
Location: Hall C
Presenter: Chih-Wei Chang, PhD – Emory University
2:30 PM – 3:45 PM ET
3146 - Stereotactic Body Radiotherapy for Prostate Cancer with Magnetic Resonance Imaging or Computed Tomography Guidance
Location: Hall C
Presenter: Enoch Chang, MD – MD Anderson Cancer Center
2:30 PM – 3:45 PM ET
3147 - Clinical Efficacy and Adverse Effects of Adjuvant Radiotherapy Following Surgery in High-Risk Renal Cell Carcinoma(RCC) Patients - A Single Center Experience
Location: Hall C
Presenter: Jiayan Chen, MD – Peking University First Hospital
2:30 PM – 3:45 PM ET
3148 - Racial Variation in the Advanced Prostate Cancer Genome
Location: Hall C
Presenter: William Chen, MD – UCSF
2:30 PM – 3:45 PM ET
3149 - Care Coordination for Patients with Cardiac Implantable Electronic Devices Scheduled to Receive Radiation
Location: Hall C
Presenter: Walter Chin, MS, BSN – Emory Clinic
2:30 PM – 3:45 PM ET
3150 - Treatment Terminations during Radiation Therapy: A Decade of Genitourinary Terminations
Location: Hall C
Presenter: Bhargava Chitti, MD – Northwell Health Center for Advanced Medicine
2:30 PM – 3:45 PM ET
3151 - Morphological Variation in Rectal Hydrogel Spacer One Month after Insertion during Low Dose Rate Brachytherapy for Prostate Adenocarcinoma
Location: Hall C
Presenter: Hyeok Choi, MD – Yonsei Cancer Center
2:30 PM – 3:45 PM ET
3152 - Dosimetric Comparison of Margin-Reduced CT-Guided with MRI-Guided Stereotactic Body Radiotherapy for Localized Prostate Cancer
Location: Hall C
Presenter: Patrick Courtney, MD, MAS – UCLA David Geffen School of Medicine/UCLA Medical Center
2:30 PM – 3:45 PM ET
3153 - Clinical and Dosimetric Outcomes of Patients Who Received Daily-Adaptive Post-Prostatectomy Salvage Radiation
Location: Hall C
Presenter: Michael Cummings, MD – University of Rochester Medical Center
2:30 PM – 3:45 PM ET
3154 - EQD2 Constraints for Organs at Risk in Re-Irradiation Planning for Thoracic and Head and Neck Cancers
Location: Hall C
Presenter: Samira Dabaghmanesh, PhD – Medical College of Wisconsin
2:30 PM – 3:45 PM ET
3155 - Evaluation of Clinical and Educational Impact of Head and Neck-Specific Chart Rounds in a High-Volume Multi-Center Integrated Health Care System
Location: Hall C
Presenter: Fara Dayani, MD, MS – Kaiser Permanente Los Angeles Medical Center
2:30 PM – 3:45 PM ET
3156 - Stereotactic Ablative Radiotherapy for Renal Cell Carcinomas - An Experience from a Single Center
Location: Hall C
Presenter: Tomás De Souza, MD – McGill University Health Centre
2:30 PM – 3:45 PM ET
3157 - Hypofractionated Intensity Modulated Radiation Therapy and Weekly Gemcitabine for Muscle Invasive Bladder Cancer. Long-Term Results
Location: Hall C
Presenter: Tomás De Souza, MD – McGill University Health Centre
2:30 PM – 3:45 PM ET
3158 - Impact of a Nurse Practitioner-Led Follow-Up Clinic within a Rapid-Access Palliative Radiotherapy Program for Patients with Metastatic Cancer
Location: Hall C
Presenter: Katherine Del poso-Lee, MSN, NP-PHC – Princess Margaret Cancer Centre
2:30 PM – 3:45 PM ET
3159 - Exploring the Role of Angiotensin Converting Enzyme Inhibitors in Genito-Urinary Toxicity Following Curative Radiotherapy for Bladder Cancer
Location: Hall C
Presenter: Ayo Olowofela, MD, MS – Medical College of Wisconsin
2:30 PM – 3:45 PM ET
3160 - International Harmonization of Technical Approaches to Kidney SABR - An International Radiosurgery Consortium of the Kidney (IROCK) Contouring Project
Location: Hall C
Presenter: Aneesh Dhar, MD, MS, FRCPC – Memorial Sloan Kettering Cancer Center
2:30 PM – 3:45 PM ET
3161 - Differential Use of Radiotherapy Fractionation Regimens for Muscle-Invasive Bladder Cancer
Location: Hall C
Presenter: Marshall Diven, MD – NYP/BMH
2:30 PM – 3:45 PM ET
3162 - Care Alerts for Readiness Excellence (CARE): Initiative to Reduce Symptom-Related Treatment Delays
Location: Hall C
Presenter: Victoria Doss, MD – Johns Hopkins Medicine
2:30 PM – 3:45 PM ET
3163 - Risk of Death in Octogenarians with Intermediate Risk Prostate Cancer Who Are Treated with Radiation Therapy (RT) Plus Androgen Deprivation Therapy (ADT) Versus Radiation Alone, an NCDB Analysis
Location: Hall C
Presenter: Timothy Dougherty, MD – Allegheny Health Network
2:30 PM – 3:45 PM ET
3164 - Apparent Diffusion Coefficient as an Early Prognostic Factor of Response to Treatment with Androgen Deprivation Therapy and Radiotherapy in Patients with Prostate Cancer
Location: Hall C
Presenter: Ana Aurora Diaz-Gavela, MD – Hospital Universitario Quiron Madrid
2:30 PM – 3:45 PM ET
3165 - Evaluating Guideline-Concordant Androgen Deprivation for High-Risk Prostate Cancer in a Statewide Quality Consortium
Location: Hall C
Presenter: Michael Dykstra, MD – University of Michigan
2:30 PM – 3:45 PM ET
3166 - Prostate Cancer in Southeast Asia: An Analysis of 2022 Incidence and Mortality Data
Location: Hall C
Presenter: Michelle Ann Eala, MD – UCLA David Geffen School of Medicine/UCLA Medical Center
2:30 PM – 3:45 PM ET
3167 - The State of Peer Review Practice in Community Radiation Oncology: Results of a National Survey of NCORP Network Sites
Location: Hall C
Presenter: Michael Farris, MD – Wake Forest University Medical Center
2:30 PM – 3:45 PM ET
3168 - Triage Schema for O-Ring vs. C-Arm Gantry Machine Load Balancing
Location: Hall C
Presenter: Seth Fehrs, MS – Emory University
2:30 PM – 3:45 PM ET
3169 - Real-World Medical Device Reports of PEG Hydrogel Spacers: Analysis of the FDA Manufacturer and User Facility Device Experience (MAUDE) Database
Location: Hall C
Presenter: Michael Folkert, MD, PhD – University of Washington-Fred Hutchinson Cancer Center
2:30 PM – 3:45 PM ET
3170 - Early Results from a Prospective Trial Testing Stereotactic Salvage Radiotherapy for Macroscopic Prostate Bed Recurrence after Prostatectomy-STARR(NCT05455736)
Location: Hall C
Presenter: Giulio Francolini, MD – Azienda Ospedaliera Universitaria Careggi
2:30 PM – 3:45 PM ET
3171 - Matching Strategy on the Use of Image-Guided Hypo-Fractionated Radiotherapy for Localized Prostate Cancer
Location: Hall C
Presenter: Yan Gao, MS – Peking University First Hospital
2:30 PM – 3:45 PM ET
3172 - Prostate Moderate Hypo-Fractionated Radiotherapy: Urethral and Bladder Dose-Effect Relations in Genitourinary Toxicity and Dosimetric Advantages of Urinary Protection Technique
Location: Hall C
Presenter: Yan Gao, MS – Peking University First Hospital
2:30 PM – 3:45 PM ET
3173 - Factors Associated with Successful CT Simulation in Prostate Cancer Radiotherapy
Location: Hall C
Presenter: Karishma George, MD, MBBS, DNB – Tom Baker Cancer Centre / University of Calgary
2:30 PM – 3:45 PM ET
3174 - Disease Site Specific Peer Review Highlights the Need for Prospective Contour Review for Head and Neck Treatment Planning
Location: Hall C
Presenter: Beth Ghavidel, MS – Winship at Emory University Hospital Midtown
2:30 PM – 3:45 PM ET
3175 - Enhancing Workflow Efficiency for Managing Patients with Cardiac Implantable Electronic Devices in Radiation Oncology: A Lean Approach
Location: Hall C
Presenter: Beth Ghavidel, MS – Winship at Emory University Hospital Midtown
2:30 PM – 3:45 PM ET
3176 - Pattern of Failure Following Salvage Radiation Therapy after Prostatectomy
Location: Hall C
Presenter: Lucia Goanta, MD – Regina Elena National Cancer Institute
2:30 PM – 3:45 PM ET
3177 - International Prostate Symptom Score Outcomes of Five Different Treatment Paradigms for Localized Prostate Cancer: A Single-Institution Experience
Location: Hall C
Presenter: Nicholas Gravbrot, MD – University of Utah Huntsman Cancer Institute
2:30 PM – 3:45 PM ET
3178 - The Effect of Age on Clinicopathological Features and Treatment Outcomes of Patients Receiving Definitive Radiotherapy for Localized Prostate Cancer
Location: Hall C
Presenter: Ozan Cem Guler, MD – Baskent University
2:30 PM – 3:45 PM ET
3179 - Prostate-Specific Membrane Antigen-Directed Focal Stereotactic Radiation Therapy in Two Fractions for Locally Recurrent Prostate Cancer after Definitive Radiation Therapy
Location: Hall C
Presenter: Liat Hammer, MD, PhD – Sheba Medical Center
2:30 PM – 3:45 PM ET
3180 - Effect of Ethnic Concordance in Post-Treatment Follow-Up and Surveillance of Korean American Breast Cancer Patients Treated with Adjuvant Radiotherapy
Location: Hall C
Presenter: Hye Ri Han, MD, MS – University of Southern California/Los Angeles General Medical Center
2:30 PM – 3:45 PM ET
3181 - Clinical Workflow Evaluation of High-Performance Imaging on a C-Arm Linear Accelerator
Location: Hall C
Presenter: Robyn Handschuh, MS, DABR – The Ohio State University James Cancer Hospital
2:30 PM – 3:45 PM ET
3182 - Stereotactic Body Radiotherapy (SBRT) as Definitive Management for Renal Cell Carcinoma with and without Real-Time MRI Guidance
Location: Hall C
Presenter: Colin Harari, MD – University of Wisconsin Carbone Cancer Center
2:30 PM – 3:45 PM ET
3183 - Toxicity Comparison of Whole Pelvic vs. Prostate Only Proton Therapy - Results from the Proton Collaborative Group PCG 001-09
Location: Hall C
Presenter: Ananya Raghavan, BS – New York Proton Center
2:30 PM – 3:45 PM ET
3184 - A Phase Il Clinical Study of Axitinib and Toripalimab Combined with Stereotactic Radiation (SBRT) for Metastatic Renal Cell Carcinoma (mRCC) after Oligoprogression from First-Line Anti-Angiogenic Ther
Location: Hall C
Presenter: Lingling Cai, MB – Sun Yat-Sen University Cancer Center
2:30 PM – 3:45 PM ET
3184 - A Phase Il Clinical Study of Axitinib and Toripalimab Combined with Stereotactic Radiation (SBRT) for Metastatic Renal Cell Carcinoma (mRCC) after Oligoprogression from First-Line Anti-Angiogenic Ther
Location: Hall C
Presenter: Liru He, PhD – Sun Yat-Sen University Cancer Center
2:30 PM – 3:45 PM ET
3185 - Rectal Wall Infiltration with Hyaluronic Acid Based Rectal Spacer and Its Reversal
Location: Hall C
Presenter: Anne Hong, MD – Austin Health
2:30 PM – 3:45 PM ET
3187 - The Performance of Multiparametric MRI in Identification of Intraprostatic Tumor Deposits after Local Prostate Radiation Therapy
Location: Hall C
Presenter: R. Hsi, MD – University of Washington-Fred Hutchinson Cancer Center
2:30 PM – 3:45 PM ET
3188 - Mid-Term Analysis of the Combination Therapy of Axitinib, Toripalimab, and Stereotactic Ablative Body Radiotherapy (SABR) in the Treatment of Recurrent Metastatic Renal Cell Carcinoma
Location: Hall C
Presenter: Ke Hu, MD – Peking University First Hospital
2:30 PM – 3:45 PM ET
3189 - Outcomes of Primary Tumor Stereotactic Ablative Body Radiotherapy for Localized and Metastatic Renal Cell Carcinoma
Location: Hall C
Presenter: Daniel Huang, MD – University of Chicago
2:30 PM – 3:45 PM ET
3190 - Analysis of High-Volume Biopsy Core Involvement and Failure after SBRT Monotherapy for Intermediate Risk Prostate Cancer
Location: Hall C
Presenter: Vianca Santos, MPH – NYU Langone Health - Long Island
2:30 PM – 3:45 PM ET
3191 - Food Insecurity and Sociodemographic Influences on PSA Screening
Location: Hall C
Presenter: Vianca Santos, MPH – NYU Langone Health - Long Island
2:30 PM – 3:45 PM ET
3192 - Personalized Deep Learning Model for Target Volume Based on CBCT for Prostate Adaptive SBRT Patients
Location: Hall C
Presenter: Jin Sung Kim, PhD
2:30 PM – 3:45 PM ET
3193 - A Feasibility Study Assessed the Predictive Ability of MRI Delta-Radiomics for GU Toxicity and IPSS Changes in PCa Hypofractionated RT
Location: Hall C
Presenter: Haruo Inokuchi, MD, PhD – Osaka Metropolitan University Graduate School of Medicine
2:30 PM – 3:45 PM ET
3194 - Long-Term Outcomes of Image-Guided Proton Therapy with Gold Fiducial Marker for Localized Prostate Cancer
Location: Hall C
Presenter: Hiromitsu Iwata, MD, PhD – Nagoya City University West Medical Center
2:30 PM – 3:45 PM ET
3196 - Assessment of OpenAI-Based Chatbots Performance in Extracting Patient Consultation Information
Location: Hall C
Presenter: Julian Jeberaeel, DO – Detroit Medical Center/Wayne State University
2:30 PM – 3:45 PM ET
3197 - Radiation Therapy for Prostate Cancer: Baseline Platelet Count and Anti-Platelet and Anticoagulant Use Are Associated with Disease Outcomes in a Cohort of 1000 Men
Location: Hall C
Presenter: Stanley Liauw, MD, FASTRO – University of Chicago
2:30 PM – 3:45 PM ET
3197 - Radiation Therapy for Prostate Cancer: Baseline Platelet Count and Anti-Platelet and Anticoagulant Use Are Associated with Disease Outcomes in a Cohort of 1000 Men
Location: Hall C
Presenter: Matthew Ji, BS – University of Chicago
2:30 PM – 3:45 PM ET
3198 - Challenges in Developing an AI-Based Analysis System for Incident Learning
Location: Hall C
Presenter: Abbas Jinia, PhD – Memorial Sloan Kettering Cancer Center
2:30 PM – 3:45 PM ET
3199 - Artificial Intelligence Model Using PSMA PET Imaging of Primary Prostate Cancer for Analyzing Metastases and Post-Treatment Progression
Location: Hall C
Presenter: Jesus Juarez Casillas, MD, MS – UCLA
2:30 PM – 3:45 PM ET
3200 - Beating the Clock: An Audit of Time Taken to Deliver Swallowing Sparing IMRT for Head and Neck Carcinoma
Location: Hall C
Presenter: Yousra Izzuddeen KN, MD, MBBS, DNB – All India Institute of Medical Sciences
2:30 PM – 3:45 PM ET
3201 - Demographic differences between consenting versus non-consenting participants for biospecimen collection on NRG prostate cancer trials
Location: Hall C
Presenter: Sophia Kamran, MD – Massachusetts General Hospital
2:30 PM – 3:45 PM ET
3202 - Patterns of Leukopenia in Men with Prostate Cancer Receiving Definitive Pelvic Irradiation
Location: Hall C
Presenter: Ari Kassardjian, MD – City of Hope Comprehensive Cancer Center
2:30 PM – 3:45 PM ET
3203 - A Prospective Study of Stereotactic Body Radiotherapy in Oligometastatic Renal Cell Carcinoma
Location: Hall C
Presenter: Rohan Katipally, MD – University of Chicago Medical Center
2:30 PM – 3:45 PM ET
3204 - Intermediate Term Urinary Outcomes Following Prostate Radiation Therapy after Neoadjuvant Prostate Artery Embolization
Location: Hall C
Presenter: Vaseem Khatri, MD – Moffitt Cancer Center
2:30 PM – 3:45 PM ET
3205 - Psmaddition: Phase 3 Trial of [¹⁷⁷lu]Lu-PSMA-617 Plus Standard of Care (SoC) vs. Soc Alone in Patients with Metastatic Hormone-Sensitive Prostate Cancer
Location: Hall C
Presenter: Hyun Kim, MD – Washington University School of Medicine in St. Louis
2:30 PM – 3:45 PM ET
3206 - Context-Dependent Impact of Tumor-Infiltrating B Cells in High-Risk Prostate Cancer and Head and Neck Cancer
Location: Hall C
Presenter: Sangwoo Kim, MD – University of California, San Diego
2:30 PM – 3:45 PM ET
3207 - Inter- and Intra-Observer Variability in Catheter Localization in High-Dose-Rate Brachytherapy for Prostate Cancer with Stepping Transverse and Twister Sagittal Volume Scanning
Location: Hall C
Presenter: Soo Kyoung Kim, MD – UC Davis Cancer Center
2:30 PM – 3:45 PM ET
3208 - Acute Toxicity and Quality of Life in Postoperative Prostate Cancer Patients Treated with Ultra-Hypofractionated Pelvic Radiation Therapy
Location: Hall C
Presenter: Isidora King, MD – Clinica IRAM
2:30 PM – 3:45 PM ET
3209 - Oncologic Outcomes of Upfront Radiation Therapy vs. Surgery, while Accounting for Intraprostatic Tumor Volume
Location: Hall C
Presenter: Martin King, MD, PhD – Brigham and Womens Hospital
2:30 PM – 3:45 PM ET
3210 - ¹⁸F-Flotufolastat Detection Rates in the Pelvis Region for Patients with Prostate Cancer Recurrence after Radical Prostatectomy and PSA Levels <1 ng/mL: Data from the Phase 3 SPOTLIGHT S
Location: Hall C
Presenter: Bridget Koontz, MD, FASTRO – AdventHealth Cancer Institute
2:30 PM – 3:45 PM ET
3211 - Association of MRI Capsular Involvement and Extraprostatic Extension on Metastasis Free and Overall Survival in Localized Prostate Cancer Treated with Radiation
Location: Hall C
Presenter: Abhishek Kumar, MD, MAS – Duke Cancer Institute
2:30 PM – 3:45 PM ET
3212 - Radiation Induced Lymphopenia Depends on Lymph Node Irradiation in Prostate Cancer Radiotherapy
Location: Hall C
Presenter: Lukasz Kuncman, MD, PhD – Fundacja im Jakuba Hrabiego Potockiego
2:30 PM – 3:45 PM ET
3213 - Efficacy of Oligometastasis Directed Stereotactic Body Radiation Therapy in De Novo Oligometastatic Prostate Cancer
Location: Hall C
Presenter: Dominic LaBella, MD – Thomas Jefferson University
2:30 PM – 3:45 PM ET
3214 - Efficacy of Oligorecurrence Directed Stereotactic Body Radiation Therapy in Oligorecurrent Prostate Cancer
Location: Hall C
Presenter: Dominic LaBella, MD – Thomas Jefferson University
2:30 PM – 3:45 PM ET
3215 - A Secondary Analysis of Radiotherapy Oncology Group (RTOG/NRG) Trials 9202, 9413, and 9910: Unknown Causes of Death and Their Impact on Prostate Cancer Specific Mortality Estimates
Location: Hall C
Presenter: Joan Lee, MD – University Hospitals Cleveland Medical Center
2:30 PM – 3:45 PM ET
3216 - Feasibility of PSMA PET-Assisted MR-Guided Radiotherapy for Prostate Cancer Patients Treated with Curative Aim
Location: Hall C
Presenter: Joon-gyo Lee, MD – Gachon University Gil Medical Center
2:30 PM – 3:45 PM ET
3217 - Prognostic Value of Central Gland Volume on MRI for Biochemical Recurrence after Prostate Cancer Radiotherapy
Location: Hall C
Presenter: Joseph Lee, MD, PhD – Corewell Health William Beaumont University Hospital
2:30 PM – 3:45 PM ET
3218 - Decoding Cancer Radiotherapy Discontinuation: A Comprehensive Analysis
Location: Hall C
Presenter: Huei Fang Yang, BS, RN – Chung Shan Medical University Hospital
2:30 PM – 3:45 PM ET
3219 - Apparent Diffusion Coefficient Tumor Volume is the Most Prognostic Radiomic Feature in Localized Prostate Cancer
Location: Hall C
Presenter: Jonathan Leeman, MD – Brigham and Women's Hospital/Dana-Farber
2:30 PM – 3:45 PM ET
3221 - The Effectiveness of Radiotherapy for Upper Tract Urothelial Carcinoma (UTUC) with Lymph Node Metastasis and Optimal Target Delineation for Clinical Target Volume
Location: Hall C
Presenter: Xiaoying Li, MD – Peking University First Hospital
2:30 PM – 3:45 PM ET
3222 - Impact of Hyaluronic Acid (HA) Rectal Spacer Quality Score (SQS) and Fischer-Valuck (FV) Spacer Symmetry Score on Rectal Dosimetry and Acute and Late Gastrointestinal (GI) Toxicity Outcomes - An Austr
Location: Hall C
Presenter: Yuan-Hong Lin, MD – Alfred Health
2:30 PM – 3:45 PM ET
3223 - Rectal Spacer Impact on MRI-Directed SBRT Prostate Microboost in Concert with Pelvic Nodal Irradiation
Location: Hall C
Presenter: Jonathan Lischalk, MD – New York University Perlmutter Cancer Center
2:30 PM – 3:45 PM ET
3225 - Exploring Gene Expression and Pathway Analysis in Localized Prostate Cancer: Insights from a Retrospective Cohort Study with a Focus on Hypoxia and Angiogenic Biomarkers Post-EBRT and HDR-BTb
Location: Hall C
Presenter: Taha Lodhi, MB, ChB – The Christie NHS Foundation Trust
2:30 PM – 3:45 PM ET
3226 - A Randomized Controlled Study of a New Model of Symptom Management Based on PRO in Patients with Head and Neck Tumors Receiving Radiotherapy
Location: Hall C
Presenter: Xiaoli Long
2:30 PM – 3:45 PM ET
3227 - A Prospective Cohort Study Assessing Patient Reported Outcomes after Post-Prostatectomy Radiation Therapy: Longer-Term Follow-Up through 5 Years
Location: Hall C
Presenter: Connor Lynch, MD – University of Chicago
2:30 PM – 3:45 PM ET
3228 - Impact of Posterior PTV Margin on the Treatment Efficiency and Adverse Effects of Radical Radiotherapy for Prostate Cancer Patients
Location: Hall C
Presenter: Lin Ma, MD – Peking University First Hospital
2:30 PM – 3:45 PM ET
3229 - A Prospective Cohort Study Evaluating the Efficacy and Safety of Adjuvant Chemotherapy in High-Risk Non-Metastatic Prostate Cancer Patients with High Gleason Scores
Location: Hall C
Presenter: Ming-Wei Ma, MD – Peking University First Hospital
2:30 PM – 3:45 PM ET
3230 - Patterns of Care and Associated Socioeconomic Determinants of Health in the Definitive Treatment of Localized Muscle-Invasive Bladder Cancer Patients
Location: Hall C
Presenter: Megan Mai, MPH – Texas Tech University Health Science Center
2:30 PM – 3:45 PM ET
3231 - Adaptive-Driven CT Simulation Free SBRT Workflow Validation and Initial Experience
Location: Hall C
Presenter: Victor Malkov, PhD, MCCPM – Mayo Clinic Rochester
2:30 PM – 3:45 PM ET
3232 - Estimating Life Expectancy prior to Curative Intent Prostate Radiation Therapy in Underserved Patient Populations
Location: Hall C
Presenter: Swati Mamidanna, MD – Rutgers Cancer Institute of New Jersey
2:30 PM – 3:45 PM ET
3233 - Evaluation of an Artificial Intelligence-Based Software for Adaptative Radiotherapy in Head and Neck Cancer Treatments
Location: Hall C
Presenter: Pauline Maury, PhD – Institut Gustave Roussy
2:30 PM – 3:45 PM ET
3234 - Peer Review as a Means of Improvement and Harmonization of Treatment Plans Among a Multinational Radiation Oncology Team
Location: Hall C
Presenter: Basma Mbarek, MD – far east medical
2:30 PM – 3:45 PM ET
3235 - Bladder Neck Dosimetry and Interfractional Variation in Proton Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer
Location: Hall C
Presenter: Hamilton McGinnis, MD – Emory University School of Medicine
2:30 PM – 3:45 PM ET
3236 - Hyaluronic Acid Rectal Spacer in Locally Recurrent Prostate Cancer with Prior Radiation Receiving SBRT: A Report on Feasibility, Safety and Toxicity
Location: Hall C
Presenter: LaToya McLean, MD, MS, BS – Thomas Jefferson University
2:30 PM – 3:45 PM ET
3237 - Magnetic Resonance-Guided Stereotactic Body Radiotherapy for Metastatic Renal Cell Carcinoma
Location: Hall C
Presenter: Elie Mehanna, MD – Harvard Radiation Oncology Program
2:30 PM – 3:45 PM ET
3238 - Reducing Patient Safety Risk with the Implementation of Intradepartmental Survey Program across a Multi-Site Large Teaching Institution
Location: Hall C
Presenter: Timothy Meier, RT, (R)(T) – Cleveland Clinic
2:30 PM – 3:45 PM ET
3239 - Radiotherapy is a Treatment Option for Cancer in the Very Old (80+): A Single Institution Experience
Location: Hall C
Presenter: Oliver Micke, MD – Franzikus Hospital Bielefeld
2:30 PM – 3:45 PM ET
3240 - Uptake and Positivity Rates of PSMA PET Staging for Newly Diagnosed Prostate Cancer in a National Healthcare System
Location: Hall C
Presenter: Sean Miller, MD – University of Michigan
2:30 PM – 3:45 PM ET
3241 - Radiotherapy Treatment with Radical Doses in De Novo Low Burden Metastatic Prostate Cancer: Early Outcomes Report.
Location: Hall C
Presenter: Benazir mir Khan, MD
2:30 PM – 3:45 PM ET
3242 - Respecting Patients Privacy Rights and Medical Data Safety at a Radiation Oncology Department during Remote Consultations and Surveillance
Location: Hall C
Presenter: Miroslawa Mocydlarz-Adamcewicz, PhD – Wielkopolskie Centrum Onkologii
2:30 PM – 3:45 PM ET
3243 - Testosterone Recovery and Associated Impact on Patient-Reported Health-Related Quality of Life (HRQoL) after Treatment with 6 Months of GnRH Agonist with or without Abiraterone Acetate plus Prednisone
Location: Hall C
Presenter: Shalini Moningi, MD – Brigham and Women's Hospital/Dana-Farber
2:30 PM – 3:45 PM ET
3244 - A Randomized Phase II Trial of High Dose-Rate (HDR) and Low Dose-Rate (LDR) Brachytherapy as Monotherapy in Localized Prostate Cancer: Analysis of Initial Arms of Canadian Cancer Trials Group PR19 (NC
Location: Hall C
Presenter: Gerard Morton, MD – Sunnybrook Health Sciences Centre
2:30 PM – 3:45 PM ET
3245 - Correlation of Circulating Tumor DNA (ctDNA) Dynamics with Clinical Response in Muscle-Invasive Bladder Cancer (MIBC) Patients Undergoing Trimodality Therapy (TMT)
Location: Hall C
Presenter: Kent Mouw, MD, PhD – Dana-Farber/Brigham and Women's Cancer Center
2:30 PM – 3:45 PM ET
3246 - Customized Electronic Quality Checklists to Reduce Errors and Improve Radiotherapy Workflow
Location: Hall C
Presenter: Hussam Hijazi, MD, MB, BS, MBBS – King Abdulaziz University
2:30 PM – 3:45 PM ET
3247 - Comparison of Local Medicare Guidance and Medicare Advantage Plans for Stereotactic Radiosurgery for Brain Metastases
Location: Hall C
Presenter: Trey Mullikin, MD – Duke Cancer Institute
2:30 PM – 3:45 PM ET
3248 - Biochemical Recurrence is Not a Surrogate for Overall Survival in Localized Prostate Cancer: Data from 2 Phase III Trials
Location: Hall C
Presenter: Abdenour Nabid, MD – CHUS
2:30 PM – 3:45 PM ET
3249 - Quality of Life and Weight Variation during Androgen Deprivation Therapy in Patients with High-Risk Prostate Cancer: Long-Term Data from a Phase III Trial
Location: Hall C
Presenter: Abdenour Nabid, MD – CHUS
2:30 PM – 3:45 PM ET
3250 - Phase 2 Prospective Trial of Re-Treatment with ¹⁷⁷lu-PSMA-617 Molecular Radiotherapy for Metastatic Castration Resistant Prostate Cancer (RE-LuPSMA): Study Protocol
Location: Hall C
Presenter: John Nikitas, MD – UCLA Radiation Oncology
2:30 PM – 3:45 PM ET
3251 - Treatment Terminations in Gynecological Malignancies
Location: Hall C
Presenter: Jason Nosrati, MD – Montefiore Einstein Cancer Center
2:30 PM – 3:45 PM ET
3252 - Comparison of Decipher vs. Oncotype (GPS) Genomic Profiling Scores in NCCN Intermediate Risk Prostate Cancer Patients
Location: Hall C
Presenter: Edward Obedian, MD – The Cancer Institute at St. Francis Hospital
2:30 PM – 3:45 PM ET
3253 - The Safety and Efficacy of Lutetium-177-PSMA-617 Therapy for Metastatic CRPC in a Real World Community Cancer Center
Location: Hall C
Presenter: Edward Obedian, MD – The Cancer Institute at St. Francis Hospital
2:30 PM – 3:45 PM ET
3254 - Investigating the Machine Learning-Derived Nomogram Models and Biomarkers for Side-Specific Prediction of Extraprostatic Extension of Prostate Cancer - Preliminary Results
Location: Hall C
Presenter: Oluwaseyi Oderinde, PhD – Purdue University
2:30 PM – 3:45 PM ET
3255 - Stereotactic Body Radiotherapy with Hydrogel Spacer for Prostate Cancer: 5-Year Follow-Up Results of a Phase 2 Trial
Location: Hall C
Presenter: Mami Ogita, MD, PhD – University of Tokyo Hospital
2:30 PM – 3:45 PM ET
3256 - Treatment Outcomes of External Beam Radiotherapy with or without Focal Boost to Intraprostatic Lesions in Patients with Localized Prostate Cancer
Location: Hall C
Presenter: Huseyin Cem Onal, MD – Baskent University Faculty of Medicine
2:30 PM – 3:45 PM ET
3257 - Impact of Definitive Radiotherapy on Metabolic Response Measured with ⁶⁸Ga-PSMA-PET/CT in Patients with Intermediate-Risk Prostate Cancer
Location: Hall C
Presenter: Huseyin Cem Onal, MD – Baskent University Faculty of Medicine
2:30 PM – 3:45 PM ET
3258 - Study on the Focal Boost to the Dominant Intraprostatic Lesions Using Proton Therapy in High-Risk Prostate Cancer Patients with Pelvic Lymph Node Irradiation: Assessing Toxicity Using the Accumulated
Location: Hall C
Presenter: Ashley Ong, PhD, CMD – National Cancer Centre Singapore
2:30 PM – 3:45 PM ET
3259 - Financial Difficulties and Long-Term Oncological Outcomes Following Prostate Radiotherapy and Androgen Deprivation Therapy - Post-Hoc Analyses of TROG0304/ RADAR Trial
Location: Hall C
Presenter: Wee Loon Ong, MBBS – Alfred Health Radiation Oncology
2:30 PM – 3:45 PM ET
3260 - Preoperative Intraprostatic Tumor Volume Is Prognostic for Metastasis after Early Salvage Post-Prostatectomy Radiation Therapy
Location: Hall C
Presenter: James Parisi, BS – Brigham and Womens Hopsital
2:30 PM – 3:45 PM ET
3261 - Brachytherapy Deserts in Texas: Assessment of Geographic Availability of Brachytherapy Centers
Location: Hall C
Presenter: Mayank Patel, MD, MBA – University of Miami
2:30 PM – 3:45 PM ET
3262 - Failure Patterns of Bladder Only Hypofractionated Radiation with Gemcitabine in Muscle Invasive Bladder Cancer (MIBC)
Location: Hall C
Presenter: Abigail Pepin, MD – University of Pennsylvania Health System
2:30 PM – 3:45 PM ET
3263 - Prospective Analysis on Tumor Control, Survival, Toxicity and Quality of Life Outcomes of an HDR-Brachytherapy Boost for Prostate Cancer
Location: Hall C
Presenter: Max Peters, RT – Radiotherapiegroep Arnhem
2:30 PM – 3:45 PM ET
3264 - Ultra-Short-Course Hormone Therapy for Intermediate Risk Prostate Cancer Treated with Definitive Radiotherapy: Retrospective Analysis of a National Healthcare System
Location: Hall C
Presenter: Alex Bryant, MD, MS – University of Michigan
2:30 PM – 3:45 PM ET
3265 - PSMA-PET Radiopharmaceutical Image Scoring Method (PRISM): A Practical Tool for Predicting ¹⁷⁷lu-PSMA-617 Therapy Outcomes in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Location: Hall C
Presenter: Hyma Polimera, MD – Penn State Cancer Institute
2:30 PM – 3:45 PM ET
3266 - Estimating Risk of Biochemical Recurrence after RT Utilizing a Convolutional Neural Network
Location: Hall C
Presenter: Martin King, MD, PhD – Brigham and Womens Hospital
2:30 PM – 3:45 PM ET
3267 - Implementation of a Patient Tracking Whiteboard for Prospective Peer Review in a Community-Based Radiation Oncology Program
Location: Hall C
Presenter: Malolan Rajagopalan, MD, MBA – Mount Carmel Health System
2:30 PM – 3:45 PM ET
3268 - Radiation Chronotherapy in Prostate Cancer: Does Time of Day of Radiation Treatment Influence Disease Outcome or Symptom Burden?
Location: Hall C
Presenter: Greeshma Rajeev-Kumar, MD – University of Chicago Medicine
2:30 PM – 3:45 PM ET
3269 - PSMA MRI Guided Prostate SBRT: Acute Toxicity and Early Results from the ARGOS-Climber Phase I/II Trial
Location: Hall C
Presenter: Sherif Ramadan, MD – Western University
2:30 PM – 3:45 PM ET
3270 - Microboost and Dosimetric Variability in Localized Prostate Cancer: Analysis of a Prospective Statewide Quality Collaborative
Location: Hall C
Presenter: Samuel Regan, MD – University of Michigan
2:30 PM – 3:45 PM ET
3271 - Metastasis-Free Survival after Adjuvant or Salvage Radiation Therapy Following Radical Prostatectomy in a National Healthcare Delivery System
Location: Hall C
Presenter: Samuel Regan, MD – University of Michigan
2:30 PM – 3:45 PM ET
3272 - Postoperative Hypofractionated Radiotherapy for Prostate Cancer: Results of a Large Cohort
Location: Hall C
Presenter: Xue-Ying Ren, MD – Peking University First Hospital
2:30 PM – 3:45 PM ET
3273 - Impact of PSMA PET-CT Findings on Dose Prescription and Target Definition in Patients with Biochemical Relapse after Radical Prostatectomy
Location: Hall C
Presenter: Christoph Resl, MD – UK Krems an der Donau
2:30 PM – 3:45 PM ET
3274 - Prostate Salvage Brachytherapy Utilization and Efficacy over Two Decades at a Single Institution
Location: Hall C
Presenter: Daniel Rosen, MD, PhD – Harvard Radiation Oncology Program
2:30 PM – 3:45 PM ET
3275 - Automated Template-Based Planning and Prostate Stereotactic Body Radiotherapy without Real-Time Seed-Tracking: A Regional Service Experience
Location: Hall C
Presenter: Amie Ross, RT – Mid North Coast Cancer Institute (MNCCI) Coffs Harbour
2:30 PM – 3:45 PM ET
3277 - Association of Absolute Amount of Pattern 4 Disease on Prostate Biopsy with Oncologic Outcomes in Intermediate-Risk Prostate Cancer: A Systematic Review
Location: Hall C
Presenter: Melissa Sam Soon, BHSc – University of Ottawa
2:30 PM – 3:45 PM ET
3278 - A Phase 2/3 Study of ¹⁷⁷Lu-TLX591 Plus SOC vs. SOC Alone in Patients with Metastatic Castration-Resistant Prostate Cancer (ProstACT GLOBAL)
Location: Hall C
Presenter: Divya Madhu, PharmD – Telix Pharmaceuticals
2:30 PM – 3:45 PM ET
3279 - Safety Profile of High-Dose Intensity Modulated Radiotherapy in Prostate Cancer: Preliminary Findings from the JROSG 17-5 Multicenter Prospective Observational Study in Japan
Location: Hall C
Presenter: Yuta Sekino, MD, PhD – University of Tsukuba
2:30 PM – 3:45 PM ET
3280 - Multi-Class Prediction Using Machine Learning to Predict Pathologic Stage in Prostate Cancer
Location: Hall C
Presenter: Hemal Semwal, MS, BS
2:30 PM – 3:45 PM ET
3281 - Hypofractionated vs. Conventionally Fractionated Radiotherapy for Prostate Cancer: A Meta-Analysis of Randomized Trials
Location: Hall C
Presenter: Parvez Shaikh, MD, ScB MScHI – West Virginia University School of Medicine
2:30 PM – 3:45 PM ET
3282 - Clinical Efficacy of Localized Salvage Prostate Cancer Retreatments Using CBCT-Guided Proton Scanning Beams with Over 2-Year Follow-Ups
Location: Hall C
Presenter: Charles Shang, MB, MS – South Florida Proton Therapy Institute
2:30 PM – 3:45 PM ET
3283 - Telemedicine Use in Older Adults with Cancer Presenting for Radiation Oncology Consultation
Location: Hall C
Presenter: Yasamin Sharifzadeh, MD – Mayo Clinic Rochester
2:30 PM – 3:45 PM ET
3284 - Patient Reported Outcomes in Radiotherapy (PRO-RT) Utilizing an Integrated Patient Portal; Results from a Prospective Single Arm Trial
Location: Hall C
Presenter: Yasamin Sharifzadeh, MD – Mayo Clinic Rochester
2:30 PM – 3:45 PM ET
3285 - Dosimetric Comparison between Adaptation Strategies for MRI-Guided Dose-Intensified Prostate Stereotactic Ablative Radiotherapy
Location: Hall C
Presenter: Julia Shi, BS – University of Texas Southwestern Medical Center
2:30 PM – 3:45 PM ET
3286 - High Risk Prostate Cancer Treated with Radiation Therapy: Favorable Outcomes in Men with PSA>20 as the Sole High Risk Factor
Location: Hall C
Presenter: Stanley Liauw, MD, FASTRO – University of Chicago
2:30 PM – 3:45 PM ET
3287 - Comparison of Urethra Morphology on CT with Urinary Catheter and MRI without Urinary Catheter after Low Dose Rate Prostate Cancer Brachytherapy
Location: Hall C
Presenter: Ingrid Sidibe, MD – CHU de Quebec - Universite Laval - Centre integre de cancerologie
2:30 PM – 3:45 PM ET
3288 - Moderately Hypofractionated Proton Therapy with or without Implantable Spacer in Patients with Localized Prostate Cancer
Location: Hall C
Presenter: Soborun Kaviraj, MD – Universitatsklinikum Dresden Klinik f Strahlentherapie und Radioonkologie
2:30 PM – 3:45 PM ET
3289 - Veterans Affairs seamless phase II/III randomized trial of STAndard systemic theRapy with or without PET-directed local therapy for Oligometastatic pRosTate cancer (VA STARPORT)
Location: Hall C
Presenter: Abhishek Solanki, MD, MS – Loyola University Chicago Stritch School of Medicine
2:30 PM – 3:45 PM ET
3290 - Practice Patterns of Primary Stereotactic Radiotherapy for Renal Cell Carcinoma in the United States
Location: Hall C
Presenter: Yash Soni, MD, BS – UT Southwestern Medical Center
2:30 PM – 3:45 PM ET
3291 - National Use of PEG Hydrogel Spacer for Men with Prostate Cancer in the U.S. over Six Years
Location: Hall C
Presenter: Daniel Spratt, MD – University Hospitals Seidman Cancer Center
2:30 PM – 3:45 PM ET
3292 - Radiotherapy vs. Radical Prostatectomy in Patients with Intraductal Carcinoma of the Prostate
Location: Hall C
Presenter: Taylor Stamey, MOP – East Carolina University Brody School of Medicine
2:30 PM – 3:45 PM ET
3293 - Impact of Nutritional Status and Therapy on Survival among Radiotherapy Patients: A Study of a Chinese Population
Location: Hall C
Presenter: Yue Su, MD – Sichuan Cancer Hospital
2:30 PM – 3:45 PM ET
3294 - A Comprehensive Evaluation of an Independent Quality Assurance System for Intensity Modulated Proton Therapy Treatment Plans and Deliveries
Location: Hall C
Presenter: Zhong Su, PhD, MBA – University of Arkansas for Medical Sciences College of Medicine
2:30 PM – 3:45 PM ET
3295 - Implications of Rectal Wall Gel Placement in Treatment Delay
Location: Hall C
Presenter: Grace Sun, MD, BS – Michigan Medicine
2:30 PM – 3:45 PM ET
3296 - Hypoxia-Guided Dose Escalated Radiation Therapy in Prostate Cancer: A Dosimetric Feasibility Study
Location: Hall C
Presenter: Dorine de Jong, PhD – RefleXion
2:30 PM – 3:45 PM ET
3297 - Progression Free Survival Prediction for Oligometastatic Renal Cell Cancer Patients after Stereotactic Ablative Radiation Therapy
Location: Hall C
Presenter: Shanshan Tang, PhD – UT Southwestern Medical Center
2:30 PM – 3:45 PM ET
3298 - Predicting Chemoradiotherapy Induced Cardiotoxicity in Breast Cancer Patients Using Machine Learning Based Clinical, Imaging and Dosimetric Radiomics Features
Location: Hall C
Presenter: Beth Ghavidel, MS – Winship at Emory University Hospital Midtown
2:30 PM – 3:45 PM ET
3299 - Organ at Risk Dose Constraints in Conventionally Fractionated Pelvic Radiation Therapy: A Systematic Review of Clinical Trials
Location: Hall C
Presenter: Leila Tchelebi, MD – Northern Westchester Hospital
2:30 PM – 3:45 PM ET
3300 - Per-Fraction Analysis of PTV Margin Reduction and Organ Dose Optimization for Intact Prostate
Location: Hall C
Presenter: Diego Toesca, MD – Mayo Clinic Arizona
2:30 PM – 3:45 PM ET
3301 - A Phase 4 Open-Label Multicenter Study of Piflufolastat F 18 PET/CT or PET/MRI in Men with Newly Diagnosed Favorable Intermediate Risk Prostate Cancer: MIRROR
Location: Hall C
Presenter: Jonathan Tward, MD, PhD, FASTRO – University of Utah
2:30 PM – 3:45 PM ET
3302 - Comparison of Perirectal Spacer Placement Quality during the Learning Curve for 3 FDA Approved Products
Location: Hall C
Presenter: Jonathan Tward, MD, PhD, FASTRO – University of Utah
2:30 PM – 3:45 PM ET
3303 - Treatment Outcomes with Neoadjuvant Chemotherapy Followed by Chemoradiation for Muscle Invasive Bladder Cancer
Location: Hall C
Presenter: Melissa Usoz, MS, BS – Prisma Health Cancer Institute
2:30 PM – 3:45 PM ET
3304 - A Pilot Study of Immunological Response to PSMA-Directed Radioligand Therapy for the Treatment of Oligometastatic Prostate Cancer
Location: Hall C
Presenter: Luca Valle, MD – UCLA Radiation Oncology
2:30 PM – 3:45 PM ET
3305 - Physician Assessment and Clinical Evaluation of the Suitability of Deep Learning Based Auto Segmentation Contours for Organs at Risk Delineation in Radiation Oncology
Location: Hall C
Presenter: Sarah Way, MS – Minneapolis Radiation Oncology PA
2:30 PM – 3:45 PM ET
3306 - Assessing Bilateral Neurovascular Bundles Function with Pulsed Wave Doppler Ultrasound: Implications for Reducing Erectile Dysfunction Following Prostate Radiotherapy
Location: Hall C
Presenter: Tian Liu, PhD – Icahn School of Medicine at Mount Sinai
2:30 PM – 3:45 PM ET
3307 - Efficacy of an Adaptive Plan Quality Predictor for Decision Support in Online MR-Guided Adaptive Radiotherapy for Prostate Stereotactic Ablative Radiotherapy
Location: Hall C
Presenter: Siqiu Wang, PhD – University of Texas Southwestern Medical Center
2:30 PM – 3:45 PM ET
3308 - Daily Online Adaptive Radiotherapy for Rectal Cancer Utilizing CT-Linac: Assessing Feasibility, Toxicities and Optimal Margins
Location: Hall C
Presenter: Weiping Wang, MD, PhD – Peking Union Medical College Hospital
2:30 PM – 3:45 PM ET
3309 - Factors Associated with Completion of Treatment Course with Lutetium-177 Vipivotide Tetraxetan in Men with Metastatic Castration-Resistant Prostate Cancer at a Single Institution
Location: Hall C
Presenter: Peter Whatts, MD – Detroit Medical Center/Wayne State University
2:30 PM – 3:45 PM ET
3310 - Characterizing Failure after Trimodality Therapy in Bladder Cancer: A Retrospective Analysis of Clinical, Spatial and Dosimetric Factors
Location: Hall C
Presenter: Matthew Whitmill, MD – UNC Health
2:30 PM – 3:45 PM ET
3311 - Baseline Characteristics of Patients Enrolled on the Prostate Advanced Radiation Technologies Investigating Quality of Life (PARTIQoL) Trial Comparing Proton Therapy vs. IMRT for Low or Intermediate R
Location: Hall C
Presenter: Jason Efstathiou, MD, PhD, FASTRO – Massachusetts General Hospital
2:30 PM – 3:45 PM ET
3312 - The Broader Impact of Specialized Outpatient Cancer Rehabilitation on Functioning and Health Outcomes during Radiation Treatment
Location: Hall C
Presenter: Kelley Wood, PhD, MS – Select Medical
2:30 PM – 3:45 PM ET
3313 - Dosimetric Study of Dose De-Escalation Using MRI-Guidance in Low and Intermediate Risk Prostate Cancer Patients with Pd-103 Low Dose Rate Brachytherapy
Location: Hall C
Presenter: Lin Wang, MS – Northwell Health
2:30 PM – 3:45 PM ET
3314 - Multivariate Analysis of Pretreatment Biomarkers Predicting Treatment Completion in Patients Undergoing Lu-177-PSMA-617 Radiopharmaceutical Therapy
Location: Hall C
Presenter: Edmond Yaghoubian, MD – UPMC
2:30 PM – 3:45 PM ET
3315 - Predictive Factors for Oliogometastatic Renal Cell Carcinoma Patients Treated with Stereotactic Ablative Radiation (SAbR)
Location: Hall C
Presenter: Joseph Kwon, MD
2:30 PM – 3:45 PM ET
3316 - HDR Brachytherapy Boost for Unfavorable Localized Prostate Cancer: A Single Center Experience from Inception to Standard of Care
Location: Hall C
Presenter: Juanita Crook, MD – BCCancer
2:30 PM – 3:45 PM ET
3317 - Calculation of Dose Perturbations Caused by 2 mm of Intraprostatic Calcification for Permanent Prostate Seed Implant Using Pd103 in Excel/Python
Location: Hall C
Presenter: Ashraf Youssef, MD, MBA – Our Lady of Lourdes Memorial Hospital Inc.
2:30 PM – 3:45 PM ET
3319 - Caring for the Carers: Factors Associated with Perceived Burden among Caregivers of Filipino Cancer Patients Undergoing Radiation Therapy in Two Tertiary Care Hospitals in the Philippines
Location: Hall C
Presenter: Jose Ma. Zaldarriaga, MD, MBA – St. Luke's Medical Center
2:30 PM – 3:45 PM ET
3322 - Analysis of Theranostic ¹⁷⁷Lu-PSMA-617 Therapy Efficacy and Toxicity in Patients with Advanced Prostate Cancer
Location: Hall C
Presenter: Anthony Zhang, BS – UCONN Health Center
2:30 PM – 3:45 PM ET
3323 - Failure Modes and Effects Analysis Applied to Total Body Irradiation
Location: Hall C
Presenter: Hongjun Zhang, PhD – Atrium Health Levine Cancer Institute
2:30 PM – 3:45 PM ET
3324 - A Novel Six-Zone Method to Guide Delineation of Clinical Target Volume (CTV) for Postoperative Radiotherapy of Prostate Cancer, Based on the Distribution of Prostate Bed Recurrence by PSMA PET
Location: Hall C
Presenter: Simone Deng, PhD – Peking University First Hospital
2:30 PM – 3:45 PM ET
3325 - Long-Term Outcomes of SAbR for Metastatic RCC
Location: Hall C
Presenter: Lucian Zhao, MD, BS – UT Southwestern Medical Center
2:30 PM – 3:45 PM ET
3326 - Impact of CT Online Adaptive Radiotherapy on Acute Toxicity in Patients Undergoing Prostate Radiotherapy
Location: Hall C
Presenter: Lin Zhu, MD, PhD – Harvard Radiation Oncology Program
2:30 PM – 3:45 PM ET
3327 - Analysis of the Treatment Planning Quality Assurance Reports for Intensity Modulated Proton Therapy at an Established Proton Center
Location: Hall C
Presenter: Mingyao Zhu, PhD – Emory University School of Medicine
2:30 PM – 3:45 PM ET
3328 - Optimizing Rectal Dose and Minimizing Toxicity in Prostate Radiotherapy in a Randomized Pivotal Trial: Assessment of Rectal Spacer Placement Effect on Rectal Dosimetry and Toxicity
Location: Hall C
Presenter: Vishesh Agrawal, MD – Advanced Radiation Centers of New York
4:00 PM – 5:00 PM ET
3329 - Prognostic Value of Quantitative PET/CT Parameters in Large B-Cell Lymphoma Patients Following CAR T-Cell Therapy Failure
Location: Hall C
Presenter: Chirayu Patel, MD, MD, MPH – Massachusetts General Hospital
4:00 PM – 5:00 PM ET
3330 - Multi-Institutional Update on Bridging Radiotherapy in Relapsed or Refractory Large B-Cell Lymphoma Patients Prior to CAR T-Cell Therapy
Location: Hall C
Presenter: Chirayu Patel, MD, MD, MPH – Massachusetts General Hospital
4:00 PM – 5:00 PM ET
3331 - Long-Term Outcomes of Surface Applicator Brachytherapy in the Management of Cutaneous Lymphomas: A 20 Year Single Institutional Experience
Location: Hall C
Presenter: Chirayu Patel, MD, MD, MPH – Massachusetts General Hospital
4:00 PM – 5:00 PM ET
3332 - Assessing ChatGPTs Utility as an Educational Aid for Cancer Patients Undergoing Radiation Therapy
Location: Hall C
Presenter: Sami Abi Farraj, MD – Hotel-Dieu de France University Hospital
4:00 PM – 5:00 PM ET
3333 - Predicting Absolute Risk of First Relapse in Classical Hodgkin Lymphoma by Incorporating Contemporary Treatment Effects
Location: Hall C
Presenter: Berthe Aleman, MD, PhD – Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL)
4:00 PM – 5:00 PM ET
3334 - Artificial Intelligence for Identification of Radiation-Related Toxicities from the Electronic Health Records of Patients with Head and Neck Cancer
Location: Hall C
Presenter: Faisal Alfadli, MB, ChB – University of Toronto
4:00 PM – 5:00 PM ET
3335 - Genome-Wide Cell-Free DNA Fragmentation Analyses for Early, Non-Invasive Detection of Treatment Response to Standard of Care Adjuvant Radiation Treatment in High-Grade Gliomas
Location: Hall C
Presenter: Akshaya Annapragada, MS, BA – Johns Hopkins University School of Medicine
4:00 PM – 5:00 PM ET
3336 - Development of Machine Learning Algorithms from Computed Tomography Images to Predict Catastrophic Airway Events in Patients with Cancers in the Aerodigestive Tract
Location: Hall C
Presenter: Hannah Bacon, MD, PhD – University of Toronto
4:00 PM – 5:00 PM ET
3337 - Dosimetric Predictors of Radiation Pneumonitis in Locally Advanced Non-Small Cell Lung Cancer Patients with Artificial-Intelligence Screened Interstitial Lung Disease
Location: Hall C
Presenter: Hannah Bacon, MD, PhD – University of Toronto
4:00 PM – 5:00 PM ET
3338 - Left Ventricular Sphericity as a Radiomic Predictor of Cardiac Outcomes after Thoracic Radiotherapy for Lung Cancer
Location: Hall C
Presenter: Mina Bakhtiar, MD – Mass General Brigham/Massachusetts General Hospital/Harvard Med School
4:00 PM – 5:00 PM ET
3339 - Validation of Multi-Modal Artificial Intelligence Biomarker for Predicting Biochemical Recurrence in Patients with Prostate Cancer Undergoing Prostatectomy
Location: Hall C
Presenter: Atallah Baydoun, MD, PhD – Case Western Reserve University
4:00 PM – 5:00 PM ET
3340 - Identifying Cancer Recurrence from the Electronic Medical Record: Using Natural Language Processing to Interpret Pathology Reports
Location: Hall C
Presenter: Diego Bayona – Mayo Clinic Alix School of Medicine
4:00 PM – 5:00 PM ET
3341 - Utilizing Large Language Models for Enhanced Clinical Trial Matching
Location: Hall C
Presenter: Jacob Beattie
4:00 PM – 5:00 PM ET
3342 - Using Large Language Models to Create Patient Centered Consent Forms
Location: Hall C
Presenter: Jacob Beattie
4:00 PM – 5:00 PM ET
3343 - Performance of Large Language Models on the Radiation and Cancer Biology Practice Exam
Location: Hall C
Presenter: Jessica Bertschmann, MD, MS, BS – University of Alberta
4:00 PM – 5:00 PM ET
3344 - Multi-Cancer Early Detection Utilizing Blood-Based Genomics: Single-Institution Case Series of Novel Cancer Screening
Location: Hall C
Presenter: Jason Burton, MD, PhD – Oregon Health and Science University
4:00 PM – 5:00 PM ET
3345 - Patterns of Intracranial Response and Relapse after Radiotherapy for Patients with Chemorefractory or Progressive Secondary CNS Lymphoma
Location: Hall C
Presenter: Gustav Cederquist, MD, PhD – Memorial Sloan Kettering Cancer Center
4:00 PM – 5:00 PM ET
3346 - Decoding Patient Heterogeneity Influencing Radiation-Induced Brain Necrosis
Location: Hall C
Presenter: Ibrahim Chamseddine, PhD – Massachusetts General Hospital, Harvard Medical School
4:00 PM – 5:00 PM ET
3347 - The Impact of Standard vs. Hypofractionated Total Skin Electron Beam Therapy (TSE) on Cytopenias in Mycosis Fungoides/Sezary Syndrome (MF/SS)
Location: Hall C
Presenter: Monica Chelius, MD – University of Pennsylvania
4:00 PM – 5:00 PM ET
3348 - Radiation in Combination with Bispecific Therapy Does Not Suggest Excess Toxicity in B-Cell Lymphomas
Location: Hall C
Presenter: Monica Chelius, MD – University of Pennsylvania
4:00 PM – 5:00 PM ET
3349 - Uncertainty Estimation in Radiotherapy Dose Prediction with Deep Learning for Head and Neck Cancers
Location: Hall C
Presenter: Liting Chen
4:00 PM – 5:00 PM ET
3350 - Segmon and Dosemon: Synergistic In-House Innovations Transforming Radiotherapy Workflow
Location: Hall C
Presenter: Arnold Pompos, PhD – University of Texas Southwestern Medical Center
4:00 PM – 5:00 PM ET
3352 - Multi-Channel 3D Convolutional Neural Network to Predict Grade 2 Xerostomia Following Definitive Radiation for Head and Neck Squamous Cell Carcinoma
Location: Hall C
Presenter: Kai-Cheng Chuang, PhD, MS – Duke University Medical Center
4:00 PM – 5:00 PM ET
3353 - Impact of Deep Learning Auto Segmentation Accuracy on Duodenal Dose-Volume Parameters for Pancreas SBRT Patients Treated with MR-Guided Online Adaptive Radiotherapy
Location: Hall C
Presenter: Asma Amjad, PhD – Medical College of Wisconsin
4:00 PM – 5:00 PM ET
3354 - Delineation of Primary Lung Cancer with Atelectasis Assisted by GANs-Based Synthetic PET Images from CT
Location: Hall C
Presenter: Baiqiang Dong, MD, PhD – Sun Yat-Sen University Cancer Center
4:00 PM – 5:00 PM ET
3355 - Radiation Therapy (RT) in a New Era of Multiple Myeloma (MM) Therapy: Trends of Engagement and Radiologic, Biochemical, and Cytogenetic Correlates of Outcomes and Response
Location: Hall C
Presenter: Alexandra Dreyfuss, MD, MS – Memorial Sloan Kettering Cancer Center
4:00 PM – 5:00 PM ET
3356 - Early Experience with Salvage RT for Relapsed / Refractory Multiple Myeloma Following BCMA-Directed CAR T Cell Therapy
Location: Hall C
Presenter: Alexandra Dreyfuss, MD, MS – Memorial Sloan Kettering Cancer Center
4:00 PM – 5:00 PM ET
3357 - Failure Patterns by PET for Relapsed / Refractory Multiple Myeloma (r/r MM) after CAR T Cell Therapy: Potential Role for Radiotherapy (RT)?
Location: Hall C
Presenter: Alexandra Dreyfuss, MD, MS – Memorial Sloan Kettering Cancer Center
4:00 PM – 5:00 PM ET
3358 - Benchmarking OpenAI ChatGPT and Google Bard on Radiation Physics Study Exams (RAPHEX) and Implication for Their Use as a Learning Tool
Location: Hall C
Presenter: Tomas Dvorak, MD – Orlando Health
4:00 PM – 5:00 PM ET
3359 - A Novel Interactive Online Visualizer for Clinical Trial Data
Location: Hall C
Presenter: Michelle Ann Eala, MD – UCLA David Geffen School of Medicine/UCLA Medical Center
4:00 PM – 5:00 PM ET
3360 - Proton Pencil Beam Scanning Facilitates Safe Treatment of Extended Radiation Targets for Hodgkin Lymphoma: A Report from the Proton Collaborative Group Registry
Location: Hall C
Presenter: Maryam Ebadi, MD – University of Washington
4:00 PM – 5:00 PM ET
3361 - AI Generated Clinical Target Volumes for Oropharyngeal Cancers Using a General Foundation Model
Location: Hall C
Presenter: Sharif Elguindi, MS – Memorial Sloan Kettering Cancer Center
4:00 PM – 5:00 PM ET
3362 - In-Depth Timing Study of AI-Assisted OAR Contouring with a Single Institution Expert
Location: Hall C
Presenter: Sharif Elguindi, MS – Memorial Sloan Kettering Cancer Center
4:00 PM – 5:00 PM ET
3363 - Automated Extraction of PSA Values from Unstructured Medical Records with a Large Language Model for Cancer
Location: Hall C
Presenter: Nicholas Eustace, MD, PhD – City of Hope National Medical Center
4:00 PM – 5:00 PM ET
3364 - Treatment Response and Risk of Local Recurrence after Radiotherapy in Patients with Plasma Cell Neoplasms
Location: Hall C
Presenter: Agnes Ewongwo, MD – Stanford University
4:00 PM – 5:00 PM ET
3365 - Bridging Radiotherapy prior to Brexucabtagene Autoleucel for Relapsed/Refractory Mantle Cell Lymphoma
Location: Hall C
Presenter: Ahmed Fetooh, MD – MD Anderson Cancer Center
4:00 PM – 5:00 PM ET
3366 - Radiotherapy Outcomes in Solitary Plasmacytoma with High Risk Cytogenetic Abnormalities
Location: Hall C
Presenter: Kelsey Frechette, MD – Mayo Clinic College of Medicine and Science Rochester
4:00 PM – 5:00 PM ET
3367 - Radiation Therapy for Oligo-Relapsed/Progressive Disease Post-Stem Cell Transplant for Multiple Myeloma: Factors Associated with Favorable Outcomes
Location: Hall C
Presenter: Beatrice Fregonese, MPH – Memorial Sloan Kettering Cancer Center
4:00 PM – 5:00 PM ET
3368 - Standardization of Treatment Protocols for Multi-Center Institutional Health Systems
Location: Hall C
Presenter: Sandeepan Ganguly, MS – Montefiore Medical Center/Albert Einstein College of Medicine
4:00 PM – 5:00 PM ET
3369 - Treatment Outcome, Toxicity and Quality of Life of Patients with Bronchus-Associated Lymphoid Tissue Lymphoma
Location: Hall C
Presenter: Lin-rui Gao, MD – Chinese Academy of Medical Sciences and Peking Union Medical College
4:00 PM – 5:00 PM ET
3370 - Biological - Physical Model of Human Glioma Cells Based on Microdosimetry
Location: Hall C
Presenter: Yunan Gao, MS – Zhongshan Hospital Fudan University
4:00 PM – 5:00 PM ET
3371 - Using a Large Language Model (LLM) for Automated Extraction of Discrete Elements from Clinical Notes for Creation of Cancer Databases
Location: Hall C
Presenter: Marissa Gilbert, BS – Henry Ford Hospital
4:00 PM – 5:00 PM ET
3372 - A CD8 T Cell Radiomics Score Correlates with Local Failure in Patients Undergoing Combined SBRT and Immune Checkpoint Inhibition in a Pooled Analysis of Three Phase I Trials
Location: Hall C
Presenter: Naomi Goldrich, MD – University of Chicago
4:00 PM – 5:00 PM ET
3373 - Using High-Repeatable Radiomic Features Improves the Cross-Institutional Generalization of Prognostic Model in Esophageal Cancer Receiving Definitive Chemoradiotherapy
Location: Hall C
Presenter: Jie Gong, PhD – Life Sciences Research Center, School of Life Sciences and Technology, Xidian University,
4:00 PM – 5:00 PM ET
3374 - Pathology AI for Risk Stratification (PAIRS): Predicting Adverse Pathological Features in Post-Operative Head and Neck Cancer with Large Language Models
Location: Hall C
Presenter: Jace Grandinetti, PhD – University of Pennsylvania
4:00 PM – 5:00 PM ET
3375 - Quantitative and Qualitative Evaluation of an Automated Planning Solution for Prostate Radiotherapy
Location: Hall C
Presenter: William Green, MD – University of Pennsylvania
4:00 PM – 5:00 PM ET
3376 - Reconstructing Active Bone Marrow Dose in a Large-Scale Study on Clonal Hematopoiesis and Leukemia Risk Following Radiotherapy
Location: Hall C
Presenter: Keith Griffin, PhD – National Cancer Institute
4:00 PM – 5:00 PM ET
3377 - Spatially Fractionated Radiation Therapy (SFRT) Based on Multimodal Imaging: A Promising Salvage Treatment Strategy for Metastatic and Refractory Cancer Patients
Location: Hall C
Presenter: Y.X. Guo, MD – Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
4:00 PM – 5:00 PM ET
3378 - The Impact of Radiotherapy on Survival Outcomes in Plasmablastic Lymphoma
Location: Hall C
Presenter: Philip Haddad, MD, MPH, MHA – LSU Health Sciences Center Shreveport
4:00 PM – 5:00 PM ET
3381 - Impact of a Pre-Treatment Electronic Frailty Index on Survival, Treatment Completion and Hospitalization in Patients Treated with Radiotherapy
Location: Hall C
Presenter: Ryan Hughes, MD – Wake Forest University School of Medicine
4:00 PM – 5:00 PM ET
3382 - Hype or Reality: Utility of Large Language Models in Radiation Oncology
Location: Hall C
Presenter: Brian Jang, MD – University of Minnesota
4:00 PM – 5:00 PM ET
3383 - Enhancing Adaptive Radiotherapy with Dynamic Prescription Modifications
Location: Hall C
Presenter: Phillip Jenkins, DO, MS – Detroit Medical Center/Wayne State University
4:00 PM – 5:00 PM ET
3384 - Lost in Lunglation: Unraveling the Mystery of Idiopathic Pulmonary Syndrome Post-Total Body Irradiation for Bone Marrow Transplant
Location: Hall C
Presenter: Ruijia Jin, MS4 – University of British Columbia
4:00 PM – 5:00 PM ET
3385 - Uncertainty Quantification in Machine Learning Radiotherapy Applications - A Scoping Review
Location: Hall C
Presenter: Zaphanlene Kaffey, MS – UT MD Anderson Cancer Center
4:00 PM – 5:00 PM ET
3386 - Utility of Analytics in a Large Community-Based Radiation Oncology Network: Consolidation and Standardization of Clinical, Operational and Quality Metrics
Location: Hall C
Presenter: Andrew Kennedy, MD, FACRO – Sarah Cannon Cancer Center at TriStar Health
4:00 PM – 5:00 PM ET
3387 - Local Disease Control in Patients with Erdheim-Chester Disease Treated with External Beam Radiation Therapy
Location: Hall C
Presenter: Adam Kessel, MD – Mayo Clinic Rochester
4:00 PM – 5:00 PM ET
3388 - A Novel Localized Student-Teacher LLM for Enhanced Toxicity Extraction in Radiation Oncology
Location: Hall C
Presenter: Reza Khanmohammadi, MS – Michigan State University
4:00 PM – 5:00 PM ET
3389 - Improving Intestinal Crypt Detection in Deep Learning Models with Reinhard Method-Based Stain Color Normalization for Evaluating Normal Tissue Radiation Response
Location: Hall C
Presenter: Matthew Kim, BS – Stanford University School of Medicine
4:00 PM – 5:00 PM ET
3390 - Treatment of Patients with Gastric Extranodal Marginal Zone Lymphomas (MZL) Using CBCT-based Adaptive Radiotherapy (ART) to Reduce Margins
Location: Hall C
Presenter: Kiran Kumar, MD, MBA – UT Southwestern Medical Center
4:00 PM – 5:00 PM ET
3391 - Multi-Omics Models can Predict Prostate Specific Membrane Antigen Avidity for Computed Tomography Lesions in Oligo-Metastatic Castration Sensitive Prostate Cancer
Location: Hall C
Presenter: Ritesh Kumar, MD – Rutgers Cancer Institute of New Jersey
4:00 PM – 5:00 PM ET
3392 - Trends in Radiation Fractionation for Early-Stage Follicular or Marginal Zone Lymphoma
Location: Hall C
Presenter: Raymond Zou, BA – City of Hope National Medical Center
4:00 PM – 5:00 PM ET
3393 - Optimizing Radiation Oncology: Integrating Clinical Decision Support and Automated Treatment Planning for Enhanced Quality, Consistency and Efficiency
Location: Hall C
Presenter: Kieu Lai, RT – GenesisCare
4:00 PM – 5:00 PM ET
3394 - Ultra-Low-Dose Adaptive Radiotherapy and Single-Agent Rituximab for Indolent Non-Hodgkin Lymphomas: Where Less is More in Combined Modality Therapy
Location: Hall C
Presenter: Katherine Lake, BA – UT Southwestern Medical School
4:00 PM – 5:00 PM ET
3395 - A Simple Walking Program to Enhance Concurrent Chemoradiotherapy Delivery: A Randomized Trial
Location: Hall C
Presenter: Travis Lambert, MD – Montefiore Medical Center/Albert Einstein College of Medicine
4:00 PM – 5:00 PM ET
3396 - Enhancing Charge Capture Accuracy in Radiation Oncology: A Comprehensive Software Analysis
Location: Hall C
Presenter: Christel Smith, PhD – Fuse Oncology, Inc.
4:00 PM – 5:00 PM ET
3397 - Auto-Segmentation of Elective Nodal Clinical Target Volumes for Anal Cancer Using Artificial Intelligence
Location: Hall C
Presenter: Bryant Law, BS – UC Davis School of Medicine
4:00 PM – 5:00 PM ET
3398 - A Comparison of Machine Learning Models to Predict Lymph Node Metastasis with Primary Tumor Transcriptome in Non-Small Cell Lung Cancer
Location: Hall C
Presenter: Victor Lee, MD, BS – Yale New Haven Hospital
4:00 PM – 5:00 PM ET
3399 - Value of Peritumoral Radiomics in Predicting Local Recurrence-Free Survival in Esophageal Squamous Cell Carcinoma Receiving Definitive (Chemo)Radiotherapy
Location: Hall C
Presenter: Jie Li
4:00 PM – 5:00 PM ET
3400 - Implementing Proton Beam Therapy for Mediastinal Lymphoma
Location: Hall C
Presenter: Suganya Sivabalasingham, MBBS, BSc MRCP FRCR MD(Res) – University College London Hospitals NHS Trust
4:00 PM – 5:00 PM ET
3401 - Research on Developing a Predictive Model for Radiation Pneumonitis Risk Based on Radiomics and Multiparameters
Location: Hall C
Presenter: Yi Li, MD – The 920th Hospital of The Joint Logistic Support Forth
4:00 PM – 5:00 PM ET
3402 - Accurate Response Prediction of Locally Advanced Rectal Cancer: A Novel Radiomic Framework Utilizing Virtual Rectum-Unfolding in Multiparametric MR Images
Location: Hall C
Presenter: Zi Rong Li, BS
4:00 PM – 5:00 PM ET
3403 - Enhancing Precision in Automated Segmentation of Ambiguous Boundaries Based on Multi-Model Deep Learning and Boundary Confidence Computation
Location: Hall C
Presenter: Zi Rong Li, BS
4:00 PM – 5:00 PM ET
3404 - Deep Learning-Based Fully Automated Detection and Segmentation of Lymph Nodes on Computed Tomography for Head and Neck Cancer: A Multi-Center Study
Location: Hall C
Presenter: Wenjun Liao, PhD
4:00 PM – 5:00 PM ET
3405 - Evaluation of Deep Learning-Based Abdominal Organ Segmentation Models: Assessing Robustness across Non-Surgery to Organ Resection Surgery Patients
Location: Hall C
Presenter: Wenjun Liao, PhD
4:00 PM – 5:00 PM ET
3406 - Deep Learning with Biopsy Whole Slide Images for Predicting Pathological Complete Response to Neoadjuvant Immunochemotherapy in Esophageal Squamous Cell Carcinoma
Location: Hall C
Presenter: Charlotte Zhao – Manteia Technologies
4:00 PM – 5:00 PM ET
3407 - Assessing the Current Clinical Application of ChatGPT-4 in Radiation Oncology
Location: Hall C
Presenter: Yen-Ting Liu, MD – National Taiwan University
4:00 PM – 5:00 PM ET
3408 - Prometheus: A Risk Classification Deep Learning Model for Predicting Liver Metastases from Pancreatic Cancer
Location: Hall C
Presenter: Yirong Liu, MD, PhD – Northwestern Memorial Hospital
4:00 PM – 5:00 PM ET
3409 - Multimodality Deep Learning Radiomics Predicts Pathological Complete Response of Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy
Location: Hall C
Presenter: Yunsong Liu, MD – National Cancer Center/National Clinical Research Center for Cancer Cancer Hospital, CAMS & PUMC
4:00 PM – 5:00 PM ET
3410 - Tumor Response to Induction Chemotherapy Followed by Radiotherapy, Chemotherapy Intensity, and Patients with Early-Stage Extranodal Natural Killer/T Cell Lymphoma
Location: Hall C
Presenter: Huang Luo, MD – Chongqing University Cancer Hospital
4:00 PM – 5:00 PM ET
3411 - Construction and Selection of the Automatic Segmentation Tools for High-Risk Clinical Tumor Volume in Brachytherapy for Cervical Cancer Based on Deep Learning
Location: Hall C
Presenter: Chenying Ma, MD, PhD – The First Affiliated Hospital of Soochow University
4:00 PM – 5:00 PM ET
3412 - The Directive Application: Enhancing Clinical Workflow and Transforming Oncology Care with Centralized Data Management
Location: Hall C
Presenter: Yijian Cao, PhD – Northwell Health
4:00 PM – 5:00 PM ET
3413 - Applying Language Models to Radiology Text for Identifying Oligometastatic Non-Small Cell Lung Cancer
Location: Hall C
Presenter: Nicholas Moore, MD – Yale School of Medicine
4:00 PM – 5:00 PM ET
3414 - Radiotherapy for Marginal Zone Lymphoma of Mucosal Associated Lymphoid Tissue (MALT) Involving the Dura
Location: Hall C
Presenter: Zachary Moore, MD, PhD – Memorial Sloan Kettering Cancer Center
4:00 PM – 5:00 PM ET
3415 - Cancer Treatment Information Differences by Bilingual Prompting in Large Language Model Chatbots
Location: Hall C
Presenter: Javier Mora, MD – Harvard Radiation Oncology Program
4:00 PM – 5:00 PM ET
3416 - Multiomic Based Bayesian Network Toxicity Modeling for Simultaneous Prediction of Multiple Toxicity Outcomes in NSCLC
Location: Hall C
Presenter: Saurabh Nair, MSc – The university of Texas M. D. Anderson Cancer Center
4:00 PM – 5:00 PM ET
3417 - Patterns of CNS Failures in Relapse/Refractory Large B-Cell Lymphoma (LBCL) Patients with Secondary CNS Disease Following Chimeric Antigen Receptor T-Cell (CAR T) Therapy
Location: Hall C
Presenter: Justyn Nakashima, DO – Moffitt Cancer Center
4:00 PM – 5:00 PM ET
3418 - National Cancer Trial Network (NCTN) Gynecologic Trial Mentions across Physician Facing Platforms
Location: Hall C
Presenter: Neethi Narasimha, BS – Edward Via College of Osteopathic Medicine
4:00 PM – 5:00 PM ET
3419 - Feasibility of Determining Heterogenous Risk Regions Using Dual Tree Wavelet Based Radiomics for Rectal Cancer Patients during MRgART
Location: Hall C
Presenter: Haidy Nasief, MS, PhD, MSCE – Froedtert and Medical College of Wisconsin
4:00 PM – 5:00 PM ET
3420 - A Machine-Learning Model to Predict Axillary Node Positivity from Clinical Characteristics and Large-Scale DNA Organization Features in Breast Cancer Biopsy Specimens
Location: Hall C
Presenter: Alan Nichol, MD, FRCPC – BC Cancer - Vancouver Centre
4:00 PM – 5:00 PM ET
3421 - Developing Blood Sparing Radiotherapy Following CAR T for Lymphoma
Location: Hall C
Presenter: Georgios Ntentas, DPhil – Guy's and St Thomas' NHS Foundation Trust
4:00 PM – 5:00 PM ET
3422 - Comparison of Physician vs. Software Assessed Cosmetic Sores Following Breast Conservation Therapy
Location: Hall C
Presenter: Anna Okabe, BS – California Northstate University College of Medicine
4:00 PM – 5:00 PM ET
3423 - Objective and Interpretable Breast Cosmesis Evaluation with Attention Guided Denoising Diffusion Anomaly Detection Model
Location: Hall C
Presenter: Sangjoon Park, MD, PhD – Yonsei University Health System
4:00 PM – 5:00 PM ET
3424 - Can Language Models Extract Features from Pathology Reports and Stage Tumors like a Physician?
Location: Hall C
Presenter: Rafe McBeth, PhD
4:00 PM – 5:00 PM ET
3425 - TMI Utilization in Second Allo-SCT for Hematologic Malignancies: Update on Mucositis and Outcomes
Location: Hall C
Presenter: Brandon Perez, MD – University of Chicago Medicine
4:00 PM – 5:00 PM ET
3426 - Prior Knowledge Based Neural Representation Learning for Patient-Specific Imaging Study
Location: Hall C
Presenter: Lianli Liu, PhD – Stanford University
4:00 PM – 5:00 PM ET
3427 - Evaluating ChatGPTs Competency in Radiation Oncology: A Comprehensive Assessment across Clinical Scenarios
Location: Hall C
Presenter: Sherif Ramadan, MD – Western University
4:00 PM – 5:00 PM ET
3428 - Validation of Known Radiomics Biomarkers for Post-Treatment Local Response for SBRT-Treated NSCLC, Using Machine Learning
Location: Hall C
Presenter: Gemini Ramasamy, MS – McGill University
4:00 PM – 5:00 PM ET
3429 - Balancing Prevalence of Contrast and Non-Contrast Computed Tomography Examples in a Limited Set and Training Transformer-Based Great Vessel Segmentation
Location: Hall C
Presenter: Chloe Choi, MS – Memorial Sloan Kettering Cancer Center
4:00 PM – 5:00 PM ET
3430 - Quantitative and Qualitative Evaluation of an Automatic and Manual GTV Contouring Tool in Pre-Radiotherapy MRI in Glioblastoma Treatment
Location: Hall C
Presenter: Charlotte Robert, MD, PhD – Gustave Roussy Institute
4:00 PM – 5:00 PM ET
3431 - Implementing AI Based Radiation Therapy Workflow Management Platform
Location: Hall C
Presenter: Doori Rose, MS – Memorial Sloan Kettering Cancer Center
4:00 PM – 5:00 PM ET
3432 - Artificial Intelligence in Oncologic Radiotherapy: A New Tool for Treatment Selection in Patients with Early Stage Breast Cancer
Location: Hall C
Presenter: Agustin Rosich, MD – UDELAR Radioterapia
4:00 PM – 5:00 PM ET
3433 - A Deep Learning-Based Method for Predicting Out-of-Field Radiotherapy Dose for Pediatric Wilms Tumor Patients
Location: Hall C
Presenter: Monjoy Saha, PhD – National Cancer Institute (NCI)
4:00 PM – 5:00 PM ET
3434 - Independent Validation and Performance Comparison of Published Radiation Pneumonitis NTCP Models for IMRT, Immunotherapy and Proton Therapy Cohorts
Location: Hall C
Presenter: Ramon Salazar, PhD – University of Texas MD Anderson Cancer Center
4:00 PM – 5:00 PM ET
3435 - Adaptive Radiation Fractionation in Head and Neck Cancer through Modeling Tumor Volume Dynamics
Location: Hall C
Presenter: Emmanuel Scott, MD, BS – Moffitt Cancer Center
4:00 PM – 5:00 PM ET
3436 - Medical Accuracy of Cancer Radiotherapy-Related ChatGPT AI Outputs in English and Spanish
Location: Hall C
Presenter: Paranjay Sharma, Medical Student – University of Missouri - Kansas City
4:00 PM – 5:00 PM ET
3437 - Synthesis of Lung CT to Proton CT Based on CycleGAN
Location: Hall C
Presenter: Cong Sheng, MS
4:00 PM – 5:00 PM ET
3438 - Implementation of a Clinically Integrated Authorization Automation Software to Decrease Prior-Authorization Burden across a Geography of Payers
Location: Hall C
Presenter: William Chen, MD – Northwell Health
4:00 PM – 5:00 PM ET
3439 - External Validation of an Artificial Intelligence Screening Tool for Interstitial Lung Disease in Patients Receiving Lung Stereotactic Ablative Radiotherapy
Location: Hall C
Presenter: Vivian Tan, MD – London Health Sciences Centre
4:00 PM – 5:00 PM ET
3440 - Current Use and Perspectives of Artificial Intelligence in Radiation Oncology: A Statewide Consortium Survey
Location: Hall C
Presenter: Amina Tanweer, BS – University of Michigan Medical School
4:00 PM – 5:00 PM ET
3441 - Patient-Facing Electronic Medical Record Care Companion for Breast Cancer Patient-Reported Outcomes and Education during Radiation Therapy
Location: Hall C
Presenter: Sewit Teckie, MD, MBA – New York City Health and Hospitals
4:00 PM – 5:00 PM ET
3442 - Responsible Artificial Intelligence in Radiation Oncology
Location: Hall C
Presenter: Ching-Ling Teng, PhD – Northwell Health Center for Advanced Medicine
4:00 PM – 5:00 PM ET
3443 - Machine Learning to Predict Genomic Risk Score/Classification in Prostate Cancer
Location: Hall C
Presenter: Eemon Tizpa, MS – Elson S. Floyd College of Medicine Washington State University
4:00 PM – 5:00 PM ET
3444 - The Association of Consolidation Strategies with Cerebral Atrophy in Primary Central Nervous System Lymphoma (PCNSL)
Location: Hall C
Presenter: Kathryn Tringale, MD, MS – UC San Diego
4:00 PM – 5:00 PM ET
3445 - Testing a Predictive AI/AutoML Based Nomogram for HDR Prostate Brachytherapy
Location: Hall C
Presenter: Birjoo Vaishnav, PhD, DABR – Mayo Clinic College of Medicine and Science Rochester
4:00 PM – 5:00 PM ET
3446 - Multi-Institutional Qualitative Evaluation of Automatic and Manual Segmentations of Organs at Risk on PRE ACT Breast Cancer Cohorts
Location: Hall C
Presenter: Karolien Verhoeven, MD, PhD – MAASTRO Clinic
4:00 PM – 5:00 PM ET
3447 - Physicians Views on Explainable Artificial Intelligence Models to Predict the Risk of Toxicity Following Breast Radiotherapy
Location: Hall C
Presenter: Karolien Verhoeven, MD, PhD – MAASTRO Clinic
4:00 PM – 5:00 PM ET
3448 - Radiation to Sites of Skeletal Involvement in Large B-Cell Lymphoma: Trends and Impact on Survival
Location: Hall C
Presenter: Kim Vo, DO, MS, BS – City of Hope Comprehensive Cancer Center
4:00 PM – 5:00 PM ET
3449 - Analysis of Dual-Energy CT (DECT) Parameters in Patients with Stage I Non-Small Cell Lung Cancer Treated with Stereotactic Ablative Body Radiation (SABR) in a Prospective Study
Location: Hall C
Presenter: Emily Vonderhaar Meister, MD, PhD – Johns Hopkins Hospital
4:00 PM – 5:00 PM ET
3450 - Interpretable Artificial Intelligence to Predict Treatment Response in Rectal Cancer
Location: Hall C
Presenter: Xiang-Bo Wan
4:00 PM – 5:00 PM ET
3451 - Genetic Subclones Identify Phenotypic Variation in Diffuse Large B cell Lymphoma
Location: Hall C
Presenter: Boya Wang, PhD – UNC Chapel Hill School of Medicine
4:00 PM – 5:00 PM ET
3452 - Fine-Tuning Large Language Models for Radiation Oncology, A Specialized Health Care Domain
Location: Hall C
Presenter: Wei Liu, PhD, MS, BS, FAAPM – Mayo Clinic
4:00 PM – 5:00 PM ET
3453 - Patterns of Locoregional Recurrence and Prognosis in Early-Stage Natural Killer/T-Cell Lymphoma after Chemotherapy with Sandwiched Radiotherapy: A Post Hoc Analysis of a Randomized Controlled Clinical
Location: Hall C
Presenter: Shubei Wang, MD – Ruijin Hospital, Shanghai Jiaotong University School of Medicine
4:00 PM – 5:00 PM ET
3454 - Treatment and Survival in Early-Stage MALT Lymphoma: A Retrospective Study of Outcomes at a Single Institution
Location: Hall C
Presenter: Xinyue Wang, MD – Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
4:00 PM – 5:00 PM ET
3455 - MRI-Guided Real-Time Adaptive Radiotherapy for Liver with Deep Learning
Location: Hall C
Presenter: Ran Wei, PhD
4:00 PM – 5:00 PM ET
3456 - Should We Enter Orders and Prescriptions at Consult Time
Location: Hall C
Presenter: Benjamin Sintay, PhD – Cone Health Cancer Center
4:00 PM – 5:00 PM ET
3457 - A Comparative Study of Large Language Models for Generating Summaries of Breast Cancer Patient-Reported Treatment Toxicities
Location: Hall C
Presenter: David Wu, MD – Stanford Cancer Institute Palo Alto
4:00 PM – 5:00 PM ET
3458 - Validated Supervised Deep Learning on Pathology Whole-Slide Images for HER2 Mutation Prediction in Lung Adenocarcinoma
Location: Hall C
Presenter: Yiyue Xu, PhD – Shandong Tumor Hospital
4:00 PM – 5:00 PM ET
3459 - Artificial Intelligence-Derived Software Improves Efficiency and Reduces Costs in Radiation Oncology Research
Location: Hall C
Presenter: Ted Yanagihara, MD, PhD – University of North Carolina
4:00 PM – 5:00 PM ET
3460 - Utilization of FCDenseNet for Auto-Contouring in Radiation Therapy for Companion Animals
Location: Hall C
Presenter: Ha-Yeong Yoon, MS – Oncosoft
4:00 PM – 5:00 PM ET
3462 - A Framework to Create and Validate Synthetic Datasets for Survival Prediction in Radiation Oncology
Location: Hall C
Presenter: Constantinos Zamboglou, MD, PhD – German Oncology Center
4:00 PM – 5:00 PM ET
3463 - Semi-Automated Topic Identification for Radiation Oncology Safety Event Reports Using Natural Language Processing and Statistical Models
Location: Hall C
Presenter: Qian Zhang, MD, PhD, MS – McGaw Medical Center of Northwestern University
4:00 PM – 5:00 PM ET
3464 - Machine Learning-Based Quantification and Classification of Fibroblasts in Gastrointestinal Cancer
Location: Hall C
Presenter: Zhen Zhang, MD, PhD – Fudan University Shanghai Cancer Center
4:00 PM – 5:00 PM ET
3465 - Feasibility of a New Paradigm: Patient-Driven Radiation Therapy Using Smart-Phone Photogrammetry
Location: Hall C
Presenter: Eric Paulson, PhD – Medical College of Wisconsin
4:00 PM – 5:00 PM ET
3466 - Delineation of Tumor Metabolic Volume in Nasopharyngeal Carcinoma on Computed Tomography Images Using a 3D U-Net Model
Location: Hall C
Presenter: Guan-Qun Zhou, MD, PhD – Sun Yat-Sen University Cancer Center
4:00 PM – 5:00 PM ET
3467 - Trends in First-Line Use of Radiation Therapy for Early-Stage Gastric Marginal Zone Lymphoma
Location: Hall C
Presenter: David Zitser, BS
4:00 PM – 5:00 PM ET
3468 - Optimizing Deep Learning Models: CNN-RNN Augmentation with Grad-CAM Analysis for Predicting Pneumonitis from Pre-Treatment CT Images
Location: Hall C
Presenter: P. Troy Teo, PhD – Northwestern University
Wednesday, October 2, 2024
10:30 AM – 11:45 AM ET
3597 - Dosimetric Evaluation of Organs-at-Risk and Quality of Life Assessment between Standard of Care and Dose De-Escalated Radiation in HPV Positive Oropharyngeal Cancer
Location: Hall C
Presenter: Amy Abdalla, MD – University of Missouri - Ellis Fischel Cancer Center
10:30 AM – 11:45 AM ET
3598 - Early Recurrence in Patients Treated with Surgical Resection and Postoperative Radiotherapy in Patients with Squamous Cell Carcinoma of the Head and Neck
Location: Hall C
Presenter: Khaled Abumansour, MBBS – Dalhousie University
10:30 AM – 11:45 AM ET
3599 - Outcomes of Curatively Treated De Novo Metastatic Nasopharyngeal Carcinoma: A Single Institution Experience
Location: Hall C
Presenter: Mohammed Almahmoud, MBBS – King Faisal Specialist Hospital and Research Centre
10:30 AM – 11:45 AM ET
3600 - Less is More: Long Term Gastrostomy Tube Dependence in Head and Neck Cancer
Location: Hall C
Presenter: Neil Almeida, MD – Roswell Park Comprehensive Cancer Center
10:30 AM – 11:45 AM ET
3601 - Lymphopenia During Radiotherapy in Nasopharyngeal Cancer: Identifying Patients at Risk and Its Effect on Survival
Location: Hall C
Presenter: Faisal Alsamari, MBBS – King Faisal Specialist Hospital and Research Centre
10:30 AM – 11:45 AM ET
3602 - Outcomes of Stage I Single Node HPV Positive Oropharynx Cancer
Location: Hall C
Presenter: Katherine Amarell, MD, BS – Cleveland Clinic Foundation
10:30 AM – 11:45 AM ET
3603 - The Use of a Low Dose Elective Volume in Head and Neck Stereotactic Body Radiation Therapy (SBRT): Initial Report of Outcomes of a Novel Planning Approach
Location: Hall C
Presenter: Katherine Amarell, MD, BS – Cleveland Clinic Foundation
10:30 AM – 11:45 AM ET
3604 - Medical Physics Teleradiotherapy Quality Assurance (QA) Capacity in Low- and Middle-Income Countries (LMICs): An International Survey
Location: Hall C
Presenter: August Anderson, MD – University of Washington
10:30 AM – 11:45 AM ET
3605 - "Big Jolts Like an Electric Shock:" Patient Perspectives on the Expectations, Experiences and Quality-of-Life Impact of Androgen Deprivation Therapy (ADT) for Prostate Cancer
Location: Hall C
Presenter: Maheen Ansari, BS – MD Anderson Cancer Center
10:30 AM – 11:45 AM ET
3606 - Climate-Smart Oncology: Can Hypofractionation Lighten Radiotherapys Environmental Load?
Location: Hall C
Presenter: Alyssa Asaro, MS, BA – St. George's University School of Medicine
10:30 AM – 11:45 AM ET
3607 - Independent Review Organization and Proton Therapy: Multi-State Analysis and Legal Procedural Strategies
Location: Hall C
Presenter: Etzer Augustin, MD, MS – UF Health Radiation Oncology – Davis Cancer Pavilion
10:30 AM – 11:45 AM ET
3608 - The Impact of Circulating Tumor Human Papillomavirus (HPV) DNA Clearance Kinetics on Disease Outcomes during Chemoradiation in Patients with HPV-Associated Oropharyngeal Cancer
Location: Hall C
Presenter: Sujith Baliga, MD – The Ohio State University
10:30 AM – 11:45 AM ET
3609 - FIERCE-HN: A Multicenter, Randomized, Placebo-Controlled, Phase 3 Study of Ficlatuzumab + Cetuximab in Pts W/ Recurrent or Metastatic (R/M) HPV-Negative Head and Neck Squamous Cell Carcinoma (HNSCC)
Location: Hall C
Presenter: Julie Bauman, MD – George Washington University Cancer Center
10:30 AM – 11:45 AM ET
3610 - The Role of Mouthguard Customization to Minimize Risk of Radiation Backscatter in Head and Neck Cancer Patients
Location: Hall C
Presenter: Idil Bilgen, MD, MD(c) – Koc University School of Medicine
10:30 AM – 11:45 AM ET
3611 - A Pilot, First in Human Study of Autologous IFN-Gamma Stimulated Mesenchymal Stromal Cells for Treatment of Radiation-Induced Xerostomia - Results of Contralateral Injections
Location: Hall C
Presenter: Randall Kimple, MD, PhD, MBA, FASTRO – Univ of Wisconsin
10:30 AM – 11:45 AM ET
3612 - Proton Beam Radiotherapy with Fixed Beam Chair-Based Delivery System for Locally Recurrent Head and Neck and Brain Malignancies
Location: Hall C
Presenter: Philip Blumenfeld, MD, MPH – Hadassah Medical Center
10:30 AM – 11:45 AM ET
3613 - Predicting 12-Month Post-Treatment Aspiration for Oropharyngeal Squamous Cell Cancer Patients
Location: Hall C
Presenter: Aaron Bogan, MA – Mayo Clinic
10:30 AM – 11:45 AM ET
3614 - Adjuvant Ruthenium Plaque Brachytherapy (BRT) after Partial Lamellar Vitreo-Uvectomy (PLSU) for Medium-Large Uveal Melanoma (UM)
Location: Hall C
Presenter: Mohamed M. Zaza, MD, MS
10:30 AM – 11:45 AM ET
3615 - Definitive and Salvage Stereotactic Body Radiation Therapy (SBRT) for Nonmelanoma Skin Cancer of the Head and Neck
Location: Hall C
Presenter: Lindsey Callier, MS – Ohio University Heritage College of Osteopathic Medicine
10:30 AM – 11:45 AM ET
3616 - Commensal Bacteria Modulate the Immune Response to Radiation Therapy (RT) in a Murine Oral Cavity Model
Location: Hall C
Presenter: Elvin Canseco, BS – Cedars-Sinai Medical Center
10:30 AM – 11:45 AM ET
3617 - Assessing Clinical and Dosimetric Benefits of Spot-Scanning Proton Arc Therapy in Ocular Melanoma Treatment
Location: Hall C
Presenter: Xi Cao, MD – William Beaumont Hospital
10:30 AM – 11:45 AM ET
3618 - Region and Language Centric, Virtual Education and Training in Latin America: Stereotactic Body Radiotherapy and Radiosurgery Curriculum in Spanish for Medical Physicists and Radiation Oncologists
Location: Hall C
Presenter: Serguei Castaneda, MD – CB Oncology Partners
10:30 AM – 11:45 AM ET
3619 - Determinants of Chemosensory Dysfunction after Treatment for Nasopharyngeal Carcinoma: A Multi-Institutional Prospective Cohort Study
Location: Hall C
Presenter: Annie Chan, MD – Massachusetts General Hospital
10:30 AM – 11:45 AM ET
3620 - Parotid Voxel Dose Analysis with Machine Learning Toward Xerostomia Prediction in Head and Neck Cancer Irradiation
Location: Hall C
Presenter: Ming Chao, PhD – Icahn School of Medicine at Mount Sinai
10:30 AM – 11:45 AM ET
3621 - Detection of Oligo-Metastases in Oropharyngeal Carcinoma Following (Chemo)Radiation Therapy
Location: Hall C
Presenter: Revadhi Chelvarajah, MBBS – Princess Margaret Cancer Center
10:30 AM – 11:45 AM ET
3622 - Outcomes and Characteristics of Patients Receiving Pre-Operative vs. Post-Operative Radiotherapy for Sinonasal Squamous Cell Carcinoma
Location: Hall C
Presenter: Revadhi Chelvarajah, MBBS – Princess Margaret Cancer Center
10:30 AM – 11:45 AM ET
3623 - Prognostic Significance of Dynamics in Pan-Immune-Inflammation Value in Patients with Head and Neck Cancer Treated with Radiotherapy: Results from a Large Cohort Study
Location: Hall C
Presenter: Hsiang Ting Chen, MD – Linkou Chang Gung Memorial Hospital
10:30 AM – 11:45 AM ET
3624 - The Correlation Study of Circadian Clock Gene Bmal1 on Growth Inhibition and Radiosensitivity in Subcutaneous Xenograft of Human Nasopharyngeal Carcinoma CNE1 in Nude Mice
Location: Hall C
Presenter: Yue Chen, MS, MBBS – The Affiliated Cancer Hospital of Guizhou Medical University
10:30 AM – 11:45 AM ET
3625 - Massive Nasal Bleeding in Patients with Nasopharyngeal Carcinoma Received Curative Radiotherapy
Location: Hall C
Presenter: Hao-Shen Cheng, MD – Taichung Veterans General Hospital
10:30 AM – 11:45 AM ET
3626 - Perception and Use of Medical Cannabis in Head and Neck Cancer
Location: Hall C
Presenter: Jennifer Chiang, MD, MS – Stanford Health Care
10:30 AM – 11:45 AM ET
3627 - Safety and Activity Profile of Fianlimab (Anti-LAG-3) in Combination With Cemiplimab (Anti-PD-1) and Cemiplimab Monotherapy in Recurrent and/or Metastatic HNSCC
Location: Hall C
Presenter: John Kaczmar, MD – Hollings Cancer Center
10:30 AM – 11:45 AM ET
3628 - Ptcog International Survey of Practice Patterns and Trends in Utilization of Proton Therapy for Breast Cancer
Location: Hall C
Presenter: Isabelle Choi, MD – New York Proton Center
10:30 AM – 11:45 AM ET
3629 - Long-Term Results of External Beam Radiation Therapy (RT) with or without Concurrent Chemotherapy in Loco-Regionally Advanced or Recurrent Differentiated Thyroid Cancer (DTC)
Location: Hall C
Presenter: Justin Choi, M.Ed. – SUNY Downstate College of Medicine
10:30 AM – 11:45 AM ET
3630 - Resource Implications of Evolving Breast Cancer Radiotherapy Treatment Protocols
Location: Hall C
Presenter: Daniel Coyle, MB, ChB, BAO, PgCert – Royal College of Surgeons in Ireland
10:30 AM – 11:45 AM ET
3631 - Clinical Parameters Associated with Carotid Artery Stenosis and Stroke Following Neck Radiotherapy
Location: Hall C
Presenter: Susanna D'Silva, BS – University of Virginia School of Medicine
10:30 AM – 11:45 AM ET
3632 - Trajectory of Geriatric Assessment and Quality of Life in Older Adults Undergoing Definitive Treatment for Head and Neck Cancer: A Pilot Study
Location: Hall C
Presenter: Ryan Davis, MD – City of Hope National Medical Center
10:30 AM – 11:45 AM ET
3633 - Radiotherapy in Interventional Clinical Trials in Cancer: The Role of Radiation Oncologists and Medical Physicists
Location: Hall C
Presenter: Kujtim Latifi, PhD – Moffitt Cancer Center
10:30 AM – 11:45 AM ET
3634 - Development of a Radiation Oncology Fee Schedule Model for Industry-Sponsored Clinical Trials
Location: Hall C
Presenter: Kujtim Latifi, PhD – Moffitt Cancer Center
10:30 AM – 11:45 AM ET
3635 - Nasopharynx Cancer in the U.S.: Disparities in Stage at Presentation
Location: Hall C
Presenter: Edward Dee, MD – Memorial Sloan Kettering Cancer Center
10:30 AM – 11:45 AM ET
3636 - Nasopharynx Cancer in Southeast Asia: An Analysis of 2022 Incidence and Mortality
Location: Hall C
Presenter: Edward Dee, MD – Memorial Sloan Kettering Cancer Center
10:30 AM – 11:45 AM ET
3637 - HPV-DNA Titers and Tumor Volume Correlation in Human Papillomavirus Related Oropharyngeal Squamous Cell Carcinoma
Location: Hall C
Presenter: Ahmed Ghanem, MD, PhD – Henry Ford Cancer Institute/Alexandria University
10:30 AM – 11:45 AM ET
3638 - Individualized Thyroid Prescriptions Based on a Novel Tolerance Dose Model for Radiation-Induced Hypothyroidism in Nasopharyngeal Carcinoma Patients
Location: Hall C
Presenter: Jianming Ding, MD – Fujian Cancer Hospital
10:30 AM – 11:45 AM ET
3639 - Comparative Performance of ctHPVDNA and Imaging Surveillance for Oropharyngeal Cancer Following Radiotherapy
Location: Hall C
Presenter: Yifu Ding, MD, PhD – Winship Cancer Institute of Emory University
10:30 AM – 11:45 AM ET
3640 - Treatment Planning Workflow and Perceptions about Automated Contouring and Treatment Planning in Africa
Location: Hall C
Presenter: Michael Dykstra, MD – University of Michigan
10:30 AM – 11:45 AM ET
3641 - CT Simulator Downtime in Africa: Survey Results from AORTIC 2023
Location: Hall C
Presenter: Michael Dykstra, MD – University of Michigan
10:30 AM – 11:45 AM ET
3642 - The Utility of Google Maps in Measuring Radiotherapy Travel Burden in LMICs: Perspectives from the Philippines
Location: Hall C
Presenter: Michelle Ann Eala, MD – UCLA David Geffen School of Medicine/UCLA Medical Center
10:30 AM – 11:45 AM ET
3643 - Quantification of Temporal Cytopenic Changes during Concurrent Head and Neck Chemoradiation
Location: Hall C
Presenter: Sasha Ebrahimi, MD, PhD – UCLA Radiation Oncology
10:30 AM – 11:45 AM ET
3644 - Radiotherapy (RT) Treatment Patterns Among Patients Treated Definitively for Primary Breast Cancer at a Major Cancer Center in Rwanda
Location: Hall C
Presenter: Keara English, MD – Johns Hopkins Radiation Oncology Kimmel Cancer Center
10:30 AM – 11:45 AM ET
3645 - Choroidal Metastasis in the Systemic Targeted Therapy Era
Location: Hall C
Presenter: Moses Evbuomwan, MD, MBA, MPH, MA – University of Iowa Hospitals & Clinics
10:30 AM – 11:45 AM ET
3646 - Psychosocial Factors Affecting Cancer Patients Undergoing Radiation Therapy in Lagos, Nigeria
Location: Hall C
Presenter: Moses Evbuomwan, MD, MBA, MPH, MA – University of Iowa Hospitals & Clinics
10:30 AM – 11:45 AM ET
3647 - Oral Cavity Carcinoma with Persistent or Rapidly Progressive Disease after Surgical Resection: Outcomes of Additional Therapy
Location: Hall C
Presenter: David Buchberger, MD, MSc – Cleveland Clinic Foundation
10:30 AM – 11:45 AM ET
3648 - Osteoradionecrosis Incidence in Oral Cavity Squamous Cell Carcinoma
Location: Hall C
Presenter: Alyssa Farley, MD – University of Cincinnati - Barrett Cancer Center
10:30 AM – 11:45 AM ET
3649 - Understanding Current Processes of Multidisciplinary Collaboration in Radiation Oncology Treatment Planning and Follow-Up across NCORP Network Practices
Location: Hall C
Presenter: Michael Farris, MD – Wake Forest University Medical Center
10:30 AM – 11:45 AM ET
3650 - A Retrospective Study of Outcomes of Patients with Pleomorphic Dermal Sarcoma Receiving Adjuvant Radiotherapy
Location: Hall C
Presenter: Harith Fernando, MD – Peter MacCallum Cancer Institute
10:30 AM – 11:45 AM ET
3651 - Clinical and Dosimetric Factors Associated with Reactive Gastrostomy Tube Placement in Patients Treated with Radiotherapy for Head and Neck Cancer
Location: Hall C
Presenter: Nicholas Gallardo, BS – Wake Forest University School of Medicine
10:30 AM – 11:45 AM ET
3652 - Patterns of FDA Approval for Novel Oncology Drugs
Location: Hall C
Presenter: Yevgeniy Gladkiy, MS – Wright State University
10:30 AM – 11:45 AM ET
3653 - Forecasted Global Brachytherapy Shortfall by 2040: Investments Needed to Overcome this Deficit
Location: Hall C
Presenter: Andre Gouveia, MD – McMaster University
10:30 AM – 11:45 AM ET
3654 - Multicenter Phase III Trial of Chemoradiation (CRT) with IMPT vs. IMRT for Oropharyngeal Squamous Cell Carcinoma (OPSCC): Secondary Analysis of Association of Lymphopenia with Treatment Modality, Emer
Location: Hall C
Presenter: Adam Grippin, MD, PhD – MD Anderson Cancer Center
10:30 AM – 11:45 AM ET
3655 - Stereotactic Body Radiotherapy with Tyrosine Kinase Inhibitors for Refractory Locoregional Progression of Non-Anaplastic Thyroid Cancer
Location: Hall C
Presenter: Bin Gui, MD, MS – Northwell Health
10:30 AM – 11:45 AM ET
3656 - Clinical Outcomes after Dose De-Escalation for Prophylactic Nodal Irradiation in Nasopharyngeal Carcinoma: A Long-Term, Single-Center Experience
Location: Hall C
Presenter: Qiaojuan Guo, MD, PhD – Fujian Medical University Oncology Hospital
10:30 AM – 11:45 AM ET
3657 - Refining the Radiologic Criteria of Parotid Node Groups Metastasis in Nasopharyngeal Carcinoma
Location: Hall C
Presenter: Qiaojuan Guo, MD, PhD – Fujian Medical University Oncology Hospital
10:30 AM – 11:45 AM ET
3658 - Dosimetric Predictors of Hypothyroidism after Combined Modality Therapy ± Immunotherapy for HPV-Related Oropharyngeal Cancer: A Secondary Analysis of Prospective Trials
Location: Hall C
Presenter: Michael Gutman, MD – University of Chicago
10:30 AM – 11:45 AM ET
3659 - Examining Rectal Spacer Use in Prostate Cancer Radiation Therapy by Treatment Modality: Insights from Medicare Claims Data
Location: Hall C
Presenter: Ryan Hankins, MD – Medstar Georgetown University Hospital
10:30 AM – 11:45 AM ET
3660 - Evaluation of Adjuvant Chemotherapy after Induction Chemotherapy and Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma Patients: A Propensity Score-Matched Analysis
Location: Hall C
Presenter: Yan He, PhD
10:30 AM – 11:45 AM ET
3662 - Multi-Sequence MRI Based Metachronous Single-Organ Metastasis Prediction of Nasopharyngeal Carcinoma
Location: Hall C
Presenter: Peng Zhang, MD – Sichuan Cancer Hospital and Institute
10:30 AM – 11:45 AM ET
3663 - Predicting the Risk of Local Failure after Treatment for Head and Neck Squamous Cell Carcinoma Using Clinical and Post-Radiotherapy PET/CT Imaging Features
Location: Hall C
Presenter: Ryan Hughes, MD – Wake Forest University School of Medicine
10:30 AM – 11:45 AM ET
3664 - Evaluation of a Novel Prognostic System for Overall Survival in Surgically Resected Oral Cavity Carcinoma
Location: Hall C
Presenter: Zain Husain, MD – Southern California Permanente Medical Group
10:30 AM – 11:45 AM ET
3665 - Impact of Depth of Invasion on Locoregional Failure in RTOG 0920-Eligible Early-Stage Oral Tongue Squamous Cell Carcinoma and Implications for Adjuvant Therapy
Location: Hall C
Presenter: Onita Bhattasali, MD, MPH – Kaiser Permanente Los Angeles Medical Center
10:30 AM – 11:45 AM ET
3666 - Global Disparities in Current Clinical Trials in Nasopharyngeal Carcinoma
Location: Hall C
Presenter: Carl Jay Jainar, MD – University of Santo Tomas Hospital, Benavides Cancer Institute
10:30 AM – 11:45 AM ET
3667 - Effect of Time-of-Day Nivolumab and Stereotactic Body Radiotherapy in Metastatic Head and Neck Squamous Cell Carcinoma: A Secondary Analysis of a Prospective Randomized Trial
Location: Hall C
Presenter: James Janopaul-Naylor, MD – Memorial Sloan Kettering Cancer Center
10:30 AM – 11:45 AM ET
3668 - Radiomic Correlates of Mandibular Osteoradionecrosis after Radiation Treatment of Head and Neck Cancer Patients
Location: Hall C
Presenter: Abdallah Mohamed, MD, PhD – Baylor College of Medicine
10:30 AM – 11:45 AM ET
3669 - Prognosis of p16 and HPV Discordant Oropharyngeal Cancers: Natural Language Processing to Classify Free-Text Pathology Reports
Location: Hall C
Presenter: Jung Kang, MD, PhD – Yale University School of Medicine
10:30 AM – 11:45 AM ET
3670 - The Geriatric 8 Score is Associated with Determination of Treatment Strategy and Survival Outcomes for Curative Radiotherapy of Head and Neck Cancer in the Elderly
Location: Hall C
Presenter: Tsuyoshi Katsuta, MD, PhD – Hiroshima University
10:30 AM – 11:45 AM ET
3671 - The Impact of National Holidays on Postoperative Radiotherapy of Squamous Cell Carcinoma of the Head and Neck
Location: Hall C
Presenter: Michael Kim, MD, BS – University of California Los Angeles
10:30 AM – 11:45 AM ET
3672 - Radiotherapy Under the Falling Bombs: Lessons from Ukraine
Location: Hall C
Presenter: Nataliya Kovalchuk, PhD – Stanford Cancer Institute Palo Alto
10:30 AM – 11:45 AM ET
3673 - Overall Survival of Anaplastic Thyroid Carcinoma in the Molecular Era
Location: Hall C
Presenter: Shreya Kuchipudi, BA – Washington University School of Medicine
10:30 AM – 11:45 AM ET
3674 - A Survival Analysis of Patients with Radiation-Induced Cancers after Prior Radiation for Head and Neck Cancer
Location: Hall C
Presenter: Eyiwunmi Laseinde, BA – Stanford University
10:30 AM – 11:45 AM ET
3675 - Cost Estimates of Brachytherapy Delivery in Northern Tanzania Using Time-Driven Activity Based Costing
Location: Hall C
Presenter: Jim Leng, MD – Duke University
10:30 AM – 11:45 AM ET
3677 - Long Term Outcomes of Adjuvant Radiation in Early-Stage Breast Cancer Women with 65 Years or Older after Breast-Conserving Surgery
Location: Hall C
Presenter: Shih-min Lin, MD – Chang Gung Memorial Hospital
10:30 AM – 11:45 AM ET
3678 - Preliminary Evaluation of HyperArc Stereotactic Body Radiotherapy for Local Recurrent Nasopharyngeal Cancer: Do Dosimetric Advantages Translate into Therapeutic Benefits?
Location: Hall C
Presenter: Yu-Wei Lin, MD, PhD, MS – Kaohsiung Veterans General Hospital
10:30 AM – 11:45 AM ET
3679 - CT-Based Radiomic Biomarkers for Predicting Progression-Free Survival in Head and Neck Squamous Cell Carcinoma
Location: Hall C
Presenter: Lei Ren, PhD – University of Maryland Radiation Oncology
10:30 AM – 11:45 AM ET
3680 - Development and Validation of a Clinical-Radiomics Model to Predict Distant Metastasis in Non-Endemic Nasopharyngeal Carcinoma
Location: Hall C
Presenter: Changhao Liu – Xijing Hospital
10:30 AM – 11:45 AM ET
3681 - Long Term Outcomes And Late Toxicity of Diffusion-Weighted Magnetic Resonance Imaging-Guided Dose Painting Radiotherapy in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma: A Randomized,
Location: Hall C
Presenter: Feng Liu, MD – Hunan Cancer Hospital
10:30 AM – 11:45 AM ET
3682 - Compare the Predictive Performance of Deep Learning and Radiomics Models for Predicting Radiation-Induced Temporal Lobe Injury in Nasopharyngeal Carcinoma
Location: Hall C
Presenter: Junyi Liu, MB
10:30 AM – 11:45 AM ET
3685 - Association of Weekly Cisplatin vs. Carboplatin and Paclitaxel with Outcomes among Patients with Head and Neck Cancer Treated with Definitive Chemoradiation
Location: Hall C
Presenter: Sung Jun Ma, MD – The James Cancer Hospital & Solove Research Institute
10:30 AM – 11:45 AM ET
3686 - Association of the Number of Weekly Cisplatin Cycles with Outcomes among Patients with Head and Neck Cancer Treated with Definitive Chemoradiation
Location: Hall C
Presenter: Sung Jun Ma, MD – The James Cancer Hospital & Solove Research Institute
10:30 AM – 11:45 AM ET
3687 - Patterns of Palliative Radiotherapy Use in Botswana
Location: Hall C
Presenter: Emily MacDuffie, MD – University of Pennsylvania
10:30 AM – 11:45 AM ET
3688 - Association of Patient Comorbidities with Treatment Regret in Prostate Cancer: Results from a Population-Based Prospective Cohort
Location: Hall C
Presenter: Rahul Mali, MD, MD, MPH – University of Kansas Medical Center
10:30 AM – 11:45 AM ET
3689 - Nasal Cavity Malignancies Treated with Definitive Proton Therapy: A Single Institutions Experience
Location: Hall C
Presenter: Nikhil Mankuzhy, MD – Memorial Sloan Kettering Cancer Center
10:30 AM – 11:45 AM ET
3690 - Association of Biologically Effective Dose and Survival in Patients Receiving Head and Neck Stereotactic Body Radiation Therapy
Location: Hall C
Presenter: César Márquez, MD, PhD – MD Anderson Cancer Center
10:30 AM – 11:45 AM ET
3691 - Trial in Progress: CTEP 10492, A Phase 1/1b Study of the AKT Inhibitor Ipatasertib with Chemoradiation for Locally Advanced Head and Neck Squamous Cell Carcinoma
Location: Hall C
Presenter: Malcolm Mattes, MD – Rutgers Cancer Institute of New Jersey
10:30 AM – 11:45 AM ET
3692 - Treatment Outcome Priorities for Patients with Human Papillomavirus-Associated Oropharyngeal Cancer (HPVOPC) before and 12 Months after Primary (Chemo)Radiation (CRT/RT): Results from a Prospective Lo
Location: Hall C
Presenter: Lachlan McDowell, PhD, MBBS, FRANZCR – Princess Alexandra Hospital
10:30 AM – 11:45 AM ET
3693 - Sexual Health, Facial Appearance and Appearance Distress in Patients with Human Papillomavirus-Associated Oropharyngeal Cancer (HPVOPC) Patients Undergoing (Chemo)Radiation (CRT/RT): Final Results fro
Location: Hall C
Presenter: Lachlan McDowell, PhD, MBBS, FRANZCR – Princess Alexandra Hospital
10:30 AM – 11:45 AM ET
3694 - Matched Cohort Analysis of Hypofractionated Adjuvant Radiation Therapy for Salivary Gland Cancer
Location: Hall C
Presenter: Brianna McGowan, BA – Lake Erie College of Osteopathic Medicine
10:30 AM – 11:45 AM ET
3695 - Spatially Fractionated Radiation Therapy for Bulky Head and Neck Malignancies: A Single Institution Experience
Location: Hall C
Presenter: Romy Megahed, MD – UAMS Radiation Oncology
10:30 AM – 11:45 AM ET
3696 - Advance Care Planning among Medicare Beneficiaries with Poor Prognosis Cancers
Location: Hall C
Presenter: Elie Mehanna, MD – Harvard Radiation Oncology Program
10:30 AM – 11:45 AM ET
3697 - Micro-Costing Analysis of Rectal Spacers in Prostate Cancer Treatment with Radiotherapy
Location: Hall C
Presenter: Benjamin Fronkier, BS – Argent Global Services
10:30 AM – 11:45 AM ET
3698 - Relationship between Elective Neck Irradiation and Severe Lymphopenia in Patients Treated with Head and Neck Chemoradiotherapy
Location: Hall C
Presenter: Townes Mickel, MD – University of Texas Southwestern Medical Center
10:30 AM – 11:45 AM ET
3699 - Dosimetric Results for Organs at Risk (OAR) from Radiotherapy Dose De-Escalation to the Subclinical Region in HPV-Mediated Oropharyngeal Cancer (HPV+ OPC): A Retrospective Analysis
Location: Hall C
Presenter: David Miller, MD, MS – Memorial Sloan Kettering Cancer Center
10:30 AM – 11:45 AM ET
3700 - Gamma Knife Stereotactic Radiosurgery with a Reduced Peripheral Dose: Outcomes in Uveal Melanoma Patients
Location: Hall C
Presenter: Shubhendu Mishra, MD, MS – University of Minnesota Radiation Oncology Clinic University Campus
10:30 AM – 11:45 AM ET
3701 - Risk Factors for Developing Radiation Related Late Toxicities after Treatment for Head and Neck Cancers and Impact on Survival
Location: Hall C
Presenter: Shao Hui Huang, MS, RT – Princess Margaret Cancer Centre
10:30 AM – 11:45 AM ET
3702 - NCDB Analysis of Low-Risk HPV-Related H&N SCC of the Oropharynx Treated with Surgery: Can Adjuvant RT be Safely Omitted in Node Positive Patients?
Location: Hall C
Presenter: Christopher Morrison, MD, PhD – Banner Health
10:30 AM – 11:45 AM ET
3703 - Characterization of Radiation Response of Muscular Tissue in the Head and Neck Using Dynamic Contrast Enhanced Magnetic Resonance Imaging
Location: Hall C
Presenter: Samuel Mulder, BS – MD Anderson Cancer Center
10:30 AM – 11:45 AM ET
3704 - Patterns of Failure in Resected Oral Cavity Squamous Cell Carcinoma
Location: Hall C
Presenter: Adam Mutsaers, MD – London Health Sciences Centre
10:30 AM – 11:45 AM ET
3705 - Impact of Weekly Dietitian Intervention during On-Treatment Visits for Head and Neck Cancer Radiation
Location: Hall C
Presenter: Roger Neuberger, BS – Baylor College of Medicine
10:30 AM – 11:45 AM ET
3706 - Time and Financial Toxicity Implications during Consideration of Pembrolizumab Infusion Frequency
Location: Hall C
Presenter: Santosh Nori, BS, MPH – University of Michigan Medical School
10:30 AM – 11:45 AM ET
3707 - Stereotactic Body Radiation Therapy for Management of Locally Advanced Periorbital Tumors: Efficacy and Toxicity Profile
Location: Hall C
Presenter: Oluwatimileyin Ojo, MD – Northwell Health
10:30 AM – 11:45 AM ET
3708 - Validation of a Novel Predictive Radiation Treatment Score for Radiation Treatment Completion in Head and Neck Cancers
Location: Hall C
Presenter: Bhupesh Parashar, MD, PhD – Zucker School of Medicine at Hofstra/Northwell
10:30 AM – 11:45 AM ET
3709 - Evaluation of Nasopharyngeal Carcinoma Clinical Target Volume Automatic Delineation Based on Recurrence Regions in Radiotherapy
Location: Hall C
Presenter: Xiaomin Ou, MD – Fudan University Shanghai Cancer Center
10:30 AM – 11:45 AM ET
3710 - Cesium-131 Brachytherapy in Patients that are Not Candidates for Post-Operative External Beam Radiation Therapy: Interim Results of a Single Arm Prospective Study
Location: Hall C
Presenter: Bhupesh Parashar, MD, PhD – Zucker School of Medicine at Hofstra/Northwell
10:30 AM – 11:45 AM ET
3711 - Management of Oral Cavity Squamous Cell Carcinoma in Elderly Patients Using Diffusing Alpha-Emitter Radiation Therapy
Location: Hall C
Presenter: Aron Popovtzer, MD – Hadassah Medical Center
10:30 AM – 11:45 AM ET
3712 - Gantry-Based Pencil Beam Scanning (PBS) Proton Therapy for Uveal Melanoma: IMPT vs. Proton Arc Therapy
Location: Hall C
Presenter: Hang Qi, PhD – New York Proton Center
10:30 AM – 11:45 AM ET
3713 - The Feasibility Study of Dual-Energy CT Virtual Non-Contrast instead of True Non-Contrast in Proton Radiotherapy Dose Calculation
Location: Hall C
Presenter: Guobin Qu
10:30 AM – 11:45 AM ET
3714 - Analysis of Avasopasem Manganese on Swallowing Outcomes for Oropharynx and Oral Cavity Patients Following Chemoradiation - A Single Institution Report
Location: Hall C
Presenter: Shri Rajan, MD – University of Iowa
10:30 AM – 11:45 AM ET
3715 - The Impact of Age and Tumor Volume on Volumetric Systemic Therapy Response in HPV-Positive Oropharyngeal HNSCC - A Pooled Analysis of Prospective Trials
Location: Hall C
Presenter: Greeshma Rajeev-Kumar, MD – University of Chicago Medicine
10:30 AM – 11:45 AM ET
3716 - Long Term Dysphagia Outcomes in Patients of Post Operative Oral Cavity Cancers Treated with Adjuvant Dysphagia Optimized vs. Standard Intensity Modulated Radiotherapy
Location: Hall C
Presenter: Madhup Rastogi, MD, MBBS – Dr.RMLIMS
10:30 AM – 11:45 AM ET
3717 - Carbon FootPrint Reduction with the Adoption of Hypofractionated Radiation Therapy in a Latin America Public Health Facility
Location: Hall C
Presenter: Jose Regis Neto, MD – Fundacao Assistencial da Paraiba (FAP)
10:30 AM – 11:45 AM ET
3718 - Tracking Circulating Tumor HPV DNA with Early Cessation of Radiotherapy in Oropharynx Cancer
Location: Hall C
Presenter: Zubir Rentiya, MD, MSc – University of Virginia
10:30 AM – 11:45 AM ET
3719 - Impact of Post-Operative Radiotherapy Neck Volume on Unstimulated Saliva Flow in Oral Cavity Squamous Cell Carcinoma
Location: Hall C
Presenter: Claire Rooney, MB, ChB – Princess Margaret Cancer Center, University Health Network
10:30 AM – 11:45 AM ET
3720 - Development of a Prediction Model for Cisplatin Tolerability during Chemoradiation in Older Adults with Head and Neck Squamous Cell Carcinoma
Location: Hall C
Presenter: Alexander Ruhle, MD – University of Leipzig, Medical Center
10:30 AM – 11:45 AM ET
3721 - Lessons Learned from an Epic Transformation of a Radiation Oncology Department in Guatemala: Keys to Success
Location: Hall C
Presenter: Edgar Aparicio Ruiz Furlan, MD – Liga Nacional Contra el Cancer
10:30 AM – 11:45 AM ET
3722 - Evaluating the Impact of Wildfires on Radiotherapy Compliance and Financial Costs: Insights from a Multi-Clinic Analysis
Location: Hall C
Presenter: Rachel Sabol, MD, PhD – UCSF
10:30 AM – 11:45 AM ET
3723 - Global Perspectives on Professional Practices and Training in Radiation Oncology: An International Survey
Location: Hall C
Presenter: Anneyuko Saito, MD, PhD – Juntendo University Faculty of Medicine
10:30 AM – 11:45 AM ET
3724 - Safe Deviation from the "5+5" Expansion Rule for the Delineation of Primary Tumor Clinical Target Volume (CTV-P) in Oropharyngeal Cancer: A Prospective Cohort Study
Location: Hall C
Presenter: Pierluigi Bonomo, MD – Azienda Ospedaliera Universitaria Careggi
10:30 AM – 11:45 AM ET
3725 - Global Interobserver Variations of Clinical Target Volume (CTV) Delineation among International Experts in Predefined Gross Tumor Volume (GTV) and Organs at Risk (OAR) Volumes in Head and Neck Cancer
Location: Hall C
Presenter: Ugur Selek, MD, FASTRO, Prof. – Koc University School of Medicine
10:30 AM – 11:45 AM ET
3726 - Global Interobserver Variations of Clinical Target Volume (CTV) Delineation among International Experts in Given Standard Gross Tumor Volume (GTV) and Organs at Risk (OAR) Volumes in Lung Cancer
Location: Hall C
Presenter: Ugur Selek, MD, FASTRO, Prof. – Koc University School of Medicine
10:30 AM – 11:45 AM ET
3727 - Global Interobserver Variations of Prescription and Plan Evaluation within Heterogeneous Clinical Target Volume (CTV) Delineations among International Experts in Head and Neck Cancers
Location: Hall C
Presenter: Ugur Selek, MD, FASTRO, Prof. – Koc University School of Medicine
10:30 AM – 11:45 AM ET
3728 - Assessing the Relationship of Radiation Treatment Breaks with the COVID-19 Pandemic and Overall Survival
Location: Hall C
Presenter: Aaron Seo, MD, PhD – MD Anderson Cancer Center
10:30 AM – 11:45 AM ET
3729 - Impact of Titanium Plate Reconstruction and Dental Amalgam on Risk of Osteoradionecrosis in Oral Cavity Cancer Patients Receiving Intensity Modulated Radiation Therapy
Location: Hall C
Presenter: Aishwarya Shah, MD – NYU Langone Health
10:30 AM – 11:45 AM ET
3731 - Heart of Care: Embracing Grief and Growth in Oncology and Palliative Medicine
Location: Hall C
Presenter: Nandan Shanbhag, MD – Tawam Hospital
10:30 AM – 11:45 AM ET
3732 - Interstitial Brachytherapy in Early-Stage Oral Cavity Carcinomas
Location: Hall C
Presenter: DN Sharma, MD
10:30 AM – 11:45 AM ET
3733 - Neoadjuvant Chemotherapy plus Tislelizumab Followed by Adjuvant Tislelizumab for Locoregionally Advanced Nasopharyngeal Carcinoma: A Single-Arm, Phase II Trial
Location: Hall C
Presenter: sun shiran, MD – Cancer Institute and Hospital Chinese Acedemy of Medical Sciences
10:30 AM – 11:45 AM ET
3734 - Long-Term Treatment Outcomes and Late Toxicity between Childhood and Adult Nasopharyngeal Carcinoma in the Era of IMRT
Location: Hall C
Presenter: sun shiran, MD – Cancer Institute and Hospital Chinese Acedemy of Medical Sciences
10:30 AM – 11:45 AM ET
3735 - Kidney Cancer Patients Treatment Preferences for Localized Disease
Location: Hall C
Presenter: Samantha Sigurdson, MD – Hamilton Health Sciences
10:30 AM – 11:45 AM ET
3736 - Comparative Study to Assess the Quality of Life in Patients with Oral Cavity Cancer Treated with Adjuvant Radiation Therapy: Standard Intensity Modulated Radiotherapy vs. Dysphagia Optimized Intensity
Location: Hall C
Presenter: Pritanjali Singh, MBBS, DNB – All India Institute of Medical Sciences Patna
10:30 AM – 11:45 AM ET
3737 - Implications of the Primary Site and Additional Clinical Target Volume Margin in Target Volume Delineation for Intensity Modulated Radiation Therapy with Moderate Hypofractionation in Head Neck Cancer
Location: Hall C
Presenter: Shwetabh Sinha, MD, MBBS – ACTREC, TMC
10:30 AM – 11:45 AM ET
3738 - Endoscopic NBI Combined with MRI to Guide the Individualized Clinical Target Volume Delineation in Eccentric Nasopharyngeal Carcinoma
Location: Hall C
Presenter: Yunrui Song, MBBS – Chongqing University Cancer Hospital
10:30 AM – 11:45 AM ET
3739 - Dose-Volume Predictors of Late Dysphagia after Definitive Radiotherapy in Larynx and Pharynx Cancer
Location: Hall C
Presenter: Ji Soo Sung, MD – Seoul National University Hospital
10:30 AM – 11:45 AM ET
3740 - Two Years of Clinical Experience with Accelerator-Based Boron Neutron Capture Therapy for Head and Neck Cancer
Location: Hall C
Presenter: Satoshi Takeno, MD, PhD – Osaka Medical and Pharmaceutical University
10:30 AM – 11:45 AM ET
3741 - A Pilot Comparative Study of Mouthbite Devices and Their Effect on Patient Experience and Treatment Setup
Location: Hall C
Presenter: Wan Wei Tan, MS, RT – National Cancer Centre Singapore
10:30 AM – 11:45 AM ET
3742 - Boosting Antiproliferative Outcomes in Oral Cancer via Combined X-Ray and 6-n-butoxy-10-nitro-12,13-dioxa-11-azatricyclo[7.3.1.0^2,7]trideca-2,4,6,10-tetraene Therapy
Location: Hall C
Presenter: Jen-Yang Tang, MD, PhD – Kaohsiung Medical University Hospital
10:30 AM – 11:45 AM ET
3743 - A Prospective Cohort Study of Chemoradiotherapy with 1.8 Gy per Fraction for Hypopharyngeal Cancer
Location: Hall C
Presenter: Akito Taniguchi, MD – Mie University Hospital
10:30 AM – 11:45 AM ET
3744 - Predictive Decision Tree Modeling for Survival Outcomes in Metastatic Oropharyngeal Cancer Patients
Location: Hall C
Presenter: Abraham Arenas, MD – Baylor College of Medicine
10:30 AM – 11:45 AM ET
3745 - A Head and Neck Contour Grading System Provides an Objective Assessment of Radiation Oncology Resident Contouring Skills
Location: Hall C
Presenter: Diego Toesca, MD – Mayo Clinic Arizona
10:30 AM – 11:45 AM ET
3746 - Depth of Dose-Response for Patient-Reported Outcomes in Two Elective Neck Ee-Escalation Trials
Location: Hall C
Presenter: Anney Tuo, BA – UT Southwestern Medical Center
10:30 AM – 11:45 AM ET
3747 - Toxicity and Outcomes in Octogenarians Receiving Radiotherapy for Non-Melanoma Skin Cancer of the Head and Neck
Location: Hall C
Presenter: Adannia Ufondu, MD, BA – Cleveland Clinic
10:30 AM – 11:45 AM ET
3748 - Long-Term Tumor Outcomes in Patients with Head and Neck Cancer Treated with Avasopasem Manganese to Mitigate Severe Oral Mucositis: A Single Institution Retrospective Analysis
Location: Hall C
Presenter: Uwajachukwumma Uzomah, MD, MPH – University of Iowa Hospitals & Clinics
10:30 AM – 11:45 AM ET
3749 - Oral Squamous Cell Carcinoma Patients with Positive Cervical Nodes and Extracapsular Extension: A Real-World Data
Location: Hall C
Presenter: Rohit Vadgaonkar, MD – Homi Bhabha Cancer Hospital and Research Centre
10:30 AM – 11:45 AM ET
3750 - Advancing Image-Based Assessment of Long-Term Parotid-Gland Toxicity in Head and Neck Cancer Radiotherapy: Ultrasound Radiomics and Machine Learning
Location: Hall C
Presenter: Tian Liu, PhD – Icahn School of Medicine at Mount Sinai
10:30 AM – 11:45 AM ET
3751 - Radiotherapy in Addition to Immunotherapy-Based Systemic Therapy Delays Progression and Prolongs Survival in Recurrent Head and Neck Cancer
Location: Hall C
Presenter: Jingbo Wang, MD – Cancer Institute and Hospital Chinese Acedemy of Medical Sciences
10:30 AM – 11:45 AM ET
3752 - The Efficacy of PD-1 Inhibitor and Induction Chemotherapy Followed by Radical Radiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinomas
Location: Hall C
Presenter: Jingbo Wang, MD – Cancer Institute and Hospital Chinese Acedemy of Medical Sciences
10:30 AM – 11:45 AM ET
3753 - Deep Transfer Learning and Dosiomics for Predicting Radiation-Induced Temporal Lobe Injury in Nasopharyngeal Carcinoma
Location: Hall C
Presenter: Li Wang, MD, PhD, MS – Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research
10:30 AM – 11:45 AM ET
3754 - Proton Therapy for Oral Cavity Cancers: A Dosimetric Comparison of Patients Enrolled on Trial of Hypofractionation
Location: Hall C
Presenter: Jessica Wilson, MD, PhD – Mayo Clinic Rochester
10:30 AM – 11:45 AM ET
3755 - Incidence and Outcome of Non-Malignant Pharyngeal Ulceration Following Definitive (Chemo)Radiation in Oropharyngeal Squamous Cell Carcinoma (SCC)
Location: Hall C
Presenter: Neil Woody, MD, MS – Cleveland Clinic
10:30 AM – 11:45 AM ET
3756 - Emergency Room (ER) Utilization Rate Among Patients with HPV related Oropharynx Cancer Undergoing Radiation De- Escalation
Location: Hall C
Presenter: Yingzhi Wu, MSN – Memorial Sloan Kettering Cancer Center
10:30 AM – 11:45 AM ET
3757 - Individualized CTV Delineation Method for Nasopharyngeal Carcinoma Based on Safe Distance Expansion from Primary Tumor: A Preliminary Efficacy Report from a Prospective Observational Study
Location: Hall C
Presenter: Zheng Wu, MD
10:30 AM – 11:45 AM ET
3758 - Efficacy of Postoperative Radiotherapy Following Induction Immunochemotherapy and Surgical Resection in Locally Advanced Head and Neck Squamous Cell Carcinoma
Location: Hall C
Presenter: Yi Xu, MD – National Cancer Center CAMS & PUMC
10:30 AM – 11:45 AM ET
3759 - MRI-Based Quantification of Intratumoral Heterogeneity in Locally Advanced Nasopharyngeal Carcinoma
Location: Hall C
Presenter: Ge Yan, MD, PhD – Shanghai General Hospital, Shanghai Jiaotong University
10:30 AM – 11:45 AM ET
3760 - Anatomical and Dosimetric Variations during VMAT in Patients with Locally Advanced Nasopharyngeal Carcinoma after Induction Therapy: Implications for Adaptive Radiation Therapy
Location: Hall C
Presenter: Kunyu Yang, MD, DSc, PhD – Union Hospital Cancer Center, Tongji Medical College, HUST
10:30 AM – 11:45 AM ET
3761 - Optimal Target-Specific PTV Margins for Nasopharyngeal Carcinoma Radiotherapy with Daily FBCT Guidance
Location: Hall C
Presenter: Yu-Xian Yang, MD – Sun Yat-Sen University Cancer Center
10:30 AM – 11:45 AM ET
3762 - Taste Changes in Patients Receiving Head and Neck Radiation - Initial Analysis from a Prospective Study
Location: Hall C
Presenter: Sreenija Yarlagadda, MD – Miami Cancer Institute
10:30 AM – 11:45 AM ET
3764 - Improvements in Imaging Appear to Increase the Association between the Rates of Synchronous and Metachronous Metastases in Patients with Cancer
Location: Hall C
Presenter: Lawrence Marks, MD, FASTRO – UNC School of Medicine
10:30 AM – 11:45 AM ET
3765 - Multimodal Magnetic Resonance-Based Clinicoradiomics for Predicting Suspicious Lymph Node Metastasis in Nasopharyngeal Carcinoma
Location: Hall C
Presenter: Jun Yin, MD – Sichuan Cancer Hospital and Institute
10:30 AM – 11:45 AM ET
3766 - Proton Therapy for Head/Neck Adenoid Cystic Carcinoma (ACC)
Location: Hall C
Presenter: Irini Youssef, MD – Memorial Sloan Kettering Cancer Center
10:30 AM – 11:45 AM ET
3767 - Evaluation of the ESMO-Magnitude of Clinical Benefit Scale Version 1.1 (ESMO-MCBS v.1.1) for the Treatment of Extracranial Oligometastatic Non-Small Cell Lung Cancer with Radiosurgery
Location: Hall C
Presenter: James Yu, MD, FASTRO, MHS – Connecticut Radiation Oncology, PC
10:30 AM – 11:45 AM ET
3768 - Outcomes of Reduced Elective Nodal Radiation Dose for Laryngeal, Hypopharyngeal and p16 Negative Oropharyngeal Cancers
Location: Hall C
Presenter: Kaveh Zakeri, MD, MAS – Memorial Sloan Kettering Cancer Center
10:30 AM – 11:45 AM ET
3769 - Exploring the Role of Serum Uric Acid as a Potential Biomarker in Nasopharyngeal Carcinoma: A Retrospective Study Post-Adjuvant Chemotherapy
Location: Hall C
Presenter: Lei Zeng, MD – The Second Affiliated Hospital of Nanchang University
10:30 AM – 11:45 AM ET
3770 - Theoretical Research on Temporal Lobe Injury after Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma Using Machine Learning Approach and its Clinical Application
Location: Hall C
Presenter: Lei Zeng, MD – The Second Affiliated Hospital of Nanchang University
10:30 AM – 11:45 AM ET
3771 - The Efficacy and Safety Profile of PRaG "Therapy" in Geriatric Patients with Advanced Refractory Solid Malignant Tumors
Location: Hall C
Presenter: Xiangrong Zhao, MS – The Second Affiliated Hospital of Soochow University
10:30 AM – 11:45 AM ET
3772 - Dosimetric Benefit of Online Adaptive Radiotherapy for Nasopharyngeal Carcinoma
Location: Hall C
Presenter: Guan-Qun Zhou, MD, PhD – Sun Yat-Sen University Cancer Center